Sogen Data · Datasets · 数据专题
心力衰竭数据集锦
空转 · bulk · sc
本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。
人源单细胞
Human · Single-cell
-
01 GSE145154 对正常和心力衰竭人类心脏进行单细胞RNA测序,分离心肌组织中的CD45-细胞与外周血中的CD45+免疫细胞,同时采集左心室非梗死/梗死心肌及不同疾病类型(扩张型/缺血型心肌病)的组织样本,采用3'和5' scRNA-seq技术检测转录组特征,并通过bulk RNA-seq验证结果。
设计对正常和心力衰竭人类心脏进行单细胞RNA测序,分离心肌组织中的CD45-细胞与外周血中的CD45+免疫细胞,同时采集左心室非梗死/梗死心肌及不同疾病类型(扩张型/缺血型心肌病)的组织样本,采用3'和5' scRNA-seq技术检测转录组特征,并通过bulk RNA-seq验证结果。
摘要we performed single cell RNA sequencing (scRNA-seq) in both normal and failed human heart. CD45- cells in the myocardium and immune cells (CD45+ cells) were isolated from myocardium and corresponding peripheral blood were sorted for scRNA-seq. Our findings were also validated with bulk RNAseq.
-
02 GSE183852 对人类心力衰竭患者及健康供体的Transmural LV Apex组织进行单细胞和单核RNA测序,比较疾病组与健康组的转录特征差异。
设计对人类心力衰竭患者及健康供体的Transmural LV Apex组织进行单细胞和单核RNA测序,比较疾病组与健康组的转录特征差异。
摘要Heart failure represents a major cause of morbidity and mortality worldwide. Single cell transcriptomics have revolutionized our understanding of cell composition and associated gene expression across human tissues. Through integrated analysis of single cell and single nucleus RNA sequencing data generated from 45 individuals, we define the cell composition of the healthy and failing human heart. We identify cell specific transcriptional signatures of heart failure and reveal the emergence of disease associated cell states. Intriguingly, cardiomyocytes converge towards a common disease associated cell state, while fibroblasts and myeloid cells undergo dramatic diversification. Endothelial cells and pericytes display global transcriptional shifts without changes in cell complexity. Collectively, our findings provide a comprehensive analysis of the cellular and transcriptomic landscape of human heart failure, identify cell type specific transcriptional programs and states associated with disease, and establish a valuable resource for the investigation of human heart failure.
-
03 GSE226314 对接受左心室辅助装置(LVAD)植入的心力衰竭患者(恢复组与非恢复组)的术前术后心脏组织样本,以及健康供体的心脏组织,进行单核RNA测序,比较恢复组与非恢复组在术前术后及与供体的转录特征差异。
设计对接受左心室辅助装置(LVAD)植入的心力衰竭患者(恢复组与非恢复组)的术前术后心脏组织样本,以及健康供体的心脏组织,进行单核RNA测序,比较恢复组与非恢复组在术前术后及与供体的转录特征差异。
摘要Recovery of cardiac function is the ultimate goal of heart failure therapy yet is infrequently observed and remains poorly understood. Here we characterize the cellular landscape and predictors of cardiac recovery by performing single nucleus RNA-sequencing (snRNA-seq) from 40 heart failure patients who recovered LV systolic function following left ventricular assist device (LVAD) implantation and patients who did not recover and non-diseased donors. We identify cell type specific transcriptional signatures of recovery in all cell types, most prominently in macrophages and fibroblasts. Pro-inflammatory macrophages and inflammatory signalling in fibroblasts were negative predictors of recovery, while downregulation of RUNX1 transcriptional activity in macrophages and fibroblasts was associated with recovery. In silico perturbation of RUNX1 in macrophages and fibroblasts recapitulated the transcriptional state of recovery. In a mouse model of cardiac recovery mediated by BRD4 inhibition, we observed a decrease in macrophage and fibroblast Runx1 expression, diminished chromatin accessibility within a Runx1 intronic peak, and acquisition of human recovery signatures. These findings suggest that cardiac recovery is a unique biological state and identify RUNX1 as a possible therapeutic target to facilitate cardiac recovery.
-
04 GSE292067 对人类左心室心肌组织进行单核 RNA 测序,比较多柔比星诱导心力衰竭(DoxCM)与非心力衰竭供体(Donor)及非缺血性心肌病(NICM)的转录特征。按总单位数与组数估计,每组约 8-9 个样本。
设计对人类左心室心肌组织进行单核 RNA 测序,比较多柔比星诱导心力衰竭(DoxCM)与非心力衰竭供体(Donor)及非缺血性心肌病(NICM)的转录特征。按总单位数与组数估计,每组约 8-9 个样本。
摘要Doxorubicin cardiomyopathy (DoxCM) remains a significant clinical problem, yet its underlying mechanisms remain incompletely understood. Identifying DoxCM mechanisms that can be translated into therapeutic interventions may improve patient outcomes. We performed single nuclear RNA-sequencing on left ventricular (LV) myocardial tissue from patients with DoxCM versus non-ischemic cardiomyopathy and non-failing donors. This approach aimed to elucidate the transcriptional changes associated with DoxCM. Additionally, we conducted immunostaining, flow cytometry, antibody neutralization, and cell depletion studies to validate our findings and define in vivo mechanisms.Compared to both donors and non-ischemic cardiomyopathy, LV myocardium from DoxCM patients exhibited increased periostin-positive (POSTN+) activated fibroblasts, down-regulation of genes involved in phagocytosis, and increased expression of the anti-phagocytic molecule CD47. Immunostaining of human cardiac sections and murine studies demonstrated increased POSTN+ cells and CD47 in DoxCM and in a murine breast cancer model. CD47 antibody neutralization both prevented and treated Dox-induced reduction in LV ejection fraction and fibrosis. Mechanistically, depletion of resident cardiac macrophages blocked the cardioprotective effects of CD47 neutralization and clearance of cardiac fibroblasts. Our data support CD47 as a disease-specific target and promising therapeutic approach for mitigating cardiac dysfunction in DoxCM
-
05 GSE298023 对非心力衰竭供体及心力衰竭患者(包括缺血性心肌病非瘢痕、缺血性心肌病瘢痕和扩张性心肌病)的左心室组织进行单核 RNA 测序与空间转录组学分析,比较不同组别成纤维细胞的激活状态、转录轨迹及空间分布差异。
设计对非心力衰竭供体及心力衰竭患者(包括缺血性心肌病非瘢痕、缺血性心肌病瘢痕和扩张性心肌病)的左心室组织进行单核 RNA 测序与空间转录组学分析,比较不同组别成纤维细胞的激活状态、转录轨迹及空间分布差异。
摘要Cardiac fibrosis is a major contributor to heart failure (HF), yet its therapeutic targeting remains limited due to the complexity of fibrosis types and distributions. This study investigates fibroblast heterogeneity and spatial organization in the left ventricle of human hearts from non-failing donors and HF patients with ischemic or dilated cardiomyopathy. Using single-nucleus RNA sequencing and spatial transcriptomics, distinct fibroblast subpopulations were identified, with resident fibroblasts being depleted in HF and replaced by disease-associated states. Differences in activation ligands, transcriptional trajectories, and spatial localization revealed divergent fibroblast transitions between scar and interstitial fibrosis, and between HF subtypes. These results provide insight into fibroblast dynamics and offer potential targets to modulate fibrosis in heart failure.
-
06 GSE349244 对人类心力衰竭患者单心室组织进行单核 RNA 测序,分析非失败(NF)与失败(SysHF)单心室样本中成纤维细胞和心内膜细胞的转录变化,比较两组间差异;同时将 HLHS 数据与成人人类和小鼠右心室衰竭数据进行参考映射,比较不同条件下的细胞类型和基因表达特征。
设计对人类心力衰竭患者单心室组织进行单核 RNA 测序,分析非失败(NF)与失败(SysHF)单心室样本中成纤维细胞和心内膜细胞的转录变化,比较两组间差异;同时将 HLHS 数据与成人人类和小鼠右心室衰竭数据进行参考映射,比较不同条件下的细胞类型和基因表达特征。
摘要Hypoplastic left heart syndrome (HLHS) is a congenital heart defect characterized by impaired development of the left ventricle, often managed through surgical palliation creating a single ventricle (SV). Failure of the anatomical right ventricle (RV) represents a common complication with high mortality. We used single-nucleus RNA sequencing to generate a map of the pediatric non-failing (NF) and failing (SysHF) SV. Fibroblasts and endocardial cells displayed the greatest transcriptional shifts between NF and SysHF. Notably, activated fibroblasts expanded in SysHF, and endocardial cells demonstrated a pro-fibrotic shift in SysHF samples. Ligand-target analysis predicted disease-state specific signaling from CCN2 expressing endocardial cells to fibroblasts in SysHF. In silico perturbation predicted FOS and JUN as regulators of fibroblast activation and endocardial pathogenesis. Finally, HLHS data was compared to adult human and murine RV failure to gain insight into shared pathological processes and the suitability of current animal models. These findings provide a foundational reference of SV and implicate cell non-autonomous signaling between endocardial cells and fibroblasts as drivers of SV systolic heart failure.
-
07 GSE288222 对12例冷冻成人左心室样本(6例非疾病组,6例缺血性心肌病组)进行单核纳米孔RNA测序,分析细胞类型特异性基因的剪接异构体差异。比较正常与心力衰竭样本的剪接模式变化,揭示异构体在心脏细胞中的表达特征及疾病相关差异。
设计对12例冷冻成人左心室样本(6例非疾病组,6例缺血性心肌病组)进行单核纳米孔RNA测序,分析细胞类型特异性基因的剪接异构体差异。比较正常与心力衰竭样本的剪接模式变化,揭示异构体在心脏细胞中的表达特征及疾病相关差异。
摘要BACKGROUND: Alternative splicing plays crucial roles in normal heart development and cardiac disease by influencing protein-coding sequences, functional domains, and molecular networks. However, a detailed characterization of the human heart isoform landscape remains incomplete. METHODS: Leveraging long-read single-nucleus RNA sequencing and computational analysis, we dissected full-length isoform heterogeneities, expression patterns, and usage shifts across cell types, cell states, and cardiac conditions of the adult left ventricle. We applied in silico approaches to assess the functional relevance of identified isoforms; validated isoform compositions of representative cardiac genes using reverse transcription quantitative polymerase chain reaction and targeted amplicon sequencing; and developed a web server for interactive navigation of our results. RESULTS: The data revealed that isoform heterogeneity is widespread in the cardiac cellular system, serving as a posttranscriptional buffer system that calibrates the molecule reservoirs in human hearts. In healthy left ventricles, ≈30% of cell type–specific genes were polyform, using multiple isoforms tailored to cell type–specific programs. Among ubiquitously expressed genes, >300 showed differential isoform usage with cell type specificity. Compared with heart failure, 379 genes in cardiomyocytes demonstrated marked isoform usage shifts, most of which are predicted to change protein coding outcomes through direct changes in protein coding sequences and switches between intron retention and non–protein-coding biotypes. In contrast, cell state–specific programs tend to operate on monoform genes associated with changes among cell states. In addition, our data revealed heart failure–associated differential isoform usage events in stromal and immune cell types in the cardiac microenvironment. CONCLUSIONS: We present a comprehensive atlas of splicing isoforms in the normal adult heart and heart failure through long-read single-nucleus RNA sequencing and comprehensive computational analyses. The results suggest crucial roles of isoforms in buffering core cellular programs and contributing to disease-associated cell states. The full-length details of these cell-specific isoforms serve as an important reference for downstream translational and mechanistic studies and are available on our online data portal at https://github.com/gaolabtools/heart-isoform-atlas. Github repo: https://github.com/gaolabtools/heart-isoform-atlas doi: 10.1161/CIRCULATIONAHA.125.074959
-
08 GSE247468 对人类心脏组织进行消化分选活细胞,采集总非心肌细胞进行单细胞RNA测序,比较正常心脏与心力衰竭伴随高血脂及高血压的样本转录组差异。
设计对人类心脏组织进行消化分选活细胞,采集总非心肌细胞进行单细胞RNA测序,比较正常心脏与心力衰竭伴随高血脂及高血压的样本转录组差异。
摘要Hyperlipidaemia and hypertension might play a role in cardiac fibrosis, in which a heterogeneous population of fibroblasts seems important. The study aimed to explore the mechanism of fibroblasts in cardiac fibrosis during hyperlipidaemia.
-
09 GSE302337 对人类心力衰竭患者和心脏功能保持患者的心脏组织进行单核 RNA 测序,比较两组心脏成纤维细胞的转录特征。样本来自植入左心室辅助装置的心力衰竭患者及接受尸检的对照患者,共 6 个 GSM 样本。
设计对人类心力衰竭患者和心脏功能保持患者的心脏组织进行单核 RNA 测序,比较两组心脏成纤维细胞的转录特征。样本来自植入左心室辅助装置的心力衰竭患者及接受尸检的对照患者,共 6 个 GSM 样本。
摘要Heart failure (HF) is a major global problem with increasing numbers of patients and deaths in many countries. Existing studies on HF have focused primarily on cardiomyocytes, with few studies targeting non-cardiomyocytes. This study focused on cardiac fibroblasts (CFs) as a cause of HF. Single-cell RNA sequencing of mouse hearts revealed six distinct subclusters of CFs at various stages after pressure overload, with one subcluster being specific to the HF stage. The transcription factor c-Myc is specifically expressed in HF-specific CFs. CFs-specific deletion of c-Myc ameliorates pressure overload-induced cardiac dysfunction without affecting fibrosis. The chemokine Cxcl1 is highly expressed in HF-specific CFs and downregulated in CFs-specific c-Myc knockout mice. Chromatin immunoprecipitation analysis revealed that c-Myc binds to the promoter region of Cxcl1 in CFs. Cxcr2, the receptor for Cxcl1, is expressed in cardiomyocytes, and blockade of the Cxcl1-Cxcr2 signalling pathway prevents pressure overload-induced cardiac dysfunction. The addition of CXCL1 reduces the contractility of cardiomyocytes of neonatal rats and human iPS-derived cardiomyocyte organoids. Human CFs from failing hearts expressed c-MYC and CXCL1, while CFs from control hearts did not. These findings suggest that HF-specific CFs play an important role in inducing HF by upregulating c-Myc and Cxcl1 and that CFs could be a novel therapeutic target for HF.
人源空转
Human · Spatial
-
01 GSE310386 对8例人类心脏移植后组织进行Xenium in situ空间转录组学检测,分析心力衰竭患者中存在口腔炎症与不存在口腔炎症的两组间CD4 T细胞谱型差异。研究对象为移植后心脏组织,检测材料包含polyA RNA,采用Xenium Onboard Analysis解码转录本,比较有/无口腔炎症状态下的CD4 T细胞分布特征。
设计对8例人类心脏移植后组织进行Xenium in situ空间转录组学检测,分析心力衰竭患者中存在口腔炎症与不存在口腔炎症的两组间CD4 T细胞谱型差异。研究对象为移植后心脏组织,检测材料包含polyA RNA,采用Xenium Onboard Analysis解码转录本,比较有/无口腔炎症状态下的CD4 T细胞分布特征。
摘要The link between poor oral health and heart failure progression has long been recognized but remains limited to epidemiological associations without mechanistic understanding. Here, we performed Xenium in situ on heart tissue post-transplantation to detect CD4 T-cells that generated in inflamed gingiva during periodontal diseases.
人源bulk 转录组
Human · Bulk RNA-seq
-
01 GSE57338 对心力衰竭患者和健康个体的左心室组织进行 RNA-Seq 分析,识别其基因表达特征;随后利用 Affymetrix 微阵列对 313 名有/无心力衰竭的个体进行验证,比较心力衰竭与非心力衰竭状态下的基因表达差异。
设计对心力衰竭患者和健康个体的左心室组织进行 RNA-Seq 分析,识别其基因表达特征;随后利用 Affymetrix 微阵列对 313 名有/无心力衰竭的个体进行验证,比较心力衰竭与非心力衰竭状态下的基因表达差异。
摘要We have utilized the RNA-Seq technology to identify genes with distinct expression patterns between failing and non-failing hearts. In an era of next-generation sequencing studies, our study demonstrates how knowledge gained from a small set of samples with accurately measured gene expressions using RNA-Seq can be leveraged as a complementary strategy to discern the genetics of complex disorders.
-
02 GSE5406 研究对象为晚期缺血性心肌病患者、晚期特发性心肌病患者及非衰竭供体心脏,采集自心脏移植或未使用供体,采用液氮快速冷冻保存,提取总RNA进行基因表达分析,比较不同疾病类型与非衰竭对照组的基因表达差异。
设计研究对象为晚期缺血性心肌病患者、晚期特发性心肌病患者及非衰竭供体心脏,采集自心脏移植或未使用供体,采用液氮快速冷冻保存,提取总RNA进行基因表达分析,比较不同疾病类型与非衰竭对照组的基因表达差异。
摘要Left ventricular myocardium was snap-frozen at time of cardiac transplantation from patients with advanced idiopathic or ischemic cardiomyopathy, or at time of harvest from unused donor heart that serve as a nonfailing control. No subjects received mechanical support devices. Keywords: disease state analysis (case:control)
-
03 GSE150736 对31例人类心脏样本进行CAGE测序,样本包括右心房、左心房、右心室、左心室、sSAN和iSAN,分为健康状态与心衰状态(failing_ICM/failing_NICM/failing_NICM-HFpEF/failing_NICM-Genetic)。采用Illumina HiSeq2500平台对CAGE文库进行高通量测序,通过信号聚类识别65,458个CAGE峰,比较健康与心衰状态下调控元件的表达差异。
设计对31例人类心脏样本进行CAGE测序,样本包括右心房、左心房、右心室、左心室、sSAN和iSAN,分为健康状态与心衰状态(failing_ICM/failing_NICM/failing_NICM-HFpEF/failing_NICM-Genetic)。采用Illumina HiSeq2500平台对CAGE文库进行高通量测序,通过信号聚类识别65,458个CAGE峰,比较健康与心衰状态下调控元件的表达差异。
摘要In this work we present atlas of human cardiac regulatory elements defined by CAGE (cap analysis of gene expression) technique. The dataset includes right and left atria and ventricles form both healthy and failing samples. The deep sequencing of CAGE libraries on Illumina HiSeq2500, mapping, and signal clustering resulted in identification of 65,458 CAGE peaks, from which 55,204 were robust decomposition peak identifiers (DPIs) and 10,254 bidirectional enhancers. We created comprehensive classification of the peaks by applying machine learning along with annotation from available databases containing cardiac data. Identified CAGE peaks were arranged into non-overlapping 400 bp consensus clusters. Our classification method determined 17,668 promoters and 14,920 enhancers active in the human heart. Differential expression analysis revealed regulatory elements activated or inactivated in healthy or failing states. About 10% of heart related GWAS SNPs were found to be located around heart CAGE clusters. The library of cardiac promoters and enhancers is available in Zenbu reports for browsing and visualization. Superior and inferior sinoatrial node samples are labeled as sSAN and iSAN, respectively.
-
05 GSE161472 对人类心脏四个腔室(右心室、左心室、右心房、左心房)的样本进行RNA-Seq测序,将非心衰(NF)供体心脏(n=10)与心衰伴射血分数降低(HFrEF)患者心脏(n=12)的相应腔室组织分别采集,比较两组间基因表达差异。
设计对人类心脏四个腔室(右心室、左心室、右心房、左心房)的样本进行RNA-Seq测序,将非心衰(NF)供体心脏(n=10)与心衰伴射血分数降低(HFrEF)患者心脏(n=12)的相应腔室组织分别采集,比较两组间基因表达差异。
摘要Heart failure with reduced ejection fraction (HFrEF) constitutes 50% of HF hospitalizations and is characterized by high rates of mortality. To explore the underlying mechanisms of HFrEF etiology and progression, we studied the molecular and cellular differences in four chambers of non-failing (NF, n=10) and HFrEF (n=12) human hearts. This study contributes to a growing body of knowledge describing chamber-specific heart transcriptomics and revealed genes and pathways that are associated with heart failure pathophysiology, which may aid in therapeutic target discovery.
-
06 GSE19303 对扩张型心肌病(DCM)患者在免疫吸附联合免疫球蛋白替代治疗(IA/IgG)前后的左心室射血分数(LVEF)和左心室舒张末径(LVDD)进行检测,采集心内膜活检样本进行转录组和蛋白质组分析,比较治疗应答者与非应答者在基因表达和蛋白水平上的差异。
设计对扩张型心肌病(DCM)患者在免疫吸附联合免疫球蛋白替代治疗(IA/IgG)前后的左心室射血分数(LVEF)和左心室舒张末径(LVDD)进行检测,采集心内膜活检样本进行转录组和蛋白质组分析,比较治疗应答者与非应答者在基因表达和蛋白水平上的差异。
摘要Immunoadsorption with subsequent immunoglobulin substitution (IA/IgG) represents a therapeutic approach for patients with dilated cardiomyopathy (DCM). Here, we studied which molecular cardiac alterations are initiated after this treatment. Transcription profiling of endomyocardial biopsies with Affymetrix whole genome arrays was performed on 33 paired samples of DCM patients collected before and six months after IA/IgG. Therapy-related effects on myocardial protein levels were analysed by label free proteome profiling for a subset of 23 DCM patients. Data were analysed regarding therapy-associated differences in gene expression and protein levels by comparing responders (defined by improvement of left ventricular ejection fraction ≥ 20% relative and ≥5% absolute) and non-responders. Responders to IA/IgG showed a decrease in serum N-terminal proBNP levels in comparison to baseline which was accompanied by a decreased expression of heart failure markers such as angiotensin converting enzyme 2 or periostin. However, despite clinical improvement even in responders IA/IgG did not trigger general inversion of DCM associated molecular alterations in myocardial tissue. Transcriptome profiling revealed reduced gene expression for connective tissue growth factor, fibronectin, and collagen type I in responders. In contrast, in non-responders after IA/IgG, for fibrosis associated genes and proteins showed elevated levels whereas values were reduced or maintained in responders. Thus, improvement of LV function after IA/IgG seems to be related to a reduced gene expression of heart failure markers and pro-fibrotic molecules as well as reduced fibrosis progression.
-
07 GSE116250 对人类左心室组织进行 polyA 富集 RNA-seq,样本包含 14 例非心衰供体、37 例扩张型心肌病及 13 例缺血型心肌病,比较不同疾病类型间的基因表达差异。
-
08 GSE135055 收集21例心力衰竭(HF)患者与9名健康供体的左心室心肌组织,进行RNA-Seq和miRNA-Seq分析。通过Masson染色计算纤维化百分比,采用Lasso回归模型识别与纤维化相关的基因,并在相同队列及独立队列(20例HF患者与9名健康供体)中通过免疫组化(IHC)和qRT-PCR验证。同时使用酶联免疫吸附测定(ELISA)检测87例HF患者血浆中COL1A1含量,比较HF患者与健康供体的转录组差异及血浆COL1A1水平与生存率的关系。
设计收集21例心力衰竭(HF)患者与9名健康供体的左心室心肌组织,进行RNA-Seq和miRNA-Seq分析。通过Masson染色计算纤维化百分比,采用Lasso回归模型识别与纤维化相关的基因,并在相同队列及独立队列(20例HF患者与9名健康供体)中通过免疫组化(IHC)和qRT-PCR验证。同时使用酶联免疫吸附测定(ELISA)检测87例HF患者血浆中COL1A1含量,比较HF患者与健康供体的转录组差异及血浆COL1A1水平与生存率的关系。
摘要Background: Heart failure (HF) has been recognized as global pandemic with a high rate of associated hospitalization, morbidity and mortality. Although numerous advances have been made, its representative molecular signatures remain largely unknown, especially the role of genes in HF progression. The aim of the present prospective follow-up study was to reveal potential biomarkers associated with the progression of heart failure. Methods: We collected left ventricular heart tissue from 21 HF patients and 9 healthy donors as study cohort and generated multi-level transcriptomic data. By using Masson staining to calculate the fibrosis percentage for each sample, we applied lasso regression model to identify the genes associated with fibrosis as well as progression. The genes were further validated by immunohistochemistry (IHC) staining in the same cohort and qRT-PCR using another independent cohort (20 HF and 9 healthy donors). Enzyme linked immunosorbent assay (ELISA) was used to measure the plasma level in validation cohort (87 HF patients) for predicting HF progression. Results: Based on the multi-level transcriptomic data, we examined differentially expressed genes [mRNAs, microRNAs, and long non-coding RNAs (lncRNAs)] in study cohort. The follow-up functional annotations and regulatory network reveal their potential roles in regulating extracellular matrix. We further identified several genes that were associated with fibrosis. By using the survival time before transplantation, COL1A1 was identified as a potential biomarker for HF progression and its up-regulation was confirmed by both IHC and qRT-PCR. Furthermore, COL1A1 content >281.7 ng/ml in plasma was found to be associated with poor survival within one year of heart transplantation from heart failure [Hazard Ratio (HR): 27.52, 95% Confidence Interval (CI): 7.474 to 101.3, Log-rank p-value<1.0×10-4]. Conclusions: Our results suggested that COL1A1 is a plasma biomarker of HF and associated with HF progression, especially to predict the 1-year survival from HF onset to transplantation.
-
09 GSE245825 对58例扩张型心肌病患者右心室间隔组织进行RNA测序,与12例非心衰左心室样本的公开转录组数据进行比较,分析基因表达特征与心脏纤维化的关系。
设计对58例扩张型心肌病患者右心室间隔组织进行RNA测序,与12例非心衰左心室样本的公开转录组数据进行比较,分析基因表达特征与心脏纤维化的关系。
摘要Dilated cardiomyopathy (DCM) represents a leading cause of heart failure among younger adults. Despite endomyocardial biopsy (EMB) transcriptome enriching our understanding of DCM, the link between its gene expression and phenotype remains unclear. RNA-seq analysis of 58 DCM samples and 12 publicly available control samples unveiled about 25,000 transcripts. A principal component analysis highlighted a distinct DCM-control separation. WGCNA revealed four transcriptome modules strongly associated with DCM. The purple module, which is the DCM-related module, was enriched with fibrosis-related genes and showed FSTL3 as a pivotal DCM-associated gene.
-
10 GSE120895 对47例符合纽约心功能分级II/III类且左室射血分数(LVEF)<45%的扩张型心肌病(DCM)患者与8名正常LVEF个体的人类心内膜活检样本进行基因表达分析,检测基因表达模式与心脏形态参数(左室舒张末期内径指数LVEDDI)、收缩功能(LVEF)及血清心钠素前体肽激素NT-proBNP水平的线性相关性。研究通过Affymetrix Power Tools基于MAS5算法计算表达摘要,采用几何平均值处理P值,比较两组间基因表达与临床参数的关联。
设计对47例符合纽约心功能分级II/III类且左室射血分数(LVEF)<45%的扩张型心肌病(DCM)患者与8名正常LVEF个体的人类心内膜活检样本进行基因表达分析,检测基因表达模式与心脏形态参数(左室舒张末期内径指数LVEDDI)、收缩功能(LVEF)及血清心钠素前体肽激素NT-proBNP水平的线性相关性。研究通过Affymetrix Power Tools基于MAS5算法计算表达摘要,采用几何平均值处理P值,比较两组间基因表达与临床参数的关联。
摘要To gain new insights into the complex pathophysiology of dilated cardiomyopathy (DCM) we performed a quantitative approach to identify genes with expression patterns that linearly correlate with parameters of cardiac morphology (left ventricular end-diastolic diameter indexed by body surface are (LVEDDI), systolic function (LV ejection fraction (LVEF)), and serum levels of cardiac peptide hormone N-terminal pro-brain natriuretic peptide (NT-proBNP) in human endomyocardial biopsies of 47 DCM patients and 8 individuals with normal LVEF. A set of genes was identified as common heart failure markers characterized by correlation of their expression with cardiac morphology, systolic function and NT-proBNP. Among them are already known genes encoding e.g. the natriuretic peptide hormones NPPA and NPPB and its converting enzyme corin, but also potential new HF markers like EP300 antisense RNA1 and dimethylarginine dimethylaminohydrolase 1 (DDAH1) along with other genes with so far unknown relation to heart function. In contrast, the expression of other genes including the Ca2+ flux regulating genes phospholamban (PLN), sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA), and extracellular matrix proteins showed significant correlation with LVEF and LVEDDI only. Those genes seem to reflect more specifically pathological alterations of systolic function and morphology in DCM hearts.
-
11 GSE2656 对不同病因的 49 例人类心力衰竭左室样本与 8 例非疾病左室样本进行基因表达分析,采用 CardioChip 平台检测 LIM 域蛋白及 Homer 蛋白基因表达变化,比较各心力衰竭类型与供体心脏间的差异,识别普遍性或特异性表达改变。
设计对不同病因的 49 例人类心力衰竭左室样本与 8 例非疾病左室样本进行基因表达分析,采用 CardioChip 平台检测 LIM 域蛋白及 Homer 蛋白基因表达变化,比较各心力衰竭类型与供体心脏间的差异,识别普遍性或特异性表达改变。
摘要The goal of this experiment was to identify gene expression changes that are common in different heart failure (HF) types or specific to an etiology of HF. HF groups studied include doxorubicin induced cardiomyopathy, familial dilated cardiomyopathy, hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, ischemic heart disease, peripartum cardiomyopathy, and viral induced cardiomyopathy. Non-diseased left ventricles (LV) were obtained from donor hearts not used for transplantation (these were considered to be unsuitable for transplantation for a variety of reasons including the lack of a tissue-compatible recipient). Failing LV were obtained from patients undergoing heart transplantation. Transmural sections of LV anterior free wall were trimmed of fat, dissected into 1-1.5 gm pieces, and immediately frozen in the operating theater. 100-200 mg of frozen transmural LV was ground to a fine powder in liquid nitrogen using a mortar and pestle. Then total RNA was isolated by a method described by Wei and Khan (A Molecular Cloning Manual). The purity of the RNA extract was assessed by measuring the absorbance at 260 nm and 280 nm. Its quantity and integrity was then examined using RNA Nano Chips on a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). 10 ?g of RNA extracts and a universal human reference RNA (Stratagene, La Jolla, CA, USA) were reverse transcribed with Cy3-dUTP and Cy5-dUTP, respectively, to produce labeled cDNA probes using Thermoscript reverse transcriptase according Hwang JJ et. al. (Physiological Genomics 10: 31-44, 2002). Raw scanned images were processed using ScanAlyze version 2.50 (Michael Eisen, Stanford University, CA, USA). Cy3 and Cy5 scans were superimposed, local backgrounds were subtracted, and the fluorescence intensities of each spot were quantified. All further analyses of CardioChips were done using GeneSpring version 6.1 (Silicon Genetics, Redwood City, CA, USA). The data from each array was normalized first to the reference RNA and then a LOWESS curve was fit to the log-intensity versus log-ratio plot for each array and for each gene across all experiments. 40.0% of the data was used to calculate the LOWESS fit at each point. Differentially expressed genes in each HF group compared to donor hearts were identified by a one-way ANOVA test (P <0.05) with the benjamini and hochberg multiple testing corrections and we selected those genes with an average difference greater than 1.5 fold. A hierarchical clustering analysis was performed using pearson correlation with the separation ratio of 1.0 and minimum distance of 0.001 as similarity measure. Using a cardiovascular-specific gene array (CardioChip) of 42 heart failure (HF) patients from a wide range of etiology groups and 8 non-failing donors, we have identified down-regulation of LIM domain protein which may be an important pathway for the clinical progression of HF. We identified six genes, encoding LIM domain and Homer proteins, that are down-regulated in terminally failing hearts. The LIM and cysteine rich domain 1 (LMCD1) gene, in particular, was significantly down-regulated in all HF samples. This novel finding suggests that the LMCD 1 is a universal biomarker for end-stage HF. Other LIM domain genes were also down-regulated but only in non-familial dilated forms of cardiomyopathy. This is probably due to the fact that down-regulation of LIM protein expression may disrupt the cytoskeletal architecture, leading to dilated cardiomyopathy. In addition to identifying the LIM domain genes as possible regulatory genes involved in HF, we also demonstrated that the gene expression profile was able to classify multiple HF patients groups. This paper is the first to examine viral-induced cardiomyopathy, doxorubicin toxicity cardiomyopathy and perimartum cardiomyopathy and to perform the clustering analysis of those HF types providing new insights into human HF. Keywords: other
-
12 GSE198945 对缺血性非终末期心力衰竭患者左心室组织与健康对照左心室组织进行mRNA和circRNA表达分析,构建心力衰竭调控RNA网络。采用RNA测序技术检测总RNA,提取自20例心力衰竭样本与20例健康对照样本,通过差异表达分析识别1031个circRNA-miRNA-mRNA互作关系,并提出竞争性内源RNA网络。
设计对缺血性非终末期心力衰竭患者左心室组织与健康对照左心室组织进行mRNA和circRNA表达分析,构建心力衰竭调控RNA网络。采用RNA测序技术检测总RNA,提取自20例心力衰竭样本与20例健康对照样本,通过差异表达分析识别1031个circRNA-miRNA-mRNA互作关系,并提出竞争性内源RNA网络。
摘要Differential expression analyses of mRNA and circRNA were performed in ischemic non end-stage heart failure (HF) left ventricle samples and in healthy controls from individuals not affected from cardiovascular dieseases. The aim of the study was to build an HF regulatory RNA network. Using expression data from HF deregulated microRNAs (Greco et al.,Diabetes 2012 Jun;61(6):1633-41) a total of 1031 circRNA-mirNA-mRNA interactions were identified, and proposed as competing endogenous RNA (ceRNA) network. KEGG pathway enrichment analysis identified among the top enriched categories several relevant pathways such as Ubiquitin mediated proteolysis, apelin signaling pathway, MAPK pathway, Cell cycle, Longevity regulating pathway, FoxO and MTOR signaling pathways.
-
13 GSE278521 对非缺血性扩张型心肌病导致的心力衰竭患者的心内膜活检组织进行bulk RNA测序,测量时间为诊断后9个月(四分位数范围4-26个月),根据每平方毫米CD3+ T细胞数(≥7)和CD45+白细胞数(≥14)分为高心脏炎症组与低心脏炎症组(分别少于3个CD3+ T细胞和5个CD45+白细胞),比较两组的基因表达差异。
设计对非缺血性扩张型心肌病导致的心力衰竭患者的心内膜活检组织进行bulk RNA测序,测量时间为诊断后9个月(四分位数范围4-26个月),根据每平方毫米CD3+ T细胞数(≥7)和CD45+白细胞数(≥14)分为高心脏炎症组与低心脏炎症组(分别少于3个CD3+ T细胞和5个CD45+白细胞),比较两组的基因表达差异。
摘要Dilated cardiomyopathy (DCM) is often driven by myocarditis, however, the underlying immune mechanism remains unknown. We performed bulk-RNA sequencing of endomyocardial biopsies taken 9 months (interquartile range 4-26 months) from DCM diagnosis and we found that in patients with high cardiac inflammation (at least 7 CD3+ T-cells per mm2 or at least 14 CD45+ leukocyte per mm2 endomyocardial biopsy) Perforin-1, Granzyme-A, Granzyme-H, and Interleukin-17 receptor subunit C were more often expressed compared to patients with low cardiac inflammation (less than 3 CD3+ T-cells per mm2 and less than 5 CD45+ leukocytes per mm2 endomyocardial biopsy).
-
14 GSE55296 对13例缺血性心肌病、13例扩张性心肌病及10例健康对照的人类左心室组织进行RNA测序,比较患者组与健康对照组的转录组差异。
设计对13例缺血性心肌病、13例扩张性心肌病及10例健康对照的人类左心室组织进行RNA测序,比较患者组与健康对照组的转录组差异。
摘要The goal of this study is to compare the transcriptome of heart failure patients (with ischemic or dilated cardiomyopathy) undergoing heart transplantation compared with healthy controls.
GEO 直达 PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed
-
15 GSE194394 研究使用心力衰竭患者和小鼠模型,提取尸源心脏组织的总RNA,分为不同处理组(如phenylephrine和isoproterenol注射后4小时和4天)及对照组,采用Nanostring nCounter分析,比较各组间的转录和翻译后修饰差异。动物实验中,8周龄C57/Bl6小鼠在注射药物后不同时间点取样,包括4小时和4天的处理组与对照组;人体实验中,心力衰竭患者与非心力衰竭患者样本分别进行分析。
设计研究使用心力衰竭患者和小鼠模型,提取尸源心脏组织的总RNA,分为不同处理组(如phenylephrine和isoproterenol注射后4小时和4天)及对照组,采用Nanostring nCounter分析,比较各组间的转录和翻译后修饰差异。动物实验中,8周龄C57/Bl6小鼠在注射药物后不同时间点取样,包括4小时和4天的处理组与对照组;人体实验中,心力衰竭患者与非心力衰竭患者样本分别进行分析。
摘要A proliferated and post-translationally modified microtubule network underlies cellular growth in cardiac hypertrophy and contributes to contractile dysfunction in heart failure. Yet how the heart achieves this modified network is poorly understood. Determining how the “tubulin code” – the permutations of tubulin isoforms and post-translational modifications - is rewritten upon cardiac stress may provide new targets to modulate cardiac remodeling. Further, while tubulin can autoregulate its own expression, it is unknown if autoregulation is operant in the heart or tuned in response to stress. Here we use heart failure patient samples and murine models of cardiac remodeling to interrogate transcriptional, autoregulatory, and post-translational mechanisms that contribute to microtubule network remodeling at different stages of heart disease. We find that autoregulation is operant across tubulin isoforms in the heart and leads to an apparent disconnect in tubulin mRNA and protein levels in heart failure. We also find that within 4 hours of a hypertrophic stimulus and prior to cardiac growth, microtubule detyrosination is rapidly induced to help stabilize the network. This occurs concomitant with rapid transcriptional and autoregulatory activation of specific tubulin isoforms and microtubule motors. Upon continued hypertrophic stimulation, there is an increase in post-translationally modified microtubule tracks and anterograde motors to support cardiac growth, while total tubulin content increases through progressive transcriptional and autoregulatory induction of tubulin isoforms. Our work provides a new model for how the tubulin code is rapidly rewritten to establish a proliferated, stable microtubule network that drives cardiac remodeling, and provides the first evidence of tunable tubulin autoregulation during pathological progression.
-
16 GSE164196 对32例终末期心力衰竭患者心脏左心室组织进行DNA甲基化分析与RNA测序,按种族分为非洲裔美国人和白人美国人组,采用Illumina HumanMethylation450芯片和MethylationEPIC芯片检测全基因组DNA甲基化特征,同时通过RNA-Seq分析基因表达水平,比较不同种族间表观遗传差异与转录组差异。
设计对32例终末期心力衰竭患者心脏左心室组织进行DNA甲基化分析与RNA测序,按种族分为非洲裔美国人和白人美国人组,采用Illumina HumanMethylation450芯片和MethylationEPIC芯片检测全基因组DNA甲基化特征,同时通过RNA-Seq分析基因表达水平,比较不同种族间表观遗传差异与转录组差异。
摘要African Americans (AA) are 70% more likely than Caucasian Americans (CA) to die from heart failure (HF) even after adjusting for known causes. Although the causal factors responsible for this racial disparity remain unknown, it is theorized that environmental stressors This alarming health disparity represents an important challenge to U.S. healthcare as global prevalence of heart failure has already exceeded epidemic levels with a disease burden that disproportionately impacts members of ethnic and racial minorities. The current multicohort study of cardiac DNA methylation identifies the cardiac epigenome as a previously unrecognized syntax that encodes race-based environmental differences in the failing human heart.
-
17 GSE48166 对人类心脏组织进行RNA-seq,比较15例正常与15例缺血性心肌病(ICM)样本的转录特征,样本在心脏移植时获取,采用Trizol提取并经RNeasy柱纯化、DNase消化处理,rRNA通过RiboMinus kit去除后构建cDNA文库。
设计对人类心脏组织进行RNA-seq,比较15例正常与15例缺血性心肌病(ICM)样本的转录特征,样本在心脏移植时获取,采用Trizol提取并经RNeasy柱纯化、DNase消化处理,rRNA通过RiboMinus kit去除后构建cDNA文库。
摘要Changes in gene expression contribute to the pathogenesis of heart failure. The sequence, expression level, and structure of the human cardiac transcriptome are incompletely described, as are their changes in heart disease. High throughput transcriptome sequencing (RNA-seq) is a quantitative and unbiased approach to measure transcript level and to identify novel transcribed elements or transcript splicing. Here we acquired 975.2 x 106 mapped RNA-seq reads in 15 control and 15 ischemic cardiomyopathy (ICM) hearts, obtained at the time of heart transplantation. We identified over 1000 differentially expressed transcripts, and thousands of novel transcribed elements, some of which were differentially expressed in between control and ICM groups. We found that transcript processing of several cardiac genes was deranged in ICM. For instance, the ratio between specific MYH6 exons was significantly changed in ICM compared to controls, while this type of inter-exon variation was not observed for the adjoining gene MYH7. This RNA-seq study of the human heart failure transcriptome revealed the diversity of transcripts expressed in the human heart and their complex patterns of expression in the diseased heart.
-
18 GSE120852 对15例人类心脏样本的右心室和左心室组织进行RNA-Seq,分组包括5例非心衰供体心脏、5例左心室心衰患者和5例双心室心衰患者,比较不同心室在不同疾病状态下的转录组差异。
设计对15例人类心脏样本的右心室和左心室组织进行RNA-Seq,分组包括5例非心衰供体心脏、5例左心室心衰患者和5例双心室心衰患者,比较不同心室在不同疾病状态下的转录组差异。
摘要Right ventricular dysfunction (RVD) independently predicts worse outcomes in both heart failure (HF) and pulmonary hypertension (PH), irrespective of their etiologies. Yet no evidence-based therapies exist for RVD and progression towards RV failure (RVF) can occur in spite of optimal medical treatment of HF or PH. This disparity reflects our insufficient understanding of the molecular pathophysiology of RVF. To identify molecular mechanisms that may uniquely underlie RVF, we investigated the cardiac ventricular transcriptome of advanced HF patients, with and without RVF. Using weighted gene co-expression network and module-phenotype analyses, we identified a 279-member gene module that correlated significantly and specifically with RVF. Within this module, WIPI1 served as a genetic hub, HSPB6, SNAP47, and MAP4 as drivers, and PRDX5 as a repressor of RVF. We subsequently confirmed the ventricular specificity and temporal relationship of Wipi1, Hspb6, and Map4 transcript expression changes in murine models of pressure overload induced RV failure versus LV failure and subsequently uncovered differential dysregulation of autophagy in the failing RV versus the failing LV, namely a shift towards excessive non-canonical, Beclin1-independent, Wipi1/LC3II-mediated autophagy in RVF. In vitro siRNA silencing of Wipi1 partially protected isolated neonatal rat ventricular cardiac myocytes against aldosterone-induced failing phenotype. Moreover, silencing Wipi1 blunted mitochondrial superoxide production and limited non-canonical autophagy in this in vitro RVF model. Our findings suggest that Wipi1 regulates mitochondrial oxidative signaling and autophagy in cardiac myocytes. Inhibition of Wipi1 may hold promise as a therapeutic target for RVF.
-
19 GSE42955 对人类心力衰竭相关心肌组织进行基因表达分析,比较扩张型心肌病、缺血型心肌病与正常心脏的差异。采用微阵列技术检测总 RNA 表达,样本取自左心室近心尖部透壁组织,分组为扩张型心肌病(n=12)、缺血型心肌病(n=12)和正常心脏(n=5)。
设计对人类心力衰竭相关心肌组织进行基因表达分析,比较扩张型心肌病、缺血型心肌病与正常心脏的差异。采用微阵列技术检测总 RNA 表达,样本取自左心室近心尖部透壁组织,分组为扩张型心肌病(n=12)、缺血型心肌病(n=12)和正常心脏(n=5)。
摘要Global gene expression is altered in heart failure. This syndrome can be caused by cardiovascular diseases, including dilated cardiomyopathy (DCM), ischemic cardiomyopathy (ICM), hypertrophic cardiomyopathy, viral or toxic myocarditis, hypertension, and valvular diseases. We used microarrays to evaluate the impact of heart failure on human nucleocytoplasmic transport-related genes examining simultaneoulsly both dilated and ischemic human cardiomyopathies compared to normal hearts.
-
20 GSE165556 本研究使用人类左心室组织样本,包含5个非心衰对照心脏和21个心衰心脏,通过深度测序生成总RNA表达谱。分组包括非心衰对照组、心衰-DCM组和心衰-ICM组,检测方式为RNA-Seq,主要比较非心衰对照组与心衰组之间的差异。
设计本研究使用人类左心室组织样本,包含5个非心衰对照心脏和21个心衰心脏,通过深度测序生成总RNA表达谱。分组包括非心衰对照组、心衰-DCM组和心衰-ICM组,检测方式为RNA-Seq,主要比较非心衰对照组与心衰组之间的差异。
摘要Purpose: In the present study, we aimed to identify novel lncRNAs associated with HF. Methods: We used left ventricular biopsies obtained from 21 explanted failing hearts and 5 non-failing control hearts. Deep RNA sequencing was performed on cardiac biopsies. RNA-seq data were aligned to human reference genome hg19 using TopHat. Differential expression analyses were conducted using the cufflinks and the DESeq2 algorithm. Results: An average of 211 million reads of total-RNA-seq librairies were generated. From these data, we identified a panel of 3247 lncRNAs that were either cardiac-enriched or differentially expressed between failing and non-failing hearts identified by either Cufflinks or DESeq2, including 1036 novel lncRNAs (i.e. not described in the GENCODE version 19 database). 232 of them were derived from novel genes and were from moderately to highly expressed in at least half samples. The novel gene derived lncRNAs differentially expressed in failing heart could correlate to at least one heart failure associated genes with a Spearman's rank correlation coefficient more than 0.7 or less than -0.7 in either ICM or DCM group.
-
21 GSE26887 对患有扩张型低动力心肌病并接受手术室修复的患者左心室活体非梗死区组织进行心脏活检,采集糖尿病合并心力衰竭(T2DM HF)患者、非糖尿病心力衰竭(non-T2DM HF)患者及健康对照样本。按年龄、性别、射血分数、终末舒张容积等参数匹配,使用Affymetrix GeneChips Human Gene 1.0 ST芯片检测全mRNA表达,比较T2DM HF组与non-T2DM HF组、T2DM HF组与对照组的基因表达差异。
设计对患有扩张型低动力心肌病并接受手术室修复的患者左心室活体非梗死区组织进行心脏活检,采集糖尿病合并心力衰竭(T2DM HF)患者、非糖尿病心力衰竭(non-T2DM HF)患者及健康对照样本。按年龄、性别、射血分数、终末舒张容积等参数匹配,使用Affymetrix GeneChips Human Gene 1.0 ST芯片检测全mRNA表达,比较T2DM HF组与non-T2DM HF组、T2DM HF组与对照组的基因表达差异。
摘要Increased morbidity and mortality associated with post-ischemic heart failure (HF) in diabetic patients underscore the need for a better understanding of the underlying molecular events. Indeed, effective HF therapy in diabetic patients requires a complex strategy encompassing the development of improved diagnostic and prognostic markers and innovative pharmacological approaches. Whole mRNAs expression was measured in the heart of patients with heart failure (HF) with or without concomitant Type 2 diabetes mellitus (T2DM) and compared it to control non-failing hearts. We identified distinct genes modulated in HF patients compared to controls, as well as to T2DM HF patients compared to not diabetic HF patients.
-
22 GSE86569 对人类心力衰竭患者和正常对照的左心室组织进行转录组芯片分析,比较高射血分数与低射血分数组的基因表达差异。按总单位数与组数估计,每组包含11个样本。
设计对人类心力衰竭患者和正常对照的左心室组织进行转录组芯片分析,比较高射血分数与低射血分数组的基因表达差异。按总单位数与组数估计,每组包含11个样本。
摘要Background: Heart failure (HF) causes various inflammatory responses. It remains unclear whether the inflammation the cause or effect of HF. Therefore, we wished to characterize the transcript profiles in the left ventricle (LV) of preserved and failed hearts respectively. Results: Twenty inflammatory genes were differentially expressed between the preserved and failed LV respectively.
-
23 GSE123976 对6例终末期心衰患者和3例非心衰供体心脏的左心室心内膜组织进行全基因组亚硫酸盐测序和RNA-Seq,比较心衰与非心衰心脏的DNA甲基化变化及代谢基因表达差异。
设计对6例终末期心衰患者和3例非心衰供体心脏的左心室心内膜组织进行全基因组亚硫酸盐测序和RNA-Seq,比较心衰与非心衰心脏的DNA甲基化变化及代谢基因表达差异。
摘要Heart Failure (HF) is a complex clinical disease and leading cause of hospitalization in the United States. Although precision-based treatment options are ultimately preferred, understanding the common underlying features of HF is also needed to develop universal therapies that address its pathogenesis. Among the etiology-independent molecular changes known to occur in HF is a global shift in the heart’s metabolic substrate preference. Transcriptional reprogramming of the heart has been shown to mediate this metabolic switch towards glycolytic metabolism; however, the molecular machinery that reactivate dormant genes remain largely unknown. In the current study, we hypothesized that the cardiac epigenome regulates metabolism via alterations in DNA methylation.
-
24 GSE84796 对终末期心力衰竭患者心脏移植时的左心室游离壁心组织与健康供体左心室游离壁心组织进行全基因组表达分析,病例组包含10个样本,对照组包含7个样本,采用微阵列技术检测总RNA的基因表达差异。
设计对终末期心力衰竭患者心脏移植时的左心室游离壁心组织与健康供体左心室游离壁心组织进行全基因组表达分析,病例组包含10个样本,对照组包含7个样本,采用微阵列技术检测总RNA的基因表达差异。
摘要Human left ventricular free wall heart tissue was obtained from end-stage heart failure patients at the moment of heart transplantation Left ventricular free wall samples were also obtained from healthy hearts of organ donors, which were not used for transplantation due to size mismatch with available recipients.
-
25 GSE111544 对终末期心力衰竭患者左心室游离壁心肌组织的总RNA进行微阵列基因表达分析,未明确分组或比较条件。
设计对终末期心力衰竭患者左心室游离壁心肌组织的总RNA进行微阵列基因表达分析,未明确分组或比较条件。
摘要Human left ventricular free wall heart tissue was obtained from end-stage heart failure patients at the moment of heart transplantation
-
26 GSE3585 对7例心力衰竭(DCM)患者移植时获取的左心室心内膜活检样本及5例非心力衰竭(NF)供体心脏因冠状动脉钙化未移植的活检样本进行微阵列表达分析,比较两组间基因表达差异。
设计对7例心力衰竭(DCM)患者移植时获取的左心室心内膜活检样本及5例非心力衰竭(NF)供体心脏因冠状动脉钙化未移植的活检样本进行微阵列表达分析,比较两组间基因表达差异。
摘要Dilated cardiomyopathy (DCM) is a common cause of heart failure and a leading cause of cardiac transplantation in western countries. The robust predictive expression profile of cardiomyopathic and NF hearts as well as the functional classification can help to identify promising candidates for DCM and may improve the early diagnosis of cardiomyopathy. Keywords: disease state analysis
-
27 GSE108157 对缺血性(ICM)与非缺血性(NICM)心力衰竭患者左心室内膜样本进行甲基化阵列与 RNA-Seq 联合分析,比较两组间 DNA 甲基化及转录组差异。甲基化检测基于 CpG 岛变化,RNA-Seq 识别差异表达基因(Fold Change > 1.5, Q < 0.05, FPKM > 2)并关联差异甲基化位点(|Percent Change| > 5%, p < 0.05)。
设计对缺血性(ICM)与非缺血性(NICM)心力衰竭患者左心室内膜样本进行甲基化阵列与 RNA-Seq 联合分析,比较两组间 DNA 甲基化及转录组差异。甲基化检测基于 CpG 岛变化,RNA-Seq 识别差异表达基因(Fold Change > 1.5, Q < 0.05, FPKM > 2)并关联差异甲基化位点(|Percent Change| > 5%, p < 0.05)。
摘要Background – Epigenetic alterations are stable modifications to chromatin structure that occur in response to environmental cues such as hypoxia or altered nutrient delivery. DNA methylation is a well-established and dynamic DNA modification that contributes to the regulation of gene expression. In the current study, we test the hypothesize that ischemic heart failure is defined by a distinct signature of DNA methylation that corresponds with altered expression of genes involved in cardiac ventricular dysfunction. Methods and Results – Using a methylation array, we quantified genome-wide DNA methylation of endomyocardial samples acquired from patients with ischemic (n = 6) or non-ischemic (n = 5) heart failure. RNA-sequencing analysis was performed in the same samples to identify transcriptomic changes (Fold Change > 1.5, Q < 0.05, FPKM > 2) associated with differential methylation (|Percent Change| > 5%, p < 0.05). Of the promoter-associated CpG Islands, which are well-established regions of negative transcriptional regulation, we identified a signature of robust hypermethylation. The methylation changes linked to significantly decreased transcripts included key fatty acid metabolic regulators (e.g. KLF15, AGPAT9, APOA1, and MXD4). Among the few hypomethylated and induced genes was PFKFB3, which encodes for the rate-limiting enzyme of glycolysis. Gene set enrichment analysis identified TGFβ as a nodal upstream regulator of the methylation changes, potentially supporting a role of DNA methylation in the increased fibrosis and apoptosis that accompanies ischemic heart failure. Conclusions – Our data identify that the DNA methylation signature recapitulates the pathologic hallmarks of ischemic heart failure. Furthermore, we show that differential DNA methylation of CpG islands within the promoter depict alterations in metabolic substrate utilization known to occur in ischemic heart failure, and may govern a return to the fetal-like metabolic program.
-
28 GSE17294 将健康和缺血性心肌病(ICM)人类心脏的左心房和左心室组织中分离的房室肌细胞进行激光捕获显微切割,提取总RNA并分析其在自建的人类离子通道剪接微阵列上的表达变化,比较健康与ICM状态下房室肌细胞的离子通道相关分子重塑。
设计将健康和缺血性心肌病(ICM)人类心脏的左心房和左心室组织中分离的房室肌细胞进行激光捕获显微切割,提取总RNA并分析其在自建的人类离子通道剪接微阵列上的表达变化,比较健康与ICM状态下房室肌细胞的离子通道相关分子重塑。
摘要Ischemic cardiomyopathy (ICM) leads to congestive heart failure and can cause sudden cardiac death due to arrhythmia. Existing molecular knowledge base of ICM is rudimentary because of lack of specific attribution to cell type and function. This study was designed to investigate cell-specific molecular remodeling of ion channels, exchangers and pumps, which are signaling molecules (SM) involved in electrical, signaling and mechanical functions of the heart. Atrial and ventricular myocytes were isolated by laser-capture microdissection from left atrium and ventricle of healthy and ICM human hearts. SM and their splice variants altered by ICM in cardiomyocytes were identified by splice microarray and validated by RT-PCR. Molecular profiling of ICM-related changes showed that SM in atrial and ventricular myocytes remodel following their unique programs. ICM affected 63 genes in ventricular myocytes and 12 genes in atrial myocytes. Only few of the identified genes were previously linked to human cardiac disfunctions.
-
29 GSE212181 对急性心肌梗死后使用 sacubitril/valsartan 的 heart failure 患者进行 RNA 测序,比较 sacubitril/valsartan 抵抗(SVR)与非抵抗(NSVR)组间差异表达的 miRNA、circRNA、lncRNA 和 mRNA 表达谱。每组包含 5 个独立样本。
设计对急性心肌梗死后使用 sacubitril/valsartan 的 heart failure 患者进行 RNA 测序,比较 sacubitril/valsartan 抵抗(SVR)与非抵抗(NSVR)组间差异表达的 miRNA、circRNA、lncRNA 和 mRNA 表达谱。每组包含 5 个独立样本。
摘要Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with therapeutic heterogeneity of sacubitril/valsartan after acute myocardial infarction Patients after Acute Myocardial Infarction Sacubitril/valsartan has a noteworthy advantage in improving ventricular remodelling, as well as reducing cardiovascular mortality and the rate of heart failure (HF) readmission. However, clinically, some patients with HF still have low sensitivity to sacubitril/valsartan, indicating sacubitril/valsartan resistance (SVR).
-
30 GSE317994 对心脏AL淀粉样变性患者、非AL心力衰竭患者及健康对照的左心室基底部中层组织进行bulk RNA测序,比较三组间基因表达差异。
设计对心脏AL淀粉样变性患者、非AL心力衰竭患者及健康对照的左心室基底部中层组织进行bulk RNA测序,比较三组间基因表达差异。
摘要Recent studies indicate that interactions between collagen and amyloid fibrils may influence disease progression in cardiac AL amyloidosis. However, the precise pathophysiological mechanisms underlying fibrosis remain largely unexplored. Here, we perform bulk RNA sequcencing of the heart from patients with cardiac AL amyloidosis and identify the upregulation of fibroblast activation genes. This upregulation of extracellular molecules suggests the involvement of cardiac fibrosis mechanisms beyond amyloid fibril deposition in the heart of patients with cardiac AL amyloidosis.
-
31 GSE71613 对移植候选者的晚期心力衰竭(HF)心脏组织及健康心脏组织进行RNA-Seq测序,比较其转录组差异。样本来自人类,共8例,包含健康对照及HF不同类型(限制性心肌病、扩张性心肌病)。通过高通量测序获取全转录组数据,分析差异表达及转录本特征。
设计对移植候选者的晚期心力衰竭(HF)心脏组织及健康心脏组织进行RNA-Seq测序,比较其转录组差异。样本来自人类,共8例,包含健康对照及HF不同类型(限制性心肌病、扩张性心肌病)。通过高通量测序获取全转录组数据,分析差异表达及转录本特征。
摘要The knowledge of an expression network signature in end-stage heart failure (HF) diseased hearts may offer important insights into the complex pathogenesis of advanced cardiac failure, as well as it may provide potential targets for therapeutic intervention. In this study, the NGS sequencing of RNA (RNA-Seq) method was employed to obtain the whole transcriptome of cardiac tissues from transplant recipients with advanced stage of HF. The analysis of RNA-Seq data presents novel challenges and many methods have been developed for the purpose of mapping reads to genomic features and quantifying gene expression. The main goal of this work was to identify, characterize and catalogue all the transcripts expressed within cardiac tissue and to quantify the differential expression of transcripts in both physio- and pathological conditions through whole transcriptome analyses. Expression levels, differential splicing, allele-specific expression, RNA editing and fusion transcripts constitute important information when comparing samples for disease related studies. Analysis methods for RNA-Seq data are continuing to evolve. Thus, in order to find the best solution for filter generated list of differentially expressed genes, an informatic approach of NOISeq BIO method has been applied in this RNA-Seq analysis. Most of the genes obtained by filtering differentially expressed gene list, have been experimentally validated by Real time RT-PCR. Noteworthy, these findings provide valuable resources for further studies of the molecular mechanisms involved in heart ischemic response thus leading to potential novel biomarkers and targets for therapeutic intervention in the onset and progression of cardiomyopathies.
-
32 GSE76701 对缺血、终末期心力衰竭(F)与非心力衰竭(NF)成人心脏的基因表达进行比较分析,采用Affymetrix微阵列平台检测左心室组织总RNA表达差异。
设计对缺血、终末期心力衰竭(F)与非心力衰竭(NF)成人心脏的基因表达进行比较分析,采用Affymetrix微阵列平台检测左心室组织总RNA表达差异。
摘要A goal of this study was to identify and investigate previously unrecognized components of the remodeling process in the progression to heart failure by comparing gene expression in ischemic, failing (F) to non-failing (NF) hearts. These results also were compared to the changes observed in a proteomic analysis of F and NF hearts.
人源·鼠源空转
Human · Mouse · Spatial
-
01 GSE168742 对小鼠心脏组织进行单细胞 RNA 测序和空间转录组学分析,研究心脏成纤维细胞通过 Htra3-TGF-β-IGFBP7 轴在心力衰竭中的调控作用。心脏成纤维细胞通过 APC 标记的 PDGFR-α 抗体和 FITC 标记的 CD31 抗体进行荧光激活细胞分选(FACS)分离,采集活细胞进行测序。同时,对心力衰竭模型小鼠进行 MI 操作,采集 MI day1 和 MI day7 的心脏组织样本,与 sham 组样本进行比较。
设计对小鼠心脏组织进行单细胞 RNA 测序和空间转录组学分析,研究心脏成纤维细胞通过 Htra3-TGF-β-IGFBP7 轴在心力衰竭中的调控作用。心脏成纤维细胞通过 APC 标记的 PDGFR-α 抗体和 FITC 标记的 CD31 抗体进行荧光激活细胞分选(FACS)分离,采集活细胞进行测序。同时,对心力衰竭模型小鼠进行 MI 操作,采集 MI day1 和 MI day7 的心脏组织样本,与 sham 组样本进行比较。
摘要Tissue fibrosis and organ dysfunction are hallmarks of age-related diseases including heart failure, but it remains elusive whether there is a common pathway to induce both events. Through single-cell RNA-seq, spatial transcriptomics, and genetic perturbation, we elucidate that high-temperature requirement A serine peptidase 3 (Htra3) is a critical regulator of cardiac fibrosis and heart failure by maintaining the identity of quiescent cardiac fibroblasts through degrading transforming growth factor-β (TGF-β). Pressure overload downregulates expression of Htra3 in cardiac fibroblasts and activated TGF-β signaling, which induces not only cardiac fibrosis but also heart failure through DNA damage accumulation and secretory phenotype induction in failing cardiomyocytes. Overexpression of Htra3 in the heart inhibits TGF-β signaling and ameliorates cardiac dysfunction after pressure overload. Htra3-regulated induction of spatio-temporal cardiac fibrosis and cardiomyocyte secretory phenotype are observed specifically in infarct regions after myocardial infarction. Integrative analyses of single-cardiomyocyte transcriptome and plasma proteome in human reveal that IGFBP7, which is a cytokine downstream of TGF-β and secreted from failing cardiomyocytes, is the most predictable marker of advanced heart failure. These findings highlight the roles of cardiac fibroblasts in regulating cardiomyocyte homeostasis and cardiac fibrosis through the Htra3-TGF-β-IGFBP7 pathway, which would be a therapeutic target for heart failure.
人源·鼠源bulk 转录组
Human · Mouse · Bulk RNA-seq
-
01 GSE133054 对小鼠和人类心脏组织进行单细胞及bulk RNA-seq,包含正常心肌细胞、肥厚心肌病组织、心力衰竭组织及TAC处理不同时间点的心肌细胞。比较各组间基因表达差异,尤其关注心力衰竭阶段与正常组织的保守表达模式。
设计对小鼠和人类心脏组织进行单细胞及bulk RNA-seq,包含正常心肌细胞、肥厚心肌病组织、心力衰竭组织及TAC处理不同时间点的心肌细胞。比较各组间基因表达差异,尤其关注心力衰竭阶段与正常组织的保守表达模式。
摘要We deposit the data of single-cell and bulk-cell rna-seq of normal mouse heart. In addition, we conducted bulk rna-seq in human sample and found that many of the heart remodelling-associated genes we discovered show conserved expression pattern in human hypertrophy and heart failure stage.
-
02 GSE312561 对人类和小鼠左心室心肌组织进行RNA-seq,比较健康捐赠者与PPCM患者的基因表达差异,并分析小鼠中野生型与Ptrh2基因敲除组的表达变化。
设计对人类和小鼠左心室心肌组织进行RNA-seq,比较健康捐赠者与PPCM患者的基因表达差异,并分析小鼠中野生型与Ptrh2基因敲除组的表达变化。
摘要The peptidyl-tRNA hydrolase 2 (PTRH2, Bit-1; BIT1) gene plays a pro-survival role during development with loss of function gene mutations causing congenital infantile multisystem disease (IMNEPD). In wild-type female mice hearts, ptrh2 protein levels significantly increase during pregnancy and decrease postpartum, demonstrating a protective role in response to pregnancy-initiated cardiac stresses. Peripartum cardiomyopathy (PPCM) is due to dysregulated protective signaling in the pregnant heart. The genetic and molecular mechanisms underlying PPCM remain poorly defined with no specific therapies. Here, we engineered a cardiac-specific Ptrh2 knockout (Ptrh2-CKO) mouse and show these maternal mice develop left ventricular systolic dysfunction, exhibit high rates of postpartum heart failure, and model key features of human PPCM. Infusion of a caspase 3-specific inhibitor attenuated the PPCM phenotype. Collectively, our findings demonstrate Ptrh2 is a negative regulator of pregnancy-induced cardiac stresses by activating pro-survival signals and blocking apoptotic signals, suggesting Ptrh2 may be a therapeutic target for the treatment of PPCM
鼠源单细胞
Mouse · Single-cell
-
01 GSE343640 对HGPS小鼠模型的心脏组织进行snRNA-seq和Bulk RNA-seq分析,比较LMNAG608G/G608G基因型与同龄野生型小鼠的转录组差异,并评估ABE处理与盐水处理对G/G小鼠病理心脏重塑的影响。研究包含8周龄LMNAG608G/G608G小鼠、同龄野生型小鼠,以及在P14日接受ABE-AAV9注射或盐水注射的G/G小鼠,共48个样本。
设计对HGPS小鼠模型的心脏组织进行snRNA-seq和Bulk RNA-seq分析,比较LMNAG608G/G608G基因型与同龄野生型小鼠的转录组差异,并评估ABE处理与盐水处理对G/G小鼠病理心脏重塑的影响。研究包含8周龄LMNAG608G/G608G小鼠、同龄野生型小鼠,以及在P14日接受ABE-AAV9注射或盐水注射的G/G小鼠,共48个样本。
摘要Background: Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by rapid premature aging. Without treatment, accelerated atherosclerosis results in death from heart attack or stroke in the early teens. Recent echocardiographic study has also demonstrated a progressive cardiomyopathy in HGPS patients, characterized by diastolic dysfunction with preserved ejection fraction. We sought to define the cardiovascular phenotype and molecular mechanisms underlying progeria-associated cardiomyopathy in a humanized mouse model, and to determine whether these abnormalities can be corrected by in vivo adenine base editing. Methods: Cardiovascular phenotypes were extensively characterized in LMNAG608G/G608G progeria mice using echocardiography, vascular biomechanical testing, histopathology, transmission electron microscopy, snRNA-seq, RNA in situ hybridization, and plasma biomarker analyses. The effects of in vivo adenine base editing on pathological cardiac remodeling were subsequently evaluated. Results: LMNAG608G/G608G mice developed progressive left ventricular diastolic dysfunction with normal ejection fraction, accompanied by severe central arterial stiffening, impaired vasoreactivity, and reduced vascular distensibility. Histological and ultrastructural analyses of the heart revealed cardiomyocyte nuclear abnormalities, sarcomere disruption, mitochondrial defects, and increased myocardial collagen deposition. Transcriptomic profiling identified a signature of pathological myocardial remodeling, characterized by activation of proteostatic stress responses, suppression of contractile and calcium signaling pathways, enhanced extracellular matrix remodeling and inflammatory signaling, and reactivation of the fetal heart failure gene program. Robust upregulation of Nppa and Nppb, two established heart failure markers, was validated by RNA in situ hybridization and accompanied by significantly elevated circulating NT-proBNP levels. In vivo delivery of an AAV9-encapsulated adenine base editor achieved partial correction of the progeria mutation in the heart and partially reversed cardiomyocyte transcriptional alterations, pathological myocardial remodeling, fibrosis, and heart failure marker expression. Conclusions: A humanized mouse model of HGPS is associated with progressive atherosclerosis, as well as a progressive cardiomyopathy characterized by diastolic dysfunction, pathological myocardial remodeling, and activation of a heart failure transcriptional program. Partial reversal of these abnormalities following in vivo adenine base editing demonstrates that progeria cardiomyopathy is therapeutically modifiable. Future human trials of gene-editing therapies for HGPS should target both the arterial tree and the myocardium.
-
02 GSE221698 对心力衰竭小鼠模型中Cx3cr1阳性髓样细胞的BRD4基因删除及IL1B中和处理,采用单细胞RNA测序和ATAC-seq分析非心肌细胞与所有心室细胞核的转录组与染色质可及性,比较不同处理组间基因表达与增强子活性差异。
设计对心力衰竭小鼠模型中Cx3cr1阳性髓样细胞的BRD4基因删除及IL1B中和处理,采用单细胞RNA测序和ATAC-seq分析非心肌细胞与所有心室细胞核的转录组与染色质可及性,比较不同处理组间基因表达与增强子活性差异。
摘要Chronic inflammation and tissue fibrosis are common stress responses that worsen organ function, yet their crosstalk is poorly understood. Here, we show that conditional deletion of the transcription co-activator Brd4 in Cx3cr1-positive myeloid cells ameliorates heart failure and is associated with a dramatic reduction in fibroblast activation. We identified a specific BRD4-occupied enhancer in Cx3cr1-positive cells that controls expression of Interleukin-1 beta (Il1b), and show that secreted IL1B activates a p65/RELA-dependent enhancer downstream of MEOX1, driving a profibrotic response in human cardiac fibroblasts. In vivo, antibody-mediated IL1B neutralization prevented stress-induced expression of MEOX1, inhibited fibroblast activation, and improved cardiac function in heart failure. The elucidation of BRD4-dependent crosstalk between a specific immune cell subset and fibroblasts through IL1B provides new therapeutic strategies for heart disease and other disorders of chronic inflammation and maladaptive tissue remodeling.
-
04 GSE304446 将C57BL/6N和C57BL/6J背景的12周龄雄性小鼠分为标准饮食组和HFD+L-NAME处理组,采集左心室组织进行单核RNA测序,比较不同处理条件下基因型间的转录组差异。
设计将C57BL/6N和C57BL/6J背景的12周龄雄性小鼠分为标准饮食组和HFD+L-NAME处理组,采集左心室组织进行单核RNA测序,比较不同处理条件下基因型间的转录组差异。
摘要BACKGROUND: Clinical management of heart failure with preserved ejection fraction (HFpEF) is hindered by a lack of disease-modifying therapies capable of altering its distinct pathophysiology. Despite the widespread implementation of a 2-hit model of cardiometabolic HFpEF to inform precision therapy, which utilizes HFD+L-NAME (ad libitum high-fat diet and 0.5% N[ω]-nitro-L-arginine methyl ester), we observe that C57BL6/J mice exhibit less cardiac diastolic dysfunction in response to HFD+L-NAME. METHODS: Genetic strain-specific single-nucleus transcriptomic analysis identified disease-relevant genes that enrich oxidative metabolic pathways within cardiomyocytes. Because C57BL/6J mice are known to harbor a loss-of-function mutation affecting the inner mitochondrial membrane protein Nnt (nicotinamide nucleotide transhydrogenase), we established an isogenic model of Nnt loss-of-function to determine whether intact NNT is necessary for the pathological cardiac manifestations of HFD+L-NAME. Twelve-week-old mice cross-bred to isolate wild-type (Nnt+/+) or loss-of-function (Nnt−/−) Nnt in the C57BL/6N background were challenged with HFD+L-NAME for 9 weeks (N=6–10). RESULTS: Nnt+/+ mice exhibited impaired ventricular diastolic relaxation and pathological remodeling, as assessed via noninvasive echocardiographic quantification of early diastolic pulse-wave velocity (E) to mitral annular velocity (e′) ratio (E/e′) (42.8 versus 21.5, P=1.2×10−10), E/A (early-to-late mitral inflow velocity ratio) (2.3 versus 1.4, P=4.1×10−2), diastolic stiffness (0.09 versus 0.04 mm Hg/μL, P=5.1×10−3), and myocardial fibrosis (P=2.3×10−2). Liquid chromatography and mass spectroscopy exposed a 40.0% reduction in NAD+ (P=8.4×10−3) and a 38.8% reduction in the ratio of reduced-to-oxidized glutathione (GSH: GSSG, P=2.6×10−2) among Nnt+/+ mice after HFD+L-NAME feeding. Using single-nucleus ligand-receptor analysis, we implicate Fgf1 (fibroblast growth factor 1) as a putative NNT-dependent mediator of cardiomyocyte-to-fibroblast signaling in myocardial fibrosis. CONCLUSIONS: Together, these findings underscore the pivotal role of mitochondrial dysfunction in HFpEF pathogenesis, implicating both NNT and Fgf1 as novel therapeutic targets.
-
05 GSE285948 对心脏组织中的杯状细胞进行单核 RNA 测序,比较 Terf2(f,f)、Terf2(f,+) 和 Terf2(+,+) 三组小鼠的基因表达差异。
设计对心脏组织中的杯状细胞进行单核 RNA 测序,比较 Terf2(f,f)、Terf2(f,+) 和 Terf2(+,+) 三组小鼠的基因表达差异。
摘要We have conducted single‑nucleus RNA sequencing to investigate mouse cardiomyocytes with Terf2 cardiomyocyte-specific knockout. Cardiomyocytes play a crucial role in heart function. The down - regulation of TRF2 may affect cellular processes and gene expression patterns within cardiomyocytes. This study aims to reveal the changes in the nuclear transcriptome of these cells, providing insights into the molecular mechanisms underlying the impact of TRF2 down - regulation on cardiomyocyte function.
-
06 GSE208425 针对心力衰竭伴射血分数保留(HFpEF)小鼠模型,采集心脏组织中的CD45+细胞进行单细胞RNA测序,比较代谢性HFpEF小鼠与正常对照组在代谢压力驱动下的炎症特征差异,并评估SGLT2抑制剂dapagliflozin治疗对炎症的潜在影响。
设计针对心力衰竭伴射血分数保留(HFpEF)小鼠模型,采集心脏组织中的CD45+细胞进行单细胞RNA测序,比较代谢性HFpEF小鼠与正常对照组在代谢压力驱动下的炎症特征差异,并评估SGLT2抑制剂dapagliflozin治疗对炎症的潜在影响。
摘要Heart failure with preserved ejection fraction (HFpEF) is a public health problem with increasing incidence and prevalence. Different phenotypes have been identified based on related risk factors, cardiac structural alterations, biomarkers and prognosis. Among these, the one with the worst prognosis is characterized by metabolic dysfunction . This clinical phenotype exhibits high levels of biomarkers related to dysregulated metabolism and TNF-a–mediated inflammation, thus underlying its close association with metabolic dysfunction and inflammation. The aim of our work is to better comprehend the involvement of the immune cells in the pathogenesis of metabolic HFpEF and to determine whether treating metabolic dysfunction with SGLT2i could ameliorate HFpEF by decreasing myocardial inflammation.
-
07 GSE249412 对C57BL6小鼠左心室组织进行单核RNA测序,比较野生型背景下的HFpEF模型与对照组在不同治疗条件下的转录组差异。HFpEF模型组接受TYA-018(15mg/kg)或Empagliflozin(10 mg/kg)治疗,对照组接受vehicle处理,每组n=2。
设计对C57BL6小鼠左心室组织进行单核RNA测序,比较野生型背景下的HFpEF模型与对照组在不同治疗条件下的转录组差异。HFpEF模型组接受TYA-018(15mg/kg)或Empagliflozin(10 mg/kg)治疗,对照组接受vehicle处理,每组n=2。
摘要Heart failure with preserved ejection fraction (HFpEF) is a prevalent health condition associated with high morbidity and mortality, but currently, there are few effective therapies. Our previous research showed that inhibiting histone deacetylase 6 (HDAC6) had a beneficial effect on a genetic cardiomyopathy model. The overlapping underlying mechanisms involving inflammation and metabolism between cardiomyopathy and HFpEF prompted us to explore the role of HDAC6 in HFpEF. The results showed that inhibiting HDAC6 with TYA-018 reversed preexisting cardiac hypertrophy and diastolic dysfunction, and improved lung congestion and exercise capacity in mouse models of HFpEF, including a newly developed model that combines moderate trans-aortic constriction and high-fat diet to mimic the systemic and cardiovascular features of human HFpEF. Moreover, mice with genetic Hdac6 deletion delayed the development of HFpEF and were resistant to the effects of TYA-018. The efficacy of TYA-018 was comparable to a SGLT2 inhibitor, and the combination showed increased effects. Mechanistically, TYA-018 restored expression of gene sets associated with hypertrophy, fibrosis, and mitochondrial energy production in heart tissue from HFpEF mice. TYA-018 also inhibited activation of human cardiac fibroblasts and increased mitochondrial respiratory capacity in induced pluripotent stem cell–derived cardiomyocytes. These findings support the direct role of HDAC6 on HFpEF pathophysiology in the heart and that inhibiting HDAC6 may be a promising approach to treating HFpEF.
-
08 GSE270896 对10周龄TAC损伤或假手术的C57BL/6J野生型及B6.Cg-Lepob/J肥胖/糖尿病型小鼠心脏组织进行单核RNA测序,每组2只小鼠。采集全心组织,分离单核后采用10x Genomics NEXT GEM 3’基因表达试剂盒v3.1制备文库,测序于Illumina NovaSeq6000 S4平台。比较野生型与肥胖/糖尿病型小鼠在TAC处理及假手术条件下的基因表达差异,重点分析胰高血糖素受体信号通路的差异。
设计对10周龄TAC损伤或假手术的C57BL/6J野生型及B6.Cg-Lepob/J肥胖/糖尿病型小鼠心脏组织进行单核RNA测序,每组2只小鼠。采集全心组织,分离单核后采用10x Genomics NEXT GEM 3’基因表达试剂盒v3.1制备文库,测序于Illumina NovaSeq6000 S4平台。比较野生型与肥胖/糖尿病型小鼠在TAC处理及假手术条件下的基因表达差异,重点分析胰高血糖素受体信号通路的差异。
摘要To understand the cellular mechanisms of heart failure with preserved ejection fraction (HFpEF), We investigated the functional outcome and the underlying mechanisms from concurrent mechanic and metabolic stresses in the heart by applying transverse aortic constriction (TAC) in lean C57Bl/6J (HFrEF phenotype) or obese/diabetic B6.Cg-Lepob/J (ob/ob) mice (HFpEF phenotype) followed by single-nuclei RNA-seq (snRNA-seq) and targeted manipulation of a top ranked signaling pathway (glucagon receptor signaling) differentially affected in the two experimental cohorts.
-
09 GSE295382 对8周龄C57BL/6 CCR2-RFP雄性小鼠进行高脂肪饮食与L-NAME联合诱导HFpEF,随后设置对照组(标准饮食)、HFpEF假处理组与HFpEF tVNS处理组,采集心脏组织进行单细胞RNA测序及流式细胞术分析,比较各组心脏驻留巨噬细胞数量及功能相关基因表达差异。
设计对8周龄C57BL/6 CCR2-RFP雄性小鼠进行高脂肪饮食与L-NAME联合诱导HFpEF,随后设置对照组(标准饮食)、HFpEF假处理组与HFpEF tVNS处理组,采集心脏组织进行单细胞RNA测序及流式细胞术分析,比较各组心脏驻留巨噬细胞数量及功能相关基因表达差异。
摘要Background: We previously showed in a rat model of heart failure with preserved ejection fraction (HFpEF) that transcutaneous vagus nerve stimulation (tVNS) reduced cardiac fibrosis and inflammation. However, macrophage-mediated mechanisms through which tVNS rescues cardiac function remain poorly understood. Methods: We induced HFpEF in 8-week-old mice by a combination of a high-fat diet and L-NAME for 5 weeks followed by 4 weeks of tVNS or sham stimulation. At this time, we analyzed cardiac function by echocardiography and immune cell numbers by single cell RNA sequencing and flow cytometry. Results: Our data demonstrate that HFpEF mice exhibited diastolic dysfunction, left ventricular hypertrophy and fibrosis, consistent with HFpEF, and that tVNS significantly improved HFpEF severity. Analysis of merged single cell RNA sequencing data from control, HFpEF + sham, and HFpEF + tVNS mice showed that HFpEF was associated with accumulation of Spp1 expressing CCR2+ cardiac resident macrophages (CRM). Further, treatment with tVNS reduced the number of CCR2+ CRM and the expression of Spp1, while also inducing the expression of Igf1 in Timd4+/Lyve1+/Folr2+ (TLF+) and MHC2+ CRM. Global deletion of Spp1 or blockade of CCR2+ CRM recruitment improved HFpEF, whereas TLF+/MHC2+ specific deletion of Igf1 reversed the protective effect of tVNS on HFpEF. The benefits of tVNS were also abolished in the setting of disrupted acetylcholine (ACh)/α7 neuronal ACh receptor (α7nAChR) signaling, either via pharmacological inhibition of α7nAChR or choline acetyltransferase deletion in CD4⁺ T cells. Conclusion: Collectively, our data indicate that tVNS improves HFpEF by reducing Spp1 expressing CCR2+ CRM and inducing expression of pro-reparative Igf1 in TLF+/MHC2+ CRM. These effects are mediated through cholinergic signaling, highlighting a neuroimmune pathway in HFpEF.
-
10 GSE122930 对心力衰竭小鼠心脏的CD45+免疫细胞进行单细胞RNA测序,比较横断主动脉缩窄(TAC)处理与假手术(Sham)对照组在1周和4周时间点的免疫激活差异。
设计对心力衰竭小鼠心脏的CD45+免疫细胞进行单细胞RNA测序,比较横断主动脉缩窄(TAC)处理与假手术(Sham)对照组在1周和4周时间点的免疫激活差异。
摘要Single-cell RNA sequencing is revolutionizing the mapping of tissues in physiology and pathology. Whilst immune responses are emerging as key mediators of heart failure, no thorough immune mapping of the ailing heart has been performed so far. Here we examined, at single-cell level, the cardiac immune composition after transverse aortic constriction, the standard murine model of non-ischemic heart failure. We identified the presence of most major immune cell subpopulations in the myocardium of both healthy and cardiopathic mice. Despite the absence of infectious agents or an autoimmune trigger, the ailing heart, especially at late-stage disease, is characterized by an immune activation that is both drastic and far more wide-ranging in the immune cell types involved than previously thought. The molecular-level detail we uncover in the cells undergoing activation in response to cardiac stress may enable the identification of novel biomarkers and therapeutic targets for heart failure.
-
11 GSE198833 对Cd34-CreERT2;R26-tdTomato小鼠心脏中的总非心肌细胞和CD34+细胞进行单细胞RNA测序,分析假手术组、TAC手术后4周组及12周组的细胞景观动态变化。
设计对Cd34-CreERT2;R26-tdTomato小鼠心脏中的总非心肌细胞和CD34+细胞进行单细胞RNA测序,分析假手术组、TAC手术后4周组及12周组的细胞景观动态变化。
摘要CD34+ cells have been used to treat the patients with heart failure, but the outcome is variable. It is of great significance to scrutinize the fate and the mechanism of CD34+ cell differentiation in vivo during heart failure and explore its intervention strategy. By analyzing the transcriptomes of single cells from the Cd34-CreERT2;R26-tdTomato heart, we illustrated the dynamics of cell landscape during the progression of heart hypertrophy, including CD34+ cells, fibroblasts, endothelial cells and immune cells. And Our study also provides a cellular landscape of CD34+ cell-derived cells in the hypertrophy heart of animal models.
-
12 GSE236585 将八周龄雄性C57BL/6N小鼠随机分为HFpEF组与对照组,HFpEF组接受高脂肪饮食及L-NAME 0.5 g/L饮用水处理,对照组为正常饮食与水。两组均维持12小时光照/黑暗周期。5周后通过心脏超声评估射血分数与舒张功能,随后用过量CO2麻醉处死小鼠,分离心脏并去除心房组织,每组获取3个单细胞测序样本和5个bulk RNA-seq样本,检测心室组织转录组特征并比较两组差异。
设计将八周龄雄性C57BL/6N小鼠随机分为HFpEF组与对照组,HFpEF组接受高脂肪饮食及L-NAME 0.5 g/L饮用水处理,对照组为正常饮食与水。两组均维持12小时光照/黑暗周期。5周后通过心脏超声评估射血分数与舒张功能,随后用过量CO2麻醉处死小鼠,分离心脏并去除心房组织,每组获取3个单细胞测序样本和5个bulk RNA-seq样本,检测心室组织转录组特征并比较两组差异。
摘要Heart failure with preserved ejection fraction (HFpEF) is a complex, heterogeneous disease involving multiple cellular lineages and mechanisms. Here, we aimed to characterize the cellular heterogeneity and potential mechanisms of HFpEF at single-cell resolution.
-
13 GSE247261 在3-5月龄C57BL/6J小鼠心脏组织中,对mEFSK阳性心脏成纤维细胞进行单细胞RNA测序和ATAC-seq,比较BET溴结构域抑制、Brd4条件性缺失及Il1b基因缺失处理下的转录组与染色质可及性差异。
设计在3-5月龄C57BL/6J小鼠心脏组织中,对mEFSK阳性心脏成纤维细胞进行单细胞RNA测序和ATAC-seq,比较BET溴结构域抑制、Brd4条件性缺失及Il1b基因缺失处理下的转录组与染色质可及性差异。
摘要Chronic inflammation and tissue fibrosis are common stress responses that worsen organ function, yet the molecular mechanisms governing their crosstalk are poorly understood. In diseased organs, stress-induced changes in gene expression fuel maladaptive cell state transitions and pathological interaction between diverse cellular compartments. Although chronic fibroblast activation worsens dysfunction of lung, liver, kidney, and heart, and exacerbates many cancers, the stress-sensing mechanisms initiating the transcriptional activation of fibroblasts are not well understood. Here, we show that conditional deletion of the transcription co-activator Brd4 in infiltrating Cx3cr1-positive myeloid cells ameliorates heart failure and is associated with a dramatic reduction in fibroblast activation. Analysis of single-cell chromatin accessibility and BRD4 occupancy in vivo in Cx3cr1-positive cells identified a large enhancer proximal to Interleukin-1 beta (Il1b), and a series of CRISPR deletions revealed the precise stress-dependent regulatory element that controlled expression of Il1b in disease. Secreted IL1B functioned non-cell autonomously to activate a p65/RELA-dependent enhancer near the transcription factor MEOX1, resulting in a profibrotic response in human cardiac fibroblasts. In vivo, antibody-mediated IL1B neutralization improved cardiac function and tissue fibrosis in heart failure. Mechanistically, systemic IL1B inhibition or targeted Il1b deletion in Cx3cr1-positive cells prevented stress-induced expression of MEOX1 and inhibited fibroblast activation. The elucidation of BRD4-dependent crosstalk between a specific immune cell subset and fibroblasts through IL1B provides new therapeutic strategies for heart disease and other disorders of chronic inflammation and maladaptive tissue remodeling.
-
14 GSE315590 对接受横纹肌切除术(TAC)或假手术(Sham)处理的小鼠心脏组织进行单细胞RNA测序,分别在手术后5天、8周和16周取样。在5天和16周时间点,将心肌细胞富集(CM)与非心肌细胞富集(NCM)样本单独处理,比较不同时间点及处理组间的细胞转录特征变化。
设计对接受横纹肌切除术(TAC)或假手术(Sham)处理的小鼠心脏组织进行单细胞RNA测序,分别在手术后5天、8周和16周取样。在5天和16周时间点,将心肌细胞富集(CM)与非心肌细胞富集(NCM)样本单独处理,比较不同时间点及处理组间的细胞转录特征变化。
摘要Single-cell RNA sequencing of mouse hearts subjected to transverse aortic constriction (TAC) or sham surgery to characterize the temporal progression of cardiac remodeling from homeostasis through compensated hypertrophy to pathological heart failure. Hearts were harvested at three timepoints (5 days, 8 weeks, and 16 weeks) post-surgery to capture progressive cellular and transcriptional changes during pressure overload-induced heart failure.
-
15 GSE331341 将雄性小鼠分为正常饮食组和HFpEF诱导饮食组(L-NAME联合高脂肪饮食,7周),采集心室组织进行单核RNA测序,比较两组基因表达差异。共6个样本,按总单位数与组数估计每组3个。
设计将雄性小鼠分为正常饮食组和HFpEF诱导饮食组(L-NAME联合高脂肪饮食,7周),采集心室组织进行单核RNA测序,比较两组基因表达差异。共6个样本,按总单位数与组数估计每组3个。
摘要Single cell or single nuclei RNA-sequencing (snRNAseq) enables high-resolution profiling of cellular states, but sample preparation is often costly and complicated by debris formation and cell clumping. We describe a cost-effective approach using commercially available buffers and standard laboratory equipment to isolate high-quality nuclei from diseased cardiac tissue for reproducible downstream snRNAseq analysis. In addition, we include a previously unpublished heart failure with preserved ejection fraction (HFpEF) vs Chow dataset generated using this protocol.
-
16 GSE180736 对心力衰竭小鼠模型中分离的心脏内皮细胞进行单细胞RNA测序,比较Sham手术组与TAC处理后1周组的转录组差异,并通过Ribo-Tag测序验证翻译水平变化。
设计对心力衰竭小鼠模型中分离的心脏内皮细胞进行单细胞RNA测序,比较Sham手术组与TAC处理后1周组的转录组差异,并通过Ribo-Tag测序验证翻译水平变化。
摘要Pathological processes underlying pressure overload triggered heart failure were mainly analyzed from a cardiomyocyte centric view. To identify new cellular mechanisms, we isolated cardiomyocytes, endothelial cells and fibroblasts as most abundant cardiac cell types from mice in the subacute and chronic stages of pressure overload (by transverse aortic constriction, TAC) and performed RNA-sequencing. We detected highly cell-type specific transcriptional responses with characteristic time courses and active intercellular communication, especially early after TAC. We focused on endothelial cells, and single-cell sequencing in this population showed enhanced expression of collagens and inflammatory mediators at this stage. Importantly, these endothelial transcriptional changes were transduced to the translational level as shown by Ribo-Tag sequencing and verification of collagen protein production by cardiac endothelial cells. In conclusion, we provide a resource of cardiac cellular gene expression in pressure overload and reveal the induction of collagens by endothelial cells as potential therapeutic target.
-
17 GSE211166 对心力衰竭保存射血分数(HFpEF)小鼠模型的心脏免疫细胞进行单细胞RNA测序,比较DOCA-salt处理组与假手术对照组的基因表达差异。心脏组织经机械与酶解消化分离免疫细胞,通过磁珠富集CD45阳性细胞,流式分选活单细胞后进行测序,每组含4个生物重复。
设计对心力衰竭保存射血分数(HFpEF)小鼠模型的心脏免疫细胞进行单细胞RNA测序,比较DOCA-salt处理组与假手术对照组的基因表达差异。心脏组织经机械与酶解消化分离免疫细胞,通过磁珠富集CD45阳性细胞,流式分选活单细胞后进行测序,每组含4个生物重复。
摘要Heart failure with preserved ejection fraction (HFpEF) is characterized by diastolic dysfunction, microvascular dysfunction and myocardial fibrosis with recent evidence implicating the immune system in orchestrating cardiac remodeling. Here, we show the mouse model of deoxycorticosterone acetate (DOCA)-salt hypertension induces key elements of HFpEF, including diastolic dysfunction, exercise intolerance, and pulmonary congestion in the setting of preserved ejection fraction. CITE-Seq analysis of cardiac immune cells reveals an altered abundance and/or transcriptional signature in multiple cell types, most notably cardiac macrophages. The DOCA-salt model results in differential expression of several known and novel genes in cardiac macrophages, including upregulation of Trem2, which was also recently implicated in obesity and atherosclerosis. The role of macrophage Trem2 in cardiac remodeling, however, is unknown. We found that mice with genetic deletion of Trem2 exhibit increased cardiac hypertrophy and decreased cardiac capillary density after DOCA-salt treatment compared to wild-type controls, and Trem2-deficient macrophages have impaired expression of pro-angiogenic gene programs. Furthermore, we found that plasma levels of soluble TREM2 are elevated in human heart failure. Together, our data suggest a novel cardioprotective role for macrophage Trem2 in cardiac remodeling and heart failure and provide an atlas for the identification of additional targets that can lead to improved diagnostic and therapeutic strategies for HFpEF.
-
18 GSE275031 对小鼠心脏间质细胞进行单细胞RNA测序,比较HFpEF模型(高脂饮食和L-NAME处理)与对照组的基因表达差异。研究对象为心室组织,分组包括2个对照组和2个HFpEF组,每组样本数按总单位数与组数估计。检测方式为单细胞RNA测序,主要比较两组间的转录特征差异。
设计对小鼠心脏间质细胞进行单细胞RNA测序,比较HFpEF模型(高脂饮食和L-NAME处理)与对照组的基因表达差异。研究对象为心室组织,分组包括2个对照组和2个HFpEF组,每组样本数按总单位数与组数估计。检测方式为单细胞RNA测序,主要比较两组间的转录特征差异。
摘要Inflammation, fibrosis and metabolic stress critically promote heart failure with preserved ejection fraction (HFpEF). Exposure to high-fat diet and nitric oxide synthase inhibitor N[w]-nitro-l-arginine methyl ester (L-NAME) recapitulate features of HFpEF in mice. To identify disease specific traits during adverse remodeling, we profiled interstitial cells in early murine HFpEF using single-cell RNAseq (scRNAseq). Diastolic dysfunction and perivascular fibrosis were accompanied by an activation of cardiac fibroblast and macrophage subsets. Integration of fibroblasts from HFpEF with two murine models for heart failure with reduced ejection fraction (HFrEF) identified a catalog of conserved fibroblast phenotypes across mouse models. Moreover, HFpEF specific characteristics included induced metabolic, hypoxic and inflammatory transcription factors and pathways, including enhanced expression of Angiopoietin-like 4 (Angptl4) next to basement membrane compounds, such as collagen IV (Col4a1). Fibroblast activation was further dissected into transcriptional and compositional shifts and thereby highly responsive cell states for each HF model were identified. In contrast to HFrEF, where myofibroblast and matrifibrocyte activation were crucial features, we found that these cell states played a subsidiary role in early HFpEF. These disease-specific fibroblast signatures were corroborated in human myocardial bulk transcriptomes. Furthermore, we identified a potential cross-talk between macrophages and fibroblasts via SPP1 and TNFɑ with estimated fibroblast target genes including Col4a1 and Angptl4. Treatment with recombinant ANGPTL4 ameliorated the murine HFpEF phenotype and diastolic dysfunction by reducing collagen IV deposition from fibroblasts in vivo and in vitro. In line, ANGPTL4, was elevated in plasma samples of HFpEF patients and particularly high levels associated with a preserved global longitudinal strain. Taken together, our study provides a comprehensive characterization of molecular fibroblast activation patterns in murine HFpEF, as well as the identification of Angiopoietin-like 4 as central mechanistic regulator with protective effects.
-
19 GSE308210 对小鼠心脏组织进行单核 RNA 测序,将对照组与非肥胖 HFpEF 模型组分别进行比较,模型组通过结合异丙肾上腺素(ISO)诱导的交感神经激活和 L-NAME 诱导的内皮功能障碍建立,对照组为未处理小鼠。样本数为 4,按总单位数与组数估计每组 2 个样本。
设计对小鼠心脏组织进行单核 RNA 测序,将对照组与非肥胖 HFpEF 模型组分别进行比较,模型组通过结合异丙肾上腺素(ISO)诱导的交感神经激活和 L-NAME 诱导的内皮功能障碍建立,对照组为未处理小鼠。样本数为 4,按总单位数与组数估计每组 2 个样本。
摘要Heart failure with preserved ejection fraction (HFpEF) is a leading cause of morbidity and mortality worldwide; nonetheless, effective therapies remain elusive. In Western populations, HFpEF is typically obesity-related, whereas in Asia it frequently develops in non-obese patients with hypertension and underlying mechanisms are poorly defined. Here, analysis of two Japanese hospital cohorts revealed that obesity and metabolic comorbidities are uncommon in HFpEF, while sympathetic overactivation and hypertension predominated. To model this condition, we combined isoproterenol (ISO)–induced sympathetic activation with L-arginine methyl ester (L-NAME)-induced endothelial dysfunction, establishing the first non-obese HFpEF mouse model. These mice exhibited hallmark HFpEF features, whereas ISO alone caused hypertensive heart disease (HHD) without HFpEF, indicating that a "second hit" is essential for HFpEF progression. HFpEF mice showed expansion and reprogramming of cardiac macrophages to Pla2g7⁺ phenotypes and fibroblast activation via PDGF signaling, as loss of Timd4⁺ resident macrophages impaired cardiomyocyte energetics due to diminished BMP signaling. These outcomes drove maladaptive remodeling and inflammation, which precedes HFpEF onset. Notably, inhibition of the inflammatory mediator ANGPTL2 attenuated cardiac inflammation and prevented HFpEF progression. Our findings identify hypertensive stress-induced macrophage reprogramming as a central mechanism of non-obese HFpEF and highlight cardiac inflammation as a promising therapeutic target.
-
20 GSE317186 将R26-stop-tdTomato小鼠与内皮特异性SR-B1缺失小鼠杂交生成三重转基因及内皮谱系追踪小鼠,包含NC Sfl/fl/RΔEC vs NC Sfl/+/RΔEC或HFpEF Sfl/fl/RΔEC vs HFpEF Sfl/+/RΔEC分组。通过FACS分选心脏左心室RFP阳性内皮细胞进行单细胞RNA测序,比较不同基因型下处理组与对照组的转录组差异。研究对象为心脏内皮细胞,检测方式为单细胞RNA测序,分组基于SR-B1基因型与饮食处理条件。
设计将R26-stop-tdTomato小鼠与内皮特异性SR-B1缺失小鼠杂交生成三重转基因及内皮谱系追踪小鼠,包含NC Sfl/fl/RΔEC vs NC Sfl/+/RΔEC或HFpEF Sfl/fl/RΔEC vs HFpEF Sfl/+/RΔEC分组。通过FACS分选心脏左心室RFP阳性内皮细胞进行单细胞RNA测序,比较不同基因型下处理组与对照组的转录组差异。研究对象为心脏内皮细胞,检测方式为单细胞RNA测序,分组基于SR-B1基因型与饮食处理条件。
摘要Cardiac microvascular endothelial cells (CMECs) dysfunction is a well-recognized mediator of heart failure with preserved ejection fraction (HFpEF), but the underlying mechanism remains unclear. Here we find that scavenger receptor class B type I (SR-B1) is predominantly expressed in CMECs and decreased significantly in HFpEF. Endothelial-specific SR-B1 deficiency exacerbates cardiac pathological remodeling and diastolic dysfunction in HFpEF, which can be prevented by endothelial SR-B1 reconstitution through adeno-associated virus serotype 1 (AAV1)-mediated delivery in endothelial-specific SR-B1-deficient mice. Single-cardiac-endothelial-cell transcriptomics and lineage-tracing system reveal that inflammatory CMECs subcluster activation is responsible for the deteriorating HFpEF progression induced by endothelial SR-B1 loss, rather than endothelial-to-mesenchymal transition. Mechanistically, SR-B1 loss drives increased CXCL10 secretion, which orchestrates CMECs activation and CXCR3-positive T-cell cardiotropism to promote diastolic dysfunction—a process associated with endothelial IRF1 activation. Most importantly, the SR-B1-CXCL10-CXCR3 axis is activated in human HFpEF cardiac tissue, and the elevated CXCL10 level in plasma is independently associated with a higher HFpEF prevalence. This study uncovers that activation of SR-B1–CXCL10-CXCR3 axis in CMECs aggravates HFpEF pathogenesis through accumulation of CXCR3-positive T-cells in hearts.
-
21 GSE343527 对16周龄雄性C57Bl/6J小鼠的心脏组织进行单核RNA测序,研究对象为野生型(WT)和miR_210敲除小鼠,分别接受假手术(sham)和横主动脉缩窄(TAC)处理,每组5个生物重复。采集手术后四周的心脏组织,分离心脏细胞核,使用10x Genomics Chromium Single Cell 3′平台进行测序,比较不同基因型与处理组的转录组差异。
设计对16周龄雄性C57Bl/6J小鼠的心脏组织进行单核RNA测序,研究对象为野生型(WT)和miR_210敲除小鼠,分别接受假手术(sham)和横主动脉缩窄(TAC)处理,每组5个生物重复。采集手术后四周的心脏组织,分离心脏细胞核,使用10x Genomics Chromium Single Cell 3′平台进行测序,比较不同基因型与处理组的转录组差异。
摘要Pressure overload_induced heart failure is associated with extensive cellular remodeling in the heart. To investigate the cell type_specific transcriptional responses regulated by miR_210, single_nucleus RNA sequencing (snRNA_seq) was performed on heart tissues collected from wild_type and miR_210 knockout mice subjected to sham surgery or transverse aortic constriction (TAC). This dataset provides transcriptomic profiles of major cardiac cell populations and can be used to characterize cellular heterogeneity and molecular pathways associated with pressure overload_induced cardiac remodeling.
鼠源空转
Mouse · Spatial
-
01 GSE318772 对心力衰竭小鼠心脏组织进行转录组分析,比较治疗组与未治疗组的转录特征变化。采用 Nanostring 数字空间分析技术,检测总 RNA 的表达情况,研究对象为心肌梗死模型小鼠心脏,分组包括未治疗组和生物制剂治疗组。
设计对心力衰竭小鼠心脏组织进行转录组分析,比较治疗组与未治疗组的转录特征变化。采用 Nanostring 数字空间分析技术,检测总 RNA 的表达情况,研究对象为心肌梗死模型小鼠心脏,分组包括未治疗组和生物制剂治疗组。
摘要Chronic heart failure remains a global epidemic without a cure. We report a first-in-class biologic that induces myocardial repair through multiple coordinated pathways including immune cell activation, anti-inflammation, and stromal cell recruitment to promote extracellular matrix (ECM) remodeling. Proteomics reveals a signature enriched in ECM reorganization and immune-modulatory pathways. The biologic acts in a site-specific, biphasic repair program: (1) an initial immune activation phase and (2) resolution characterized by the emergence of TREM2+ reparative macrophages and recruitment of stromal cells. These processes re-establish a regenerative milieu reminiscent of the neonatal heart. By integrating immune, stromal, and cardiomyocyte crosstalk, the biologic establishes a durable pro-reparative microenvironment that restores myocardial structure and function. This immune-guided strategy is a new paradigm for treating chronic ischemic heart failure.
鼠源bulk 转录组
Mouse · Bulk RNA-seq
-
01 GSE348752 对7周龄雄性HFpEF小鼠的心室组织进行RNA测序,实验在扩展的BXD品系面板中开展。所有小鼠接受高脂饮食加L-NAME处理7周,采集心室组织进行RNA-Seq分析,比较不同BXD品系间的转录组差异。
设计对7周龄雄性HFpEF小鼠的心室组织进行RNA测序,实验在扩展的BXD品系面板中开展。所有小鼠接受高脂饮食加L-NAME处理7周,采集心室组织进行RNA-Seq分析,比较不同BXD品系间的转录组差异。
摘要Systems genetics strategy across multiple Hybrid Mouse Diversity Panel (HMDP) cohorts. RNA sequencing of ventricles from HFpEF mice was performed primarily in an expanded panel of BXD strains, together with a small number of classic inbred strains. This submission represents the expanded BXD component of the HFpEF HMDP project.
-
02 GSE670 对心力衰竭(HF)小鼠模型及转基因救援组(betaARKct)和正常组进行左心室基因表达分析,使用微阵列技术比较各组差异。研究包含12只正常小鼠、12只心力衰竭小鼠及12只转基因救援小鼠的左心室总RNA样本,共53个生物样本,通过Affymetrix Mu11K芯片检测,分析基因表达谱在不同状态下的变化。
设计对心力衰竭(HF)小鼠模型及转基因救援组(betaARKct)和正常组进行左心室基因表达分析,使用微阵列技术比较各组差异。研究包含12只正常小鼠、12只心力衰竭小鼠及12只转基因救援小鼠的左心室总RNA样本,共53个生物样本,通过Affymetrix Mu11K芯片检测,分析基因表达谱在不同状态下的变化。
摘要Numerous murine models of heart failure (HF) have been described, many of which develop progressive deterioration of cardiac function. We have recently demonstrated that several of these can be "rescued" or prevented by transgenic cardiac expression of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARKct). To uncover genomic changes associated with cardiomyopathy and/or its phenotypic rescue by the betaARKct, oligonucleotide microarray analysis of left ventricular (LV) gene expression was performed in a total of 53 samples, including 12 each of Normal, HF, and Rescue. Multiple statistical analyses demonstrated significant differences between all groups, and further demonstrated that betaARKct Rescue returned gene expression toward that of Normal. In our statistical analyses, we found that the HF phenotype is blindly predictable based solely on gene expression profile. To investigate the progression of HF, LV gene expression was determined in young mice with mildly diminished cardiac function and in older mice with severely impaired cardiac function. Interestingly, mild and advanced HF mice shared similar gene expression profiles and, importantly, the mild HF mice were predicted as having a HF phenotype when blindly subjected to our predictive model described above. These data not only validate our predictive model, but further demonstrate that, in these mice, the HF gene expression profile appears to already be set in the early stages of HF progression. Thus, we have identified methodologies that have the potential to be used for predictive genomic profiling of cardiac phenotype, including cardiovascular disease. Keywords: other
-
03 GSE49937 对携带SR-BI-/- apoE-/-双基因敲除(dKO)或SR-BI+/- apoE-/-杂合(HET)基因型的小鼠心脏组织,按21、31、43天龄分组,采用标准饮食或Probucol饮食处理,进行微阵列分析,比较不同年龄和处理条件下基因表达差异。
设计对携带SR-BI-/- apoE-/-双基因敲除(dKO)或SR-BI+/- apoE-/-杂合(HET)基因型的小鼠心脏组织,按21、31、43天龄分组,采用标准饮食或Probucol饮食处理,进行微阵列分析,比较不同年龄和处理条件下基因表达差异。
摘要Mice with homozygous null mutations in the HDL receptor (SR-BI) and apoE genes (SR-BI KO/apoE double KO (dKO) mice) spontaneously develop occlusive, atherosclerotic coronary artery disease (CAD) and die prematurely (50% mortality at 42 days of age) on standard chow diet feeding. Microarray analysis was performed to investigate the changes in gene expression profiles during the development of spontaneous severe CAD, which includes myocardial infarction and heart failure. These data will provide new insights in understanding the pathophysiology of CAD.
-
04 GSE66630 对心力衰竭小鼠模型进行转录组动态分析,比较野生型(WT)与 Ndufs4 基因敲除(ndufs4H-/-)小鼠在主动脉缩窄术(TAC)和假手术(Sham)处理下,于手术后 1 周、2 周、4 周、8 周四个时间点采集心脏组织的 RNA-Seq 数据,以分析疾病进展阶段的转录组变化。
设计对心力衰竭小鼠模型进行转录组动态分析,比较野生型(WT)与 Ndufs4 基因敲除(ndufs4H-/-)小鼠在主动脉缩窄术(TAC)和假手术(Sham)处理下,于手术后 1 周、2 周、4 周、8 周四个时间点采集心脏组织的 RNA-Seq 数据,以分析疾病进展阶段的转录组变化。
摘要Comprehensive knowledge of the dynamic changes in the cardiac transciptome can inform disease mechanism. Previous transcriptome profiling studies on heart failure rely on either microarray or RNA-Seq with low coverage, leaving a large portion of the transcriptome unexplored. Additionally, previous studies only examined two end stages of the disease, onset and late-stage heart failure. Profile of the transcriptome in the middle stage of disease progression can reveal critical molecular events underlying disease transition. Towards these goals, we conducted a multi-factorial RNA-Seq experiment, comparing the dynamic changes in the transcriptome of two murine models of heart failure, pressure overload and loss of mitochondrial complex I. Our data represents the deepest transcriptome coverage to date, covering onset, progression, and late stage of the disease. We found extensive differences in the expression magnitude and dynamics of the transciptomes in different heart failure models. In addition, such differences are associated with progressive worsening of cardiac physiology. Our analysis revealed that mitochondrial dysfunction combined with stress leads to increased number of differentially expressed long intergenic noncoding RNAs, including a recently identified lincRNA that is a master regulator of the cardiac lineage during development.
-
05 GSE207648 对Tgαq*44小鼠与同龄FVB小鼠心脏组织(左心室尖端)进行RNA测序,比较不同年龄(4、8、10、12、14个月)下两组基因表达差异;同时对老年FVB小鼠(8、10、12、14个月)与年轻4月龄FVB小鼠心脏组织进行RNA测序比较,分析老化相关基因表达变化。所有样本按年龄分组,采用RNA-Seq技术检测转录组差异,通过Gene Ontology数据库注释基因到生物过程并评估过表达情况。
设计对Tgαq*44小鼠与同龄FVB小鼠心脏组织(左心室尖端)进行RNA测序,比较不同年龄(4、8、10、12、14个月)下两组基因表达差异;同时对老年FVB小鼠(8、10、12、14个月)与年轻4月龄FVB小鼠心脏组织进行RNA测序比较,分析老化相关基因表达变化。所有样本按年龄分组,采用RNA-Seq技术检测转录组差异,通过Gene Ontology数据库注释基因到生物过程并评估过表达情况。
摘要To investigate ageing-related changes in cardiac transcriptome of FVB mice we performed differential gene expression profiling analysis using data obtained from RNA-seq of five life time points (4-, 8-, 10-, 12-, 14 months) by comparing older FVB mice (8-, 10-, 12-, 14 months) to young 4-month-old FVB mice (FVB vs. FVB analysis). Genes that were differentially expressed in FVB vs. FVB analysis were also annotated to the respective biological processes based on Gene Ontology database, assessed for their overrepresentation to indicate processes involved in cardic ageing process in FVB mice. To investigate heart failure-related as well as ageing-related changes in cardiac transcriptome of Tgαq*44 mice we performed differential gene expression profiling analysis using data obtained from RNA-seq of five life time points (4-, 8-, 10-, 12-, 14 months) by comparing Tgαq*44 to age-matched FVB mice (Tgαq*44 vs. FVB analysis). Genes that were differentially expressed in Tgαq*44 vs. FVB analysis were also annotated to the respective biological processes based on Gene Ontology database, assessed for their overrepresentation to indicate processes iniciated along heart failure development as well as cardiac ageing process in Tgαq*44 mice. To investigate early activated ageing-related changes in cardiac transcriptome of Tgαq*44 mice during entire heart failure development we searched for the presence of ageing-related genes (those identified in cardiac transcriptome of older FVB mice) among genes which were differentially expressed commonly at each measured time points in Tgαq*44 vs. FVB analysis. To investigate early activated aging-related biological processes in cardiac transcriptome of Tgαq*44 mice during entire heart failure development, we searched for the presence of ageing-related processes (those identified in cardiac transcriptome of older FVB mice) among processes which were overrepresented commonly at each measured time points in Tgαq*44 vs. FVB analysis.
-
06 GSE284286 对40周龄的LARP6转基因或野生型C57BL/6J小鼠心脏组织进行RNA-seq测序,比较转基因与野生型小鼠在Ang II输注(1000 ng/kg/min,21天)与生理盐水处理下的基因表达差异。研究对象为心肌细胞来源的LARP6,检测方式包括RNA测序与免疫组化,主要比较转基因与野生型小鼠在高血压应激下的心脏重塑及纤维化变化。
设计对40周龄的LARP6转基因或野生型C57BL/6J小鼠心脏组织进行RNA-seq测序,比较转基因与野生型小鼠在Ang II输注(1000 ng/kg/min,21天)与生理盐水处理下的基因表达差异。研究对象为心肌细胞来源的LARP6,检测方式包括RNA测序与免疫组化,主要比较转基因与野生型小鼠在高血压应激下的心脏重塑及纤维化变化。
摘要La ribonucleoprotein 6, Translational Regulator (LARP6), a multifunctional mRNA binding protein with well-described pro-fibrotic effects, increases type I collagen mRNA half-life, translation, and deposition in non-cardiac tissues. In the heart LARP6 is expressed in cardiomyocytes, not primarily involved in fibrosis, where its role is unknown. To investigate the role of cardiomyocyte-derived LARP6 on cardiac function and remodeling, we generated a cardiomyocyte-specific LARP6 overexpressing transgenic mouse model (LARP6-Tg). Baseline longitudinal studies up to 10 months of age revealed that constitutive overexpression of LARP6 had no significant effect on cardiac function or morphology despite inducing mild interstitial fibrosis versus wild-type littermates (WT). Subsequently, we hypothesized that cardiomyocyte-specific LARP6-Tg mice would exhibit exacerbated cardiac remodeling and dysfunction in response to hypertensive stress via angiotensin II (Ang II) infusion. Ang II (1000 ng/kg/min for 21 days) induced hypertension and cardiac hypertrophy in WT and LARP6-Tg mice of both sexes. Unexpectedly, Ang II-induced cardiac dysfunction was prevented in LARP6-Tg mice. Cardiac gene expression profiling predicted increased fibrosis and cardiomyocyte death in Ang II-treated WT mice and inhibition of cardiomyocyte death in Ang II-treated LARP6-Tg mice, versus saline-treated controls. Surprisingly, Ang II-induced interstitial fibrosis was reduced in LARP6-Tg mice and associated with attenuation of cardiomyocyte cell death and reduced myofibroblast activation. These data support a mild pro-fibrotic action of cardiomyocyte LARP6 in unstressed mice and, paradoxically, that LARP6 overexpression is sufficient to prevent Ang II-induced cardiac interstitial fibrosis and dysfunction. Sustained induction of LARP6 has therapeutic potential in hypertensive heart disease.
-
07 GSE152005 对心力衰竭小鼠模型的左心室组织、心脏非心肌细胞及心肌细胞进行RNA测序,比较JQ1处理组与相应vehicle对照组在不同年龄和疾病阶段的基因表达差异。
-
08 GSE68857 将3个月龄的PKCε转基因小鼠与非转基因FVB/N小鼠按基因型分组,各组接受抗CTGF抗体FG-3149或非免疫IgG处理,持续3个月。采集左心室组织进行基因表达分析,比较转基因与非转基因小鼠在不同处理条件下的基因表达差异。
设计将3个月龄的PKCε转基因小鼠与非转基因FVB/N小鼠按基因型分组,各组接受抗CTGF抗体FG-3149或非免疫IgG处理,持续3个月。采集左心室组织进行基因表达分析,比较转基因与非转基因小鼠在不同处理条件下的基因表达差异。
摘要Cardiac structural changes associated with dilated cardiomyopathy (DCM) include cardiomyocyte hypertrophy and myocardial fibrosis. Connective Tissue Growth Factor (CTGF) has been associated with tissue remodeling and is highly expressed in failing hearts. To test if inhibition of CTGF would alter the course of cardiac remodeling and preserve cardiac function in the protein kinase Cε (PKCε) mouse model of DCM. Transgenic mice expressing constitutively active PKCε in cardiomyocytes develop cardiac dysfunction that was evident by 3 months of age, and that progressed to heart failure, cardiac fibrosis, and increased mortality. Beginning at 3 months of age, mice were treated with an antibody to CTGF (FG-3149) or non-immune IgG control antibody for an additional 3 months. CTGF inhibition significantly improved left ventricular (LV) systolic and diastolic function in PKCε mice, and slowed the progression of LV dilatation. Using gene arrays and quantitative PCR, the expression of many genes associated with tissue remodeling were elevated in PKCε mice, but significantly decreased by CTGF inhibition, however total collagen deposition was not attenuated. The observation of significantly improved LV function by CTGF inhibition in PKCε mice suggests that CTGF inhibition may benefit patients with DCM.
-
09 GSE168610 对携带磷脂烷 p.(Arg14del) 病变的小鼠左心室组织进行转录组分析,比较野生型(wt)与 PLN-R14del 纯合突变型小鼠在 3 周、5 周、8 周龄时的基因表达差异,并与缺血再灌注(I/R)损伤、心肌梗死(MI)手术及假手术(sham)模型进行对比。样本包括 3 周龄 wt 左心室、PLN-R14del 纯合突变型左心室;5 周龄 wt 左心室、PLN-R14del 纯合突变型左心室;8 周龄 wt 左心室、PLN-R14del 杂合突变型左心室及纯合突变型左心室,同时包含 I/R 损伤 3 天后、MI 手术 8 周后及 sham 手术 3 天后、8 周后的左心室组织。检测方式为 RNA 测序,样本量为 39 个 GSM 记录。
设计对携带磷脂烷 p.(Arg14del) 病变的小鼠左心室组织进行转录组分析,比较野生型(wt)与 PLN-R14del 纯合突变型小鼠在 3 周、5 周、8 周龄时的基因表达差异,并与缺血再灌注(I/R)损伤、心肌梗死(MI)手术及假手术(sham)模型进行对比。样本包括 3 周龄 wt 左心室、PLN-R14del 纯合突变型左心室;5 周龄 wt 左心室、PLN-R14del 纯合突变型左心室;8 周龄 wt 左心室、PLN-R14del 杂合突变型左心室及纯合突变型左心室,同时包含 I/R 损伤 3 天后、MI 手术 8 周后及 sham 手术 3 天后、8 周后的左心室组织。检测方式为 RNA 测序,样本量为 39 个 GSM 记录。
摘要Background: The p.(Arg14del) pathogenic variant (R14del) of the phospholamban (PLN) gene is a prevalent cause of cardiomyopathy with heart failure. The exact underlying pathophysiology is unknown, and a suitable therapy is unavailable. We aim to identify molecular perturbations underlying this cardiomyopathy in a clinically relevant PLN-R14del mouse model. Methods: We investigated progression of cardiomyopathy in PLN-R14∆/∆ mice using echocardiography, electrocardiography and histological tissue analysis. RNA sequencing and mass spectrometry were performed on cardiac tissues at 3 weeks of age (before onset of disease), 5 weeks (mild cardiomyopathy), and 8 weeks (end-stage). Data were compared with cardiac expression levels of mice that underwent myocardial ischemia-reperfusion or myocardial infarction surgery, in an effort to identify alterations that are specific to PLN-R14del-related cardiomyopathy. Results: At 3 weeks of age, PLN-R14∆/∆ mice had normal cardiac function, but from the age of 4 weeks, we observed increased myocardial fibrosis and impaired global longitudinal strain. From 5 weeks onwards, ventricular dilatation, decreased contractility and diminished electrocardiogram voltages were observed. Strikingly, PLN protein aggregation was present prior to onset of functional deficits. Transcriptomics and proteomics revealed differential regulation of processes involved in remodeling, inflammation and metabolic dysfunction, in part similar to ischemic cardiomyopathy. Altered protein homeostasis pathways were identified exclusively in PLN-R14∆/∆ mice, even before disease onset, in concert with aggregate formation. Conclusions: We mapped the development of PLN-R14del-related cardiomyopathy, and identified alterations in proteostasis and PLN protein aggregation amongst the first manifestations of this disease, which could possibly be a novel target for therapy.
-
10 GSE245034 对C57BL6小鼠左心室组织进行RNA测序,比较长期治疗后3个月的对照组(非心衰,n=8)、HFpEF模型组(n=8)、HFpEF+TYA-018处理组(n=11)和HFpEF+Empagliflozin处理组(n=11)的基因表达差异。研究采用bulk RNA-seq技术,样本经TRI Reagent裂解后提取总RNA,经DNase I处理并用Direct-zol-96 RNA Kit纯化,最终通过SuperScript III系统合成cDNA进行测序。
设计对C57BL6小鼠左心室组织进行RNA测序,比较长期治疗后3个月的对照组(非心衰,n=8)、HFpEF模型组(n=8)、HFpEF+TYA-018处理组(n=11)和HFpEF+Empagliflozin处理组(n=11)的基因表达差异。研究采用bulk RNA-seq技术,样本经TRI Reagent裂解后提取总RNA,经DNase I处理并用Direct-zol-96 RNA Kit纯化,最终通过SuperScript III系统合成cDNA进行测序。
摘要Heart failure with preserved ejection fraction (HFpEF) is a prevalent health condition associated with high morbidity and mortality, but currently, there are few effective therapies. Our previous research showed that inhibiting histone deacetylase 6 (HDAC6) had a beneficial effect on a genetic cardiomyopathy model. The overlapping underlying mechanisms involving inflammation and metabolism between cardiomyopathy and HFpEF prompted us to explore the role of HDAC6 in HFpEF. The results showed that inhibiting HDAC6 with TYA-018 reversed preexisting cardiac hypertrophy and diastolic dysfunction, and improved lung congestion and exercise capacity in mouse models of HFpEF, including a newly developed model that combines moderate trans-aortic constriction and high-fat diet to mimic the systemic and cardiovascular features of human HFpEF. Moreover, mice with genetic Hdac6 deletion delayed the development of HFpEF and were resistant to the effects of TYA-018. The efficacy of TYA-018 was comparable to a SGLT2 inhibitor, and the combination showed increased effects. Mechanistically, TYA-018 restored expression of gene sets associated with hypertrophy, fibrosis, and mitochondrial energy production in heart tissue from HFpEF mice. TYA-018 also inhibited activation of human cardiac fibroblasts and increased mitochondrial respiratory capacity in induced pluripotent stem cell–derived cardiomyocytes. These findings support the direct role of HDAC6 on HFpEF pathophysiology in the heart and that inhibiting HDAC6 may be a promising approach to treating HFpEF.
-
11 GSE107569 对小鼠心脏左心室组织进行表达分析,比较不同处理组在4周和6周收获时的基因表达差异。处理组包括:TAC+MI处理后0周与2周sham手术、TAC+MI处理后0周与2周TAC移除、以及0周sham手术与2周sham手术,所有样本在4周或6周收获。
-
12 GSE234210 对心肌细胞特异性过表达 SIRT4 的转基因小鼠(cSirt4-Tg)及对照小鼠(Control)进行横主动脉缩窄(TAC)或假手术处理,并给予 Vehicle 或 MitoQ 治疗,采集全心组织进行 RNA 测序,比较不同基因型与处理组间的转录差异。
设计对心肌细胞特异性过表达 SIRT4 的转基因小鼠(cSirt4-Tg)及对照小鼠(Control)进行横主动脉缩窄(TAC)或假手术处理,并给予 Vehicle 或 MitoQ 治疗,采集全心组织进行 RNA 测序,比较不同基因型与处理组间的转录差异。
摘要Sirtuin 4 (SIRT4) is a mitochondrially-localized stress-responsive NAD+-dependent deacylase predominantly regulating energy metabolism and ROS homeostasis. While SIRT4 has been implicated in pathological cardiac hypertrophy, underlying mechanisms remain incompletely understood. Here, we show that myocardial expression of SIRT4 was decreased in individuals with severe dilated cardiomyopathy (-73%) but was relatively higher in subjects with concomitant type 2 diabetes (T2D; +56%). To evaluate consequences and mechanisms of altered myocardial SIRT4 expression, mice with global Sirt4 deletion (Sirt4-/-) or cardiomyocyte-specific Sirt4 overexpression (cSirt4-Tg) underwent transverse aortic constriction (TAC) or sham procedures. Cardiac structure and function were similar in Sirt4-/- and WT mice 12 weeks following TAC, whereas cSirt4-Tg mice displayed aggravated cardiac dilation, dysfunction, and fibrosis following TAC. Transcriptional analysis using RNA sequencing revealed synergistic upregulation of collagens and profibrotic regulators in TAC-treated cSirt4-Tg mice, including transforming growth factor beta (TGF), connective tissue growth factor (CTGF), or follistatin-like 1 (Fstl1). These alterations were reversed by mitochondria-targeted antioxidant treatment using MitoQ, along with attenuation of cardiac dysfunction and remodeling, and reversal of tissue fibrosis. SIRT4 overexpression may drive oxidative stress and fibrotic signaling via synergistically increased NOX4 expression (> 7-fold), and/or direct modulation of SIRT4 targets newly identified by protoarray experiments, including calcitonin gene-related peptide (CGRP) receptor component protein (RCP), cyclophilin A, and interleukin-2 receptor β. Thus, SIRT4 overexpression aggravates cardiac remodeling and dysfunction in response to chronic pressure overload by ROS-mediated enhancement of profibrotic transcriptional signaling, suggesting that relatively higher SIRT4 expression may aggravate heart failure development in individuals with concomitant T2D.
-
13 GSE3383 对心力衰竭相关转基因小鼠心脏组织进行时间序列基因表达分析,比较Akt1激活前、诱导后2周、诱导2周后抑制2天、诱导6周及诱导6周后抑制2周的转录组变化。研究对象为Tet-myrAkt1/?MHC-tTA转基因雄性小鼠,按不同Akt1诱导/抑制时间点分组,采集心脏组织进行DNA微阵列检测,分析短期与长期Akt1激活对心脏转录特征的影响及代偿性肥大向心力衰竭过渡的基因表达差异。
设计对心力衰竭相关转基因小鼠心脏组织进行时间序列基因表达分析,比较Akt1激活前、诱导后2周、诱导2周后抑制2天、诱导6周及诱导6周后抑制2周的转录组变化。研究对象为Tet-myrAkt1/?MHC-tTA转基因雄性小鼠,按不同Akt1诱导/抑制时间点分组,采集心脏组织进行DNA微阵列检测,分析短期与长期Akt1激活对心脏转录特征的影响及代偿性肥大向心力衰竭过渡的基因表达差异。
摘要To investigate molecular mechanisms involved in the development of cardiac hypertrophy and heart failure, a tetracycline-regulated transgenic system to conditionally switch a constitutively-active form of the Akt1 protein kinase on or off in the adult heart was developed. Short-term activation (2 weeks) of Akt1 resulted in completely reversible hypertrophy with maintained contractility. In contrast, chronic Akt1 activation (6 weeks) induced extensive cardiac hypertrophy, severe contractile dysfunction, and massive interstitial fibrosis. The focus of this study was to create a transcript expression profile of the heart as it undergoes reversible Akt1-mediated hypertrophy and during the transition from compensated hypertrophy to heart failure. Heart tissue was analyzed before transgene induction, 2 weeks after transgene induction, 2 weeks of transgene induction followed by 2 days of repression, 6 weeks after transgene induction and 6 weeks of transgene induction followed by 2 weeks of repression. Acute over expression of Akt1 (2 weeks) leads to changes in the expression of 826 transcripts relative to non-induced hearts, whereas chronic induction (6 weeks) led to changes in the expression of 1611, of which 65% represented transcripts that were regulated during the pathological phase of heart growth. Another set of genes identified were uniquely regulated during heart regression but not growth, indicating that non-overlapping transcription programs participate in the processes of cardiac hypertrophy and atrophy. These data define the gene regulatory programs downstream of Akt that control heart size and contribute to the transition from compensatory hypertrophy to heart failure. Keywords: transgenic mice, Akt1, time course, cardiac hypertrophy and contractile dysfunction, DNA microarrays
-
14 GSE194151 本研究将C57BL/6J小鼠按性别(雄性、雌性)和饮食(对照饮食或高脂肪饮食加L-NAME)分组,采集心脏组织进行RNA-Seq,比较不同性别和饮食处理组间线粒体基因表达与舒张功能的关联。研究基于Hybrid Mouse Diversity Panel(HMDP)遗传多样性模型,样本量为30。
设计本研究将C57BL/6J小鼠按性别(雄性、雌性)和饮食(对照饮食或高脂肪饮食加L-NAME)分组,采集心脏组织进行RNA-Seq,比较不同性别和饮食处理组间线粒体基因表达与舒张功能的关联。研究基于Hybrid Mouse Diversity Panel(HMDP)遗传多样性模型,样本量为30。
摘要As part of genetic studies of heart failure in mice, we observed that heart mitochondrial DNA levels and function tend to be reduced in females as compared to males. We also observed that expression of genes encoding mitochondrial proteins were higher in males than females in human cohorts. Heart failure with preserved ejection fraction (HFpEF) exhibits a sex bias, being more common in women than men, and we hypothesized that mitochondrial sex differences might underlie this bias. We tested this in a panel of genetically diverse inbred strains of mice, termed the Hybrid Mouse Diversity Panel (HMDP). Indeed, we found that mitochondrial gene expression was highly correlated with diastolic function, a key trait in HFpEF. Consistent with this, studies of a “two-hit” mouse model of HFpEF confirmed that mitochondrial function differed between sexes and was strongly associated with a number of HFpEF traits. By integrating data from human heart failure and the mouse HMDP cohort, we identified the mitochondrial protein Acsl6 as a genetic determinant of diastolic function. We validated its role in HFpEF using adenoviral over-expression in the heart. We conclude that sex differences in mitochondrial function underlie, in part, the sex bias in diastolic function.
-
15 GSE200496 对C57BL/6J雄性小鼠心脏和白色脂肪组织进行RNA-Seq,比较AAV8-F11过表达组与AAV8-GFP对照组的基因表达差异。小鼠注射AAV8-GFP或AAV8-F11后,喂养高脂饮食加l-NAME 7周,于15周龄收集组织样本。
-
16 GSE239912 对新生大鼠心室肌细胞(NRVM)进行 siRNA 敲低 ERRalpha 和 ERRgamma 或非靶向 scramble siRNA 处理,分别加入 10uM 915 或等体积溶剂(DMSO)培养 24h;同时在压力过载模型中,对小鼠实施 TAC 或 Sham 手术并注射 332 或等体积溶剂持续 6 周,采集心肌组织进行 RNA-Seq 测序,比较不同基因型与处理组间的基因表达差异。
设计对新生大鼠心室肌细胞(NRVM)进行 siRNA 敲低 ERRalpha 和 ERRgamma 或非靶向 scramble siRNA 处理,分别加入 10uM 915 或等体积溶剂(DMSO)培养 24h;同时在压力过载模型中,对小鼠实施 TAC 或 Sham 手术并注射 332 或等体积溶剂持续 6 周,采集心肌组织进行 RNA-Seq 测序,比较不同基因型与处理组间的基因表达差异。
摘要Cardiac metabolic dysfunction is a hallmark of heart failure. Estrogen related receptors ERRalpha and ERRgamma are essential regulators of cardiac metabolism. Therefore, activation of ERR could be a potential theraputic intervention for heart failure. However, in vivo studies demonstrating the potential utility of ERR agonists for heart failure treatment are lacking, as compounds with pharmackinetics appropriate for in vivo use have not been available. Using a structure-based design approach, we designed and synthesized two structurally distinct pan-ERR agonists, SLU-PP-332 (332) and SLU-PP-915 (915), which significantly improved ejection fraction, ameliorated fibrosis and increased survival associated with pressure overload-induced heart failure without affecting cardiac hypertrophy. Mechanistically, a broad spectrum of metabolic genes was transcriptionally activated by ERR agonists, particulary genes involved in fatty acid metabolism and mitochondrial function. Using both in vitro and in vivo genetic dependency experiments, we show that ERRgamma is the main mediatorof ERR agonism-induced transcriptional regulation and cardioprotection and definitively demonstrated target specificity. Additionally, ERR agonism also led to downregulation of cell cycle and development pathways, which was partially mediated by E2F1 in cardiomyocyte. In summary, ERR agonists maintain oxidative metabolism, which confers cardiac protection against pressure overload-induced heart failure in vivo. Our results provide direct pharmacological evidence supporting the further in vivo development of ERR agonists as novel heart failure theraputics.
-
17 GSE285966 对肥胖-糖尿病HFpEF小鼠模型(db/db + Aldo)及野生型对照组进行慢性恩格列净治疗,采集心脏室组织进行全基因组RNA测序,比较不同处理组间基因表达差异及心脏功能参数变化。
设计对肥胖-糖尿病HFpEF小鼠模型(db/db + Aldo)及野生型对照组进行慢性恩格列净治疗,采集心脏室组织进行全基因组RNA测序,比较不同处理组间基因表达差异及心脏功能参数变化。
摘要Effective treatments for heart failure with preserved ejection fraction (HFpEF) are limited. Empagliflozin, a sodium-glucosecotransporter-2 (SGLT2) inhibitor, provides cardiovascular benefits for patients with HFpEF. SGLT2 expression is virtually absent in cardiomyocytes, hence the exact protective mechanism of empagliflozin is unclear. We aimed to study the effect of in vivo empagliflozin treatment on excitation–contraction coupling (ECC), electrophysiology, and gene transcription in a translational two-hit HFpEF mouse model that combines the obese-diabetic leptin receptor-deficient db/db mice with chronic aldosterone infusion (db/db + Aldo). We performed morphometry, echocardiography, cardiomyocyte electrophysiology, intracellular Ca imaging, and whole-heart RNA-sequencing in empagliflozin-treated db/db + Aldo and vehicle control mice. In db/db + Aldo mice, empagliflozin (in vivo, 4weeks) reduced the elevated plasma blood glucose (13 ± 5 mmol/L versus 23 ± 8 mmol/L) and BNP levels, prevented pulmonary congestion, and ameliorated diastolic dysfunction. However, empagliflozin did not reduce cardiac hypertrophy and obesity. In healthy control mice, empagliflozin had no functional effect. Chronic in vivo empagliflozin treatment in db/db + Aldo also normalized the changes in cardiomyocyte electrophysiology and Ca handling properties measured in the absence of empagliflozin in the perfusion solution during cell experiments, indicating a true phenotypic rescue. Differentially expressed gene clusters were identified characteristic of the db/db genotype, aldosterone, and empagliflozin treatments. Interestingly, empagliflozin did not just reverse the HFpEF-altered gene expression but shifted it further away from control to a new expression profile. We conclude that chronic in vivo empagliflozin treatment restores cardiomyocyte electrophysiological and ECC properties, ameliorates diastolic function in cardiometabolic HFpEF, and induces complex gene expression changes.
-
18 GSE335239 对野生型(WT)和cMyBP-Ct/t基因型小鼠心脏组织进行RNA测序,比较两组基因表达差异。
设计对野生型(WT)和cMyBP-Ct/t基因型小鼠心脏组织进行RNA测序,比较两组基因表达差异。
摘要RNA sequencing was performed to investigate the role of inflammation and molecular changes in cardiac pathology and heart failure. Inflammation and array of fetal gene reprogramming often associated with the hypertrophied mouse hearts. To determine its functional consequences, transcriptomic profiling was used to characterize gene expression changes in a murine model of hypertrophic transition to dilated cardiomyopathy associated with loss of cMyBP-C, providing insight into the pathological pathways involved in transition from hypertrophic to dilated cardiomyopathy.
-
19 GSE56348 对3月龄雌性C57Bl6/J小鼠双心室组织进行转录组学与代谢组学分析,比较压力超负荷诱导的心肌肥大(TAC)与假手术对照、心力衰竭(HF)与假手术对照、运动训练(Run)与静息对照的差异。每个分组包含5个生物重复,检测方式为微阵列基因表达分析及代谢物通路水平测定,主要比较TAC与Sham-CH、HF与Sham-HF、Run与Sed的基因表达及代谢特征差异。
设计对3月龄雌性C57Bl6/J小鼠双心室组织进行转录组学与代谢组学分析,比较压力超负荷诱导的心肌肥大(TAC)与假手术对照、心力衰竭(HF)与假手术对照、运动训练(Run)与静息对照的差异。每个分组包含5个生物重复,检测方式为微阵列基因表达分析及代谢物通路水平测定,主要比较TAC与Sham-CH、HF与Sham-HF、Run与Sed的基因表达及代谢特征差异。
摘要Compelling evidence suggests that mitochondrial dysfunction contributes to the pathogenesis of heart failure, including defects in the substrate oxidation, and the electron transport chain (ETC) and oxidative phosphorylation (OXPHOS). However, whether such changes occur early in the development of heart failure, and are potentially involved in the pathologic events that lead to cardiac dysfunction is unknown. To address this question, we conducted transcriptomic/metabolomics profiling in hearts of mice with two progressive stages of pressure overload-induced cardiac hypetrophy: i) cardiac hypertrophy with preserved ventricular function achieved via transverse aortic constriction for 4 weeks (TAC) and ii) decompensated cardiac hypertrophy or heart failure (HF) caused by combining 4 wk TAC with a small apical myocardial infarction. Transcriptomic analyses revealed, as shown previously, downregulated expression of genes involved in mitochondrial fatty acid oxidation in both TAC and HF hearts compared to sham-operated control hearts. Surprisingly, however, there were very few changes in expression of genes involved in other mitochondrial energy transduction pathways, ETC, or OXPHOS. Metabolomic analyses demonstrated significant alterations in pathway metabolite levels in HF (but not in TAC), including elevations in acylcarnitines, a subset of amino acids, and the lactate/pyruvate ratio. In contrast, the majority of organic acids were lower than controls. This metabolite profile suggests “bottlenecks” in the carbon substrate input to the TCA cycle. This transcriptomic/metabolomic profile was markedly different from that of mice PGC-1a/b deficiency in which a global downregulation of genes involved in mitochondrial ETC and OXPHOS was noted. In addition, the transcriptomic/metabolomic signatures of HF differed markedly from that of the exercise-trained mouse heart. We conclude that in contrast to current dogma, alterations in mitochondrial metabolism that occur early in the development of heart failure reflect largely post-transcriptional mechanisms resulting in impedance to substrate flux into the TCA cycle, reflected by alterations in the metabolome.
-
20 GSE180720 从8-10周龄雄性C57Bl6N小鼠心脏中分离心肌细胞、内皮细胞和成纤维细胞,分别设置sham组与TAC处理组,TAC组在1周和8周后采集样本进行RNA-Seq和Ribo-Tag测序,检测不同细胞类型在压力过载下的转录与翻译水平变化,比较处理组与对照组的差异。
设计从8-10周龄雄性C57Bl6N小鼠心脏中分离心肌细胞、内皮细胞和成纤维细胞,分别设置sham组与TAC处理组,TAC组在1周和8周后采集样本进行RNA-Seq和Ribo-Tag测序,检测不同细胞类型在压力过载下的转录与翻译水平变化,比较处理组与对照组的差异。
摘要Pathological processes underlying pressure overload triggered heart failure were mainly analyzed from a cardiomyocyte centric view. To identify new cellular mechanisms, we isolated cardiomyocytes, endothelial cells and fibroblasts as most abundant cardiac cell types from mice in the subacute and chronic stages of pressure overload (by transverse aortic constriction, TAC) and performed RNA-sequencing. We detected highly cell-type specific transcriptional responses with characteristic time courses and active intercellular communication, especially early after TAC. We focused on endothelial cells, and single-cell sequencing in this population showed enhanced expression of collagens and inflammatory mediators at this stage. Importantly, these endothelial transcriptional changes were transduced to the translational level as shown by Ribo-Tag sequencing and verification of collagen protein production by cardiac endothelial cells. In conclusion, we provide a resource of cardiac cellular gene expression in pressure overload and reveal the induction of collagens by endothelial cells as potential therapeutic target.
-
21 GSE48110 对接受 TAC 或假手术的小鼠心脏在 3 天、11 天、28 天时间点分别进行 dmso 处理或 JQ1 处理,采集总 RNA 进行基因表达分析,比较 TAC 手术组与假手术组在不同处理条件下的基因表达差异。
设计对接受 TAC 或假手术的小鼠心脏在 3 天、11 天、28 天时间点分别进行 dmso 处理或 JQ1 处理,采集总 RNA 进行基因表达分析,比较 TAC 手术组与假手术组在不同处理条件下的基因表达差异。
摘要Heart failure (HF) is driven via interplay between master regulatory transcription factors and dynamic alterations in chromatin structure. While pathologic gene transactivation in this context is known to be associated with recruitment of histone acetyl-transferases and local chromatin hyperacetylation, the role of epigenetic reader proteins in cardiac biology is unknown. We therefore undertook a first study of acetyl-lysine reader proteins, or bromodomains, in HF. Using a chemical genetic approach, we establish a central role for BET-family bromodomain proteins in gene control during HF pathogenesis. BET inhibition potently suppresses cardiomyocyte hypertrophy in vitro and pathologic cardiac remodeling in vivo. Integrative transcriptional and epigenomic analyses reveal that BET proteins function mechanistically as pause-release factors critical to activation of canonical master regulators and effectors that are central to HF pathogenesis and relevant to the pathobiology of failing human hearts. This study implicates epigenetic readers in cardiac biology and identifies BET co-activator proteins as therapeutic targets in HF.
-
22 GSE179656 使用BAG3缺陷的诱导多能干细胞来源的心肌细胞(iPSC-CMs)和BAG3心脏敲除(BAG3cKO)小鼠模型,分别设置野生型(WT)与BAG3cKO基因型,每组接受Vehicle或TYA-018处理,采集心脏组织进行RNA-Seq分析,比较BAG3cKO处理组与相应对照组的基因表达差异。
设计使用BAG3缺陷的诱导多能干细胞来源的心肌细胞(iPSC-CMs)和BAG3心脏敲除(BAG3cKO)小鼠模型,分别设置野生型(WT)与BAG3cKO基因型,每组接受Vehicle或TYA-018处理,采集心脏组织进行RNA-Seq分析,比较BAG3cKO处理组与相应对照组的基因表达差异。
摘要Dilated cardiomyopathy (DCM) is characterized by reduced cardiac output, as well as thinning and enlargement of left ventricular chambers. These characteristics eventually lead to heart failure. Current standards of care do not target the underlying molecular mechanisms associated with genetic forms of heart failure, driving a need to develop novel therapeutics for DCM. To identify candidate therapeutics, we developed an in vitro DCM model using induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) deficient in BCL2-associated athanogene 3 (BAG3). With these BAG3-deficient iPSC-CMs, we identified cardioprotective drugs with a phenotypic screen and deep learning. Using a library of 5500 bioactive compounds and siRNA validation, we identified that inhibiting histone deacetylase 6 (HDAC6) was cardioprotective at the sarcomere level. We translated this finding to a BAG3 cardiac-knockout (BAG3cKO) mouse model of DCM, showing that inhibiting HDAC6 with two isoform-selective inhibitors (tubastatin A and a novel inhibitor TYA-018) protected heart function. In BAG3cKO and BAG3 E455K mice, HDAC6 inhibitors improved left ventricular ejection fraction and reduced left ventricular diameter at diastole and systole. We also found that HDAC6 inhibitors protected the microtubule network from mechanical damage, increased autophagic flux, decreased apoptosis, and reduced inflammation in the heart. Our results demonstrate the power of combining iPSC-CMs with phenotypic screening and deep learning to accelerate target and drug discovery, and they support the development of novel therapies that address underlying mechanisms associated with heart disease.
-
23 GSE134121 对野生型、OGA转基因、OGT转基因及OGA x OGT双转基因小鼠的心脏组织进行RNA测序,比较各组转录特征。
设计对野生型、OGA转基因、OGT转基因及OGA x OGT双转基因小鼠的心脏组织进行RNA测序,比较各组转录特征。
摘要Heart failure is a leading cause of death worldwide, and failing heart muscle is marked by increased O-GlcNAcylation (OGN). It is unknown if excessive OGN contributes to cardiomyopathy and heart failure. OGN modifies serines and threonines, total OGN levels follow cellular nutrient and metabolic flux in addition to net activity of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). We developed new transgenic mouse models with myocardial delimited over-expression of OGA and OGT, and found that OGT transgenic mice developed severe cardiomyopathy and premature death. In contrast, OGA transgenic hearts had normal function, but were resistant to pathological stress. Interbreeding OGA transgenic mice rescued cardiomyopathy and premature death in OGT transgenic mice. RNA Seq and functional studies highlighted disrupted metabolism in hearts from OGT transgenic mice that was rescued by OGA transgenic interbreeding. Here we show excessive OGN causes cardiomyopathy, identify gene programs responsive to pathological OGN, and suggest attenuation of OGN may be an effective therapy for heart failure.
-
24 GSE186081 对小鼠心脏组织进行 RNA-Seq 测序,比较运动八周、TAC 两周及 TAC 八周处理组与相应对照组的转录组差异。研究对象为 C57BL/6 小鼠,样本按 'Heart, Sedentary' 'Heart, Running' 'Heart, Sham-LVH' 'Heart, TAC-LVH' 'Heart, Sham-HF' 'Heart, TAC-HF' 分组,每组样本数按总单位数 24 与组数 6 估计。检测方式为 Illumina Casava1.8 软件处理的 RNA-Seq 数据,采集组织为心脏,检测材料为 total RNA,未明确混池方式。
设计对小鼠心脏组织进行 RNA-Seq 测序,比较运动八周、TAC 两周及 TAC 八周处理组与相应对照组的转录组差异。研究对象为 C57BL/6 小鼠,样本按 'Heart, Sedentary' 'Heart, Running' 'Heart, Sham-LVH' 'Heart, TAC-LVH' 'Heart, Sham-HF' 'Heart, TAC-HF' 分组,每组样本数按总单位数 24 与组数 6 估计。检测方式为 Illumina Casava1.8 软件处理的 RNA-Seq 数据,采集组织为心脏,检测材料为 total RNA,未明确混池方式。
摘要The heart grows in response to pathological and physiological stimuli, while the former often precedes cardiomyocyte loss and heart failure, the latter paradoxically protects the heart and enhances cardiomyogenesis. Long noncoding RNAs (lncRNAs) are important in cardiac development and disease, less is known about their roles in physiological hypertrophy or cardiomyogenesis. The purpose of this study was to compare transcriptome profilings in exercise-induced physiological cardiac growth and stress-induced pathological cardiac growth. We identified a set of lncRNAs called long noncoding exercise associated cardiac transcripts (lncExACT). One of them, lncExACT1, whose cardiac expression was downregulated after exercise but upregulated after transverse aortic constriction. Inhibition of lncExACT1 induced physiolgoical cardiac growth while overexpression of lncExACT1 induced pathological hypertrophy and heart failure.
-
25 GSE192643 将雄性 C57BL/6J 小鼠分为 Sham 和 TAC 两组以模拟心脏衰竭状态,每组再分为苯暴露组和 HEPA 过滤空气对照组,每组 6 个样本,共 24 个样本。采集小鼠心脏左心室和室间隔组织进行 RNA 测序,比较不同处理条件下心脏组织基因表达差异。
设计将雄性 C57BL/6J 小鼠分为 Sham 和 TAC 两组以模拟心脏衰竭状态,每组再分为苯暴露组和 HEPA 过滤空气对照组,每组 6 个样本,共 24 个样本。采集小鼠心脏左心室和室间隔组织进行 RNA 测序,比较不同处理条件下心脏组织基因表达差异。
摘要Benzene is a ubiquitous environmental pollutant abundant in household products, petrochemicals and cigarette smoke. Benzene is a well-known carcinogen in humans and experimental animals; however, little is known about the cardiovascular toxicity of benzene. Recent population-based studies indicate that benzene exposure is associated with an increased risk for heart failure. Nonetheless, it is unclear whether benzene exposure is sufficient to induce and/or exacerbate heart failure. We examined the effects of benzene (50 ppm, 6 h/day, 5 days/week, 6 weeks) or HEPA-filtered air exposure on transverse aortic constriction (TAC)-induced pressure overload in male C57BL/6J mice. Our data show that benzene exposure had no effect on cardiac function in the Sham group; however, it significantly compromised cardiac function as depicted by a significant decrease in fractional shortening and ejection fraction, as compared with TAC/Air-exposed mice. RNA-seq analysis of the cardiac tissue from the TAC/benzene-exposed mice showed a significant increase in several genes associated with adhesion molecules, cell-cell adhesion, inflammation, and stress response. In particular, neutrophils were implicated in our unbiased analyzes. Indeed, immunofluorescence studies showed that TAC/benzene exposure promotes infiltration of CD11b+/S100A8+/myeloperoxidase+-positive neutrophils in the hearts by 3-fold. In vitro, the benzene metabolites, hydroquinone and catechol, induced the expression of P-selectin in cardiac microvascular endothelial cells by 5-fold and increased the adhesion of neutrophils to these endothelial cells by 1.5-2.0-fold. Benzene metabolite-induced adhesion of neutrophils to the endothelial cells was attenuated by anti-P-selectin antibody. Together, these data suggest that benzene exacerbates heart failure by promoting endothelial activation and neutrophil recruitment.
-
26 GSE198036 对血管内皮细胞进行 SOX9 遗传操作,采集心脏和肺部组织进行 bulk RNA 测序,比较敲除组与野生型小鼠在 HFPEF 饮食、BLM 注射及 Chow/NaCl 处理下的基因表达差异。
设计对血管内皮细胞进行 SOX9 遗传操作,采集心脏和肺部组织进行 bulk RNA 测序,比较敲除组与野生型小鼠在 HFPEF 饮食、BLM 注射及 Chow/NaCl 处理下的基因表达差异。
摘要Chronic fibrosis is a hallmark of pathologic tissue remodelling that deteriorates organ function and eventually leads to death. Although fibroblasts are typically made responsible, it was recently suggested that endothelial cells contribute to fibrosis, although the functional importance of this phenomenon remained unclear. In this study, we addressed this question by genetic manipulation of the fibrogenic HMG-box transcription factor SOX9 specifically in vascular endothelial cells. Induced transgenic overexpression of SOX9 in these cells in mice triggered extensive fibrosis, organ growth and dysfunction in the heart, lung, liver and spleen. We found an upregulation of endogenous Sox9 in endothelial cells during cardiac, lung and liver fibrosis, and endothelial specific Sox9 deletion prevented fibrosis and organ dysfunction in mouse models of systolic and diastolic heart failure, as well as in mouse bleomycin induced pulmonary and non-alcoholic steato-hepatitis (NASH) triggered liver fibrosis. Mechanistically, a combined approach of bulk and single cell RNA sequencing of endothelial cells across multiple vascular beds revealed that Sox9 promoted the expression of extracellular matrix and matrix remodelling genes, growth factors, and inflammatory mediators, which triggered the expression of extracellular matrix directly by endothelial cells, but also activated fibroblasts. As we found the upregulation of endothelial Sox9 also in failing human hearts, we propose that endothelial Sox9 could be a target for anti-fibrotic therapy.
-
27 GSE280863 将心肌细胞特异性 Sirt5 敲除(cSirt5-/-)和过表达(cSirt5-Tg)小鼠与对照组(未表达重组酶的转基因小鼠)进行比较,分别接受横断主动脉缩窄(TAC)或假手术(Sham)处理,采集心脏组织进行超声心动图、心肌纤维化和心肌细胞大小定量分析,同时进行代谢组学分析和 RNA 测序,以评估 SIRT5 对心脏重塑和功能障碍的影响。
设计将心肌细胞特异性 Sirt5 敲除(cSirt5-/-)和过表达(cSirt5-Tg)小鼠与对照组(未表达重组酶的转基因小鼠)进行比较,分别接受横断主动脉缩窄(TAC)或假手术(Sham)处理,采集心脏组织进行超声心动图、心肌纤维化和心肌细胞大小定量分析,同时进行代谢组学分析和 RNA 测序,以评估 SIRT5 对心脏重塑和功能障碍的影响。
摘要Objectives: To explore how modulation of cardiomyocyte SIRT5 levels affects the development of pathological cardiac remodeling and dysfunction. Background: SIRT5 is a mitochondrial NAD+-dependent deacylase, which regulates metabolic enzymes upon desuccinylation, demalonylation, and deglutarylation. Its role in the development of heart failure is not completely understood. Methods: Mice with cardiomyocyte-specific Sirt5 deletion (Sirt5-/-) or Sirt5 overexpression (cSirt5-Tg) underwent transverse aortic constriction (TAC) or Sham surgery. Cardiac structure and function were assessed by echocardiography and quantification of myocardial fibrosis and cardiomyocyte cell size. Metabolomic analysis and RNA sequencing were performed to identify potential novel pathways regulated by SIRT5. Results: While cardiac structure and function were similar in cSirt5-Tg compared to control mice, cSirt5-/- mice displayed exacerbated cardiac dilation, dysfunction, and fibrosis following TAC. Accumulation of metabolites involved in purine metabolism, particularly inosine and hypoxanthine, and reductions in nucleosides, adenosine and adenine, and nucleotides, AMP and ADP, were observed in hearts of cSirt5-/- mice and following TAC. Moreover, transcriptional analysis revealed upregulation of purine-nucleoside phosphorylase (PNP) and 5' nucleotidase, ecto (NT5E) and downregulation of adenosine kinase (ADK), which is likely to contribute to enhanced degradation of purine nucleotides and resulting accumulation of inosine and hypoxanthine in hearts of cSirt5-/- mice following TAC. Lastly, reduced SIRT5 expression and protein succinylation in left-ventricular tissue of patients with heart failure correlates with reduced ADK expression. Conclusions: Loss of SIRT5 aggravates cardiac remodeling and dysfunction in response to chronic pressure-overload possibly by dysregulation of genes involved in purine and pyrimidine metabolism, resulting in impaired ATP regeneration from adenosine.
-
28 GSE7487 将非转基因小鼠、PI3K 活性降低的转基因小鼠和 PI3K 活性增强的转基因小鼠分别分为心肌梗死组和假手术组,采集心组织进行表达分析,比较不同 PI3K 活性状态下的心肌梗死组与假手术组的基因表达差异。
设计将非转基因小鼠、PI3K 活性降低的转基因小鼠和 PI3K 活性增强的转基因小鼠分别分为心肌梗死组和假手术组,采集心组织进行表达分析,比较不同 PI3K 活性状态下的心肌梗死组与假手术组的基因表达差异。
摘要Cardiac hypertrophy can lead to heart failure, and is induced either by physiological stimuli eg postnatal development, chronic exercise training or pathological stimuli eg pressure or volume overload. Majority of new therapies for heart failure has mixed outcomes. A combined mouse model and oligo-array approach are used to examine whether phosphoinositide 3-kinase (p110-alpha isoform) activity is critical for maintenance of cardiac function and long-term survival in a setting of heart failure. The significance and expected outcome are to recognise genes involved in models of heart failure ie pathological- vs physiology-hypertrophy, and examine the molecular mechanisms responsible for such activity. Growth of the heart can be induced by physiological stimuli e.g., postnatal development, chronic exercise training, or pathological stimuli e.g., pressure or volume overload. Physiological hypertrophy (“good”) is characterised by a normal organisation of cardiac structure, and normal or enhanced cardiac function. In comparison, pathological hypertrophy (”bad”) is associated with fibrosis, cardiac dysfunction, and increased morbidity and mortality. The mechanistic process which allows the heart to enlarge in response to physiological stimuli while maintaining normal or enhanced function is of great clinical relevance because one potential therapeutic strategy is to inhibit the pathological growth process while augmenting the physiological growth process. One of the major process that regulate heart size is by phosphoinositide 3-kinase (PI3K). Thus the end goal of this project is to determine whether the p110 alpha isoform of PI3K could be a potential tool for augmenting physiological growth and improving cardiac function of the failing diseased heart, and to examine the underlying mechanisms responsible. Keywords: Disease progression analysis
-
29 GSE284354 对两种 HFpEF 动物模型小鼠的全心组织进行 RNA 测序,比较 HFD+L-NAME 处理组与正常饮食对照组、db/db+Aldo 处理组与 db/db 饲养对照组的基因表达差异,同时分析雄性与雌性小鼠间的电生理特性及收缩耦合机制变化。
设计对两种 HFpEF 动物模型小鼠的全心组织进行 RNA 测序,比较 HFD+L-NAME 处理组与正常饮食对照组、db/db+Aldo 处理组与 db/db 饲养对照组的基因表达差异,同时分析雄性与雌性小鼠间的电生理特性及收缩耦合机制变化。
摘要Heart failure (HF) with preserved ejection fraction (HFpEF) comprises heterogenous clinical phenotypes and presence of various co-morbidities. Recent two-hit translational animal models, including the hypertensive, nitrosative-stressed mice fed with high-fat diet and L-NAME (HFD+L-NAME) and the obese-diabetic leptin receptor-deficient db/db mice with excess aldosterone (db/db+Aldo), may phenocopy select subgroups of HFpEF. We systematically compared mechanisms of excitation-contraction coupling (ECC), electrophysiology, and gene transcription in these key preclinical HFpEF models and between sexes to advance translation. We performed morphometry, echocardiography, cellular electrophysiology, intracellular Ca2+ imaging, and RNA-sequencing. The multiorgan HFpEF phenotype showed key differences between the 2 models, db/db+Aldo mice were markedly obese, had severe hyperglycaemia and hepatomegaly, whereas male HFD+L-NAME mice had more pronounced cardiac hypertrophy. Diastolic dysfunction was more severe in db/db+Aldo mice and worse in females therein, whereas female sex was protective in HFD+L-NAME. Marked proarrhythmic action potential (AP) changes (AP prolongation, increased short-term variability and alternans threshold) occurred in db/db+Aldo (in both sexes), these AP changes were less severe in male HFD+L-NAME and absent in female HFD+L-NAME. In line with these, differential ionic current and Ca2+ handling changes occurred between these two HFpEF models and between sexes in each model. RNA-sequencing revealed highly distinctive gene expression profiles between HFpEF models. We conclude that marked differences exist in cardiomyocyte ECC, electrophysiology, and gene expression between HFD+L-NAME and db/db+Aldo mice and between sexes. This indicates that a combination of translational HFpEF models that mimic select HFpEF sub-phenogroups are needed to better understand HFpEF mechanisms for therapeutic drug development.
-
30 GSE134085 将野生型(WT)和VCP转基因(TG)小鼠的左心室组织分别在sham手术后2周及TAC术后2周收集,进行转录组分析。比较两种基因型在sham和TAC处理下的基因表达差异。
设计将野生型(WT)和VCP转基因(TG)小鼠的左心室组织分别在sham手术后2周及TAC术后2周收集,进行转录组分析。比较两种基因型在sham和TAC处理下的基因表达差异。
摘要This sstudy was designed to investigate the gene netweork regulated by valosin-containing protein (VCP), an ATPase-associated protein, whic acts as a novel regulator against the cardiac stress of pressure overload. We performed transcriptome analyses to compare cardiac-specific VCP overexpression transgenic (TG) mice and wild-type (WT) mice in a series of pathological models. The left ventricular (LV) tissues were collected from both WT and VCP TG mice at 2w post TAC and at 2w post sham operations. mRNA was extracted and sequenced to generate gene expression profiles. Multiple comparisons were performed between VCP TG and WT mice at two treatment conditions: sham and 2w post TAC. Our studies revealed novel molecular mechanisms by which VCP protects heart against pressure overload-induced cardiac hypertrophy and the transition to the heart failure.
-
31 GSE112055 对C57BL/6J小鼠进行sham或TAC(心脏压力过载)手术,随后分别给予PDE5A或PDE9A抑制剂处理,采集左心室心肌组织进行mRNA测序,比较不同处理组与sham对照组的基因表达差异。每组样本数为5-6,共21个样本。
设计对C57BL/6J小鼠进行sham或TAC(心脏压力过载)手术,随后分别给予PDE5A或PDE9A抑制剂处理,采集左心室心肌组织进行mRNA测序,比较不同处理组与sham对照组的基因表达差异。每组样本数为5-6,共21个样本。
摘要Purpose: This study aimed to determine how two drugs, both ultimately activating the same effector kinase, may differentially modulate mRNA expression in a mouse model of cardiac pressure-overload-induced heart failure. Methods: C57Bl/6J mice were subjected to sham or TAC surgeries to induce cardiac pressure-overload and subsequent heart failure. After one week, treatment with either a PDE5A inhibitor (PDE5A-I) or PDE9A inhibitor (PDE9A-I) was initiated and continued for 4 weeks, with cardiac functional measurements to assess treatment efficacy occurring weekly. At 5 weeks after surgery, mice were sacrificed and myocardium collected. Left ventricular myocardium was used for RNA isolation and subsequent mRNA sequencing on an Illumina HiSeq 2500. Data was aligned using HISAT2 v2.0.5, and transcript counts were quantified using RSEM v1.3.0. Count data was further analyzed for differential expression using Bioconductor's DESeq2 package (v1.18.1). Results and Conclusions: Our study details how two treatments, both targeting the same kinase and with similar phenotypic improvements, result in similar pathways being altered, albeit often through modulation of different genes in the pathway. Our data demonstrates how subcellular compartmentalization of signaling pathway components can differentially impact gene expression, while still ultimately converging on similar overall effects on modification of cellular signaling.
-
32 GSE262105 将雄性小鼠分为 vehicle 组、sema treatment 组、TAC+vehicle 组和 TAC+sema 组,其中 TAC 组接受压力超载手术,其余组接受相应药物处理。所有小鼠在超声后按 60.0 mg/kg/day 剂量持续注射 8 或 4 周,采集心脏左心室组织进行 RNA 测序,比较各组间基因表达差异。
设计将雄性小鼠分为 vehicle 组、sema treatment 组、TAC+vehicle 组和 TAC+sema 组,其中 TAC 组接受压力超载手术,其余组接受相应药物处理。所有小鼠在超声后按 60.0 mg/kg/day 剂量持续注射 8 或 4 周,采集心脏左心室组织进行 RNA 测序,比较各组间基因表达差异。
摘要Semaglutide, a glucagon-like peptide-1 receptor agonist, is clinically used as a glucose-lowering and weight loss medication due to its effects on energy metabolism. In heart failure, energy production is impaired due to altered mitochondrial function and increased glycolysis. However, the impact of semaglutide on cardiomyocyte metabolism under pressure overload remains unclear. Here we demonstrate that semaglutide improves cardiac function and reduces hypertrophy and fibrosis in a mouse model of pressure overload-induced heart failure. Semaglutide preserves mitochondrial structure and function under chronic stress. Metabolomics reveals that semaglutide reduces mitochondrial damage, lipid accumulation, and ATP deficiency by promoting pyruvate entry into the tricarboxylic acid cycle and increasing fatty acid oxidation. Transcriptional analysis shows that semaglutide regulates myocardial energy metabolism through the Creb5/NR4a1 axis in the PI3K/AKT pathway, reducing NR4a1 expression and its translocation to mitochondria. NR4a1 knockdown ameliorates mitochondrial dysfunction and abnormal glucose and lipid metabolism in the heart. These findings suggest that semaglutide may be a therapeutic agent for improving cardiac remodeling by modulating energy metabolism.
-
33 GSE310767 将雄性 C57BL/6 小鼠按不同时间点开始低水平迷走神经刺激(LL-VNS)进行分组,采集左心室组织进行 RNA 测序,比较各组基因表达差异。
设计将雄性 C57BL/6 小鼠按不同时间点开始低水平迷走神经刺激(LL-VNS)进行分组,采集左心室组织进行 RNA 测序,比较各组基因表达差异。
摘要Heart failure (HF) affects approximately 56 million people worldwide with a 5-year mortality rate exceeding 50%. This study investigated the molecular mechanisms underlying the cardioprotective effects of low-level vagus nerve stimulation (LL-VNS) delivered via a biodegradable triboelectric nanogenerator (BTENG) in a murine aortic banding model. Male C57BL/6 mice underwent aortic banding surgery to induce pressure overload-induced heart failure. LL-VNS treatment (4 μA peak-to-peak, 2 Hz) was initiated at different timepoints (1, 2, or 4 weeks post-surgery) to evaluate stage-specific therapeutic effects. Two stimulation durations (10 or 20 minutes daily) were tested for the 1-week intervention group. RNA sequencing was performed on cardiac tissue collected at 8 weeks post-surgery to identify gene expression changes and pathway alterations. Results demonstrate that LL-VNS significantly modulates extracellular matrix remodeling, programmed cell death, and muscle structure development pathways across different intervention timepoints, providing molecular evidence for its therapeutic efficacy in preventing and reversing cardiac remodeling and heart failure progression.
-
34 GSE5500 研究对象为小鼠心脏组织,采用 Gata4 杂合缺失模型(G4D)与野生型(WT)小鼠进行比较。将 G4D 和 WT 小鼠在基础状态及压力过载(TAC)处理后采集样本,通过 RNA 测序检测基因表达差异,重点比较 TAC 处理下两组小鼠心脏肥大模式及纤维化、凋亡相关基因变化。
设计研究对象为小鼠心脏组织,采用 Gata4 杂合缺失模型(G4D)与野生型(WT)小鼠进行比较。将 G4D 和 WT 小鼠在基础状态及压力过载(TAC)处理后采集样本,通过 RNA 测序检测基因表达差异,重点比较 TAC 处理下两组小鼠心脏肥大模式及纤维化、凋亡相关基因变化。
摘要An important event in the pathogenesis of heart failure is the development of pathological cardiac hypertrophy. In cultured cardiac cardiomyocytes, the transcription factor Gata4 is required for agonist-induced cardiomyocyte hypertrophy. We hypothesized that in the intact organism Gata4 is an important regulator of postnatal heart function and of the hypertrophic response of the heart to pathological stress. To test this hypothesis, we studied mice heterozygous for deletion of the second exon of Gata4 (G4D). At baseline, G4D mice had mild systolic and diastolic dysfunction associated with reduced heart weight and decreased cardiomyocyte number. After transverse aortic constriction (TAC), G4D mice developed overt heart failure and eccentric cardiac hypertrophy, associated with significantly increased fibrosis and cardiomyocyte apoptosis. Inhibition of apoptosis by overexpression of the insulin-like growth factor 1 receptor prevented TAC-induced heart failure in G4D mice. Unlike WT-TAC controls, G4D-TAC cardiomyocytes hypertrophied by increasing in length more than width. Gene expression profiling revealed upregulation of genes associated with apoptosis and fibrosis, including members of the TGF? pathway. Our data demonstrate that Gata4 is essential for cardiac function in the postnatal heart. After pressure overload, Gata4 regulates the pattern of cardiomyocyte hypertrophy and protects the heart from load-induced failure. Keywords: genetic modification, pressure overload stress response
-
35 GSE200665 对心肌细胞特异性 Wnt5a 敲除小鼠与对照小鼠的心脏样本进行 RNA 测序,比较压力过载条件下两组间机械敏感基因表达差异。实验组为 Wnt5a floxed 与 Myh6-Cre/Esr 1 联合基因型小鼠,对照组为 Wnt5a floxed 小鼠,分别接受 TAC 手术、假手术或无手术处理,采集心脏组织进行转录组分析。
设计对心肌细胞特异性 Wnt5a 敲除小鼠与对照小鼠的心脏样本进行 RNA 测序,比较压力过载条件下两组间机械敏感基因表达差异。实验组为 Wnt5a floxed 与 Myh6-Cre/Esr 1 联合基因型小鼠,对照组为 Wnt5a floxed 小鼠,分别接受 TAC 手术、假手术或无手术处理,采集心脏组织进行转录组分析。
摘要Non-canonical Wnt signaling activated by Wnt5a and Wnt11 is required for the development of second heart field cardiac progenitor cells in mice. However, the pathophysiological role of non-canonical Wnt signaling in the adult heart has not been fully elucidated. Here we show that cardiomyocyte-specific Wnt5a knockout mice exhibit improved systolic function and reduced expression of mechanosensitive genes including Nppb compared to control mice when subjected to pressure overload. In cultured cardiac myocytes, Wnt5a knockdown reduces the upregulation of Nppb gene expression and YAP nuclear translocation induced by cyclic cell stretch. Wnt5a knockdown-induced Nppb downregulation in response to cell stretch is rescued by inhibition of Hippo pathway, and the rescue effect of Hippo inhibition is canceled by YAP knockdown. These results collectively suggest that Wnt5a-YAP signaling axis mediates mechanotransduction in cardiac myocytes and contributes to the transition to heart failure.
-
36 GSE247576 对20周龄心肌组织和骨骼肌样本进行RNA测序,比较野生型小鼠与TAFAZZIN敲低小鼠的基因表达差异。心肌组织和骨骼肌均来自接受多西环素处理的转基因小鼠,野生型小鼠同步接受相同处理。检测方式为150bp配对端RNA-Seq,总样本数20个。
设计对20周龄心肌组织和骨骼肌样本进行RNA测序,比较野生型小鼠与TAFAZZIN敲低小鼠的基因表达差异。心肌组织和骨骼肌均来自接受多西环素处理的转基因小鼠,野生型小鼠同步接受相同处理。检测方式为150bp配对端RNA-Seq,总样本数20个。
摘要Barth Syndrome (BTHS) is an inherited cardiomyopathy caused by defects in the mitochondrial transacylase TAFAZZIN (Taz), required for the synthesis of the phospholipid cardiolipin. BTHS is characterized by heart failure, increased propensity for arrhythmias and a blunted inotropic reserve. Defects in Ca2+-induced Krebs cycle activation contribute to these functional defects, but despite oxidation of pyridine nucleotides, no oxidative stress developed in the heart. Here, we investigated how retrograde signaling pathways orchestrate metabolic rewiring to compensate for mitochondrial defects. In mice with an inducible knockdown (KD) of TAFAZZIN, mitochondrial uptake and oxidation of fatty acids was strongly decreased, while glucose uptake was increased. Unbiased transcriptomic analyses revealed that the activation of the eIF2/ATF4 axis of the integrated stress response upregulates one-carbon metabolism, which diverts glycolytic intermediates towards the biosynthesis of serine and fuels the biosynthesis of glutathione. In addition, strong upregulation of the glutamate/cystine antiporter xCT increases cardiac cystine import required for glutathione synthesis. Increased glutamate uptake facilitates anaplerotic replenishment of the Krebs cycle, sustaining energy production and antioxidative pathways. These data indicate that ATF4-driven rewiring of metabolism compensates for defects in mitochondrial uptake of fatty acids to sustain energy production and antioxidation.
-
37 GSE302867 将野生型和 cardiomyocyte PGC-1α 敲除型小鼠按静止与 6 周耐力训练分组,采集心脏组织进行 RNA-Seq,比较各组间基因表达差异及运动训练对 PGC-1α 敲除小鼠心脏适应性的影响。
设计将野生型和 cardiomyocyte PGC-1α 敲除型小鼠按静止与 6 周耐力训练分组,采集心脏组织进行 RNA-Seq,比较各组间基因表达差异及运动训练对 PGC-1α 敲除小鼠心脏适应性的影响。
摘要Endurance exercise promotes adaptive growth and improved function of cardiomyocytes, which is supported by increased mitochondrial activity. In skeletal muscle, these benefits are coordinated by the transcriptional protein peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). The importance of PGC-1α to exercise-induced adaptations in the heart has been unclear. Here, we show that deleting PGC-1α specifically in cardiomyocytes prevents the expected benefits from exercise and instead confers heart failure after just six weeks of training. Supporting this, rare genetic variants in the human PPARGC1A gene, which encodes PGC-1α, are associated with risk of heart failure in the UK Biobank. We identify the stress-induced cytokine growth-differentiation factor 15 (GDF15) as a key factor increased in PGC-1α–deficient hearts that contributes to this dysfunction. Blocking cardiac Gdf15 expression improves cardiac performance and exercise capacity in these mice. Finally, in human heart tissue, lower cardiomyocyte PGC-1α expression is associated with higher GDF15 and with fewer cardiomyocytes. These findings implicate a crucial role for cardiomyocyte PGC-1α in enabling healthy heart adaptation to exercise in part through suppression of GDF15.
-
38 GSE107567 将11周龄雌性C57BL/6小鼠分为三组:接受假手术(sham)的对照组(n=6)、TAC+MI后保持束带(HF_shDB,n=7)和TAC+MI后去带(HF_DB,n=6)。在4周时采集心脏左心室组织,通过转录组分析比较各组基因表达差异。评估LV重塑通过2D超声心动图在TAC+MI后14天及去带后2周进行。
设计将11周龄雌性C57BL/6小鼠分为三组:接受假手术(sham)的对照组(n=6)、TAC+MI后保持束带(HF_shDB,n=7)和TAC+MI后去带(HF_DB,n=6)。在4周时采集心脏左心室组织,通过转录组分析比较各组基因表达差异。评估LV重塑通过2D超声心动图在TAC+MI后14天及去带后2周进行。
摘要Wild type, female, C57BL/6 mice were subjected to sham (n=6) surgery, or TAC + MI to cause progressive LV remodeling (n=13). At 2wks post-TAC, one group of mice underwent de-banding (HF-DB, n=6), whereas in a second group of mice the band remained intact (HF_shDB; n = 7). LV remodeling was evaluated by 2D echocardiography at 14 days post-TAC+MI , and 2 wks post-debanding. At 4 wks the hearts were excised and analyzed for changes in gene expression using transcriptional profiling.
-
39 GSE36074 对七周龄雄性 C57BL/6 小鼠进行主动脉结扎(AB)或假手术(sAB)处理,4 周后处死,根据肺重和左心房直径(LAD)将 AB 小鼠分为无心力衰竭(ABnonHF)和心力衰竭(ABHF)组,采集左心室心肌组织进行表达分析,比较 ABnonHF 与 ABHF 组的 ECM 成分调控差异。
设计对七周龄雄性 C57BL/6 小鼠进行主动脉结扎(AB)或假手术(sAB)处理,4 周后处死,根据肺重和左心房直径(LAD)将 AB 小鼠分为无心力衰竭(ABnonHF)和心力衰竭(ABHF)组,采集左心室心肌组织进行表达分析,比较 ABnonHF 与 ABHF 组的 ECM 成分调控差异。
摘要The aim of the present study was to examine potential differences in the regulation of myocardial ECM constituents, in mice that develop hypertrophy only (ABnonHF) and in mice that develop overt heart failure (ABHF) as response to pressure overload. Seven weeks old male C57BL/6 mice were subjected to aortic banding (AB) or sham operation (sAB), with sacrifice 4 weeks after banding. Prior to sacrifice, cardiac function and geometry were evaluated by echocardiography. Animals with comparable gradients over the banded ascending aorta, comparable cardiac output and heart rate were divided into two groups: ABnonHF and ABHF. Our criterion for dividing AB animals into these two groups was based on lung weight and left atrial diameter (LAD), as an increase in these parameters most likely is due to pulmonary congestion. Heart failure (HF) was defined as an increase in lung weight and LAD defining ABnonHF as lung weight/tibia length ≤ 10.5 mg/mm and LAD ≤ 2.0 mm and ABHF as lung weight/tibia length ≥ 15 mg/mm and LAD ≥ 2.4 mm.
-
40 GSE54681 对心力衰竭发展及恢复阶段的小鼠左心室心肌组织进行全基因组基因表达分析,采集非失败对照组(基线)、心脏损伤后2天、3天、10天及28天的样本,比较不同时间点的基因表达差异。研究对象为表达突变雌激素受体-Cre的小鼠,通过tamoxifen给药诱导短暂性心肌病,样本包括5个非失败对照组、3个Tamoxifen处理2天组、3个Tamoxifen处理3天组、3个Tamoxifen处理5天后持续5天正常饮食组及4个Tamoxifen处理5天后持续23天正常饮食组,检测方式为基于微阵列的基因表达分析。
设计对心力衰竭发展及恢复阶段的小鼠左心室心肌组织进行全基因组基因表达分析,采集非失败对照组(基线)、心脏损伤后2天、3天、10天及28天的样本,比较不同时间点的基因表达差异。研究对象为表达突变雌激素受体-Cre的小鼠,通过tamoxifen给药诱导短暂性心肌病,样本包括5个非失败对照组、3个Tamoxifen处理2天组、3个Tamoxifen处理3天组、3个Tamoxifen处理5天后持续5天正常饮食组及4个Tamoxifen处理5天后持续23天正常饮食组,检测方式为基于微阵列的基因表达分析。
摘要Altered myocardial gene expression from heart failure (HF) has mostly been identified by single-point analysis of end-stage disease. This may miss earlier changes in gene expression that are transient and/or directionally opposite to those observed later. By sampling left ventricular myocardial tissue at different time points in a mouse model of cardiomyopathy, we examined differentially expressed transcripts between non-failing controls, early-HF (2 and 3 days after cardiac insult), peak-HF (10 days) and after recovery from HF (28 days). As a results, we found that gene expression followed varying patterns: Downregulation of metabolic pathways occurred early and was sustained into late stage-HF. In contrast, most signaling pathways undergo a complex biphasic pattern: Calcium signaling, p53, apoptosis and MAP-kinase pathways displayed a bi-directional response, declining early but rising late, while NF-κB-related transcription displayed the opposite pattern. The HF-induced transcriptomic changes were reversed after recovery at 28 days. We conclude that the myocardial transcriptome in evolving HF displays distinct and dynamic transcript clusters. Therapies targeting different phases of HF should consider these dynamic features when identifying high-value targets.
-
41 GSE100532 对成年小鼠心脏组织进行RNA测序,分别采集野生型对照组和Salv条件性敲除组在假手术或左前降支冠状动脉结扎处理后的样本,采用总全心RNA和翻译核糖体亲和纯化(TRAP)方法分离心肌细胞特异性mRNA,比较两种基因型在不同处理条件下的转录组差异。
设计对成年小鼠心脏组织进行RNA测序,分别采集野生型对照组和Salv条件性敲除组在假手术或左前降支冠状动脉结扎处理后的样本,采用总全心RNA和翻译核糖体亲和纯化(TRAP)方法分离心肌细胞特异性mRNA,比较两种基因型在不同处理条件下的转录组差异。
摘要Mammalian organs vary widely in regenerative capacity, and poorly regenerative organs, such as the heart are particularly vulnerable to organ failure. Once established, heart failure commonly results in in considerable mortality and early demise. The Hippo pathway, a kinase cascade that prevents adult cardiomyocyte proliferation and regeneration, is upregulated in human heart failure. We show that deletion of the Hippo pathway component Salvador (Salv) in mouse hearts with established ischemic heart failure after myocardial infarction induced a reparative genetic program characterized by increased scar border vascularity, reduced fibrosis, and recovery of pumping function to that of sham-operated controls. To isolate cardiomyocyte specific translating mRNA we used TRAP (translating ribosomal affinity purification) followed by RNA sequencing. Hippo deficient cardiomyocytes had increased expression of proliferative, and stress response genes. Interestingly the mitochondrial quality control gene, Park2 was among the stress response genes. Further genetic studies indicated that Park2 was essential for heart repair in both the neonatal mouse and the adult Salv conditional knockout mouse. Thus, suggesting a requirement for mitochondrial quality control in the regenerating myocardium. Our findings indicate that the failing heart has a previously unrecognized capacity for repair involving more than cardiomyocyte renewal.
-
42 GSE107568 将雌性C57BL/6小鼠按不同处理分组:HF组接受持续6周的TAC+MI处理,HF-DB组在2周TAC+MI后解除结扎并持续4周,sham组在TAC+MI和解除结扎时均接受假手术。所有样本在6周时采集左心室组织进行转录组分析,比较各组基因表达差异。HF-DB组与HF组均来自13周龄小鼠,sham组未明确年龄。检测方式为转录组测序,未说明具体技术平台。
设计将雌性C57BL/6小鼠按不同处理分组:HF组接受持续6周的TAC+MI处理,HF-DB组在2周TAC+MI后解除结扎并持续4周,sham组在TAC+MI和解除结扎时均接受假手术。所有样本在6周时采集左心室组织进行转录组分析,比较各组基因表达差异。HF-DB组与HF组均来自13周龄小鼠,sham组未明确年龄。检测方式为转录组测序,未说明具体技术平台。
摘要Wild type, female, C57BL/6 mice were subjected to sham (n=6) surgery, or TAC + MI to cause progressive LV remodeling (n=12). At 2wks post-TAC, one group of mice underwent de-banding (HF-DB, n=6), whereas in a second group of mice the band remained intact (HF; n = 6). LV remodeling was evaluated by 2D echocardiography at 14 days post-TAC+MI , and 4 wks post-debanding. At 6 wks the hearts were excised and analyzed for changes in gene expression using transcriptional profiling. e-banding in the HF-DB mice resulted in normalization of LV volumes and LV mass, and normalization of cardiac myocyte hypertrophy at 6wks, without significant changes in myofibrillar collagen in the HF and HF-DB mice. Both LV ejection fraction (LVEF) and LV radial strain improved numerically following de-banding; however, both measurements remained significantly depressed in the HF-DB mice compared to sham, and were not significantly different from HF mice at 6wks. Reverse LV remodeling in the HF-DB mouse hearts was accompanied by a partial (80%) normalization of the genes that became dysregulated during LV remodeling, whereas 20% of genes remained persistently dysregulated following reverse LV remodeling.
-
43 GSE164353 对小鼠左心室组织进行MeDIP-Seq、RNA-Seq和YTHDC1-RIPSeq检测,比较野生型(WT)与Ythdc1敲除(KO)组的mRNA表达差异。研究对象为C57BL/6小鼠,样本量按总单位数与组数估计为每组9个,采用polyA RNA作为测序材料,通过RiboMinus Eukaryote Kit去除rRNA建立RNA-seq库。
设计对小鼠左心室组织进行MeDIP-Seq、RNA-Seq和YTHDC1-RIPSeq检测,比较野生型(WT)与Ythdc1敲除(KO)组的mRNA表达差异。研究对象为C57BL/6小鼠,样本量按总单位数与组数估计为每组9个,采用polyA RNA作为测序材料,通过RiboMinus Eukaryote Kit去除rRNA建立RNA-seq库。
摘要N6-methyladenosine (m6A) is the most common internal modification in eukaryotic messenger RNAs (mRNAs) and plays essential roles in mammals. The function of this chemical modification is deciphered by m6A-specific binding proteins of the YTH family. Recent studies indicated that m6A methyltransferase METTL3 ('writer') and demethylase FTO ('eraser') play critical roles in cardiovascular diseases. However, function of m6A 'reader' proteins in the heart is still largely unknown. Here, we report that cardiac-specific ablation of Ythdc1 in postnatal heart exhibits progressive dilated cardiomyopathy, heart failure and dramatically increases the incidence of postnatal lethality. Mechanically, the transcript of Titin-the major DCM and heart failure related gene-is decorated by m6A modification and directly recognized by YTHDC1, deficiency of Ythdc1 in heart results in abnormal splicing of TTN and disarray of sarcomeric structures in the cardiomyocytes subsequently. Collectively, we demonstrated that YTHDC1-dependent TTN splicing is crucial for the postnatal heart development and cardiac function, which probably provides a potential target for treating DCM through tuning m6A modification of TTN mRNA.
-
44 GSE225008 对MLPKO小鼠与同年龄野生型小鼠的左心室中层心肌组织进行RNA-seq测序,比较三周、六周和十周龄时基因表达差异。每组样本数量为3。
设计对MLPKO小鼠与同年龄野生型小鼠的左心室中层心肌组织进行RNA-seq测序,比较三周、六周和十周龄时基因表达差异。每组样本数量为3。
摘要To investigate molecular profiles of progressive heart failure, we studied mice that lack expression of the muscle LIM protein (MLPKO). These mice showed dramatic HF progression between three and six weeks of age. We then performed gene expression profile analysis using data obtained from RNA-seq of mid wall left ventricular heart tissue from MLPKO mice and wild-type (WT) controls at three, six, and ten weeks of age (n=3 per group).
-
45 GSE234867 针对心力衰竭小鼠模型,采集心肌组织分离心肌细胞进行RNA测序。研究包含两种心力衰竭诱导方式:TAC手术(8周龄小鼠)和Ang II皮下灌注(28天)。每个模型设置三组:对照组(TAC模型接受假手术,Ang II模型接受盐水灌注)、心力衰竭组(TAC模型未处理,Ang II模型注射空载体)和JV001治疗组(注射基因治疗载体)。实验后通过RNA测序分析心肌细胞基因表达,比较治疗组与对照组差异。
设计针对心力衰竭小鼠模型,采集心肌组织分离心肌细胞进行RNA测序。研究包含两种心力衰竭诱导方式:TAC手术(8周龄小鼠)和Ang II皮下灌注(28天)。每个模型设置三组:对照组(TAC模型接受假手术,Ang II模型接受盐水灌注)、心力衰竭组(TAC模型未处理,Ang II模型注射空载体)和JV001治疗组(注射基因治疗载体)。实验后通过RNA测序分析心肌细胞基因表达,比较治疗组与对照组差异。
摘要Telomeric ends are capped to prevent activation of DNA damage response by the shelterin complex. To design a gene therapy that recap telomeric ends, engineering of the telomerase protein was considered given its preference to bind 3’ overhang terminally. We designed a pan-HF gene therapy (the modified TERT, JV001) – that acts through telomeric reprotection and restore myocardial mitochondrial biogenesis – and validate safety and efficacy in heart failure murine models. Heart failure were induced with the TAC surgery and the use of Ang II, and the study about either of the two models of heart failure consisted of three groups: control group, heart failure group, heart failure with JV001 treatment group. The control group standed for mice receiving sham surgery in the TAC study, and mice receiving saline infusion in the Ang II study. The heart failure group induced with either TAC or Ang II were injected with empty vector, for the comparison with the JV001 group. After the experiment, we employed RNA-sequencing to analyze the cardiomyocytes from the mouse models.
-
46 GSE25765 对apoE缺陷小鼠和C57BL/6J小鼠的心脏组织进行微阵列基因表达分析,比较不同年龄、压力过载时长及疾病状态下的基因表达差异。研究包含四组:(i) 18月龄apoE缺陷小鼠与同龄B6对照小鼠的 failing 心脏组织;(ii) 6月龄apoE缺陷小鼠(2个月慢性腹主动脉缩窄AAC)与同龄假手术apoE缺陷及B6对照小鼠的 failing 心脏组织;(iii) 10月龄B6小鼠(6个月AAC)与同龄假手术B6对照小鼠的 failing 心脏组织;(iv) 5月龄B6小鼠(1个月AAC)与同龄B6对照小鼠的 hypertrophic 心脏组织。检测通过微阵列平台GPL1261进行,样本采集基于 echocardiography 确定的心力衰竭指标(射血分数≤33%)及年龄匹配原则。
设计对apoE缺陷小鼠和C57BL/6J小鼠的心脏组织进行微阵列基因表达分析,比较不同年龄、压力过载时长及疾病状态下的基因表达差异。研究包含四组:(i) 18月龄apoE缺陷小鼠与同龄B6对照小鼠的 failing 心脏组织;(ii) 6月龄apoE缺陷小鼠(2个月慢性腹主动脉缩窄AAC)与同龄假手术apoE缺陷及B6对照小鼠的 failing 心脏组织;(iii) 10月龄B6小鼠(6个月AAC)与同龄假手术B6对照小鼠的 failing 心脏组织;(iv) 5月龄B6小鼠(1个月AAC)与同龄B6对照小鼠的 hypertrophic 心脏组织。检测通过微阵列平台GPL1261进行,样本采集基于 echocardiography 确定的心力衰竭指标(射血分数≤33%)及年龄匹配原则。
摘要Atherosclerosis and pressure overload are major risk factors for the development of heart failure in patients. Cardiac hypertrophy often precedes the development of heart failure. However, underlying mechanisms are incompletely understood. To investigate pathomechanisms underlying the transition from cardiac hypertrophy to heart failure we used experimental models of atherosclerosis- and pressure overload-induced cardiac hypertrophy and failure, i.e. apolipoprotein E (apoE)-deficient mice, which develop heart failure at an age of 18 months, and non-transgenic C57BL/6J (B6) mice with heart failure triggered by 6 months of pressure overload induced by abdominal aortic constriction (AAC). The development of heart failure was monitored by echocardiography, invasive hemodynamics and histology. The microarray gene expression study of cardiac genes was performed with heart tissue from failing hearts relative to hypertrophic and healthy heart tissue, respectively. The microarray study revealed that the onset of heart failure was accompanied by a strong up-regulation of cardiac lipid metabolism genes involved in fat synthesis, storage and oxidation.
-
47 GSE268984 将4周龄的Gαq转基因小鼠与野生型(WT)小鼠分别喂食含或不含SGLT2抑制剂ertugliflozin(0.5 mg/g饲料)的饮食,持续16周后取左心室组织进行RNA测序和31P NMR检测,比较基因型(Gαq vs WT)与ERTU处理的交互作用对心肌线粒体基因表达及功能的影响。
设计将4周龄的Gαq转基因小鼠与野生型(WT)小鼠分别喂食含或不含SGLT2抑制剂ertugliflozin(0.5 mg/g饲料)的饮食,持续16周后取左心室组织进行RNA测序和31P NMR检测,比较基因型(Gαq vs WT)与ERTU处理的交互作用对心肌线粒体基因表达及功能的影响。
摘要Background. Mitochondrial dysfunction with decreased ATP production and increased release of reactive oxygen species (ROS) is a hallmark of the failing heart. Although SGLT2 inhibitors have been shown to improve myocardial metabolism in the failing heart, independent of diabetes, the mechanism of this effect is not clear. Objectives. Our goal was to test the effect of the SGLT2 inhibitor ertugliflozin on mitochondrial gene expression and function in myocardium and isolated mitochondria from non-diabetic mice with dilated cardiomyopathy due to cardiac-specific over-expression of Gαq. Methods. Gαq and wild-type (WT) littermates 4 weeks of age were treated for 16 weeks with or without the SGLT2 inhibitor ertugliflozin (ERTU) formulated in the chow (0.5 mg/g chow). Results. From weeks 4 to 20, Gαq mice developed progressive cardiac hypertrophy, dilation, contractile dysfunction, myocyte apoptosis and interstitial fibrosis – all of which were prevented by ERTU treatment. Isolated cardiac mitochondria from Gαq mice had decreased maximal ATP production and increased ROS release - both of which were normalized by ERTU. In isolated beating hearts from Gαq mice, contractile reserve and high energy phosphates measured simultaneously by 31P NMR spectroscopy were decreased - and both were improved by ERTU. In Gαq mice, marked suppression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism was reversed by ERTU. Conclusions. The SGLT2 inhibitor ERTU corrected the expression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism, thereby leading to increased production of ATP, decreased release of mitochondrial ROS, and amelioration of the consequences of mitochondrial dysfunction on myocardial structure and function.
-
48 GSE304630 将 Alms1−/− (Foz/Foz) 小鼠与野生型小鼠按基因型分组,分别给予正常饮食 (Chow) 或西方饮食 (WD) 处理,持续 24 周或 12 周 WD 后转为 Chow 饮食 12 周,同步评估肝脏代谢表型与心脏左室功能变化,采集心脏左室组织进行 bulk RNA 测序并分析差异表达与通路富集,结合超声心动图、心功能检测及心肌细胞收缩性实验,比较不同处理组间心脏功能与转录组差异。
设计将 Alms1−/− (Foz/Foz) 小鼠与野生型小鼠按基因型分组,分别给予正常饮食 (Chow) 或西方饮食 (WD) 处理,持续 24 周或 12 周 WD 后转为 Chow 饮食 12 周,同步评估肝脏代谢表型与心脏左室功能变化,采集心脏左室组织进行 bulk RNA 测序并分析差异表达与通路富集,结合超声心动图、心功能检测及心肌细胞收缩性实验,比较不同处理组间心脏功能与转录组差异。
摘要Background Metabolic dysfunction-associated steatotic liver disease (MASLD) and its advanced form, MASH, are closely linked to cardiac dysfunction, particularly heart failure with preserved ejection fraction (HFpEF). However, the mechanisms underlying MASLD-associated HFpEF and its reversibility remain poorly understood, largely due to the lack of robust preclinical models. Here, we established a translational model of MASLD-associated cardiac dysfunction that recapitulates the key features of human HFpEF. We applied functional and transcriptomic analyses of the left ventricle (LV) to define the pathways associated with cardiac dysfunction and its reversibility. Methods Alms1−/− (Foz/Foz) mice and wild-type littermates were fed normal chow (NC) or Western diet (WD) for up to 36 weeks (wk). Reversibility was modeled by switching WD-fed Foz/Foz mice at 12wk back to NC for 12wk. Cardiac assessment included echocardiography, invasive hemodynamics with dobutamine stimulation, histopathology, electron microscopy and isolated cardiomyocyte contractility. LV transcriptomes were profiled by bulk RNA sequencing and analyzed by differential expression and pathway enrichment. Results Foz/Foz mice on WD for 24wk developed metabolic syndrome and MASH with advanced liver fibrosis. Cardiac phenotyping showed LV hypertrophy, impaired cardiomyocyte contractility, reduced β-adrenergic reserve, elevated plasma BNP, and increased mortality while the ejection fraction was preserved (>50%), consistent with HFpEF. The progression of cardiac dysfunction was closely associated with liver fibrosis that developed during MASH. Switching WD-fed Foz/Foz mice at 12wk to normal chow diet reversed hepatic fibrosis, restored LV function, and reduced mortality, demonstrating plasticity of the liver-heart axis. LV transcriptomic analysis revealed that cardiac impairment in these mice was associated with mitochondrial dysfunction, altered substrate utilization, extracellular matrix remodeling, and metabolic stress; pathways that are similarly dysregulated in human HFpEF. Cardiac electron microscopy revealed swollen mitochondria with disrupted cristae, which improved following dietary intervention. Conclusions Mitochondrial dysfunction and fibroinflammatory remodeling are prominent features of MASLD-associated cardiac dysfunction. Reversal of hepatic and cardiac phenotypes with dietary intervention, together with elucidation of underlying pathways, establish the Foz/Foz model as a useful translational platform for studying liver-heart axis in MASLD.
-
49 GSE4728 在压力超载诱导的心力衰竭模型中,使用Tet-myrAkt1/?MHC-tTA转基因小鼠,于主动脉缩窄前、4周和6周后采集心脏组织进行转录组分析,比较Akt激活前后的心脏转录特征变化。每个时间点进行三次独立杂交实验。
设计在压力超载诱导的心力衰竭模型中,使用Tet-myrAkt1/?MHC-tTA转基因小鼠,于主动脉缩窄前、4周和6周后采集心脏组织进行转录组分析,比较Akt激活前后的心脏转录特征变化。每个时间点进行三次独立杂交实验。
摘要Akt is a serine/threonine protein kinase that is activated by a variety of growth factors or cytokines in a PI3-kinase dependent manner. Using a conditional transgenic system in which Akt signaling can be turned on or off in the adult heart, we have recently demonstrated that short-term Akt activation induces a ‘physiological’ form of cardiac hypertrophy with enhanced coronary angiogenesis and maintained contractility. Here we tested the hypothesis that induction of physiological hypertrophy by short-term Akt activation might improve contractile function in failing hearts. When Akt signaling was transiently activated in murine hearts with impaired contractility induced by pressure overload or adriamycin treatment, contractile dysfunction was attenuated in both cases. Importantly, improvement of contractility was observed before the development of cardiac hypertrophy, indicating that Akt improves contractile dysfunction independently of its growth-promoting effects. To gain mechanistic insights into Akt-mediated positive inotropic effects, transcriptional profiles in the heart were determined in a pressure overload-induced heart failure model. Biological network analysis of differentially expressed transcripts revealed significant alterations in the expression of genes associated with cell death, and these alterations were reversed by short-term Akt activation. Thus, short-term Akt activation improves contractile dysfunction in failing hearts. This beneficial effect of Akt on contractility is hypertrophy-independent and may be mediated in part by inhibition of cell death associated with heart failure. Keywords: transgenic mice, Akt1, cardiac hypertrophy after ascending aortic constriction and contractile dysfunction, DNA microarrays
-
50 GSE591 对心脏特异性 TNF-alpha 转基因小鼠与野生型小鼠的总 RNA 进行 Affymetrix U74V2A 芯片分析,检测其在代偿性肥大和扩张型心力衰竭时间点的基因表达谱,包含 3 周、13 周和 40 周样本。
设计对心脏特异性 TNF-alpha 转基因小鼠与野生型小鼠的总 RNA 进行 Affymetrix U74V2A 芯片分析,检测其在代偿性肥大和扩张型心力衰竭时间点的基因表达谱,包含 3 周、13 周和 40 周样本。
摘要Cardiac-specific TNF-alpha transgenic mice are an excellent model to study the pathologenesis of heart failure. Affymetrix U74V2A was used to analyze the gene expression profile of male and female wildtype FVB and TNF-alpha transgenic mice at the time point of compensated hypertrophy and dilated heart failure. 3 week, 13 week and 40 week samples examined. Keywords: other
-
51 GSE336233 对12–16月龄的hMut小鼠和Ctrl小鼠心脏组织进行Bulk RNA-seq,比较两种基因型的转录组差异。
设计对12–16月龄的hMut小鼠和Ctrl小鼠心脏组织进行Bulk RNA-seq,比较两种基因型的转录组差异。
摘要Mitochondrial DNA (mtDNA) mutations accumulate with age, but their mechanistic contribution to ageing remains unclear. The classical mtDNA mutator mouse expresses a proofreading-deficient mtDNA polymerase (POLGD257A) and accumulates mtDNA mutations across all tissues leading to premature ageing. However, this model cannot resolve whether the ageing phenotype results from systemic dysfunction or cell-intrinsic effects of somatic mtDNA mutations. To overcome this limitation, we generated PolgiMut mice allowing spatial and temporal control of POLGD257A expression. We demonstrate here that mtDNA mutations induced in cardiomyocytes cause progressive contractile dysfunction and respiratory chain deficiency in the heart without accompanying systemic pathology. Proteomic analyses link cardiac mosaic OXPHOS dysfunction to a progressive immune response, characterized by upregulation of antigen-processing proteins and immune cell infiltration. In contrast, longevity-associated pathways are suppressed and uncoupled from mitochondrial and immune alterations, indicating distinct regulatory mechanisms. These findings demonstrate that mtDNA mutations can drive cardiac dysfunction and reveal a mechanistic link between mitochondrial dysfunction, immune responses and ageing.
-
52 GSE125603 对86周龄野生型和CAP2敲除小鼠心脏组织进行RNA-seq,比较其基因表达差异;同时对13周龄Loxp小鼠及L/L,Myh6-cre+小鼠进行实验,分析不同基因型的mRNA特征。实验A包含3个野生型与3个CAP2 KO样本,实验B包含5个13周龄Loxp小鼠与4个L/L,Myh6-cre+小鼠,采用Illumina GAIIx平台进行深度测序,检测方式为RNA-Seq,库类型为cDNA,主要比较不同基因型与年龄组的转录组差异。
设计对86周龄野生型和CAP2敲除小鼠心脏组织进行RNA-seq,比较其基因表达差异;同时对13周龄Loxp小鼠及L/L,Myh6-cre+小鼠进行实验,分析不同基因型的mRNA特征。实验A包含3个野生型与3个CAP2 KO样本,实验B包含5个13周龄Loxp小鼠与4个L/L,Myh6-cre+小鼠,采用Illumina GAIIx平台进行深度测序,检测方式为RNA-Seq,库类型为cDNA,主要比较不同基因型与年龄组的转录组差异。
摘要About one third of dilated cardiomyopathy (DCM) cases are caused by mutations in sarcomere or cytoskeletal proteins. Yet treating the cytoskeleton directly is not possible because drugs that bind to actin are not well tolerated. Mutations in the actin binding protein CAP2 can cause DCM and knockout mice, either whole body (CAP2 KO) or cardiomyocyte specific knockouts (CAP2 CKO), develop DCM with cardiac conduction disease. RNA-seq analysis of CAP2 KO hearts and isolated cardiomyocytes revealed over-activation of fetal genes including serum response factor (SRF) regulated genes such as Myl9 and Acta2 prior to the emergence of cardiac disease. To test if we could treat CAP2 KO mice, we synthesized and tested the SRF inhibitor CCG-1423-8u. CCG-1423-8u reduced expression of the SRF targets Myl9 and Acta2, as well as the biomarker of heart failure, NPPA. The median survival of CAP2 CKO mice was 98 days, while CCG-1423-8u treated CKO mice survived for 116 days and also maintain normal cardiac function longer. These results suggest that some forms of sudden cardiac death and cardiac conduction disease are under cytoskeletal stress and that inhibiting signaling through SRF may benefit DCM by reducing cytoskeletal stress.
-
53 GSE16243 将myo-/-小鼠与野生型小鼠心脏组织分别分为对照组和异丙肾上腺素处理组,每组8只,通过慢性异丙肾上腺素灌注诱导心脏肥大。使用40k小鼠寡核苷酸芯片分析基因表达谱,比较不同基因型处理组与对应对照组间的基因表达差异,观察心脏肥大模型下基因表达变化对心力衰竭发展的影响。
设计将myo-/-小鼠与野生型小鼠心脏组织分别分为对照组和异丙肾上腺素处理组,每组8只,通过慢性异丙肾上腺素灌注诱导心脏肥大。使用40k小鼠寡核苷酸芯片分析基因表达谱,比较不同基因型处理组与对应对照组间的基因表达差异,观察心脏肥大模型下基因表达变化对心力衰竭发展的影响。
摘要Myoglobin knockout mice (myo-/-) adapt to the loss of myoglobin by the activation of a variety of compensatory mechanisms on the structural and functional level. In order to analyze to what extent myo-/- mice would tolerate cardiac stress we used the model of chronic isoproterenol application to induce cardiac hypertrophy in myo-/- mice and wild type (WT) controls. After 14 d of isoproterenol infusion cardiac hypertrophy in WT and myo-/- mice reached a similar level. WT mice developed lung oedema and left ventricular dilatation indicating the development of heart failure. In contrast, myo-/- mice displayed conserved cardiac function and no signs of heart failure. Analysis of the cardiac gene expression profile using 40 k mouse oligonucleotide arrays showed that isoproterenol affected the expression of 180 genes in WT but only 92 genes of myo-/- hearts. Only 40 of these genes were regulated in WT and myo-/- hearts. Whereas in WT hearts a prononced induction of genes of the extracellular matrix occurred suggesting a higher level of remodelling, in myo-/- hearts genes of carbon metabolism and genes linked to inhibition of apoptosis and muscular repair were altered. Interestingly, a subset of genes which was altered in myo-/- mice already under basal conditions was differentially expressed in WT hearts under isoproterenol treatment. In summary, our data show, that the genetic background (WT, myo-/-) has a major impact on cardiac gene expression even in the context of an aggressive hypertrophy model such as chronic isoproterenol stimulation. Keywords: gene expression profiling of isoproterenol induced heart failure in WT and myo-/- mice
-
54 GSE16246 将野生型(WT)小鼠与myoglobin knockout(myo-/-)小鼠心脏组织分别设置为对照组和处理组,每组8只,慢性异丙肾上腺素(4 mg/kg/day)处理14天后采集样本,采用40 k小鼠寡核苷酸阵列分析基因表达,比较WT与myo-/-小鼠在处理前后的基因表达差异及两组间共同调控基因。
设计将野生型(WT)小鼠与myoglobin knockout(myo-/-)小鼠心脏组织分别设置为对照组和处理组,每组8只,慢性异丙肾上腺素(4 mg/kg/day)处理14天后采集样本,采用40 k小鼠寡核苷酸阵列分析基因表达,比较WT与myo-/-小鼠在处理前后的基因表达差异及两组间共同调控基因。
摘要Myoglobin knockout mice (myo-/-) adapt to the loss of myoglobin by the activation of a variety of compensatory mechanisms on the structural and functional level. In order to analyze to what extent myo-/- mice would tolerate cardiac stress we used the model of chronic isoproterenol application to induce cardiac hypertrophy in myo-/- mice and wild type (WT) controls. After 14 d of isoproterenol infusion cardiac hypertrophy in WT and myo-/- mice reached a similar level. WT mice developed lung oedema and left ventricular dilatation indicating the development of heart failure. In contrast, myo-/- mice displayed conserved cardiac function and no signs of heart failure. Analysis of the cardiac gene expression profile using 40 k mouse oligonucleotide arrays showed that isoproterenol affected the expression of 180 genes in WT but only 92 genes of myo-/- hearts. Only 40 of these genes were regulated in WT and myo-/- hearts. Whereas in WT hearts a prononced induction of genes of the extracellular matrix occurred suggesting a higher level of remodelling, in myo-/- hearts genes of carbon metabolism and genes linked to inhibition of apoptosis and muscular repair were altered. Interestingly, a subset of genes which was altered in myo-/- mice already under basal conditions was differentially expressed in WT hearts under isoproterenol treatment. In summary, our data show, that the genetic background (WT, myo-/-) has a major impact on cardiac gene expression even in the context of an aggressive hypertrophy model such as chronic isoproterenol stimulation. Keywords: gene expression profiling of isoproterenol induced heart failure in WT and myo-/- mice
-
55 GSE237156 将7–8周龄ApoE KO和野生型C57BL/6J雄性小鼠分为标准饮食(CD)或高脂饮食(HFD)组,喂养7或8周后随机分配至治疗或对照组。治疗组经口给予1.0 mg/kg/d dapagliflozin,对照组及另一野生型组给予载体。采集Ccr2+和Ccr2-巨噬细胞进行单细胞RNA测序,比较不同处理组间基因表达差异。
设计将7–8周龄ApoE KO和野生型C57BL/6J雄性小鼠分为标准饮食(CD)或高脂饮食(HFD)组,喂养7或8周后随机分配至治疗或对照组。治疗组经口给予1.0 mg/kg/d dapagliflozin,对照组及另一野生型组给予载体。采集Ccr2+和Ccr2-巨噬细胞进行单细胞RNA测序,比较不同处理组间基因表达差异。
摘要Heart failure with preserved ejection fraction (HFpEF) is a public health problem with increasing incidence and prevalence. Different phenotypes have been identified based on related risk factors, cardiac structural alterations, biomarkers and prognosis. Among these, the one with the worst prognosis is characterized by metabolic dysfunction . This clinical phenotype exhibits high levels of biomarkers related to dysregulated metabolism and TNF-a–mediated inflammation, thus underlying its close association with metabolic dysfunction and inflammation. The aim of our work is to better comprehend the involvement of the immune cells in the pathogenesis of metabolic HFpEF and to determine whether treating metabolic dysfunction with SGLT2i could ameliorate HFpEF by decreasing myocardial inflammation.
-
56 GSE241022 对3-4月龄雄性BBLN转基因小鼠与非转基因FVB/N小鼠的右心室和左心室心脏标本进行RNA测序,比较两组在右心室和左心室的转录组差异。转基因小鼠为FVB/N-TgMHCBBLN品系,每组每心室包含4个样本。
设计对3-4月龄雄性BBLN转基因小鼠与非转基因FVB/N小鼠的右心室和左心室心脏标本进行RNA测序,比较两组在右心室和左心室的转录组差异。转基因小鼠为FVB/N-TgMHCBBLN品系,每组每心室包含4个样本。
摘要The study performed NGS to investigate the cardiac transcriptomes of right and left ventricular heart specimens of 3-4-month-old BBLN-transgenic mice with FVB/N background in comparison to those of non-transgenic FVB/N mice. BBLN-transgenic (Tg-BBLN) mice with myocardium-specific BBLN expression were generated to investigate the cardiac phenotype of increased cardiac BBLN transcript levels because the function of BBLN (Bublin coiled-coil protein), which is the chromosome 9 open reading frame(C9orf16), is largely unknown. Tg-BBLN mice with increased cardiac BBLN levels developed features of heart failure with increasing age. Pathomechanisms of heart failure induced by BBLN were investigated by NGS of right and left ventricular heart specimens of male, BBLN-transgenic mice (age: 3-4 months). NGS data reveal transcriptome changes in right and left ventricular heart specimens induced by increased expression of BBLN in the heart.
-
57 GSE276289 将野生型小鼠与心脏特异性Gαq过表达小鼠(扩张型心肌病模型)分别按4周龄和20周龄处死,采集左心室组织进行RNA测序,比较两种基因型在不同时间点的基因表达差异。同时评估心脏线粒体功能,包括ATP生成能力和活性氧释放量,比较处理组与对照组的差异。
设计将野生型小鼠与心脏特异性Gαq过表达小鼠(扩张型心肌病模型)分别按4周龄和20周龄处死,采集左心室组织进行RNA测序,比较两种基因型在不同时间点的基因表达差异。同时评估心脏线粒体功能,包括ATP生成能力和活性氧释放量,比较处理组与对照组的差异。
摘要Background. Mitochondrial dysfunction with decreased ATP production and increased release of reactive oxygen species (ROS) is a hallmark of the failing heart. Although SGLT2 inhibitors have been shown to improve myocardial metabolism in the failing heart, independent of diabetes, the mechanism of this effect is not clear. Objectives. Our goal was to test the effect of the SGLT2 inhibitor ertugliflozin on mitochondrial gene expression and function in myocardium and isolated mitochondria from non-diabetic mice with dilated cardiomyopathy due to cardiac-specific over-expression of Gαq. Methods. Gαq and wild-type (WT) littermates 4 weeks of age were treated for 16 weeks with or without the SGLT2 inhibitor ertugliflozin (ERTU) formulated in the chow (0.5 mg/g chow). Results. From weeks 4 to 20, Gαq mice developed progressive cardiac hypertrophy, dilation, contractile dysfunction, myocyte apoptosis and interstitial fibrosis – all of which were prevented by ERTU treatment. Isolated cardiac mitochondria from Gαq mice had decreased maximal ATP production and increased ROS release - both of which were normalized by ERTU. In isolated beating hearts from Gαq mice, contractile reserve and high energy phosphates measured simultaneously by 31P NMR spectroscopy were decreased - and both were improved by ERTU. In Gαq mice, marked suppression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism was reversed by ERTU. Conclusions. The SGLT2 inhibitor ERTU corrected the expression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism, thereby leading to increased production of ATP, decreased release of mitochondrial ROS, and amelioration of the consequences of mitochondrial dysfunction on myocardial structure and function.
-
58 GSE289265 对正常饮食(ND)和高脂肪饮食(HFD)处理的 SETD7 野生型(WT)及 SETD7 敲除型(KO)小鼠的心脏组织进行 RNA-Seq 测序,比较不同饮食处理与基因型组合下的心肌细胞转录组差异。研究对象为心肌细胞,材料来自心脏组织,分组包括 ND-WT、ND-KO、HFD-WT、HFD-KO,各组样本数按总单位数与组数估计。检测方式为 RNA-Seq,使用 Kallisto 伪比对,参考基因组为 GENCODE Mus musculus GRCh39 Release M31。
设计对正常饮食(ND)和高脂肪饮食(HFD)处理的 SETD7 野生型(WT)及 SETD7 敲除型(KO)小鼠的心脏组织进行 RNA-Seq 测序,比较不同饮食处理与基因型组合下的心肌细胞转录组差异。研究对象为心肌细胞,材料来自心脏组织,分组包括 ND-WT、ND-KO、HFD-WT、HFD-KO,各组样本数按总单位数与组数估计。检测方式为 RNA-Seq,使用 Kallisto 伪比对,参考基因组为 GENCODE Mus musculus GRCh39 Release M31。
摘要Cardiometabolic heart failure with preserved ejection fraction (cHFpEF) is highly prevalent and associated with a poor outcome. Pathological gene expressions in heart failure are accompanied by changes in active histone marks without major alterations in DNA methylation. Whether chromatin modifications participate to obesity-induced HFpEF is largely unknown. We will investigate whether chromatin marks participate to obesity-induced HFpEF in vivo.
-
59 GSE298172 对HFpEF小鼠模型的PBMCs进行bulk RNA测序,比较HFpEF组与对照组的免疫细胞特征。HFpEF组通过高脂饮食联合L-NAME诱导15周,其中部分小鼠在最后4周额外接受NO₂-OA处理,对照组为正常饮食小鼠。
设计对HFpEF小鼠模型的PBMCs进行bulk RNA测序,比较HFpEF组与对照组的免疫细胞特征。HFpEF组通过高脂饮食联合L-NAME诱导15周,其中部分小鼠在最后4周额外接受NO₂-OA处理,对照组为正常饮食小鼠。
摘要Background: HFpEF is a heterogeneous clinical picture that is closely related to extracardiac comorbidities such as obesity, hypertension and diabetes and is associated with chronic, low-grade systemic inflammation. Previous studies on myocardial biopsies of HFpEF patients showed intramyocardial inflammatory activity, suggesting that the inflammatory processes in HFpEF are predominantly systemic and exhibit compartment specific-patterns. Methods: We performed single cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) of HFpEF patients (n=6), HFrEF patients (n=8) and healthy controls (n=7) taking obesity status into account. For validation, bulk RNA sequencing was performed on whole blood samples. In parallel, the systemic immune cell response was investigated in a HFpEF mouse model (induced by a high-fat diet plus L-NAME), with one group additionally administered the anti-inflammatory agent nitro-oleic acid (NO₂-OA). Results: Analysis of human PBMCs revealed a HFpEF-specific inflammatory fingerprint, which manifested in obesity-related increased expression of cytokine signaling genes (e.g. CCL2, TNF) and obesity-independent increases in mitochondrial-associated activity. In the mouse model, HFpEF animals showed a comparable increase in inflammatory markers, with treatment with NO₂-OA leading to a partial normalization of immunological signatures and a significant improvement in diastolic function. Conclusion: Our results demonstrate that the immune cells of patients with HFpEF are characterized by a distinct transcriptional immune signature that differs from that of patients with HFrEF. The conserved immunological signatures between humans and mice, and the beneficial effect of NO₂-OA in a preclinical model, provide important translational insights and generate hypotheses for personalized interventions in HFpEF.
-
60 GSE307669 对心肌组织进行RNA-seq,比较野生型Gpr91fl/fl小鼠与心肌细胞特异性Gpr91敲除小鼠(Myh6Cre Gpr91fl/fl)在HFpEF模型下,接受或不接受succinate补充的差异。
设计对心肌组织进行RNA-seq,比较野生型Gpr91fl/fl小鼠与心肌细胞特异性Gpr91敲除小鼠(Myh6Cre Gpr91fl/fl)在HFpEF模型下,接受或不接受succinate补充的差异。
摘要Disrupted cardiomyocyte energy metabolism underlies HFpEF. We found that cardiac succinate and GPR91 were reduced in HFpEF. In WT mice, succinate supplementation restored metabolism, improved diastolic function, and alleviated hypertrophy and fibrosis, whereas these benefits were abolished in global and cardiomyocyte-specific Gpr91 knockouts. Transcriptomics and mechanistic studies revealed that succinate–GPR91 signaling activated AMPK via Gq, enhanced NAD⁺ production, and promoted glucose–lipid metabolic reprogramming. Thus, the succinate–GPR91 axis is essential for cardiometabolic regulation and represents a promising therapeutic target in HFpEF.
-
61 GSE322779 对TFEB敲除小鼠与野生型小鼠的左心室组织进行Bulk RNA-seq,比较基因型与处理条件(sham或TAC)的转录组差异,每组设4个生物重复。
设计对TFEB敲除小鼠与野生型小鼠的左心室组织进行Bulk RNA-seq,比较基因型与处理条件(sham或TAC)的转录组差异,每组设4个生物重复。
摘要Pathological cardiac remodeling and increased afterload-driven demand contribute to heart failure. TFEB is a key regulator of lysosomal genes and mitochondrial function and is activated in response to external stress. To elucidate TFEB-dependent transcriptional programs under hypertrophic stress, we profiled left ventricular transcriptomes from a cardiomyocyte-specific TFEB knockout mouse model subjected to transverse aortic constriction (TAC) or sham surgery, with wild-type littermate controls, followed by downstream multi-omics integration.
-
62 GSE338319 将 C57BL/6N 女性小鼠按 AAV 载体类型(PERM1 或 GFP)与手术类型(TAC 或 Sham)分组,每组样本数分别为 PERM1-Sham(n=4)、PERM1-TAC(n=4)、GFP-Sham(n=4)、GFP-TAC(n=3),采集心室心肌组织进行 Bulk RNA-Seq 分析,比较不同基因型与处理条件下心肌组织的转录特征差异。
设计将 C57BL/6N 女性小鼠按 AAV 载体类型(PERM1 或 GFP)与手术类型(TAC 或 Sham)分组,每组样本数分别为 PERM1-Sham(n=4)、PERM1-TAC(n=4)、GFP-Sham(n=4)、GFP-TAC(n=3),采集心室心肌组织进行 Bulk RNA-Seq 分析,比较不同基因型与处理条件下心肌组织的转录特征差异。
摘要Heart failure with reduced ejection fraction (HFrEF) is characterized by impaired contractile function and mitochondrial dysfunction, yet therapies that simultaneously restore cardiac energetics and mechanical performance remain limited. Here, we demonstrate that adeno-associated virus (AAV)-mediated PERM1 gene delivery prevents pressure overload-induced HFrEF in mice. AAV-PERM1 preserved mitochondrial respiration, maintained compact mitochondrial morphology and mitochondrial DNA content, and attenuated pathological hypertrophy and fibrosis. Unexpectedly, these effects occurred despite persistent suppression of oxidative phosphorylation and fatty acid oxidation transcripts, revealing a mechanism independent of transcriptional metabolic reprogramming. Instead, PERM1 localized to a mitochondria-sarcomere microdomain, whereas it associates with ribosomal proteins and a creatine kinase-troponin C complex, suppressed pathological O-GlcNAcylation, and post-transcriptionally preserved electron transport chain protein abundance. Functionally, PERM1 enhanced myofibrillar force generation. These findings identify PERM1 as a previously unrecognized organizer of a sarcomere-mitochondria energetic microdomain that preserves mitochondrial protein homeostasis and couples energy production to force generation, thereby conferring resilience against heart failure.
-
63 GSE72132 将12周龄C57BL6雄性小鼠随机分为对照组、L-NAME处理组、AngII处理组及L-NAME+AngII组合处理组,每组4个重复。L-NAME(0.3 mg/ml含1% NaCl)通过饮用水给药5周,AngII(0.7 mg/kg/day)通过皮下微泵给药4周。采集小鼠左心室组织进行微阵列分析,检测基因表达变化并比较各处理组间线粒体功能及代谢通路差异。
设计将12周龄C57BL6雄性小鼠随机分为对照组、L-NAME处理组、AngII处理组及L-NAME+AngII组合处理组,每组4个重复。L-NAME(0.3 mg/ml含1% NaCl)通过饮用水给药5周,AngII(0.7 mg/kg/day)通过皮下微泵给药4周。采集小鼠左心室组织进行微阵列分析,检测基因表达变化并比较各处理组间线粒体功能及代谢通路差异。
摘要We characterized the metabolic and cardiac mitochondrial function in a mouse model of non-ischemic HF. Inhibition of nitric oxide synthesis and hypertension, which often present together, are two important risk factors in human non-ischemic HF. Compared with L-NAME L-NG-Nitroarginine methyl ester (L-NAME), an inhibitor of nitric oxide synthesis or Angiotensin II (AngII), a hypertensive agent treatment alone, L-NAME+AngII induced the most severe HF phenotype characterized by edema, hypertrophy, fibrosis, increased blood pressure and reduced ejection fractions. L-NAME+AngII treated mice had robust deterioration of cardiac mitochondrial function we observed. Microarray analyses revealed majority of the gene changes attributed to the combination of L-NAME+AngII. Pathway analyses indicated significant changes in metabolic pathways such as mitochondrial oxidative phosphorylation, fatty acid metabolism and tricarboxylic acid pathways etc.in L-NAME+AngII hearts. We conclude that combination of L-NAME+AngII exacerbates cardiac contractile and mitochondrial functional de-regulation compared with L-NAME and AngII alone, resulting in non-ischemic HF. This model of heart failure may be highly valuable in studying mechanisms and treatments for non-ischemic heart failure.
-
64 GSE180065 对野生型雄性C57BL/6J小鼠进行高脂饮食联合L-NAME处理构建HFpEF模型,分别在干预5周和7周时采集心脏组织总RNA进行RNA测序,比较正常组与不同干预时间点模型组的基因表达差异。
设计对野生型雄性C57BL/6J小鼠进行高脂饮食联合L-NAME处理构建HFpEF模型,分别在干预5周和7周时采集心脏组织总RNA进行RNA测序,比较正常组与不同干预时间点模型组的基因表达差异。
摘要Our study helps to understand the molecular pathogenesis of HFpEF and identifiy genes and pathways that may be potential therapeutic targets for HFpEF treatment
-
65 GSE198926 研究对象为小鼠心脏组织,将小鼠分为野生型(WT)和SIRT5过表达(SIRT5OE)基因型,每组再分为假手术(sham)和主动脉缩窄(TAC)处理组,共四个组。采用RNA测序技术检测转录组变化,比较不同基因型和处理组间的差异。
设计研究对象为小鼠心脏组织,将小鼠分为野生型(WT)和SIRT5过表达(SIRT5OE)基因型,每组再分为假手术(sham)和主动脉缩窄(TAC)处理组,共四个组。采用RNA测序技术检测转录组变化,比较不同基因型和处理组间的差异。
摘要Heart failure (HF) is defined as an inability of the heart to pump blood sufficiently to meet the metabolic demands of the body. HF with reduced systolic function is characterized by cardiac hypertrophy, ventricular fibrosis and remodeling, and decreased cardiac contractility, leading to cardiac functional impairment and death. Transverse aortic constriction (TAC) is a well-established model for inducing hypertrophy and HF in rodents. Mice globally deficient in sirtuin 5 (SIRT5), a NAD+-dependent deacylase, are hypersensitive to cardiac stress and display increased mortality after TAC. Prior studies assessing SIRT5 functions in the heart have all employed loss-of-function approaches. In this study, we generated SIRT5 overexpressing (SIRT5OE) mice, and evaluated their response to chronic pressure overload using TAC. Compared to littermate controls, SIRT5OE mice were protected against adverse functional consequences of TAC, left ventricular dilation, and impaired ejection fraction. Transcriptomic analyses revealed that SIRT5 suppresses key HF sequelae, including the metabolic switch from fatty acid oxidation to glycolysis, immune activation, and fibrotic signaling pathways. We conclude that SIRT5 is a limiting factor in the preservation of cardiac function in response to experimental pressure overload.
-
66 GSE240804 对重组小鼠IL11(rmIl11)注射后不同时间点的小鼠心脏进行RNA-seq分析,比较rmIl11处理组与PBS对照组的基因表达差异。将rmIl11注射至雄性C57BL6/J小鼠心脏,分别在注射后1小时、3小时、6小时采集样本,同时包含基线对照。采用免疫印迹、qRT-PCR、ATAC-seq检测心肌信号通路及基因组变化,评估心肌细胞收缩功能和整体心脏生理状态。
设计对重组小鼠IL11(rmIl11)注射后不同时间点的小鼠心脏进行RNA-seq分析,比较rmIl11处理组与PBS对照组的基因表达差异。将rmIl11注射至雄性C57BL6/J小鼠心脏,分别在注射后1小时、3小时、6小时采集样本,同时包含基线对照。采用免疫印迹、qRT-PCR、ATAC-seq检测心肌信号通路及基因组变化,评估心肌细胞收缩功能和整体心脏生理状态。
摘要Background: Interleukin-11 (IL11) was initially identified as a fibroblast secreted factor that supports haematopoietic cell function. This led to its development as a drug to increase platelet counts in patients with thrombocytopenia. However, IL11 was later found redundant for hematopoiesis and its use in humans causes severe and unexplained cardiac side effects. Here we identify and dissect mechanisms underlying previously unappreciated cardiac toxicities associated with IL11 therapy. Methods: We injected recombinant mouse lL11 (rmIl11) at clinically relevant doses to study its effects on myocardial signalling using immunoblotting and genomic variation using qRT-PCR, RNA-seq and ATAC-seq. The physiological impact of Il11 was assessed by echocardiography in vivo and cardiomyocyte contractility assays in vitro. To determine the specific activity of IL11 in cardiomyocytes we generated two distinct cardiomyocyte-specific IL11 receptor knockout (CMKO) mouse models using either AAV9-mediated, Tnnt2-restricted (vCMKO) or mhy6 (m6CMKO) Cre expression in an Il11ra1 floxed mouse strain. In pharmacologic studies, we studied the effects of JAK/STAT inhibition following rmIl11 injection to mice.Results: Injection of rmIl11 to mice caused dose-dependent impairment of left ventricular ejection fraction (LVEF: saline, 64.2%±1.62; rmIl11 (50 mg/kg), 31.6±2.0; p<0.0001). RNA-seq of hearts one and three hours following rmIl11 injection revealed strong upregulation of the TNF, NFkB and JAK/STAT pathways as well as increased Nppa and Rrad levels. vCMKO mice were protected from rmIl11-induced STAT3 activation, Rrad upregulation and LV impairment. Similarly, m6CMKO mice of both sexes, were protected from the molecular, cellular and whole organ cardiac toxicities associated with Il11. Administration of JAK inhibitors prevented rmIl11-induced STAT3 activation and preserved cardiac function. Conclusions: Here we show that Il11 injection to mice is strongly proinflammatory in the heart. Furthermore, Il11 has profound negative inotropic effects that are mediated via its on-target activation of JAK/STAT3 signalling in cardiomyocytes. Our data explain the cardiac side effects associated with IL11 therapy and question its continued use in patients.
-
67 GSE296034 将经历TAC手术4周的野生型小鼠随机分为三组,分别接受生理盐水、donepezil(5 mg/kg/day)或EVP-6124(2 mg/kg/day)处理,采集心脏组织进行RNA测序,比较各组间的基因表达差异。按总单位数与组数估计每组5只小鼠。
设计将经历TAC手术4周的野生型小鼠随机分为三组,分别接受生理盐水、donepezil(5 mg/kg/day)或EVP-6124(2 mg/kg/day)处理,采集心脏组织进行RNA测序,比较各组间的基因表达差异。按总单位数与组数估计每组5只小鼠。
摘要Autonomic neuronal dysfunction is associated with heart failure (HF). Here, we report that targeted vagal nerve stimulation (VNS) using optogenetics attenuates cardiac remodelling and HF induced by pressure overload. Unbiased approaches revealed that VNS decreased the proportion of the Ccrl2+ macrophage subset, which derived from myeloid monocytes and exhibited a distinct tumour necrosis factor-alpha (TNFα)-responsive, pro-hypertrophic, and profibrotic signature. Elimination of Ccrl2+ macrophages prevented cardiac remodelling and HF. Functional characterisation by Ccrl2+ macrophage-specific overexpression or global genetic loss of α7 nicotinic acetylcholine receptor (α7nAChR) highlighted its crucial contribution to VNS-mediated cardioprotection. Mechanistically, activation of α7nAChR inhibited the TNFα responsiveness through upregulated expression of the transcription factor NRF2. Cardiac Ccrl2+ macrophages and TNFα-responsive proteins were positively correlated with cardiac remodelling and dysfunction in humans. Finally, an α7nAChR agonist effectively blocked the development of HF. These results suggest that the vagal neuroimmune axis modulates heart failure and is a promising target for treatment.
-
68 GSE296709 对小鼠心脏内皮细胞进行 RNA 测序,比较 EC STING 敲除小鼠与野生型小鼠在横主动脉缩窄(TAC)和假手术处理下的基因表达差异。将 Cad5CreERT2+/+STINGfl/fl 和 Cad5CreERT2-/-STINGfl/fl 小鼠心脏内皮细胞分别按 Sham 和 TAC 处理,采集 RNA 构建测序库,使用 HISAT2 映射至 mm10 基因组并经 FeatureCounts 生成计数矩阵,分析不同基因型与处理条件对内皮细胞-心肌细胞通信及 IL-6 表达的影响。
设计对小鼠心脏内皮细胞进行 RNA 测序,比较 EC STING 敲除小鼠与野生型小鼠在横主动脉缩窄(TAC)和假手术处理下的基因表达差异。将 Cad5CreERT2+/+STINGfl/fl 和 Cad5CreERT2-/-STINGfl/fl 小鼠心脏内皮细胞分别按 Sham 和 TAC 处理,采集 RNA 构建测序库,使用 HISAT2 映射至 mm10 基因组并经 FeatureCounts 生成计数矩阵,分析不同基因型与处理条件对内皮细胞-心肌细胞通信及 IL-6 表达的影响。
摘要Capillary rarefaction and cardiomyocyte (CM) hypertrophy are hallmarks of the complex syndrome of heart failure (HF), a leading cause of hospitalization and death. Molecular signals within and between cellular components of the heart have emerged as central hubs that modulate cardiac pathophysiology. Here, we discovered that the Stimulator of Interferon Genes (STING) is highly expressed in human and mouse cardiac endothelial cells (EC) and is activated in the onset of HF. Using global and inducible EC-specific STING-/- mice, we report that EC STING is required for contractile dysfunction in an experimental model of HF induced by transverse aortic constriction (TAC), through the regulation of CM hypertrophy and capillary rarefaction. We report that ECs sorted from TAC EC-STING-/- mice are enriched in gene sets related to integrin and cell adhesion pathways to extracellular matrix (ECM) compared to controls and have decreased expression of the pro-hypertrophic gene IL-6. CellChat analysis of human cardiac cells from patients with non-ischemic cardiomyopathy revealed EC-CM communication, and mechanistically, we found that STING activation induces IL-6 secretion, and that EC derived IL-6 is necessary to induce pro-hypertrophic gene expression in CMs in a STING dependent manner. Our study demonstrates a novel role for STING in ECs contributing to hypertrophy and contractile dysfunction in experimental HF.
-
69 GSE189475 将9-10周龄小鼠分为sham或TAC手术组,术后两周通过超声心动图筛选出TAC组中射血分数40-60%的30只小鼠及正常功能的10只sham小鼠。每组再分为接受AAV2/9-GFP或AAV2/9-JP2NT病毒处理的两组,尾静脉注射1x10E12 vg(100 ul)。术后8周采集心室组织进行RNA-Seq分析,比较不同手术与病毒处理组合下的转录组差异。
设计将9-10周龄小鼠分为sham或TAC手术组,术后两周通过超声心动图筛选出TAC组中射血分数40-60%的30只小鼠及正常功能的10只sham小鼠。每组再分为接受AAV2/9-GFP或AAV2/9-JP2NT病毒处理的两组,尾静脉注射1x10E12 vg(100 ul)。术后8周采集心室组织进行RNA-Seq分析,比较不同手术与病毒处理组合下的转录组差异。
摘要Our previous work found a variety of cardiac stresses initiate site-specific cleavage of junctophilin-2 (JP2), an essential component of the E-C coupling apparatus, producing a 75-kDa N-terminal fragment (JP2NT) which unexpectedly translocates into cardiomyocyte nuclei and functions as a transcriptional repressor. We also determined that transgenic overexpression of JP2NT in cardiomyocytes attenuates pressure-overload induced hypertrophy and heart failure by blunting the induction of maladaptive transcripts. To test whether JP2NT could be utilized by gene therapy approaches for treating heart failure, we developed cardiotropic adeno-associated GFP and JP2NT expressing viruses for testing in a preclinical model of heart failure. Our results show that the transcriptional and pathological changes from pressure overload can be reduced through viral expression of JP2NT once hypertrophy and heart failure has already begun.
-
70 GSE113251 对6月龄小鼠左心室组织进行基因表达分析,比较不同处理组间的差异。Nkx2-5Δtrab组在胚胎期E10.5和E11.5注射他莫昔芬,Nkx2-5Δcomp组在胎儿期E13.5和E14.5注射他莫昔芬,control组未注射。每组4个独立样本,采用微阵列技术检测基因表达,分析胚胎期与胎儿期不同阶段Nkx2-5条件性删除对左心室组织基因表达的影响。
设计对6月龄小鼠左心室组织进行基因表达分析,比较不同处理组间的差异。Nkx2-5Δtrab组在胚胎期E10.5和E11.5注射他莫昔芬,Nkx2-5Δcomp组在胎儿期E13.5和E14.5注射他莫昔芬,control组未注射。每组4个独立样本,采用微阵列技术检测基因表达,分析胚胎期与胎儿期不同阶段Nkx2-5条件性删除对左心室组织基因表达的影响。
摘要Left ventricular non-compaction (LVNC) is a rare cardiomyopathy associated with a hypertrabeculated phenotype and a large spectrum of symptoms. The developmental origins and mechanistic basis of varying severity of this pathology are unknown. To investigate these issues, we inactivated the cardiac transcription factor Nkx2-5 in trabecular myocardium at different stages of trabecular morphogenesis. Conditional deletion of Nkx2-5 at embryonic stages, during trabecular formation, provokes a severe hypertrabeculated phenotype associated with subendocardial fibrosis and Purkinje fiber hypoplasia. A milder phenotype was observed after Nkx2-5 deletion at fetal stages, during trabecular compaction. A longitudinal study of cardiac function in adult Nkx2-5 conditional mutant mice demonstrates that excessive trabeculation is associated with complex ventricular conduction defects, progressively leading to strain defects, and, in 50% of mutant mice, to heart failure. Progressive impaired cardiac function correlates with conduction and strain defects independently of the degree of hypertrabeculation. Transcriptomic analysis of molecular pathways reflects myocardial remodeling with a larger number of differentially expressed genes in the severe versus mild phenotype and identifies Six1 as a marker upregulated in hypertrabeculated hearts. Our results provide insights into the etiology of LVNC and link its pathogenicity with compromised trabecular development including compaction defects and ventricular conduction system hypoplasia.
-
71 GSE120573 对心肌细胞糖皮质激素受体(GR)缺失的雄性与雌性小鼠心脏组织进行RNA测序,比较不同性别与基因型(野生型 vs GR缺失)间的转录组差异,分析GR缺失对心脏功能的影响,包括左心室收缩功能障碍及钙离子调节相关基因表达变化。
设计对心肌细胞糖皮质激素受体(GR)缺失的雄性与雌性小鼠心脏组织进行RNA测序,比较不同性别与基因型(野生型 vs GR缺失)间的转录组差异,分析GR缺失对心脏功能的影响,包括左心室收缩功能障碍及钙离子调节相关基因表达变化。
摘要Background The contribution of glucocorticoids to sexual dimorphism in the heart is essentially unknown. Therefore, we sought to determine the sexually dimorphic actions of glucocorticoid signaling in cardiac function and gene expression. To accomplish this goal, we conducted studies on mice lacking glucocorticoid receptors (GR) in cardiomyocytes (cardioGRKO mouse model). Methods and Results Deletion of cardiomyocyte GR leads to an increase in mortality because of the development of spontaneous cardiac pathology in both male and female mice; however, females are more resistant to GR signaling inactivation in the heart. Male cardioGRKO mice had a median survival age of 6 months. In contrast, females had a median survival age of 10 months. Transthoracic echocardiography data showed phenotypic differences between male and female cardioGRKO hearts. By 3 months of age, male cardioGRKO mice exhibited left ventricular systolic dysfunction. Conversely, no significant functional deficits were observed in female cardioGRKO mice at the same time point. Functional sensitivity of male hearts to the loss of cardiomyocyte GR was reversed following gonadectomy. RNA‐Seq analysis showed that deleting GR in the male hearts leads to a more profound dysregulation in the expression of genes implicated in heart rate regulation (calcium handling). In agreement with these gene expression data, cardiomyocytes isolated from male cardioGRKO hearts displayed altered intracellular calcium responses. In contrast, female GR‐deficient cardiomyocytes presented a response comparable with controls. Conclusions These data suggest that GR regulates calcium responses in a sex‐biased manner, leading to sexually distinct responses to stress in male and female mice hearts, which may contribute to sex differences in heart disease, including the development of ventricular arrhythmias that contribute to heart failure and sudden death.
-
72 GSE137442 对野生型或 ADAM12 敲除小鼠心脏组织进行基因表达分析,比较其在假手术(sham operation)与压力过载手术(TAC)后两周的转录组差异。每组基因型包含 3 个生物重复,共 12 个样本。采用 Affymetrix Mouse Clariom D (MTA 1.0) 微阵列平台检测总 RNA 表达水平,分析手术诱导的心脏基因表达特征。
设计对野生型或 ADAM12 敲除小鼠心脏组织进行基因表达分析,比较其在假手术(sham operation)与压力过载手术(TAC)后两周的转录组差异。每组基因型包含 3 个生物重复,共 12 个样本。采用 Affymetrix Mouse Clariom D (MTA 1.0) 微阵列平台检测总 RNA 表达水平,分析手术诱导的心脏基因表达特征。
摘要To investigated global changes caused by pressure overload-induced heart failure in ADAM12 knockout mice using a microarray analysis. A disintegrin and metalloproteinase (ADAM) 12 is has long been considered to promote cardiac dysfunction based on according to the finding report that a small molecule ADAM12 inhibitor, KB-R7785 ameliorated cardiac function in a transverse aortic constriction (TAC) model by inhibiting the through inhibition of proteolytic activation of HB-EGF signaling. HoweverOn the other hand, this compound has poor selectivity for ADAM12, and the role of ADAM12 inon cardiac dysfunction has not yet been investigated usingby genetic loss-of-function mice. Anoperation. ADAM12 deficiency resulted in significantly more expanded cardiac fibrosis accompanied byaccompanying with increased collagen-related gene expression in their failing hearts. The results of a genome-wide transcriptional analysis suggested a strongly enhanced highly elevated focal adhesion- and fibrosis-related signaling pathway in ADAM12 knockout hearts. The present results study revealed that the loss of ADAM12 enhanced focal adhesion and canonical TGF-β signaling by regulating the abundance of the integrin β1 and TGF-β receptors.
-
73 GSE142125 对转基因疾病模型小鼠与野生型小鼠的心脏成肌细胞进行RNA测序,比较两组间基因表达差异。研究对象为2周龄心脏成肌细胞,材料包括Myocyte-Specific Lamin A/C Null Mice(Myh6-cre:LmnaF/F)和Control野生型小鼠,按6只/组分两组,分选后提取总RNA进行RNA-Seq检测,未提及混池或重复方式。
设计对转基因疾病模型小鼠与野生型小鼠的心脏成肌细胞进行RNA测序,比较两组间基因表达差异。研究对象为2周龄心脏成肌细胞,材料包括Myocyte-Specific Lamin A/C Null Mice(Myh6-cre:LmnaF/F)和Control野生型小鼠,按6只/组分两组,分选后提取总RNA进行RNA-Seq检测,未提及混池或重复方式。
摘要Deletion of Lmna, encoding nuclear membrane protein LMNA, specifically in mouse cardiac myocytes activates BRD4 and leads to heart failure, arrhythmias, myocardial fibrosis, apoptosis, and premature death, which were partially rescued upon inhibition of BRD4.
-
74 GSE149095 对3周龄野生型小鼠和Myh6-Cre:LmnaF/F小鼠的心肌细胞进行RNA-seq分析,其中Myh6-Cre:LmnaF/F小鼠分为载体处理组与JQ1处理组,采集核糖体耗竭RNA,比较各组基因表达差异。
设计对3周龄野生型小鼠和Myh6-Cre:LmnaF/F小鼠的心肌细胞进行RNA-seq分析,其中Myh6-Cre:LmnaF/F小鼠分为载体处理组与JQ1处理组,采集核糖体耗竭RNA,比较各组基因表达差异。
摘要Deletion of Lmna, encoding nuclear membrane protein LMNA, specifically in mouse cardiac myocytes activates BRD4 and leads to heart failure, arrhythmias, myocardial fibrosis, apoptosis, and premature death, which were partially rescued upon inhibition of BRD4.
-
75 GSE157035 对CD14+/CD64+心脏巨噬细胞进行RNA测序,比较生理盐水植入对照组、异丙肾上腺素泵处理14天的HCC组与28天的IC组基因表达差异。样本来自心脏组织,按3组分选并处理,共包含12个GSM记录(按总单位数与组数估计每组4个样本)。
-
76 GSE194149 对心脏肥大向心力衰竭过渡的机制研究,采用心脏特异性 CIP 过表达小鼠模型与同窝对照组,通过腹腔注射他莫昔芬激活 Cre 重组酶以实现 CIP 转基因在心脏的表达,建立心脏转录组测序分析,比较两组小鼠心脏组织的基因表达差异。
设计对心脏肥大向心力衰竭过渡的机制研究,采用心脏特异性 CIP 过表达小鼠模型与同窝对照组,通过腹腔注射他莫昔芬激活 Cre 重组酶以实现 CIP 转基因在心脏的表达,建立心脏转录组测序分析,比较两组小鼠心脏组织的基因表达差异。
摘要Heart failure is characterized by the inability of the heart to pump effectively and generate proper blood circulation to meet the body's needs; it is a devastating condition that affects more than 100 million people globally. In spite of this, little is known about the mechanisms regulating the transition from cardiac hypertrophy to heart failure. Previously, we identified a cardiomyocyte-enriched gene, CIP, which regulates cardiac homeostasis under pathological stimulation. Here, we show that the cardiac transcriptional factor GATA4 binds the promotor of CIP gene and regulates its expression. We further determined that both CIP mRNA and protein decrease in diseased human hearts. In a mouse model, induced cardiac-specific overexpression of CIP after the establishment of cardiac hypertrophy protects the heart by inhibiting disease progression toward heart failure. Transcriptome analyses revealed that the IGF, mTORC2 and TGFβ signaling pathways mediate the inhibitory function of CIP on pathologic cardiac remodeling. Our study demonstrates GATA4 as an upstream regulator of CIP gene expression in cardiomyocytes, as well as the clinical significance of CIP expression in human heart disease. More importantly, our investigation suggests CIP is a key regulator of the transition from cardiac hypertrophy to heart failure. The ability of CIP to intervene in the onset of heart failure suggests a novel therapeutic avenue of investigation forthe prevention of heart disease progression.
-
77 GSE20172 将野生型与转基因 PLN 小鼠(FVB/N 背景,11 周龄)的整个心脏组织进行总 RNA 提取,采用微阵列技术检测基因表达,比较两组间差异。
设计将野生型与转基因 PLN 小鼠(FVB/N 背景,11 周龄)的整个心脏组织进行总 RNA 提取,采用微阵列技术检测基因表达,比较两组间差异。
摘要These mice have been genetically modified so that the mouse PLN gene has been replace with the human PLN gene. Phopspholamban (PLN), the reversible inhibitor of the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a), is a key regulator of myocyte Ca2+-cycling with a significant role in heart failure. We previously showed that the single amino acid difference between human and mouse PLN results in increased inhibition of Ca2+-cycling, cardiac remodeling and attenuated stress responses, in transgenic mice expressing the human PLN in the null background (hPLN). This set of microarray experiments aimed at deciphering the molecular mechanisms implicated in this process.
-
79 GSE221502 对野生型 C57Bl6J/129X1 混合小鼠的整个左心室心肌进行 RNA 测序,比较 NaCl 处理组与 AngII/PE 输注组在 3 天后的基因表达差异。研究包含雌性与雄性小鼠,每组按总样本数 12 与 4 个分组估计样本量。
设计对野生型 C57Bl6J/129X1 混合小鼠的整个左心室心肌进行 RNA 测序,比较 NaCl 处理组与 AngII/PE 输注组在 3 天后的基因表达差异。研究包含雌性与雄性小鼠,每组按总样本数 12 与 4 个分组估计样本量。
摘要Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome with multisystem organ dysfunction in which patients develop symptoms of HF as the result of high left ventricular (LV) diastolic pressure Continuous infusion of angiotensin II and phenylephrine (AngII/PE) demonstrates a strong HFpEF phenotype RNAseq data demonstrate activation of pathways leading to myocardial metabolic changes, activation of ECM deposition, microvascular rarefaction, and pressure and volume related myocardial stress
-
80 GSE223346 将 C57BL/6J 小鼠按基因型(WT 或 CD163−/−)与处理方式(sham 或 TAC)分组,采集心脏组织进行 RNA-Seq 测序,比较 WT-TAC 与 WT-SHAM、CD163−/− TAC 与 CD163−/− SHAM 的基因表达差异。
设计将 C57BL/6J 小鼠按基因型(WT 或 CD163−/−)与处理方式(sham 或 TAC)分组,采集心脏组织进行 RNA-Seq 测序,比较 WT-TAC 与 WT-SHAM、CD163−/− TAC 与 CD163−/− SHAM 的基因表达差异。
摘要Cardiac macrophages (cMacs) elimination exacerbates pressure overload-induced heart failure. However, the role of functionally distinct subsets of cMacs in heart failure remains largely unknown. CD163, a macrophage-specific scavenger receptor expressed in a subset of cMacs, has been associated with cardiovascular events through its circulating soluble form. This study aimed to elucidate the functional role of the CD163+ cMacs subset in pressure overload-induced heart failure. Transverse aortic constriction (TAC) was used to induce pressure overload. TAC-induced left ventricular systolic dysfunction, characterized by reduced ejection fraction and fractional shortening, was significantly aggravated in Cd163−/− mice post-surgery. Genes differentially expressed due to CD163 deficiency were enriched in pathways related to mitochondrial bioenergetics and homeostasis. Transmission electron microscopy revealed an increase in dysfunctional mitochondria in cardiomyocytes of Cd163−/− mice post-TAC. Additionally, decreased serum interleukin (IL)-10 levels and reduced IL-10 expression in cMacs were observed in Cd163−/− mice post-TAC. IL-10 supplementation significantly reversed TAC-induced reductions in left ventricular systolic function in Cd163−/− mice and improved mitochondrial functions in cardiomyocytes. Furthermore, decreased IL-10 levels and increased soluble CD163 were identified as risk factors for heart failure in hypertensive patients. Thus, CD163 in cMacs attenuates pressure overload-induced left ventricular systolic dysfunction through IL-10.
-
81 GSE236584 将八周龄雄性C57BL/6N小鼠随机分为HFpEF组与对照组,HFpEF组接受高脂肪饮食及L-NAME 0.5g/L饮用水处理,对照组为正常饮食及水。两组均处于12小时光照/黑暗循环环境。5周后通过心脏超声评估射血分数与舒张功能,随后用过量CO2安乐死,取心室组织进行bulk RNA-seq分析,比较两组基因表达差异。
设计将八周龄雄性C57BL/6N小鼠随机分为HFpEF组与对照组,HFpEF组接受高脂肪饮食及L-NAME 0.5g/L饮用水处理,对照组为正常饮食及水。两组均处于12小时光照/黑暗循环环境。5周后通过心脏超声评估射血分数与舒张功能,随后用过量CO2安乐死,取心室组织进行bulk RNA-seq分析,比较两组基因表达差异。
摘要Heart failure with preserved ejection fraction (HFpEF) is a complex, heterogeneous disease involving multiple cellular lineages and mechanisms. Here, we aimed to characterize the cellular heterogeneity and potential mechanisms of HFpEF at single-cell resolution.
-
82 GSE248443 对8周龄DDX5fl/fl MYH6Cre+小鼠心脏组织与同龄DDX5fl/fl对照心脏组织进行RNA测序,比较两组基因表达差异;同时对注射7天他莫昔芬的Ddx5flox/flox Myh6MerCreMer小鼠心脏组织与同龄DDX5fl/fl心脏组织注射相同剂量他莫昔芬的对照进行RNA测序,比较两组基因表达差异。所有样本均为小鼠左心室组织,采用Trizol法提取总RNA,通过Illumina Novaseq 6000平台生成150 bp配对末端测序数据。
设计对8周龄DDX5fl/fl MYH6Cre+小鼠心脏组织与同龄DDX5fl/fl对照心脏组织进行RNA测序,比较两组基因表达差异;同时对注射7天他莫昔芬的Ddx5flox/flox Myh6MerCreMer小鼠心脏组织与同龄DDX5fl/fl心脏组织注射相同剂量他莫昔芬的对照进行RNA测序,比较两组基因表达差异。所有样本均为小鼠左心室组织,采用Trizol法提取总RNA,通过Illumina Novaseq 6000平台生成150 bp配对末端测序数据。
摘要The cardiomyocyte-specific deletion of Ddx5 in mice resulted in heart failure characterized by diminished cardiac function, enlarged heart chambers, and heightened fibrosis. Proteomic analysis unveiled the involvement of DDX5 in RNA splicing within cardiomyocytes. Our study identified DDX5 as a regulator of the abnormal splicing of CamkIIδ, preventing the generation of CaMKIIδA. This isoform activates LTCC through serine phosphorylation of Cacna1c, disrupting Ca2+ homeostasis. Consistently, DDX5-depleted cardiomyocytes exhibited elevated intracellular Ca2+ transients and increased sarcoplasmic reticulum Ca2+ content.
-
83 GSE260492 将野生型(WT)与Alox5基因敲除(Alox5ko)小鼠心脏组织分别接受手术处理(TAC)或未处理(NS),提取总RNA进行RNA测序,比较不同基因型与处理条件组合下的心脏转录组差异。
设计将野生型(WT)与Alox5基因敲除(Alox5ko)小鼠心脏组织分别接受手术处理(TAC)或未处理(NS),提取总RNA进行RNA测序,比较不同基因型与处理条件组合下的心脏转录组差异。
摘要Untargeted metabolomics showed that serum 5-HETE (a primary product of Alox5) levels were little changed in patients with cardiac hypertrophy, while Alox5 expression was significantly upregulated in murine hypertensive cardiac samples and human cardiac samples of hypertrophy, which prompted us to test whether high Alox5 levels under hypertensive stimuli were directly associated with pathologic myocardium in an enzymatic activity-independent manner. Herein, we revealed that Alox5 deficiency significantly ameliorated transverse aortic constriction (TAC)-induced hypertrophy. Cardiomyocyte-specific Alox5 depletion attenuated hypertensive ventricular remodeling. Conversely, cardiac-specifical Alox5 overexpression showed a pro-hypertrophic cardiac phenotype. Ablation of Alox5 in bone marrow-derived cells did not affect pathological cardiac remodeling and heart failure.
-
84 GSE278517 将心力衰竭 bulk 模型小鼠的心肌细胞进行 RNA 测序,比较假手术组(注射生理盐水)与 JV001 处理组、慢性肾病组(AngII 高盐饮食单肾切除并注射生理盐水)与 JV001 处理组的基因表达差异。
设计将心力衰竭 bulk 模型小鼠的心肌细胞进行 RNA 测序,比较假手术组(注射生理盐水)与 JV001 处理组、慢性肾病组(AngII 高盐饮食单肾切除并注射生理盐水)与 JV001 处理组的基因表达差异。
摘要Cardio-renal syndromes type 4 (CRS4) is defined as heart failure driven by chronic kidney disease (CKD). Cardiovascular mortality is the leading cause of mortality in advanced CKD patients. Current medical treatments exhibit limited efficacy. This study demonstrates that telomere shortening in cardiomyocytes is characteristic of CRS4. We engineered an adeno-associated virus9 (AAV9) gene therapy overexpressing catalytic inactive and nuclear localized human telomerase reverse transcriptase (modhTERT) under cardiac troponin T (cTnT) promotor. Overexpression of modhTERT recapped myocardial telomeres, reversed cardiac dysfunction, cardiac hypertrophy, cardiac fibrosis and mitochondrial dysfunction in two CRS4 animal models: 5/6 nephrectomy and Angiotensin II-high salt-uninephrectomy murine models.
-
85 GSE294246 对10周龄野生型和Prkca T497A突变小鼠心脏组织进行RNA-Seq分析,分别接受Sham手术或TAC手术处理,术后5周采集样本。研究对象为小鼠左心室组织,材料为心肌细胞,分组依据基因型(WT/Prkca T497A)与手术类型(Sham/TAC),检测方式为RNA测序,主要比较不同基因型与手术处理间的转录组差异。
设计对10周龄野生型和Prkca T497A突变小鼠心脏组织进行RNA-Seq分析,分别接受Sham手术或TAC手术处理,术后5周采集样本。研究对象为小鼠左心室组织,材料为心肌细胞,分组依据基因型(WT/Prkca T497A)与手术类型(Sham/TAC),检测方式为RNA测序,主要比较不同基因型与手术处理间的转录组差异。
摘要BACKGROUND: The global prevalence of heart failure is increasing significantly, and the prognosis for patients with heart failure remains poor, highlighting the urgent need for novel therapeutic strategies. Protein kinase C alpha (PKCα) plays a central role in heart failure progression. Phosphorylation of PRKCA at T497 triggers a series of phosphorylation cascades, leading to its activation. Ablation of T497 phosphorylation leads to reduced protein stability and activity. However, there is no therapeutic strategy for heart failure targeting PKCα T497. METHODS: We employed CRISPR-Cas9 adenine base editing to ablate the phosphorylation site T497 of PKCα. We generated mice harboring a PKCα phosphoresistant T497A mutation in the germline and administered adeno-associated virus 9 (AAV9) harboring base editor of PrkcaT497A to postnatal wild-type (WT) mice to explore its clinical feasibility. To model for heart failure, mice were subjected to transverse aortic constriction (TAC). Cardiac function, hypertrophy, fibrosis, and transcriptional changes were evaluated by echocardiography, wheat germ agglutinin staining, Masson’s trichrome staining, and RNA sequencing, respectively. The editing efficiency of PrkcaT497A was assessed using Sanger sequencing and deep amplicon sequencing. Cellular Ca2+ homeostasis was analyzed using epifluorescence microscopy in Fura-2–loaded human induced pluripotent stem cells-derived cardiomyocytes (iPSC-CMs) carrying the PRKCAT497A mutation under chronic angiotensin II (AngII) stimulation. RESULTS: The T497A mutation in PKCα prevented subsequent phosphorylation and led to PKCα degradation. Four weeks after TAC surgery, WT mice showed dramatically impaired cardiac function, cardiac remodeling, and increased lung weight, whereas PKCα phosphoresistant mice were protected from these effects. PKCα phosphoresistant mice also showed protection against heart failure-related aberrant changes in cardiac gene expression, cardiac hypertrophy, and fibrosis. Likewise, mice administrated with AAV9-base editors exhibited similar cardioprotective effects against TAC-induced heart failure. In vitro, PKCα-edited iPSC-CMs were protected from AngII-induced impairments in contractility and Ca2+ transients observed in WT iPSC-CMs. CONCLUSIONS: The editing of PRKCAT497A through adenine base editing may potentially provide a promising therapeutic approach for human cardiac diseases.
-
86 GSE306122 将C57Bl/6J小鼠心室组织分为Sham组(PBS注射)、TAC mice注射AAV9-MHCK7-mScarlet及TAC mice注射AAV9-MHCK7-BacNav-mScarlet三组,共12个样本进行Bulk RNA-sequencing,比较不同处理组的基因表达差异。
设计将C57Bl/6J小鼠心室组织分为Sham组(PBS注射)、TAC mice注射AAV9-MHCK7-mScarlet及TAC mice注射AAV9-MHCK7-BacNav-mScarlet三组,共12个样本进行Bulk RNA-sequencing,比较不同处理组的基因表达差异。
摘要Despite continued progress, therapies to augment contractile function and prevent arrhythmias in patients with heart disease remain limited. Here, we present a two-pronged gene therapy approach whereby simultaneous augmentation of peak Na+ current and Ca2+ transient amplitude in cardiomyocytes (CMs) effectively alleviates pathogenesis of heart failure. Specifically, using in vitro engineered tissue models of neonatal rat CMs, ex vivo adult mouse CMs, and in silico rabbit CMs, we show that expression of prokaryotic Na+ channels (BacNav) dose-dependently enhances Ca2+ transient amplitude and contractility of CMs by modulating the activity of the Na+/Ca2+ exchanger and increasing sarcoplasmic reticulum Ca2+ stores. In vivo, AAV9-mediated BacNav therapy rescues contractile deficit and prevents arrhythmias in a pressure-overload induced model of chronic heart failure in mice. BacNav therapy also confers protective effects on pressure-overload induced dysregulation of the cardiac transcriptome. We further establish the safety of long-term systemic delivery of AAV9-BacNav in mice. Collectively, these studies support the translational promise of BacNav gene delivery as a novel therapy for electrical and contractile dysfunction in heart failure.
-
87 GSE308849 对10周龄野生型(WT)和Prkca T497A突变小鼠的心脏组织进行RNA测序,比较Sham手术与TAC手术后1周的转录组差异。WT与Prkca T497A小鼠分别接受Sham或TAC处理,每组3个样本,共12个GSM记录。检测方式包括RNA测序,同时采用超声心动图、小麦胚芽凝集素染色、Masson三色染色评估心脏功能、肥大和纤维化。编辑效率通过Sanger测序和深度扩增子测序验证,细胞内钙离子稳态分析基于Fura-2加载的人诱导多能干细胞来源的心肌细胞(iPSC-CMs)在慢性AngII刺激下的表现。
设计对10周龄野生型(WT)和Prkca T497A突变小鼠的心脏组织进行RNA测序,比较Sham手术与TAC手术后1周的转录组差异。WT与Prkca T497A小鼠分别接受Sham或TAC处理,每组3个样本,共12个GSM记录。检测方式包括RNA测序,同时采用超声心动图、小麦胚芽凝集素染色、Masson三色染色评估心脏功能、肥大和纤维化。编辑效率通过Sanger测序和深度扩增子测序验证,细胞内钙离子稳态分析基于Fura-2加载的人诱导多能干细胞来源的心肌细胞(iPSC-CMs)在慢性AngII刺激下的表现。
摘要BACKGROUND: The global prevalence of heart failure is increasing significantly, and the prognosis for patients with heart failure remains poor, highlighting the urgent need for novel therapeutic strategies. Protein kinase C alpha (PKCα) plays a central role in heart failure progression. Phosphorylation of PRKCA at T497 triggers a series of phosphorylation cascades, leading to its activation. Ablation of T497 phosphorylation leads to reduced protein stability and activity. However, there is no therapeutic strategy for heart failure targeting PKCα T497. METHODS: We employed CRISPR-Cas9 adenine base editing to ablate the phosphorylation site T497 of PKCα. We generated mice harboring a PKCα phosphoresistant T497A mutation in the germline and administered adeno-associated virus 9 (AAV9) harboring base editor of PrkcaT497A to postnatal wild-type (WT) mice to explore its clinical feasibility. To model for heart failure, mice were subjected to transverse aortic constriction (TAC). Cardiac function, hypertrophy, fibrosis, and transcriptional changes were evaluated by echocardiography, wheat germ agglutinin staining, Masson’s trichrome staining, and RNA sequencing, respectively. The editing efficiency of PrkcaT497A was assessed using Sanger sequencing and deep amplicon sequencing. Cellular Ca2+ homeostasis was analyzed using epifluorescence microscopy in Fura-2–loaded human induced pluripotent stem cells-derived cardiomyocytes (iPSC-CMs) carrying the PRKCAT497A mutation under chronic angiotensin II (AngII) stimulation. RESULTS: The T497A mutation in PKCα prevented subsequent phosphorylation and led to PKCα degradation. Four weeks after TAC surgery, WT mice showed dramatically impaired cardiac function, cardiac remodeling, and increased lung weight, whereas PKCα phosphoresistant mice were protected from these effects. PKCα phosphoresistant mice also showed protection against heart failure-related aberrant changes in cardiac gene expression, cardiac hypertrophy, and fibrosis. Likewise, mice administrated with AAV9-base editors exhibited similar cardioprotective effects against TAC-induced heart failure. In vitro, PKCα-edited iPSC-CMs were protected from AngII-induced impairments in contractility and Ca2+ transients observed in WT iPSC-CMs. CONCLUSIONS: The editing of PRKCAT497A through adenine base editing may potentially provide a promising therapeutic approach for human cardiac diseases.
-
88 GSE13336 对TG1306/1R转基因小鼠的心脏组织(左右心室及间隔)进行基因表达分析,样本按心脏重量指数(5.8 mg/g、8.1 mg/g、9.2 mg/g)和分子标志物上调程度分为高血压表型(Hyp1、Hyp3、Hyp4)与扩张型心力衰竭表型(Dil1、Dil2、Dil3、Dil4),并分别与同年龄同性别的野生型小鼠(WT2、WT3、WT4)比较。采用微阵列分析(GPL4371平台)检测基因表达,数据经print tip lowess归一化处理,通过t检验识别显著变化基因(p≤0.05)。
设计对TG1306/1R转基因小鼠的心脏组织(左右心室及间隔)进行基因表达分析,样本按心脏重量指数(5.8 mg/g、8.1 mg/g、9.2 mg/g)和分子标志物上调程度分为高血压表型(Hyp1、Hyp3、Hyp4)与扩张型心力衰竭表型(Dil1、Dil2、Dil3、Dil4),并分别与同年龄同性别的野生型小鼠(WT2、WT3、WT4)比较。采用微阵列分析(GPL4371平台)检测基因表达,数据经print tip lowess归一化处理,通过t检验识别显著变化基因(p≤0.05)。
摘要Agonist-induced cardiac hypertrophy in TG1306/1R transgenic mice with cardiac angiotensin II overproduction leads to a gradual transition from a compensatory hypertrophic state to heart failure. To gain insight into the molecular mechanisms that play a role in maintaining cardiac integrity in the diseased heart, we performed a comparative study of gene expression between wild-type (WT) and transgenic (TG) hearts using microarray analysis. TG1306/1R transgenics were separated into two phenotypic groups (hypertrophic and dilated) based on morphological parameters (cardiac weight index and histology) and either a moderate (hypertrophic) or a high (dilated) upregulation of molecular markers for hypertrophy and failure, and compared to age and sex-matched wild-types.
-
89 GSE132701 对心肌梗死后4天的小鼠心肌细胞进行RNA测序,比较转基因GRK5小鼠与非转基因对照小鼠的转录组差异。研究对象为转基因(TgGRK5)和非转基因(NLC)小鼠的心肌细胞,分组为转基因组与非转基因对照组,每组包含5个独立重复,检测方式为RNA-Seq,主要比较两组间的转录特征差异。
设计对心肌梗死后4天的小鼠心肌细胞进行RNA测序,比较转基因GRK5小鼠与非转基因对照小鼠的转录组差异。研究对象为转基因(TgGRK5)和非转基因(NLC)小鼠的心肌细胞,分组为转基因组与非转基因对照组,每组包含5个独立重复,检测方式为RNA-Seq,主要比较两组间的转录特征差异。
摘要Myocardial ischemia (MI) is the most common cause of heart failure (HF) in the United States. G protein‑coupled receptor (GPCR) kinase 5 (GRK5) has been found to be upregulated in failing human myocardium. While the canonical role of GRKs is to desensitize receptors via phosphorylation, GRK5 can also translocate to the nucleus of cardiomyocytes where it exerts GPCR‑independent effects that promote maladaptive cardiac hypertrophy. The role of GRK5 in ischemic heart disease is still unknown
-
90 GSE153988 将3个月龄和12个月龄的Control及Prdm16 knockout小鼠心脏组织进行RNA测序,比较不同基因型在两个年龄组间的转录组差异,分析心脏肥大、纤维化、线粒体功能及代谢重塑的表达特征。
设计将3个月龄和12个月龄的Control及Prdm16 knockout小鼠心脏组织进行RNA测序,比较不同基因型在两个年龄组间的转录组差异,分析心脏肥大、纤维化、线粒体功能及代谢重塑的表达特征。
摘要Hypertrophic cardiomyopathy (HCM) is one of the most frequent inherited heart condition and a well-established risk factor for cardiovascular mortality worldwide. Although hypertrophy is traditionally regarded as an adaptive response to increased workload caused by physiological or pathological stress, prolonged hypertrophy can lead to heart failure characterized by impaired systolic function, increased apoptosis, fibrosis, ventricular dilation, and impaired metabolic substrate flexibility. While the key regulators for cardiac hypertrophy are well studied, the role of Prdm16 in this process remains poorly understood. In the present study, we demonstrate that Prdm16 is dispensable for cardiac development. However, it is required in the adult heart to preserve mitochondrial function and inhibit hypertrophy with advanced age. Cardiac-specific deletion of Prdm16 results in cardiac hypertrophy, excessive ventricular fibrosis, mitochondrial dysfunction, and impaired metabolic flexibility, leading to heart failure. We demonstrate that Prdm16 and euchromatic histone-lysine N- methyltransferase factors (Ehmts) act together to reduce the expression of fetal genes reactivated in pathological hypertrophy by inhibiting the functions of pro- hypertrophic transcription factor Myc. Although young Prdm16 knockout mice show normal cardiac function, they are predisposed to develop heart failure in response to metabolic stress. Collectively, our results demonstrate that Prdm16 protects the heart against age-dependent cardiac hypertrophy, fibrosis, mitochondrial dysfunction, adverse metabolic remodeling, and heart failure.
-
91 GSE183504 对小鼠右心室组织进行基因表达分析,比较肺动脉结扎(PAC)处理与未处理的野生型、C3敲除(C3KO)和Cfd敲除小鼠之间的差异。检测采用Agilent平台,样本按不同基因型和处理条件分组,每组样本数按总单位数与组数估计。
设计对小鼠右心室组织进行基因表达分析,比较肺动脉结扎(PAC)处理与未处理的野生型、C3敲除(C3KO)和Cfd敲除小鼠之间的差异。检测采用Agilent平台,样本按不同基因型和处理条件分组,每组样本数按总单位数与组数估计。
摘要Right ventricular (RV) failure plays a critical role in any type of heart failure. However, there is no specific therapy developed for RV failure. To understand RV failure, we focused on the RV specific genes. Global gene expression analysis showed that alternative complement pathway-related genes including C3 and Cfd were significantly upregulated in right ventricle in murine heart. We generated the RV failure by right ventricle-specific pressure overload model mice, pulmonary artery constriction (PAC), which induces RV failure around 14 days. In C3 knockout (C3KO) mice, PAC-induced RV dysfunction and fibrosis were significantly attenuated. C3a is produced from C3 by C3 convertase complex including Cfd. Cfd knockout mice also attenuated PAC-induced RV failure. Moreover, C3a receptor (C3aR) antagonist dramatically improved PAC-induced RV dysfunction in wild type mice. Here we revealed the crucial role of C3-Cfd-C3a-C3aR axis in RV failure and highlight the potential therapeutic target for RV failure with no pharmacologic option.
-
92 GSE249409 对C57BL6小鼠左心室组织进行RNA测序,比较HFD/mTAC HFpEF模型组与对照组的基因表达差异。模型组为高脂饮食结合中度主动脉缩窄诱导的HFpEF小鼠(n=5),对照组为非HFpEF状态小鼠(n=5),两组均接受vehicle处理。
设计对C57BL6小鼠左心室组织进行RNA测序,比较HFD/mTAC HFpEF模型组与对照组的基因表达差异。模型组为高脂饮食结合中度主动脉缩窄诱导的HFpEF小鼠(n=5),对照组为非HFpEF状态小鼠(n=5),两组均接受vehicle处理。
摘要Heart failure with preserved ejection fraction (HFpEF) is a prevalent health condition associated with high morbidity and mortality, but currently, there are few effective therapies. Our previous research showed that inhibiting histone deacetylase 6 (HDAC6) had a beneficial effect on a genetic cardiomyopathy model. The overlapping underlying mechanisms involving inflammation and metabolism between cardiomyopathy and HFpEF prompted us to explore the role of HDAC6 in HFpEF. The results showed that inhibiting HDAC6 with TYA-018 reversed preexisting cardiac hypertrophy and diastolic dysfunction, and improved lung congestion and exercise capacity in mouse models of HFpEF, including a newly developed model that combines moderate trans-aortic constriction and high-fat diet to mimic the systemic and cardiovascular features of human HFpEF. Moreover, mice with genetic Hdac6 deletion delayed the development of HFpEF and were resistant to the effects of TYA-018. The efficacy of TYA-018 was comparable to a SGLT2 inhibitor, and the combination showed increased effects. Mechanistically, TYA-018 restored expression of gene sets associated with hypertrophy, fibrosis, and mitochondrial energy production in heart tissue from HFpEF mice. TYA-018 also inhibited activation of human cardiac fibroblasts and increased mitochondrial respiratory capacity in induced pluripotent stem cell–derived cardiomyocytes. These findings support the direct role of HDAC6 on HFpEF pathophysiology in the heart and that inhibiting HDAC6 may be a promising approach to treating HFpEF.
-
93 GSE277624 将 Cd163-/- 小鼠与野生型小鼠心脏组织进行转录组 RNA-Seq 分析,比较压力超载诱导的心力衰竭模型中两组基因表达差异;同时对腹腔巨噬细胞进行 dexamethasone 处理并检测其转录组,分析 CD163 缺陷对巨噬细胞功能的影响;此外采集高血压患者血清样本,比较心力衰竭与非心力衰竭组 CD163 相关指标变化。
设计将 Cd163-/- 小鼠与野生型小鼠心脏组织进行转录组 RNA-Seq 分析,比较压力超载诱导的心力衰竭模型中两组基因表达差异;同时对腹腔巨噬细胞进行 dexamethasone 处理并检测其转录组,分析 CD163 缺陷对巨噬细胞功能的影响;此外采集高血压患者血清样本,比较心力衰竭与非心力衰竭组 CD163 相关指标变化。
摘要Background Chronic sustained pressure overload induces cardiac remodeling, which often leads to heart failure. Cardiac macrophages (cMacs) are heterogeneous cell populations, and their elimination has been shown to exacerbate pressure overload-induced heart failure. CD163, a macrophage-specific scavenger receptor expressed in a subset of cMacs, has been linked to cardiovascular events through its serum soluble form. This study aimed to elucidate the functional role of the CD163+ cMacs subset in pressure overload-induced heart failure. Methods Transverse aortic constriction (TAC) was performed on wild-type and CD163-deficient (Cd163-/-) mice to investigate the role of CD163 in pressure overload-induced cardiac remodeling and heart failure. Echocardiography was used to assess heart structure and function. Transcriptomic analysis and transmission electron microscopy were employed to observe mitochondrial structure in cardiomyocytes. Flow cytometry was used to quantify cMacs and cytokine-expressing cMacs in the heart. Additionally, serum samples from hypertensive patients with and without heart failure were analyzed to explore the relationship between CD163 and heart failure. Results TAC-induced left ventricular systolic dysfunction, including reduced ejection fraction and fractional shortening, was significantly aggravated in Cd163-/- mice post-surgery. Genes differentially expressed due to CD163 deficiency were enriched in pathways related to mitochondrial bioenergetics and homeostasis. Transmission electron microscopy revealed an increase in dysfunctional mitochondria in cardiomyocytes of Cd163-/- mice post-TAC. Additionally, decreased serum interleukin (IL)-10 levels and reduced IL-10 expression in cMacs were observed in Cd163-/- mice post-TAC. IL-10 supplementation significantly reversed TAC-induced reductions in left ventricular systolic function and improved mitochondrial bioenergetics and homeostasis in Cd163-/- mice. Conclusions The protective functions of CD163 in cMacs are associated with IL-10 expression during pressure overload-induced heart failure.
-
94 GSE304830 对MLPKO小鼠模型的左心室组织进行bulk RNA-seq,比较MLPKO-RADfloxed/floxed与MLPKO-RADfloxed/floxed-MYH6_MerCreMer两组在10周龄时给予tamoxifen诱导cRADΔ/Δ后的基因表达差异。每组采集5个心脏样本,检测时间点为1个月后,采用cDNA文库策略,通过RNA-Seq技术分析心脏组织的转录组特征,主要比较两组间病理信号通路及促肥厚基因表达的变化。
设计对MLPKO小鼠模型的左心室组织进行bulk RNA-seq,比较MLPKO-RADfloxed/floxed与MLPKO-RADfloxed/floxed-MYH6_MerCreMer两组在10周龄时给予tamoxifen诱导cRADΔ/Δ后的基因表达差异。每组采集5个心脏样本,检测时间点为1个月后,采用cDNA文库策略,通过RNA-Seq技术分析心脏组织的转录组特征,主要比较两组间病理信号通路及促肥厚基因表达的变化。
摘要Heart failure with reduced ejection fraction (HFrEF) is a major health problem. Increasing L-type calcium channel (LTCC) activity deteriorates heart function; however, myocardial RRAD knockout (cRADΔ/Δ) instills tonic modulated LTCC current (ICa,L) that preserves healthy myocardium. Thus, we chose to challenge the dogma that enhanced trigger Ca2+ is maladaptive. The study objective was to test the hypothesis that modulated ICa,L in cRADΔ/Δ mice rescues dilated cardiomyopathy by providing tonic modulated trigger Ca2+. Methods and Results Mouse and human models were tested. The muscle lim protein knockout mouse (MLPKO) is a murine model of dilated cardiomyopathy (DCM) and HFrEF. The experimental timeline was to induce cRADΔ/Δ after onset of DCM (2.5 months of age) and follow subjects for up to 1-year. Longitudinal echocardiography and cardiac magnetic resonance imaging (CMR) showed that cRADΔ/Δ intervention rescued systolic function. Patch clamp recordings of isolated cardiomyocytes of MLPKO with cRADΔ/Δ demonstrated augmented LTCC activity, along with rescue of dysfunctional Ca2+ handling and sarcomere function. Bulk RNAseq of hearts demonstrated downregulated pathological signaling cascades and pro-hypertrophic gene expression which comported with the reduction in eccentric hypertrophy observed with gravimetrics, CMR, and echocardiography. RRAD knockdown effects translate from mouse to human heart. Ventricle slices from HFrEF patients were treated with lentiviral shRNA targeting RRAD and recapitulated the inotropic and lusitropic effects observed in the mouse model of DCM. Conclusions Induction of cardiomyocyte-restricted RAD knockout in MLPKO mice after onset of DCM rescued cardiac dysfunction and attenuated pathological remodeling. cRADΔ/Δ intervention provided positive inotropy and lusitropy and reverted transcriptional signatures towards healthy myocardium. This study introduces targeting myocardial RAD regulation of the LTCC as a novel therapeutic strategy for systolic heart failure.
-
95 GSE328472 将小鼠左心室组织分为Vehicle组和Osimertinib组,每组5个样本(按总样本数10与组数2估计),进行RNA-Seq分析,比较两组间的基因表达差异。
设计将小鼠左心室组织分为Vehicle组和Osimertinib组,每组5个样本(按总样本数10与组数2估计),进行RNA-Seq分析,比较两组间的基因表达差异。
摘要Osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), has significantly improved outcomes in non–small cell lung cancer (NSCLC) patients harboring the T790M mutation; however, emerging clinical evidence indicates a substantial risk of cardiotoxicity. Here, we establish the first in vivo preclinical model of osimertinib-induced cardiotoxicity using transverse aortic constriction (TAC) in mice. Osimertinib treatment resulted in profound cardiac dysfunction, impaired hypertrophic remodeling, and increased markers of heart failure and fibrosis. Unbiased transcriptomic profiling revealed a maladaptive myocardial stress response characterized by activation of p53-associated cell death pathways, mitochondrial dysfunction, and negative enrichment of histone acetyltransferase (HAT) complexes, indicating epigenetic repression. Mechanistically, osimertinib-treated hearts exhibited increased expression of multiple histone deacetylase (HDAC) isoforms, reduced acetylation of key histones, and enhanced cardiomyocyte apoptosis via Bax/caspase-mediated pathways. There was only a minimal, transient effect on inflammation, supporting a type I, cell-autonomous cardiotoxic mechanism. Consistent with this, in vitro and in vivo analyses demonstrated suppression of pro-survival ERK/AKT signaling, mitochondrial dysfunction, and activation of intrinsic apoptotic pathways. Given the central role of HDAC activation, we tested whether pharmacologic HDAC inhibition could mitigate osimertinib-induced cardiotoxicity. Treatment with the FDA-approved HDAC inhibitor vorinostat (SAHA) restored histone acetylation, attenuated p53 activation, reduced cardiomyocyte death, and rescued cardiac function in osimertinib-treated mice. Translational studies in human NSCLC-derived PC9 cells further demonstrated that SAHA enhances osimertinib anti-tumor efficacy while alleviating cardiotoxicity. Collectively, these findings define HDAC-dependent epigenetic repression as a key mechanism underlying osimertinib-induced cardiotoxicity and identify HDAC inhibition as a therapeutically actionable strategy to improve both cardiac safety and cancer treatment efficacy.
-
96 GSE96690 对小鼠左心室分离的心肌细胞进行RNA-Seq分析,包含control组(3个样本)、CTCF knockout组(6个样本)和压力超负荷组(1个样本),比较各组间基因表达差异。CTCF knockout小鼠与压力超负荷处理小鼠均表现出类似心力衰竭的基因表达变化。
设计对小鼠左心室分离的心肌细胞进行RNA-Seq分析,包含control组(3个样本)、CTCF knockout组(6个样本)和压力超负荷组(1个样本),比较各组间基因表达差异。CTCF knockout小鼠与压力超负荷处理小鼠均表现出类似心力衰竭的基因表达变化。
摘要Understanding the principles of endogenous chromatin structure has key implications for epigenetic therapy. To determine the mechanisms of genome structure-function in post-mitotic cells, genome-wide chromatin conformation capture was performed in cardiac myocytes, a non-dividing, differentiated cell responsible for cardiac contraction. Cardiac-specific CTCF knockout mice demonstrated that loss of CTCF had minimal effect on topologically associating domains; however, it selectively altered boundary strength and A/B compartmentalization, with gene expression changes mimicking those in heart failure. Loss of CTCF (or subjecting wild-type mice to clinically relevant pressure overload stress) remodeled long-range chromatin looping to alter 3D proximity of enhancers and disease causing genes. Depletion of CTCF was sufficient to induce heart failure in mice and human heart failure patients receiving mechanical unloading to attenuate disease progression show increased CTCF expression. These findings establish CTCF in the maintenance of chromatin looping and identify global chromatin remodeling as a causative factor in heart failure.
-
97 GSE136308 将C57BL/6雄性小鼠分为假手术组(n=5)和心室重构手术组(n=4),术后6周收集左心室组织进行基因表达检测,比较两组间基因表达差异。
设计将C57BL/6雄性小鼠分为假手术组(n=5)和心室重构手术组(n=4),术后6周收集左心室组织进行基因表达检测,比较两组间基因表达差异。
摘要Background: Cardiac kinases play a critical role in the development of heart failure, and represent potential tractable therapeutic targets. However, only a very small fraction of the cardiac kinome has been investigated. To identify novel cardiac kinases involved in heart failure, we employed an integrated transcriptomics and bioinformatics analysis and identified Homeodomain-Interacting Protein Kinase 2 (HIPK2) as a novel candidate kinase. The role of HIPK2 in cardiac biology is unknown. Methods: We used the Expression2Kinase algorithm for the screening of kinase targets. To determine the role of HIPK2 in the heart, we generated cardiomyocyte-specific HIPK2 knockout (CM-KO) and heterozygous (CM-Het) mice. Heart function was examined by echocardiography and related cellular and molecular mechanisms were examined. Adeno-associated virus serotype 9 (AAV9) carrying cardiac-specific constitutively active MEK1 (TnT-MEK1-CA) were administrated to rescue cardiac dysfunction in CM-KOs. Results: To our knowledge, this is the first study to define the role of HIPK2 in cardiac biology. Using multiple HIPK2 loss-of-function mouse models, we demonstrated that reduction of HIPK2 in cardiomyocytes leads to cardiac dysfunction—suggesting a causal role in heart failure. Importantly, cardiac dysfunction in HIPK2 KOs developed with advancing age, but not during development. In addition, CM-KO and CM-Het exhibited a gene dose-response relationship of cardiomyocyte HIPK2 on heart function. HIPK2 expression in the heart was significantly reduced in human end-stage ischemic cardiomyopathy compared to non-failing myocardium, suggesting a clinical relevance of HIPK2 in cardiac biology. In vitro studies with neonatal rat ventricular cardiomyocytes corroborated the in vivo findings. Specifically, adenovirus-mediated overexpression of HIPK2 suppressed the expression of heart failure markers, NPPA and NPPB, at basal condition and abolished phenylephrine-induced pathological gene expression. An array of mechanistic studies revealed impaired ERK1/2 signaling in HIPK2 deficient hearts. In vivo rescue experiment with AAV9 TnT-MEK1-CA nearly abolished the detrimental phenotype of KOs suggesting that impaired ERK signaling mediated apoptosis as the key factor driving the detrimental phenotype in CM-KO hearts. Conclusions: Taken together, these findings suggest that cardiomyocyte HIPK2 is required to maintain normal cardiac function via ERK signaling
-
98 GSE185450 将C57BL/6J小鼠心脏组织按Sham、TAC、LD分组,每组3个生物重复,采用RNA-Seq检测转录组变化,比较LD处理组与TAC模型组在心脏功能及信号通路差异,同时分析补偿与失代偿状态下AKT-GSK3β/mTOR和MAPKs通路蛋白表达变化。
设计将C57BL/6J小鼠心脏组织按Sham、TAC、LD分组,每组3个生物重复,采用RNA-Seq检测转录组变化,比较LD处理组与TAC模型组在心脏功能及信号通路差异,同时分析补偿与失代偿状态下AKT-GSK3β/mTOR和MAPKs通路蛋白表达变化。
摘要Heart failure (HF), a major health concern worldwide, with high morbidity and mortality, renders the urgent need for new treatments. Lingguizhugan decoction (LD), a classic Chinese formula, has been clinically used to treat HF. However, the molecular mechanisms involved are not fully elucidated. In this study, we first used the experimental model of transverse aortic constriction (TAC)-induced HF in C57BL/6J mice to evaluate the therapeutic efficacy of LD. Our results showed that LD exerted protective effects against TAC-induced HF by alleviating cardiac dysfunction and cardiac dilation, which might be associated with LD’s effects on down-regulating CH-related gene and protein expression. To further reveal the potential molecular mechanisms of LD in the treatment of HF, we utilized the network pharmacology to predict the core targets and potential pathways and further utilized the transcriptomics to provide changed gene profile in the heart tissue. Our results suggested that cardiac hypertrophy signaling including AKT and MAPKs signaling pathways were significantly enriched, indicating that these pathways may be the major regulatory for LD on HF treatment. Furthermore, the protein levels in AKT-GSK3β/mTOR and MAPKs pathway were determined in both compensated and decompensated states. LD inhibited the MAPKs activation, especially, reducing phosphorylated levels of p38 from the compensated state and phosphorylated levels of ERK from the decompensated state, and the latter might depend on the regulation of AMPK by LD. Moreover, LD exerts a dual role in regulating AKT-GSK3β/mTOR/P70S6K signaling pathway, characterized by active effects in the compensated state, and inhibitory effects in the decompensated state. The regulatory effect of LD on mTOR might rely on activating AKT in the compensatory state, while might be jointly determined by AKT and AMPKαin the decompensated state. Finally, by using UPLC-QE-MS/MS analysis, we detected 62 compounds in LD extract, and found 19 of which were detected in plasma of rats. Among them, 17 bioactive compounds likely regulate AKT-GSK3β/mTOR and MAPKs signaling pathway by using bioinformatics prediction. Taken together, our study showed that LD did have a better therapeutic effect on HF via dynamically balancing AKT-GSK3β/mTOR/P70S6K pathway and MAPKs pathway. Moreover, our study also provides possible bioactive compounds responsible for LD treatment on HF.
-
99 GSE191316 对8月龄雄性RKIP转基因小鼠、GRK2转基因小鼠及非转基因FVB/N对照小鼠的心脏转录组进行RNA-Seq分析,比较转基因组与对照组的基因表达差异。RKIP转基因小鼠在心肌特异性alpha-MHC启动子驱动下表达RKIP(PEBP1),GRK2转基因小鼠在CMV启动子驱动下表达GRK2,非转基因对照为同龄雄性FVB/N小鼠。每组包含3只小鼠,采集心脏组织进行转录组测序,分析转基因诱导的心脏功能异常及基因表达变化。
设计对8月龄雄性RKIP转基因小鼠、GRK2转基因小鼠及非转基因FVB/N对照小鼠的心脏转录组进行RNA-Seq分析,比较转基因组与对照组的基因表达差异。RKIP转基因小鼠在心肌特异性alpha-MHC启动子驱动下表达RKIP(PEBP1),GRK2转基因小鼠在CMV启动子驱动下表达GRK2,非转基因对照为同龄雄性FVB/N小鼠。每组包含3只小鼠,采集心脏组织进行转录组测序,分析转基因诱导的心脏功能异常及基因表达变化。
摘要The RAF kinase inhibitor protein, RKIP, is a dual inhibitor of the RAF1 kinase and the G-protein-coupled receptor kinase 2 (GRK2). By inhibition of the proto-oncogenic and pro-survival RAF1-MAPK pathway, the RAF kinase inhibitor protein, RKIP, acts as a tumor suppressor, which enhances cardiomyocyte death and promotes the development of symptoms of heart failure. To elucidate pathomechanisms of heart failure induced by RKIP, the study determined the cardiac transcriptomes of eight-month-old, male, transgenic mice with cardiac-specific expression of RKIP (PEBP1) under control of the myocardium-specific, alpha-MHC promoter. In addition, the study determined the cardiac transcriptomes of GRK2-transgenic mice. Tg-GRK2 mice have a slightly increased transgenic expression of GRK2. According to NGS data, cardiac GRK2-Grk2 transcript levels of Tg-GRK2 mice are 1.59±0.10-fold higher than those of non-transgenic FVB hearts. In Tg-GRK2 mice, transgenic GRK2 is expressed under control of the ubiquitous CMV immediate-early promoter/enhancer. The non-transgenic control group are age-matched, male, nontransgenic FVB/N mice. NGS data of this study document transcriptome changes underlying the heart failure phenotype induced by transgenic RKIP expression and cardiac degeneration induced by GRK2 expression.
-
100 GSE218733 对HFpEF模型小鼠心脏组织进行bulk RNA-seq,比较正常饮食组(Ctrl)、高脂肪饮食+L-NAME诱导组(Ctrl_HF)及转基因高脂肪饮食+L-NAME组(TTg_HF)的基因表达差异。实验开始后15周处死小鼠,每组包含3个独立重复样本(Ctrl_rep1-3,Ctrl_HF_rep1-3,TTg_HF_rep1-3),采集全心室组织提取总RNA,采用RNA-Seq策略检测,未明确对照组设置。
设计对HFpEF模型小鼠心脏组织进行bulk RNA-seq,比较正常饮食组(Ctrl)、高脂肪饮食+L-NAME诱导组(Ctrl_HF)及转基因高脂肪饮食+L-NAME组(TTg_HF)的基因表达差异。实验开始后15周处死小鼠,每组包含3个独立重复样本(Ctrl_rep1-3,Ctrl_HF_rep1-3,TTg_HF_rep1-3),采集全心室组织提取总RNA,采用RNA-Seq策略检测,未明确对照组设置。
摘要Fibrosis is important pathogenesis in heart failure with preserved ejection fraction (HFpEF). We previously reported that the overexpression of cardiac transcription factors, Mef2c/Gata4/Tbx5/Hand2 (MGTH) could directly reprogram cardiac fibroblasts (CFs) into induced CMs (iCMs) and reduce fibrosis. Here we show that in vivo cardiac reprogramming generated iCMs from resident CFs, improved cardiac function, and reversed fibrosis in HFpEF model using a novel transgenic mouse system. RNA-seq revealed that the MGTH activated the cardiac program and concomitantly suppressed fibroblast and inflammatory signatures. Thus, cardiac reprogramming improves HFpEF via myocardial regeneration and anti-fibrosis.
-
101 GSE244904 对糖尿病小鼠(db/db)和野生型小鼠(Wild Type)的左心室组织进行RNA测序,分别采用AAV9_null和AAV9_USP28处理,比较两种基因型下不同处理组的转录组差异。
设计对糖尿病小鼠(db/db)和野生型小鼠(Wild Type)的左心室组织进行RNA测序,分别采用AAV9_null和AAV9_USP28处理,比较两种基因型下不同处理组的转录组差异。
摘要The majority of diabetics are susceptible to cardiac dysfunction and heart failure, while conventional drug therapy cannot correct diabetic cardiomyopathy (DCM) progression. Herein, we assessed the potential role and therapeutic value of ubiquitin-specific protease 28 (USP28) on the metabolic vulnerability of DCM. cardiac USP28 deficient diabetic mice showed cardiac dysfunction, lipid accumulation, and mitochondrial disarrangement, compared to their controls. Conversely, USP28 overexpression improved systolic and diastolic dysfunction and ameliorated cardiac hypertrophy and fibrosis in the diabetic heart. Mechanistically, USP28 directly interacted with peroxisome proliferator-activated receptor α (PPARα), deubiquitinating and stabilizing PPARα (Lys152) to promote mitofusin 2 (Mfn2) transcription, thereby impeding mitochondrial morphofunctional defects.
-
102 GSE254172 对小鼠心脏组织进行RNA-Seq,比较野生型(WT)与c-Myc敲除小鼠在TAC处理和假手术(sham)条件下的转录组差异。WT-sham组包含Control1、Control2、Control3,WT-TAC组包含TACcontrol2、TACcontrol3、TACcontrol4,c-Myc KO-TAC组包含TACKO1、TACKO2、TACKO3。
设计对小鼠心脏组织进行RNA-Seq,比较野生型(WT)与c-Myc敲除小鼠在TAC处理和假手术(sham)条件下的转录组差异。WT-sham组包含Control1、Control2、Control3,WT-TAC组包含TACcontrol2、TACcontrol3、TACcontrol4,c-Myc KO-TAC组包含TACKO1、TACKO2、TACKO3。
摘要Heart failure (HF) is a global concern, marked by limited therapeutic options. While existing studies primarily focus on cardiomyocytes, there is a notable absence of drugs targeting noncardiomyocytes for HF. We focused on cardiac fibroblasts (CFs), utilising single-cell RNA-sequencing analysis. The analysis of murine hearts revealed one subcluster exclusive to the HF stage. The transcription factor c-Myc is specifically expressed in heart failure-specific fibroblasts (HF-Fibro). Cardiac fibroblast-specific deletion of c-Myc ameliorates pressure overload-induced cardiac dysfunction without affecting fibrosis. To elucidate the molecular function of c-Myc in HF-Fibro, transcriptome analysis by RNA-seq was conducted, in vivo.
-
103 GSE335971 对心室组织进行 bulk RNA 测序,比较野生型小鼠与心肌细胞特异性 Flnc 缺失小鼠、以及接受 AAV 治疗的 Flnc 缺失小鼠之间的转录组差异。研究对象为 Myh6-MerCreMer;Flnc fl/fl 小鼠,分三组:对照组(PBS + Oil)、Flnc iCKO 组(PBS + TAM)和 AAV 治疗组(AAV + TAM),每组含 3 个生物重复。处理包括 5 周龄时 retro-orbital 注射 PBS 或 Myo-AAV 药物混合液,6 周龄时 PBS + TAM 和 AAV + TAM 组接受 tamoxifen 治疗,15 周龄时采集心室尖端组织进行 RNA 提取和测序。
设计对心室组织进行 bulk RNA 测序,比较野生型小鼠与心肌细胞特异性 Flnc 缺失小鼠、以及接受 AAV 治疗的 Flnc 缺失小鼠之间的转录组差异。研究对象为 Myh6-MerCreMer;Flnc fl/fl 小鼠,分三组:对照组(PBS + Oil)、Flnc iCKO 组(PBS + TAM)和 AAV 治疗组(AAV + TAM),每组含 3 个生物重复。处理包括 5 周龄时 retro-orbital 注射 PBS 或 Myo-AAV 药物混合液,6 周龄时 PBS + TAM 和 AAV + TAM 组接受 tamoxifen 治疗,15 周龄时采集心室尖端组织进行 RNA 提取和测序。
摘要Loss-of-function variants in filamin-C (FLNC) are a major genetic cause of dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM). These variants are associated with progressive ventricular dysfunction, malignant ventricular arrhythmias, heart failure, and an increased risk of sudden cardiac death. Although current clinical therapies can alleviate symptoms and reduce arrhythmic burden, they do not directly restore FLNC expression or address the underlying molecular defect. To investigate the transcriptional consequences of FLNC deficiency and the molecular effects of FLNC restoration, we performed bulk RNA sequencing on ventricular tissues from control mice, cardiomyocyte-specific inducible Flnc knockout (iCKO) mice, and iCKO mice treated with a 3-intein adeno-associated virus (AAV) system designed to reconstitute full-length FLNC expression. Comparative transcriptomic analyses identified gene expression changes associated with Flnc deficiency and their modulation following AAV-mediated FLNC replacement. This dataset provides a resource for studying the molecular mechanisms underlying FLNC-related cardiomyopathy and evaluating gene replacement strategies for inherited cardiac diseases.
-
104 GSE348247 将小鼠心脏组织分为 Sham、MI 和 MI + GRh2 三组(每组 3 个样本),通过 RNA 测序分析基因表达差异,同时采用 ELISA 和 Western blotting 测定氧化应激、纤维化指标及 TGF-β/Smad2 通路相关蛋白水平,比较各组间基因型与处理条件对心脏功能的影响。
设计将小鼠心脏组织分为 Sham、MI 和 MI + GRh2 三组(每组 3 个样本),通过 RNA 测序分析基因表达差异,同时采用 ELISA 和 Western blotting 测定氧化应激、纤维化指标及 TGF-β/Smad2 通路相关蛋白水平,比较各组间基因型与处理条件对心脏功能的影响。
摘要Background: Myocardial fibrosis and oxidative stress are key drivers of post-myocardial infarction heart failure (post-MI HF). Ginsenoside Rh2 (GRh2) has shown cardioprotective potential, but its role in post-MI HF and the underlying mechanism remain unclear. The current study aimed to investigate the therapeutic effect of GRh2 on post-MI HF and to validate its regulatory mechanism using murine, cellular, and cardiac organoid models. Methods: In vivo, Cardiac function and myocardial fibrosis were evaluated. Transcriptome analysis was performed to identify enriched signaling pathways. In vitro, H9C2 cardiomyocytes and cardiac organoids were subjected to oxygen-glucose deprivation (OGD). Cardiac injury indicators, fibrotic and oxidative stress markers, and proteins associated with the TGF-β/Smad2 pathway were measured via enzyme-linked immunosorbent assay (ELISA) and Western blotting. Results: In vivo, GRh2 treatment markedly improved cardiac function and reduced myocardial fibrosis in mice with post-MI heart failure. Transcriptomic analysis revealed that the TGF-β signaling pathway was substantially enriched. In vitro, GRh2 treatment significantly improved cell viability and reduced oxidative stress and fibrosis in OGD-exposed H9C2 cardiomyocytes and cardiac organoids. These protective effects were strongly associated with the suppression of the TGF-β/Smad2 signaling pathway. Conclusions: Ginsenoside Rh2 inhibits the TGF‑β/Smad2 signaling pathway to ameliorate cardiac dysfunction in post-MI heart failure, suggesting its potential as a therapeutic candidate.
-
105 GSE69401 将免疫缺陷小鼠心脏分为慢性心力衰竭模型组、EVs处理组、alpha-MEM对照组和假手术组,通过超声心动图比较LV end-systolic volume等指标差异,同时分析纤维化、血管生成及基因表达变化。
设计将免疫缺陷小鼠心脏分为慢性心力衰竭模型组、EVs处理组、alpha-MEM对照组和假手术组,通过超声心动图比较LV end-systolic volume等指标差异,同时分析纤维化、血管生成及基因表达变化。
摘要Introduction: Cell-derived extracellular vesicles ([EVs], i.e., exosomes and microparticles) have been reported to mediate the cardioprotective effects of stem cells. However, a head-to-head comparison of their effects with those of the cells from which they derive has not been reported. Hypothesis: The effects of the EV content of human embryonic stem cell (hESC)-derived cardiac progenitors may be equivalent to those of the parent cells. Methods: Two series of immunodeficient (nude) mice underwent permanent coronary artery ligation. Three weeks later, those with an echocardiographically-determined LV ejection fraction ≤ 50% were randomly allocated to receive transcutaneous echo-guided peri-infarct injections of alpha-MEM media (controls), hESC-derived SSEA-1+ cardiac progenitors (500000 cells in 30 μL), or total EV secreted by those 500000 cells in 48 hours in an equivalent volume. The second series also included sham-operated animals for which the needle was inserted into the myocardium in three places without injection. EVs were collected from the cell-secreted medium by ultracentrifugation and characterized by flow cytometry, and nanosight NTS. Outcomes were assessed after 6 weeks by echocardiography, taking LV end-systolic volume (ESV) as the primary end point. Hearts were processed for the assessment of fibrosis and angiogenesis. Total RNA was extracted from carefully selected animals for gene expression analysis by Affymetrix chip. Only animals with similar VTS at baseline were used for this analysis. All data were collected and analyzed blindly. Results: Cardiac progenitors were successfully generated by exposure of the pluripotent ESC to bone morphogenetic protein-2, purified by anti-CD15 immunomagnetic sorting and then cultured on vitronectin for 48 hours, after which cells or EVs derived from the same cell batch were injected. After 6 weeks in the first series, LVESV [m±SEM] in controls did not significantly differ from the pre-injection value (difference: -2.64 ± 1.54 µL, p=0.12, n= 12). Conversely, in the cell-treated group, LVESV significantly decreased by -4.20 ± 0.96 µL (p=0.0007, n=16). A similar decrease was seen in the EV-treated group: -5.73 ± 1.21 µL (p=0.0003, n=15). Similar patterns were seen for LV end-diastolic volumes: controls (-2.46 ± 1.19 µL, p=NS), cells (-4.48 ± 1.47 µL, p=0.009), EV (-4.29 ± 1.31 µL, p=0.005). For the second series, the VTD of cell- and EV-treated animals remained stable (cell: -1.85 ± 3.27 µL, p=NS, n= 4; EV: +0.05 ± 1.53 µL, p=NS, n = 4), whereas sham- and control-treated animals deteriorated significantly (sham: +2.20 ± 0.35 µL, p = 0.003, n = 5; control: +3.27 ± 0.87 µL, p = 0.03, n = 4). The trend held for VTS, though differences were not significant. Analysis of gene expression data revealed interesting pathways that were more highly expressed in cell- and EV-treated animals than in controls and sham-operated animals. Conclusions: These data support the hypothesis that EVs may be critical mediators of the paracrine effects of cell therapy, and for the sake of streamlining translational processes, deserve to be considered as potential alternatives to stem cell transplantation.
-
106 GSE96057 对12周龄雄性C57BL/6JOlaHsd背景的野生型和OMA1基因敲除小鼠心脏组织进行转录组分析,比较其在慢性异丙肾上腺素处理(7天)与未处理状态下的基因表达差异。样本按基因型分为野生型(含处理组和对照组)及OMA1 KO组(含处理组和对照组),采用RNA-Seq技术检测总RNA表达,分析不同处理条件下基因型间的转录组变化。
设计对12周龄雄性C57BL/6JOlaHsd背景的野生型和OMA1基因敲除小鼠心脏组织进行转录组分析,比较其在慢性异丙肾上腺素处理(7天)与未处理状态下的基因表达差异。样本按基因型分为野生型(含处理组和对照组)及OMA1 KO组(含处理组和对照组),采用RNA-Seq技术检测总RNA表达,分析不同处理条件下基因型间的转录组变化。
摘要Heart failure (HF) is a major health and economic burden in developed countries. It has been proposed that the pathogenesis of HF may involve the action of mitochondria. Here we evaluate three different models of HF: tachycardiomyopathy, HF with preserved left ventricular (LV) ejection fraction, and LV myocardial ischemia and hypertrophy. Regardless of whether LVEF is preserved or reduced, our results indicate that the three models share common molecular features: an increase in mitochondrial ROS, followed by ultrastructural alterations in the mitochondrial cristae and loss of mitochondrial integrity that lead to cardiomyocyte death. We show that the ablation of the mitochondrial protease OMA1 averts cardiomyocyte death in all three experimental HF models, and thus, plays a direct role in cardiomyocyte protection. This finding identifies OMA1 as a potential target for preventing the progression of myocardial damage in HF associated to a variety of etiologies.
-
107 GSE182985 研究对象为小鼠心肌组织,采用RNA测序检测压力过载诱导心力衰竭过程中的mRNA表达差异。样本分为sham组和TAC后2、4、8周的三个压力过载组,每组含2个独立样本。通过比较压力过载组与sham组的基因表达谱,筛选可能影响心力衰竭进程的候选mRNA。
设计研究对象为小鼠心肌组织,采用RNA测序检测压力过载诱导心力衰竭过程中的mRNA表达差异。样本分为sham组和TAC后2、4、8周的三个压力过载组,每组含2个独立样本。通过比较压力过载组与sham组的基因表达谱,筛选可能影响心力衰竭进程的候选mRNA。
摘要To identify the role of mRNA on the mouse heart during pressure overload induced heart failure, we have employed high-throughput sequencing to detect mRNA expression. Samples were collected from the sham group and the pressure overload groups (2, 4 and 8 weeks after TAC), with 2 samples per group. The candidate mRNA that may affect the process of heart failure was screened by comparing the pressure overload groups and the sham group.
-
108 GSE18703 对8周龄C57Bl/6小鼠心脏组织进行转录组分析,比较结扎左冠状动脉降支诱导的缺血性心力衰竭模型与假手术对照组的基因表达差异。采集血浆检测IgM、IgG及炎症细胞因子水平,采用AECOM 32k小鼠微阵列分析心脏RNA样本,使用自制绿色标记通用小鼠参考进行杂交比较。
设计对8周龄C57Bl/6小鼠心脏组织进行转录组分析,比较结扎左冠状动脉降支诱导的缺血性心力衰竭模型与假手术对照组的基因表达差异。采集血浆检测IgM、IgG及炎症细胞因子水平,采用AECOM 32k小鼠微阵列分析心脏RNA样本,使用自制绿色标记通用小鼠参考进行杂交比较。
摘要After myocardial infarction (MI) activation of the immune system and inflammatory mechanisms, among others, can lead to ventricular remodeling and heart failure (HF). Interaction between these systemic alterations and corresponding changes in the heart has not been extensively examined in the setting of chronic ischemia. The main purpose of this study was to investigate alterations in cardiac gene and systemic cytokine profile in mice with post-ischemic HF. Plasma was tested for IgM and IgG anti-heart reactive repertoire and inflammatory cytokines. Heart samples were assayed for gene expression. Ischemic HF significantly increased the levels of serum IgM (by 5.2 fold) and IgG (by 3.6 fold) associated with remarkable content of anti-heart specificity. Comparable increase was observed in levels of circulating pro-inflammatory cytokines, such as IL-1β (3.8x) and TNF-α (6.0x). IFN-gamma was also increased in the MI group by 3.1x. However, IL-4 and IL-10 showed no significant difference between MI and sham groups. Chemokines such as MCP-1 and IL-8 were enhanced in the plasma of infarcted mice. We identified 2079 well annotated unigenes that were significantly regulated by the post-ischemic HF. Complement activation and immune response was among the most up-regulated processes. Interestingly, 21 out of the 101 quantified unigenes involved in inflammatory response were significantly up-regulated and none were down-regulated. These data indicate that post-ischemic heart remodeling is accompanied by immune mediated mechanisms that act both systemically and locally.
-
109 GSE207581 将野生型(WT)和Set7敲除(KO)雄性小鼠按基因型分组,分别接受异丙肾上腺素(60 mg/kg)或生理盐水皮下注射处理,持续14天。采集心脏组织进行RNA测序,比较不同基因型与处理组间的转录组差异。
设计将野生型(WT)和Set7敲除(KO)雄性小鼠按基因型分组,分别接受异丙肾上腺素(60 mg/kg)或生理盐水皮下注射处理,持续14天。采集心脏组织进行RNA测序,比较不同基因型与处理组间的转录组差异。
摘要The Set7 methyltransferase regulates the expression of several genes through the methylation of histones and modulates the activity of non-histone proteins. However, the role of Set7 in cardiac remodeling and heart failure remains unknown. To address this question, wild type (WT) and Set7 knockout (KO) male mice were injected with isoproterenol (60 mg/kg) or saline subcutaneously for 14 days. WT mice injected with isoproterenol displayed a decrease in Set7 activity in the heart, although Set7 protein levels were unchanged. WT and Set7 KO mice injected with isoproterenol exhibited an increase in the heart weight and cardiomyocyte area compared to their respective controls. However, Set7 KO mice displayed an exacerbated cardiac hypertrophy in response to isoproterenol compared to WT mice. In addition, Set7 deletion attenuated isoproterenol-induced cardiac fibrosis. Echocardiograms revealed that WT mice injected with isoproterenol had lowered ejection fractions and fractional shortening, and increased E/A ratios compared to their controls. Conversely, Set7 KO mice did not show alteration in these parameters in response to isoproterenol. Both isoproterenol and Set7 deletion changed the transcriptional profile of the heart. Moreover, Set7 deletion increased the expression of mitochondrial biogenesis and antioxidant factors in the heart and reduced the expression of cellular senescence and inflammation markers. Taken together, our data suggest that Set7 deletion reduces isoproterenol-induced myocardial fibrosis and prevents heart failure, suggesting that Set7 plays an important role in cardiac remodeling and function.
-
110 GSE213707 对实验性扩张型心肌病(DCM)小鼠模型及对照小鼠进行脂质组学、转录组学和免疫印迹分析,比较心脏脂质代谢特征与基因表达差异。研究对象为3周龄C57BL6雄性小鼠,分为DCM(Mst1-TG)和对照(WT)组,其中DCM组通过Mst1基因过表达诱导,部分样本同时进行Galectin-3基因删除处理。采集左心室组织检测脂质类别及基因表达,观察到DCM小鼠心脏脂质谱显著改变,包括鞘脂类升高、甘油三酯减少及线粒体特异性心磷脂下降,同时通过转录组分析揭示特定基因集表达失调。比较对象为同龄健康对照组,未涉及成年小鼠。
设计对实验性扩张型心肌病(DCM)小鼠模型及对照小鼠进行脂质组学、转录组学和免疫印迹分析,比较心脏脂质代谢特征与基因表达差异。研究对象为3周龄C57BL6雄性小鼠,分为DCM(Mst1-TG)和对照(WT)组,其中DCM组通过Mst1基因过表达诱导,部分样本同时进行Galectin-3基因删除处理。采集左心室组织检测脂质类别及基因表达,观察到DCM小鼠心脏脂质谱显著改变,包括鞘脂类升高、甘油三酯减少及线粒体特异性心磷脂下降,同时通过转录组分析揭示特定基因集表达失调。比较对象为同龄健康对照组,未涉及成年小鼠。
摘要Dilated cardiomyopathy (DCM) and heart failure are associated with mitochondrial dysfunction and dysregulated lipid metabolism. Recent studies have implicated a pivotal role of Hippo pathway activation in the development of DCM with profound metabolic remodelling. However, alterations in the cardiac lipid profile and responsible molecular mechanisms, including upregulated galectin-3, remain unclear in the setting of DCM. Mice with DCM induced by Hippo pathway activation (Mst1 gene overexpression alone or with galectin-3 gene deletion) were studied by lipidomic profiling, transcriptomic profiling and immunoblotting for mRNA and protein expression. Profound alterations in cardiac lipid classes were observed, notably elevated sphingolipids, reduced triacylglycerol (TG) and ether lipids, alterations in phospholipid species, elevated lysophosphatidylcholine, and a profound reduction in mitochondria-specific cardiolipin and coenzyme Q10. Relative to adult mice with advanced DCM, reduced TG content was evident but sphingolipid accumulation was absent in young mice at early phase of DCM. Mechanistically, the lipidomic profile in DCM heart was in consistent with dysregulated expression of specific gene sets for biosynthesis of ceramides or TG, TG storage/hydrolysis, mitochondrial lipid metabolism, peroxisome biogenesis, and suppressed PPAR-alpha signaling. Furthermore, galectin-3 gene deletion resulted in changes in some lipid classes and numerous lipid species in settings of healthy and DCM. Multiple alterations in cardiac lipids were identified by lipidomics in a mouse model of DCM due to activation of the Hippo pathway. By employing transcriptome and galectin-3 gene deletion, we revealed underlying mechanisms for lipid abnormalities involving upregulated galectin-3, downregulated expression of specific gene sets of lipid metabolism, and attenuated PPAR-alpha signaling.
-
111 GSE283352 对CMI3OE小鼠进行AAV-PGC-1a或AAV-EGFP处理3周后,通过口服他莫昔芬(30mg/kg)诱导IRF3-2D基因表达,采集左心室组织总RNA进行RNA-seq,比较两组处理后的转录组差异。
设计对CMI3OE小鼠进行AAV-PGC-1a或AAV-EGFP处理3周后,通过口服他莫昔芬(30mg/kg)诱导IRF3-2D基因表达,采集左心室组织总RNA进行RNA-seq,比较两组处理后的转录组差异。
摘要Heightened sterile inflammation and mitochondrial metabolic dysfunction drives the pathophysiology of heart failure in ischemic cardiomyopathy. Yet, the transcriptional regulators within cardiomyocytes driving crosstalk between inflammation and energy metabolism remain ill-defined. Here we identify elevated Ser396/Ser398 phosphorylation of the type I interferon (IFN) response regulating transcription factor IRF3 in the myocardium of patients and male mice with ischemic cardiomyopathy. Cardiomyocyte-specific IRF3 deficiency attenuates ischemia induced contractile dysfunction. Conversely, IRF3 activation in cardiomyocytes through a phosphomimetic IRF3 mutant represses Ppargc1α expression leading to dysfunctional mitochondrial oxidative phosphorylation, altered metabolic flux in the pentose phosphate pathway/TCA cycle, impaired NAD metabolism and an excessive type I IFN activation, collectively detrimental for cardiac function. Restoring cardiomyocyte-specific Ppargc1α expression in IRF3-overexpressor male mice attenuates contractile dysfunction by augmenting a metabolic shift towards fatty acid oxidation and decreasing inflammatory fibrotic responses. These findings identify IRF3 activation in cardiomyocytes as a transcriptional nexus between cardiac inflammation and metabolic fuel switch contributing to heart failure progression.
-
112 GSE283353 对心肌细胞特异性IRF3激活的转基因小鼠(CMI3OE)与对照小鼠(Ctrl Cre)进行口服他莫昔芬处理,采集左心室组织进行RNA测序,比较两组的转录组差异。研究对象为雄性小鼠,样本按总单位数与组数估计每组4只,检测方式为RNA-Seq,组织来源为左心室。
设计对心肌细胞特异性IRF3激活的转基因小鼠(CMI3OE)与对照小鼠(Ctrl Cre)进行口服他莫昔芬处理,采集左心室组织进行RNA测序,比较两组的转录组差异。研究对象为雄性小鼠,样本按总单位数与组数估计每组4只,检测方式为RNA-Seq,组织来源为左心室。
摘要Heightened sterile inflammation and mitochondrial metabolic dysfunction drives the pathophysiology of heart failure in ischemic cardiomyopathy. Yet, the transcriptional regulators within cardiomyocytes driving crosstalk between inflammation and energy metabolism remain ill-defined. Here we identify elevated Ser396/Ser398 phosphorylation of the type I interferon (IFN) response regulating transcription factor IRF3 in the myocardium of patients and male mice with ischemic cardiomyopathy. Cardiomyocyte-specific IRF3 deficiency attenuates ischemia induced contractile dysfunction. Conversely, IRF3 activation in cardiomyocytes through a phosphomimetic IRF3 mutant represses Ppargc1α expression leading to dysfunctional mitochondrial oxidative phosphorylation, altered metabolic flux in the pentose phosphate pathway/TCA cycle, impaired NAD metabolism and an excessive type I IFN activation, collectively detrimental for cardiac function. Restoring cardiomyocyte-specific Ppargc1α expression in IRF3-overexpressor male mice attenuates contractile dysfunction by augmenting a metabolic shift towards fatty acid oxidation and decreasing inflammatory fibrotic responses. These findings identify IRF3 activation in cardiomyocytes as a transcriptional nexus between cardiac inflammation and metabolic fuel switch contributing to heart failure progression.
-
113 GSE295777 对C57BL/6雄性小鼠的心脏组织进行RNA测序,比较MerCreMer对照组与心脏特异性YY1敲除组在转主动脉缩窄处理后一周的基因表达差异,共8个样本。
设计对C57BL/6雄性小鼠的心脏组织进行RNA测序,比较MerCreMer对照组与心脏特异性YY1敲除组在转主动脉缩窄处理后一周的基因表达差异,共8个样本。
摘要The pleiotropic transcription factor Yin Yang 1 (YY1) regulates cellular metabolism in a stage- and tissue-dependent manner. However, its role in cardiac energetic regulation remains unclear. We found that cardiac-specific YY1 knockout (cYY1 KO) mice exhibited cardiac dysfunction after two weeks of swimming exercise, suggesting an impaired adaptive cardiac response. Further analysis revealed that exercise-induced upregulation of transcription factor networks controlling cardiac metabolism, including peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), was blunted in cYY1 KO mice. Consistently, citrate synthase activity, an indicator of mitochondrial content, was reduced in these mice. In response to transaortic constriction (TAC), cYY1 KO mice developed significantly exacerbated heart failure. RNA sequencing showed downregulation of metabolic genes and pathways, including PGC-1α, in TAC cYY1 KO mice hearts. Additionally, mitochondrial complex protein levels and complex I activity were reduced, consistent with suppressed metabolic gene transcription. Previously, we observed increased YY1 expression in hearts subjected to both exercise and TAC. However, while cardiac metabolism was enhanced with exercise, it was impaired with TAC. We found that p300 binding to YY1 increased during exercise, whereas histone deacetylase 3 (HDAC3) binding to YY1 increased in TAC hearts. These findings suggest that YY1-mediated transcriptional regulation of metabolic genes is modulated by the epigenetic regulators p300 and HDAC3.
-
114 GSE298801 对12周龄成年小鼠心室裂解物进行RNA-seq分析,比较Med13/13L敲除(Cre Positive)与Med13/13L fl/fl(Cre Negative)样本的基因表达差异。研究对象为转基因疾病模型小鼠,处理条件为Tamoxifen Chow,样本按每组4只混池,共8个独立样本。
设计对12周龄成年小鼠心室裂解物进行RNA-seq分析,比较Med13/13L敲除(Cre Positive)与Med13/13L fl/fl(Cre Negative)样本的基因表达差异。研究对象为转基因疾病模型小鼠,处理条件为Tamoxifen Chow,样本按每组4只混池,共8个独立样本。
摘要Background: Previous studies have linked mutations in the Mediator complex, specifically Mediator 13 (Med13) and Mediator 13-like (Med13L), with both congenital heart defects and cardiovascular diseases. Med13 and Med13L are mutually exclusive paralogs within the kinase submodule of the Mediator complex that have been shown to have partially redundant functions in embryonic development and transcription, but their combined roles have not been investigated in the adult heart. We investigated the critical yet redundant roles of Med13 and Med13L in adult murine cardiomyocytes for basal cardiac function. Methods: We generated an inducible Med13 and Med13L cardiomyocyte-specific knockout mouse model to investigate Med13 and Med13L regulation of cardiac function and transcription. We performed RNAseq on mice four weeks after the start of tamoxifen to identify changes in gene expression. Differentially expressed genes were compared across cardiac knockouts of Med13/13L, Med13, Med12, Med1, and Med30 elucidating similar mechanisms of cardiac dysfunction. Results: Med13/13L knockout resulted in decreased cardiac function leading to lethal heart failure in a median timeframe of 6 weeks from the start of tamoxifen. There is significant gene dysregulation after Med13/13L knockout with similar gene dysregulation of fibrotic pathways and calcium handling across Mediator cardiac knockouts. Conclusions: Med13 and Med13L function partially redundantly within the heart to maintain basal cardiac function and transcription, as well as redundancies within cardiac phenotypes related to mediator complex disruptions.
-
115 GSE299359 将cardiomyocyte-specific Smad7 knockout小鼠与aMHC Cre Control+小鼠的心脏组织进行转录组分析,比较两组在压力过载(TAC 56天)处理后的差异。研究共包含8个独立样本,每组4个。
设计将cardiomyocyte-specific Smad7 knockout小鼠与aMHC Cre Control+小鼠的心脏组织进行转录组分析,比较两组在压力过载(TAC 56天)处理后的差异。研究共包含8个独立样本,每组4个。
摘要Cardiomyocytes are the major effectors of cardiac remodeling under pressure overload, undergoing hypertrophy and contractile dysfunction in response to sustained mechanical stress. These maladaptive changes are orchestrated by transforming growth factor beta (TGF-β), a key mediator of hypertrophic and profibrotic signaling. Smad7, an inhibitory Smad, negatively regulates TGF-β signaling, but its cardiomyocyte-specific role in pathological remodeling is unclear. We hypothesized that Smad7 acts as an endogenous inhibitor of cardiomyocyte dysfunction during pressure overload. To investigate this, we generated cardiomyocyte-specific Smad7 knockout (CMS7KO) mice and subjected them to transverse aortic constriction (TAC). Echocardiography, RNA-sequencing, histological, and molecular analyses were performed. Smad7 expression was upregulated in cardiomyocytes of TAC mouse hearts and in patients with non-ischemic cardiomyopathy. While baseline cardiac function was preserved in CMS7KO mice, TAC induced an increase in systolic and diastolic dysfunction, ventricular dilation, and hypertrophy compared to controls. Histological analysis revealed increased cardiomyocyte size and macrophage infiltration, without significant fibrosis. Transcriptomic profiling showed downregulation of contractile and sarcomeric genes. Cardiomyocyte-specific Smad7 loss enhanced TGF-β/Smad3 and ERBB2 signaling in vivo. In H9c2 cardiomyocyte-like cells, Smad7 knockdown increased TbR1 and Smad3 phosphorylation, confirming a direct inhibitory effect. These findings identify cardiomyocyte Smad7 as a critical regulator of pathological remodeling and a potential therapeutic target in heart failure.
-
116 GSE306545 将野生型和 Mertk 敲低小鼠心脏组织进行 RNA-Seq 测序,比较两组在压力过载后的基因表达差异。
设计将野生型和 Mertk 敲低小鼠心脏组织进行 RNA-Seq 测序,比较两组在压力过载后的基因表达差异。
摘要Macrophages play a critical role in the pathogenesis and progression of heart failure, wherein sustained cardiomyocyte apoptosis is a key feature. The MER proto-oncogene tyrosine kinase (MERTK) is a critical receptor that mediates the efferocytosis of apoptotic cells by macrophages. However, the role and mechanism of action of MERTK in pressure overload-induced heart failure remains unclear. Here, we demonstrate that MERTK expression was upregulated in cardiac tissue macrophages of mice with pressure overload-induced heart failure. Deletion of MERTK ameliorated transverse aortic constriction (TAC)- and Ang II-induced cardiac hypertrophy and heart failure. This protective effect was associated with reduced type I interferon signaling and was reversed by interferon receptor activation. Efferocytosis assays were performed to demonstrate that mitochondrial double-stranded RNA from apoptotic cardiomyocytes activated Toll-like receptor 3 in macrophages, promoting Interferon beta (IFNb) expression. In vitro experiment identified that IFNb sensitized cardiomyocytes to Ang II stimulation by augmenting the P53 pathway, suppressing Ang II-induced protective mitophagy and promoting cardiomyocyte apoptosis. In conclusion, macrophage MERTK receptor exacerbated post-TAC heart failure and cardiac hypertrophy by mediating the phagocytosis of apoptotic cardiomyocytes and promoting IFNb expression. This study provides novel insights into the role of macrophage MERTK-mediated efferocytosis and type I interferon response in the pathogenesis of heart failure. These findings highlight an unrecognized function of MERTK in pressure overload-induced cardiac remodeling and identify IFNb as a key downstream effector of MERTK in this pathological process
-
117 GSE112319 将野生型小鼠与Ttn-KO小鼠左心室组织分别进行RNA测序,比较Ttn shRNA处理组与对照组的基因表达差异。研究通过胰岛素注射器在产后第10天向小鼠胸腔注射Control shRNA或Ttn shRNA病毒,3周后采集心室组织样本。共包含3只对照组和4只Ttn-KO组小鼠,所有样本均为小鼠左心室组织。
设计将野生型小鼠与Ttn-KO小鼠左心室组织分别进行RNA测序,比较Ttn shRNA处理组与对照组的基因表达差异。研究通过胰岛素注射器在产后第10天向小鼠胸腔注射Control shRNA或Ttn shRNA病毒,3周后采集心室组织样本。共包含3只对照组和4只Ttn-KO组小鼠,所有样本均为小鼠左心室组织。
摘要Dilated cardiomyopathy (DCM), defined by left ventricular (LV) enlargement associated with impaired cardiac performance, is a major cause of heart failure (HF). This results in a dilated, thin-walled left ventricle that fails to supply sufficient blood to the body. Truncating variants in TTN (TTNtv), coding for the largest structural protein in the sarcomere, contribute to the largest portion of familial and ambulatory DCM. The mechanisms for how TTNtv lead to cardiac dilation are unclear. Here, we show that reduction of Ttn expression by shRNA (Ttn shRNA) generated DCM in both mouse and rat. Ttn shRNA transduced mice developed typical DCM manifestations including impaired cardiac performance, enlarged LV and reduced LV wall thickness. Gene profiling indicates cardiac metabolism, cell proliferation and survival related genes are significantly dysregulated in Ttn shRNA-induced DCM. TUNEL assay showed Ttn shRNA induced a significant increase of cardiac cell apoptosis. A screen of 15 dysregulated downstream genes identified candidates, including Esrra, Esrrb and Yy1 significantly suppressed Ttn shRNA-induced cardiac dilation and/or DCM. Ttn shRNA induced cardiac cell apoptosis was ameliorated by Yy1. Importantly, by inducing D-type cyclin, Yy1 initiated cardiomyocyte cell cycle reentry facilitating the restoration of cardiac performance. Our findings demonstrate that DCM caused by Ttn insufficiency can be treated by therapeutically enhancing cardiac cell proliferation and survival.
-
118 GSE138280 将10周龄C57BL/6小鼠心脏组织分为alphaMHC-MCM-Fktn-cKO(Fktnflox/flox;αMHC-MCM+/-)组与对照组,使用他莫昔芬处理4天后进行微阵列分析,比较两组间基因表达差异。
设计将10周龄C57BL/6小鼠心脏组织分为alphaMHC-MCM-Fktn-cKO(Fktnflox/flox;αMHC-MCM+/-)组与对照组,使用他莫昔芬处理4天后进行微阵列分析,比较两组间基因表达差异。
摘要Heart failure is the major cause of death for muscular dystrophy patients; however, the molecular pathomechanism remains unknown. Here, we show the detailed molecular pathogenesis of muscular dystrophy-associated cardiomyopathy in mice lacking the fukutin gene (Fktn), the causative gene for Fukuyama muscular dystrophy. Although cardiac Fktn elimination markedly reduced alpha-dystroglycan glycosylation and dystrophin-glycoprotein complex proteins in sarcolemma at all developmental stages, cardiac dysfunction was observed only in later adulthood, suggesting that membrane fragility is not the sole etiology of cardiac dysfunction. During young adulthood, Fktn-deficient mice were vulnerable to pathological hypertrophic stress with downregulation of Akt and the MEF2-histone deacetylase axis. Acute Fktn elimination caused severe cardiac dysfunction and accelerated mortality with myocyte contractile dysfunction and disordered Golgi-microtubule networks, which were ameliorated with colchicine treatment. These data reveal fukutin is crucial for maintaining myocyte physiology to prevent heart failure, and thus, the results may lead to strategies for therapeutic intervention.
-
119 GSE300969 对12周龄雄性小鼠心室裂解物进行RNA-seq分析,比较Sham组与Trans-aortic Banding组的替代剪接事件。样本按每组3-4只小鼠混池,共7个独立样本,检测对象为CDK8基因的替代剪接位点。
设计对12周龄雄性小鼠心室裂解物进行RNA-seq分析,比较Sham组与Trans-aortic Banding组的替代剪接事件。样本按每组3-4只小鼠混池,共7个独立样本,检测对象为CDK8基因的替代剪接位点。
摘要The regulation of eukaryotic gene expression is a multifacted system in which both gene transcription and post transcriptional modifications play a crucial role in maintaining proper gene expression. The Mediator complex and its associated proteins are integral in the enhancer-driven gene expression with previous literature investigating the potential connections between disrupted Mediator complex function and neurological, cardiovascular, and developmental disease states. Another well-understood mechanism regulating eukaryotic protein expression is alternative splicing of mRNA transcripts, generating protein diversity from a single gene. Alternative splicing is thought to contribute to cellular differentiation and developmental processes and is associated with human disease and cancer. Therefore, the discovery of alternative splicing events in critical genes within essential complexes, like the Mediator complex, may grant better understanding of human disease, and thus lead to better treatments and health outcomes. In this study, we identified alternative splice sites within the mediator complex through RNAseq analysis of murine Sham and Trans-aortic banding ventricular lysates. We also identified alternative splice sites within the mediator complex when comparing human ventricular cardiomyocyte RNA-seq between healthy and decompensated heart failure patients secondary to pulmonary hypertension. Our findings display significant changes in alternative splicing of CDK8 transcripts in models of cardiovascular disease in murine and human samples. This finding implicates the alternative splicing of CDK8 kinase domain as a regulatory mechanism underlying gene expression changes in heart failure.
-
120 GSE228199 对8周龄雄性小鼠的左心室组织进行RNA测序,比较TAC处理组与Sham处理组在Week 6时的基因表达差异。样本量为6,按总样本数与两组分组估计每组3个样本。
设计对8周龄雄性小鼠的左心室组织进行RNA测序,比较TAC处理组与Sham处理组在Week 6时的基因表达差异。样本量为6,按总样本数与两组分组估计每组3个样本。
摘要To investigate the mechanism of chronic heart failure induced by pressure overload, we established an animal model in mice by transverse aortic constriction (TAC), with mice undergoing sham surgery as control.
-
121 GSE233064 将携带可诱导EC特异性Hif2α敲除突变的ecHif2α–/–小鼠与野生型对照小鼠分组,诱导心肌梗死(MI)后28天收集心脏组织,提取总RNA进行RNA-Seq分析,比较两组心脏组织中血管通透性相关基因与胶原合成基因的表达差异。同时对ecHif2α–/–小鼠与对照小鼠进行超声心动图评估、Evans蓝渗漏检测、血浆IL6水平测定及组织学分析,检测心脏功能、微血管渗漏、炎症反应和纤维化程度。在体外培养的ECs中,通过siRNA敲低Hif2α观察其对内皮屏障功能(电细胞阻抗法)、紧密连接蛋白丰度及炎症标志物表达的影响,并通过ARNT过表达实验验证其可逆性。
设计将携带可诱导EC特异性Hif2α敲除突变的ecHif2α–/–小鼠与野生型对照小鼠分组,诱导心肌梗死(MI)后28天收集心脏组织,提取总RNA进行RNA-Seq分析,比较两组心脏组织中血管通透性相关基因与胶原合成基因的表达差异。同时对ecHif2α–/–小鼠与对照小鼠进行超声心动图评估、Evans蓝渗漏检测、血浆IL6水平测定及组织学分析,检测心脏功能、微血管渗漏、炎症反应和纤维化程度。在体外培养的ECs中,通过siRNA敲低Hif2α观察其对内皮屏障功能(电细胞阻抗法)、紧密连接蛋白丰度及炎症标志物表达的影响,并通过ARNT过表达实验验证其可逆性。
摘要Experiments were conducted with mice carrying an inducible EC-specific Hif2α-knockout (ecHif2α–/–) mutation, with mouse cardiac microvascular endothelial cells (CMVECs) isolated from the hearts of ecHif2α–/– mice after the mutation was induced, and with human CMVECs and umbilical-vein endothelial cells transfected with ecHif2α siRNA. After MI induction, echocardiographic assessments of cardiac function were significantly lower, while measures of cardiac microvascular leakage (Evans blue assay), plasma IL6 levels, and cardiac neutrophil accumulation and fibrosis (histology) were significantly greater, in ecHif2α–/– mice than in control mice, and RNA-sequencing analysis of heart tissues from both groups indicated that the expression of genes involved in vascular permeability and collagen synthesis was enriched in ecHif2α–/– hearts. In cultured ECs, ecHif2α deficiency was associated with declines in endothelial barrier function (electrical cell impedance assay) and the reduced abundance of tight-junction proteins, as well as an increase in the expression of inflammatory markers, all of which were largely reversed by the overexpression of ARNT. We also found that ARNT, but not Hif2α, binds directly to the IL6 promoter and suppresses IL6 expression.
-
122 GSE240310 对心肌梗死后2或3个月的小鼠心脏组织进行基因表达分析,比较转基因组与对照组的转录组差异,采用微阵列技术检测RNA表达,包含2个生物学重复。
设计对心肌梗死后2或3个月的小鼠心脏组织进行基因表达分析,比较转基因组与对照组的转录组差异,采用微阵列技术检测RNA表达,包含2个生物学重复。
摘要Heart failure (HF) is a leading cause of morbidity and mortality. As adult cardiomyocytes (CMs) have little regenerative capacity, after myocardial infarction (MI), resident cardiac fibroblasts (CFs) synthesize extracellular matrix to form scar tissues, resulting in myocardial remodeling and HF. Thus, both cardiac regeneration and fibrosis are therapeutic targets for chronic MI. We previously reported that fibroblasts were directly reprogrammed into induced CMs (iCMs) by overexpression of cardiogenic transcription factors in acute and chronic MI. Here we show that in vivo cardiac reprogramming improved cardiac function, and reversed cardiac remodeling in chronic MI using a novel transgenic mouse system. Transcriptome analysis revealed that in vivo cardiac reprogramming suppressed signs of fibrosis and inflammation. Thus, in vivo cardiac reprogramming may be a promising approach for chronic HF.
-
123 GSE247062 对心力衰竭模型小鼠的左心室心脏组织进行RNA测序,比较心肌梗死加安慰剂(MI-NS)与心肌梗死加达格列净(MI-DAPA)处理组的基因表达差异,分析达格列净对心脏纤维化和炎症的影响。
设计对心力衰竭模型小鼠的左心室心脏组织进行RNA测序,比较心肌梗死加安慰剂(MI-NS)与心肌梗死加达格列净(MI-DAPA)处理组的基因表达差异,分析达格列净对心脏纤维化和炎症的影响。
摘要The specific mechanism of sodium-glucose cotransporter 2 (SGLT2) inhibitor in heart failure (HF) needs to be elucidated. In this study, we use SGLT2 global knockout (SGLT2-KO) mice to assess the mechanism of SGLT2 inhibitor on HF. Dapagliflozin ameliorates both myocardial infarction (MI)-and transverse aortic constriction (TAC) -induced HF. Global SGLT2-deficiency doesn’t exert protection against adverse remodeling in both MI- and TAC-induced HF models. Dapagliflozin blurs MI- and TAC-induced HF phenotypes in SGLT2-KO mice. Dapagliflozin causes major changes in cardiac fibrosis and inflammation. Based on single-cell RNA sequencing dapagliflozin causes significant differences in the gene expression profile of macrophages and fibroblasts. Moreover, dapagliflozin directly inhibites macrophage inflammation, thereby suppressing cardiac fibroblasts activation. The cardio-protection of dapagliflozin is blurred in mice treated with a C-C chemokine receptor type 2 (CCR2) antagonist. Taken together the protective effects of dapagliflozin against HF are independent of SGLT2, macrophage inhibition is the main target of dapagliflozin against HF.
-
124 GSE25766 对10月龄心力衰竭B6小鼠心脏组织进行基因表达分析,比较未治疗组与接受两个月ranolazine治疗组的差异。心力衰竭通过6个月腹主动脉缩窄(AAC)诱导,对照组为同龄未处理假手术B6小鼠。所有样本均采用微阵列技术检测,按总样本数6与组数3估计每组2个独立样本。
设计对10月龄心力衰竭B6小鼠心脏组织进行基因表达分析,比较未治疗组与接受两个月ranolazine治疗组的差异。心力衰竭通过6个月腹主动脉缩窄(AAC)诱导,对照组为同龄未处理假手术B6小鼠。所有样本均采用微阵列技术检测,按总样本数6与组数3估计每组2个独立样本。
摘要Heart failure is a leading cause of cardiovascular mortality with limited options for treatment. We analyzed whether the anti-ischemic drug ranolazine could retard the progression of heart failure in an experimental model of heart failure induced by 6 months of chronic pressure overload. The study showed that 2 months of ranolazine treatment improved cardiac function of aortic constricted C57BL/6J (B6) mice with symptoms of heart failure as assessed by echocardiography. The microarray gene expression study of heart tissue from failing hearts relative to ranolazine-treated and healthy control hearts identified heart failure-specific genes that were normalized during treatment with the anti-ischemic drug ranolazine.
-
125 GSE25767 对18月龄apoE缺陷小鼠心力衰竭模型与同龄B6对照小鼠进行基因表达分析,其中apoE缺陷小鼠接受两个月ranolazine治疗。采集心组织样本进行微阵列检测,比较治疗组与未治疗对照组的基因表达差异,同时包含未治疗apoE缺陷小鼠心力衰竭样本与同龄B6未治疗对照样本。
设计对18月龄apoE缺陷小鼠心力衰竭模型与同龄B6对照小鼠进行基因表达分析,其中apoE缺陷小鼠接受两个月ranolazine治疗。采集心组织样本进行微阵列检测,比较治疗组与未治疗对照组的基因表达差异,同时包含未治疗apoE缺陷小鼠心力衰竭样本与同龄B6未治疗对照样本。
摘要Heart failure is a leading cause of cardiovascular mortality with limited options for treatment. We used 18 month-old apolipoprotein E (apoE)- deficient mice as a model of atherosclerosis-induced heart failure to analyze whether the anti-ischemic drug ranolazine could retard the progression of heart failure. The study showed that 2 months of ranolazine treatment improved cardiac function of 18 month-old apoE-deficient mice with symptoms of heart failure as assessed by echocardiography. To identify changes in cardiac gene expression induced by treatment with ranolazine a microarray study was performed with heart tissue from failing hearts relative to ranolazine-treated and healthy control hearts. The microarray approach identified heart failure-specific genes that were normalized during treatment with the anti-ischemic drug ranolazine.
-
126 GSE268694 将野生型(fl/fl)与心脏特异性 Mpc2-/-(CS-Mpc2-/-)小鼠的左心室心脏组织分别按每组 2 个样本混池,形成 3 个混池样本/组,进行 RNA-Seq 测定,比较两组基因表达差异。研究对象为 30 周龄 chow 饲喂小鼠的左心室心脏组织,检测方式包括靶向代谢组学、13C-葡萄糖同位素追踪、糖原生化检测及透射电镜分析,主要比较 CS-Mpc2-/- 与 fl/fl 小鼠心脏代谢特征差异。
设计将野生型(fl/fl)与心脏特异性 Mpc2-/-(CS-Mpc2-/-)小鼠的左心室心脏组织分别按每组 2 个样本混池,形成 3 个混池样本/组,进行 RNA-Seq 测定,比较两组基因表达差异。研究对象为 30 周龄 chow 饲喂小鼠的左心室心脏组织,检测方式包括靶向代谢组学、13C-葡萄糖同位素追踪、糖原生化检测及透射电镜分析,主要比较 CS-Mpc2-/- 与 fl/fl 小鼠心脏代谢特征差异。
摘要Background: Heart failure involves metabolic alterations including increased glycolysis despite unchanged or decreased glucose oxidation. The mitochondrial pyruvate carrier (MPC) regulates pyruvate entry into the mitochondrial matrix, and cardiac deletion of the MPC in mice causes heart failure. How MPC deletion results in heart failure is unknown. Methods: We performed targeted metabolomics and isotope tracing in wildtype (fl/fl) and cardiac-specific Mpc2-/- (CS-Mpc2-/-) hearts after in vivo injection of 13C-glucose. Cardiac glycogen was measured biochemically and by transmission electron microscopy. Cardiac glucose uptake of 2-deoxyglucose was measured and western blotting performed to analyze insulin signaling and enzymatic regulators of glycogen synthesis and degradation. Isotope tracing and glycogen analysis was also performed in hearts from mice fed either low-fat diet or a ketogenic diet previously shown to reverse the heart failure in CS-Mpc2-/- mice. Cardiac glycogen was also assessed in mice infused with angiotensin-II that were fed either low-fat or ketogenic diet. Results: Failing CS-Mpc2-/- hearts contained normal levels of ATP and phosphocreatine, suggesting their heart failure is not caused by energetic stress. These hearts displayed increased enrichment from 13C-glucose and increased glycolytic metabolite pool sizes. 13C enrichment and pool size was also increased for the glycogen intermediate UDP-glucose, as well as increased enrichment of the glycogen pool. Glycogen levels were increased ~6-fold in the failing CS-Mpc2-/- hearts, and glycogen granules were easily detected by electron microscopy. This increased glycogen synthesis occurred despite enhanced inhibitory phosphorylation of glycogen synthase and reduced expression of the priming enzyme glycogenin-1. In young, non-failing CS-Mpc2-/- hearts, increased glycolytic 13C enrichment occurred, but glycogen levels remained low and unchanged compared to fl/fl hearts. Feeding a ketogenic diet to CS-Mpc2-/- mice reversed the heart failure and normalized the cardiac glycogen and glycolytic metabolite accumulation. Cardiac glycogen levels were also elevated in mice infused with angiotensin II, and both the cardiac hypertrophy and glycogen levels were improved by ketogenic diet. Conclusions: Our results indicate that loss of MPC in the heart increases glycolytic metabolism and ultimately glycogen accumulation and heart failure, while a ketogenic diet can reverse both the glycogen accumulation and heart failure. We conclude that maintaining mitochondrial pyruvate import and metabolism is critical for the heart, unless cardiac pyruvate metabolism is dramatically reduced by consumption of a ketogenic diet.
-
127 GSE276884 将9个月龄的Fiona/dko和Het/Fiona小鼠心脏组织进行bulk RNA测序,比较两组基因表达差异,样本包含不同性别,按总样本数6与组数2估计每组3个独立单位。
设计将9个月龄的Fiona/dko和Het/Fiona小鼠心脏组织进行bulk RNA测序,比较两组基因表达差异,样本包含不同性别,按总样本数6与组数2估计每组3个独立单位。
摘要Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder characterized by progressive muscle degeneration and cardiomyopathy leading to heart failure. While the inflammatory environment in dystrophic skeletal muscle has been well-studied, little is known about inflammation in the progression of DMD cardiomyopathy due to the lack of adequate animal models. To address this, we developed the Fiona/dko mouse model, which exhibits severe, isolated dystrophic cardiomyopathy. In this study, we used Fiona/dko mice to characterize the immune cell composition in dystrophic heart and investigated the contribution of T-cells to the onset and progression of cardiac pathology. Flow cytometry analysis revealed that T-cells constitute a significant proportion of the immune cell population in Fiona/dko hearts, in contrast to the predominantly myeloid signature observed in dystrophic skeletal muscle. Furthermore, we demonstrated that T-cell infiltration precedes the development of cardiac fibrosis and dysfunction in Fiona/dko mice and that depletion of circulating CD3+ T-cells ameliorates early pathology, suggesting a role for T-cells in the initiation and persistence of dystrophic cardiomyopathy. These findings highlight the distinct inflammatory environment in the dystrophic heart and provide new insights into the pathogenesis of DMD cardiomyopathy, paving the way for the development of targeted anti-inflammatory therapies.
-
128 GSE28031 对 apoE 缺陷小鼠心脏组织进行微阵列基因表达分析,比较 rosiglitazone 治疗组与未治疗 apoE 缺陷小鼠及非转基因 B6 小鼠的基因表达差异。研究对象为 8 月龄 apoE 缺陷小鼠,其中治疗组接受 2 个月 rosiglitazone 治疗(30 mg/kg/day),对照组包括同龄未治疗 apoE 缺陷小鼠和非转基因 B6 小鼠。心脏组织样本来自治疗后 8 月龄小鼠,检测方式为 Affymetrix GeneChip 微阵列平台,主要比较治疗组与两组对照的基因表达差异。
设计对 apoE 缺陷小鼠心脏组织进行微阵列基因表达分析,比较 rosiglitazone 治疗组与未治疗 apoE 缺陷小鼠及非转基因 B6 小鼠的基因表达差异。研究对象为 8 月龄 apoE 缺陷小鼠,其中治疗组接受 2 个月 rosiglitazone 治疗(30 mg/kg/day),对照组包括同龄未治疗 apoE 缺陷小鼠和非转基因 B6 小鼠。心脏组织样本来自治疗后 8 月龄小鼠,检测方式为 Affymetrix GeneChip 微阵列平台,主要比较治疗组与两组对照的基因表达差异。
摘要The anti-diabetic drug and agonist of the peroxisome proliferator-activated receptor gamma (Pparg), rosiglitazone, was recently withdrawn in many countries because the drug use was associated with an increased risk of heart failure. To investigate underlying pathomechanisms, we chose 6-month-old apolipoprotein E (apoE)-deficient mice, which are prone to atherosclerosis and insulin resistance, and thereby mimic the risk profile of patients with cardiovascular disease. After 8 weeks of rosiglitazone treatment (30 mg/kg/day), echocardiography and histology analyses demonstrated that rosiglitazone had induced heart failure with cardiac dilation. Concomitantly, cardiac lipid overload and lipid-induced cardiomyocyte death developed. The microarray gene expression study of heart tissue from rosiglitazone-treated apoE-deficient mice relative to untreated apoE-deficient mice and non-transgenic B6 mice identified cardiac Pparg-dependent lipid metabolism genes in rosiglitazone-treated mice, which seem to trigger a major heart failure promoting pathway.
-
129 GSE281344 将野生型小鼠与心肌细胞特异性 RBM20 过表达(RBM20cKI)小鼠的左心室组织进行 RNA 测序,比较两组间 RBM20 过表达对 Atp6v0a1 剪接事件的影响;通过 LysoTracker 和 RFP-GFP-LC3 报告系统评估 RBM20 对自噬流的阻断作用,同时利用 AAV9 转染测试全长 Atp6v0a1 对 RBM20cKI 小鼠心脏功能的改善效果。
设计将野生型小鼠与心肌细胞特异性 RBM20 过表达(RBM20cKI)小鼠的左心室组织进行 RNA 测序,比较两组间 RBM20 过表达对 Atp6v0a1 剪接事件的影响;通过 LysoTracker 和 RFP-GFP-LC3 报告系统评估 RBM20 对自噬流的阻断作用,同时利用 AAV9 转染测试全长 Atp6v0a1 对 RBM20cKI 小鼠心脏功能的改善效果。
摘要Dilated cardiomyopathy (DCM) is a common cause of heart failure and mutations in RNA-binding motif protein 20 (RBM20) are linked to hereditary DCM. However, the role of unmutated RBM20 in idiopathic DCM is still ambiguous. In this study, we found that RBM20 expression was upregulated by the transcription factor c-JUN in idiopathic DCM. Mice with cardiomyocyte-specific RBM20 overexpression (RBM20cKI) resulted in heart failure with ventricle dilation and lysosome accumulation. Using LysoTracker and a tandem fluorescence RFP-GFP-LC3 reporter system, we elucidated RBM20 blocks autophagic flux in DCM by alkalinizing lysosomal pH. RNA sequencing revealed RBM20 overexpression leads to vacuolar H+-ATPase proton translocation domain subunit a1 (Atp6v0a1) exon6 and exon7 exclusion, which was validated by sanger sequencing and serial amplification product electrophoresis. Transgenic expression of full-length Atp6v0a1 isotype attenuated cardiac dysfunction and restored lysosomal acidification in RBM20cKI mice. Our data suggest that RBM20 activity precisely regulates various cellular process in cardiomyocytes and any therapy targeting RBM20 requires extra cautious.
-
130 GSE284743 对心力衰竭(ICM)小鼠模型和患者的心肌细胞进行RNA测序,比较两组的基因表达差异。研究采用心脏组织样本,共6个样本,分为ICM模型组和假手术对照组,使用CLC Genomics Workbench v11.0.1进行数据处理。
设计对心力衰竭(ICM)小鼠模型和患者的心肌细胞进行RNA测序,比较两组的基因表达差异。研究采用心脏组织样本,共6个样本,分为ICM模型组和假手术对照组,使用CLC Genomics Workbench v11.0.1进行数据处理。
摘要Ischemic cardiomyopathy (ICM) is characterized by the insufficient capacity of the heart to effectively pump blood, which ultimately contributes to heart failure (HF). In this study, the down regulation of SNEP1 is identified in the cardiomyocyte of ICM mouse models and in patients. The depletion of SENP1 exacerbates hypoxia-induced apoptosis of cardiomyocytes in vitro and deteriorated cardiomyocyte injury of ICM mice in vivo. Mechanistically, SENP1 directly interacted and deSUMOylates the SUMO2-mediated modification of MEF2C at lysine 407, consequently promoting the protein stability and phase separation of MEF2C. When rescuing SENP1 expression using adeno-associated virus serotype 9, the attenuation of cardiomyocyte injury is discerned in the mouse model of ICM. Therefore, these finding elicits a previously unrecognized role and mechanism of SENP1 in safeguarding cardiomyocyte in ICM progression while establishing a basis for the development of SENP1 as a potential marker for ICM diagnosis and treatment.
-
131 GSE296255 对心力衰竭模型小鼠进行压力超载处理(TAC)后8周,将接受光遗传学迷走神经刺激(VNS)的实验组与未处理对照组进行bulk RNA-sequencing,比较两组心脏组织的转录组差异,分析免疫相关通路变化。
设计对心力衰竭模型小鼠进行压力超载处理(TAC)后8周,将接受光遗传学迷走神经刺激(VNS)的实验组与未处理对照组进行bulk RNA-sequencing,比较两组心脏组织的转录组差异,分析免疫相关通路变化。
摘要Autonomic neuronal dysfunction is associated with heart failure (HF). Here, we report that targeted vagal nerve stimulation (VNS) using optogenetics attenuates cardiac remodelling and HF induced by pressure overload. Unbiased approaches revealed that VNS decreased the proportion of the Ccrl2+ macrophage subset, which derived from myeloid monocytes and exhibited a distinct tumour necrosis factor-alpha (TNFα)-responsive, pro-hypertrophic, and profibrotic signature. Elimination of Ccrl2+ macrophages prevented cardiac remodelling and HF. Functional characterisation by Ccrl2+ macrophage-specific overexpression or global genetic loss of α7 nicotinic acetylcholine receptor (α7nAChR) highlighted its crucial contribution to VNS-mediated cardioprotection. Mechanistically, activation of α7nAChR inhibited the TNFα responsiveness through upregulated expression of the transcription factor NRF2. Cardiac Ccrl2+ macrophages and TNFα-responsive proteins were positively correlated with cardiac remodelling and dysfunction in humans. Finally, an α7nAChR agonist effectively blocked the development of HF. These results suggest that the vagal neuroimmune axis modulates heart failure and is a promising target for treatment.
-
132 GSE306975 将雄性 SPF 级 C57BL/6 小鼠按 ISO 慢性注射(10 mg/kg/day,3 周)与正常盐水对照分组,采集左心室组织进行 RNA 测序;同时用 ISO(10 μM,48 h)处理 HL-1 心肌细胞,通过 siRNA 敲低 Cpeb4 后检测细胞活性、凋亡及 Eif4a2 可变剪接差异,比较 ISO 处理组与对照组、Cpeb4 敲低组与对照组的基因表达及功能变化。
设计将雄性 SPF 级 C57BL/6 小鼠按 ISO 慢性注射(10 mg/kg/day,3 周)与正常盐水对照分组,采集左心室组织进行 RNA 测序;同时用 ISO(10 μM,48 h)处理 HL-1 心肌细胞,通过 siRNA 敲低 Cpeb4 后检测细胞活性、凋亡及 Eif4a2 可变剪接差异,比较 ISO 处理组与对照组、Cpeb4 敲低组与对照组的基因表达及功能变化。
摘要Heart failure (HF) involves pathological cardiac remodeling, including cardiomyocyte loss and dysfunction. While the RNA-binding protein CPEB4 has been linked to cardiomyocyte activation, its role in HF remains unclear. We established in vivo and in vitro models of cardiac injury using isoproterenol (ISO). An HF mouse model was induced by chronic ISO administration (10 mg/kg/day, 3 weeks), while cellular injury was modeled by treating HL-1 cardiomyocytes with ISO (10 μM, 48 h). To investigate the molecular mechanisms, we employed transcriptome sequencing, qRT-PCR, and functional assays following siRNA-mediated knockdown of Cpeb4. Key endpoints included cell viability (CCK-8), apoptosis (Annexin V/7-AAD flow cytometry), and the alternative splicing of Eif4a2. In the HF mouse model, we observed significant cardiac hypertrophy and inflammatory infiltration, which correlated with a marked upregulation of Cpeb4 expression in cardiomyocytes. Notably, in vitro, siRNA-mediated knockdown of Cpeb4 significantly attenuated ISO-induced apoptosis and enhanced cell viability in HL-1 cells. Mechanistically, Cpeb4 depletion corrected the ISO-induced dysregulation of Eif4a2 alternative splicing, restoring the expression of its major isoforms and thereby ameliorating cellular injury. Our study identifies the Cpeb4-Eif4a2 axis as a key regulator in heart failure, with Cpeb4 driving cardiomyocyte apoptosis via aberrant Eif4a2 splicing, suggesting a promising therapeutic target.
-
133 GSE308324 对代谢驱动型心力衰竭(HFpEF)小鼠模型进行转录组分析,将 HFpEF 诱导后的小鼠随机分为 HFpEF + PBS 对照组和 HFpEF + L-proline(300 mg/kg/day 腹腔注射)处理组,持续 4–8 周。采集左心室组织进行 RNA 提取与 RNA-Seq 测序,比较两组间与铁死亡相关基因及 PPARγ 通路调控差异。检测方式为 Illumina NovaSeq 6000 平台的高通量测序,样本量按总单位数 6 与组数估计为每组 3 个。
设计对代谢驱动型心力衰竭(HFpEF)小鼠模型进行转录组分析,将 HFpEF 诱导后的小鼠随机分为 HFpEF + PBS 对照组和 HFpEF + L-proline(300 mg/kg/day 腹腔注射)处理组,持续 4–8 周。采集左心室组织进行 RNA 提取与 RNA-Seq 测序,比较两组间与铁死亡相关基因及 PPARγ 通路调控差异。检测方式为 Illumina NovaSeq 6000 平台的高通量测序,样本量按总单位数 6 与组数估计为每组 3 个。
摘要This study investigates the molecular mechanisms by which L-proline contributes to diabetic heart failure with preserved ejection fraction (HFpEF) through the induction of ferroptotic stress under metabolic conditions. We found that L-proline exacerbates ferroptosis-related oxidative and lipid peroxidation stress in cardiac tissue within a metabolically driven HFpEF context. Mechanistically, L-proline markedly suppressed PPARγ signaling, a key regulator of lipid metabolism, redox homeostasis, and ferroptosis resistance. Downregulation of PPARγ was accompanied by upregulation of pro-ferroptotic mediators, including ACSL4 and TFR1, indicating enhanced iron-dependent lipid peroxidation and ferroptotic susceptibility. These findings support a mechanistic link between amino acid metabolic remodeling and fibroblast-centered cardiac vulnerability in diabetic HFpEF, highlighting the role of the proline–PPARγ–ferroptosis axis in promoting myocardial fibrosis and diastolic dysfunction under chronic metabolic stress.
-
134 GSE308625 对12周龄C57BL/6N雄性小鼠的心脏组织进行RNA测序,将3只未处理小鼠与3只连续接受ISO+L-NAME处理6周的小鼠作为比较组,分析非肥胖心力衰竭伴射血分数保留表型的转录组变化。
设计对12周龄C57BL/6N雄性小鼠的心脏组织进行RNA测序,将3只未处理小鼠与3只连续接受ISO+L-NAME处理6周的小鼠作为比较组,分析非肥胖心力衰竭伴射血分数保留表型的转录组变化。
摘要This project encompasses RNA-seq analysis of left ventricular tissue from 12week-old C57BL/6N male mice. Three mice received no treatment (control), and three mice were subjected to continuous administration of isoproterenol (ISO) and L-NAME for 6 weeks to induce a non-obese heart failure with preserved ejection fraction (HFpEF) phenotype. The study aims to identify transcriptomic alterations associated with non-obese HFpEF development and cardiac remodeling.
-
135 GSE310316 将 Mdx/Utrn dKO 雄性小鼠(2-3 月龄)每日口服 Setanaxib(60 mg/kg/day)或玉米油载体,持续 12 周。处死后收集心脏组织,提取总 RNA 进行 RNA-Seq,比较处理组与对照组的基因表达差异。
设计将 Mdx/Utrn dKO 雄性小鼠(2-3 月龄)每日口服 Setanaxib(60 mg/kg/day)或玉米油载体,持续 12 周。处死后收集心脏组织,提取总 RNA 进行 RNA-Seq,比较处理组与对照组的基因表达差异。
摘要Duchenne Muscular Dystrophy (DMD) is caused by mutations in dystrophin, leading to degeneration and weakness of the skeletal and cardiac muscles. Despite numerous efforts in developing therapies for this devastating disease, DMD remains a fatal disease. Our recent study showed that loss of the cardiac Isl1-interacting protein (CIP), which interacts with dystrophin in sarcolemma of cardiomyocytes, accelerates the progression of dystrophic cardiomyopathy. We identified Nox4 as one of the downstream mediators of this process. Here, we report that Setanaxib, a Nox1/4 inhibitor, protected the heart of CIP/Mdx double knockout (dKO) mice from heart failure and reduced cardiac fibrosis. Similarly, Setanaxib treatment exhibited lower cardiac fibrosis and protection against heart failure in Mdx/Utrn dKO mouse, another murine model for dystrophic cardiomyopathy. Additionally, treatment with Nox4 inhibitor reduced the expression of cardiomyopathy genes in dystrophic mice. Interestingly, transcriptomic analysis of the hearts from Mdx/Utrn dKO mice treated with Nox4 inhibitor reveals an enrichment of genes associated with fatty acid metabolism, oxidative phosphorylation, and protein binding, while genes related to inflammation and epithelial-mesenchymal transition were downregulated. Consistent with these results, we found increased expression of Pgc1a and Tcap in the hearts of Mdx/Utrn dKO mice treated with Nox 4 inhibitor, and reduced expression of Mcp1. Collectively, these findings suggest that Nox4 plays a key role in development of myocardial fibrosis and heart failure caused by dystrophin deficiency, and suggest that Nox4 inhibition could be a potential novel therapy to alleviate cardiomyopathy in DMD patients.
-
136 GSE311564 对CD1小鼠左心房组织进行RNA-seq,比较假手术(sham)与横断主动脉缩窄(TAC)术后第9天的基因表达差异。研究对象为携带R26CreERT2和Tbx5fl/fl;R26CreERT2基因型的小鼠,分别接受sham或TAC处理,术后1周处死并采集左心房组织。样本按每组12μg总RNA处理,使用mouse GlobinClear kit去除血红蛋白RNA。
设计对CD1小鼠左心房组织进行RNA-seq,比较假手术(sham)与横断主动脉缩窄(TAC)术后第9天的基因表达差异。研究对象为携带R26CreERT2和Tbx5fl/fl;R26CreERT2基因型的小鼠,分别接受sham或TAC处理,术后1周处死并采集左心房组织。样本按每组12μg总RNA处理,使用mouse GlobinClear kit去除血红蛋白RNA。
摘要Transcriptomic profiles of cardiac tissue from CD1 mice subjected to sham or transverse aortic constriction (TAC) surgery, a pressure-overload mouse model. Left atrial tissue was collected 9 days post-surgery, and RNA-seq was performed to identify differentially expressed genes between sham and TAC.
-
137 GSE311638 对心肌细胞特异性 TGFB3 敲除小鼠与野生型小鼠的心脏组织进行 RNA 测序,比较两种基因型在压力超载条件下的基因表达差异。
设计对心肌细胞特异性 TGFB3 敲除小鼠与野生型小鼠的心脏组织进行 RNA 测序,比较两种基因型在压力超载条件下的基因表达差异。
摘要Heart failure (HF), the common end-stage of cardiovascular diseases, features cardiac fibrosis. Transforming growth factor-β3 (TGFB3), a key TGFB/SMAD ligand, is upregulated in cardiac disorders, but its cellular source and precise role are debated. This study examined TGFB3 in human and mouse heart failure tissues. Histological and molecular analyses showed its increase mainly from cardiomyocytes, induced by angiotensin II. Circulating TGFB3 in patients positively correlated with plasma proBNP, a heart failure severity marker. A cardiomyocyte-specific TGFB3 knockout mouse model showed its absence worsens cardiac dysfunction and fibrosis under pressure overload. Mechanically, TGFB3 competes with TGFB1 for receptors, reducing Smad3 phosphorylation and profibrotic gene activation. Loss of TGFB3 in cardiomyocytes increased expression of profibrotic mediators such as CTGF and SERPINE1, ultimately accelerating fibrotic remodeling during HF progression. These findings identify cardiomyocyte-derived TGFB3 as a crucial endogenous modulator that protects against pathological cardiac fibrosis and highlight its therapeutic potential in HF.
-
138 GSE322841 将18个月龄雌性小鼠分为sham手术组和TAC手术组,每组3只,采集心脏组织进行RNA-Seq分析,比较两组间基因表达差异。
设计将18个月龄雌性小鼠分为sham手术组和TAC手术组,每组3只,采集心脏组织进行RNA-Seq分析,比较两组间基因表达差异。
摘要The occurrence of cardiovascular diseases increases dramatically in postmenopausal aged women. Accumulating evidence has indicated that estrogen protects hearts from cardiovascular diseases. However, the underlying mechanisms was not fully elucidated. This present study was designed to investigate the function of GPR30 in pathological heart failure of aged female mice with the focus of neutrophil extracellular traps (NETs). Transverse aortic constriction (TAC) surgery was performed to induce heart failure in aged female mice. RNA-seq and flow cytometry were employed to study neutrophils activity during heart failure of aged female mice. Heart function and cardiac fibrosis as well as NETs level were assessed. Reduction of NETs by DNase I administration、 G1 treatment and Trex1 overexpression in macrophage were conducted to elucidate the role of NETs in this pathological process. Co-culture of RAW264.7 macrophages and neutrophils were used to examine the function of Trex1 in macrophage. Our bulk RNA-seq analysis showed that neutrophil migration and neutrophil chemotaxis were markedly enhanced at the early stage of pathological cardiac hypertrophy in aged female hearts. We further demonstrated that NETs generated by these activated neutrophils in aged female myocardium at the late stage were significantly increased following TAC surgery accompanied with the reduction of GPR30 expression. GPR30 agonist G1 treatment preserved cardiac function and reduced myocardial fibrosis in aged female mice with heart failure. To further validate the key role of NETs, DNase I administration markedly enhanced cardiac performance and attenuated cardiac fibrosis with the overall neutrophil reduction in the myocardium. Our in vitro results showed that overexpression of Trex1 in RAW264.1 macrophage enhanced neutrophil NETs clearance, thus indicating that GPR30 activation could increase the exonuclease three prime repair exonuclease 1 (Trex1) expression which may be associated with the reduction of NETs level in hypertrophied hearts. NETs generated by neutrophils exacerbate pressure overload–induced heart failure in aged female mice. GPR30 activates Trex1 signaling in macrophage to enhance NTEs degradation and thus attenuates TAC-induced cardiac dysfunction, providing an avenue for the novel therapeutics against cardiac dysfunction in postmenopausal women.
-
139 GSE335235 对野生型(WT)与 cMyBP-C-Exon33del 基因型小鼠心脏组织进行 RNA 测序,比较两种基因型的基因表达差异。研究对象为 28-31 周龄小鼠,采集心脏组织样本,每组包含 3 个独立样本,总样本数 6。检测方式为 RNA-Seq,采用 HISAT 和 Bowtie2 进行比对,DEseq2 分析差异表达。
设计对野生型(WT)与 cMyBP-C-Exon33del 基因型小鼠心脏组织进行 RNA 测序,比较两种基因型的基因表达差异。研究对象为 28-31 周龄小鼠,采集心脏组织样本,每组包含 3 个独立样本,总样本数 6。检测方式为 RNA-Seq,采用 HISAT 和 Bowtie2 进行比对,DEseq2 分析差异表达。
摘要RNA sequencing was performed to investigate the role of fast skeletal myosin binding protein-C (fMyBP-C) in cardiac pathology and heart failure. fMyBP-C, a paralog of cardiac myosin binding protein-C (cMyBP-C), is upregulated in diseased mouse hearts. To determine its functional consequences, we generated a Mybpc3_Exon 33 deletion model, which alters the structure of the C10 domain of cMyBP-C. Transcriptomic profiling was used to characterize gene expression changes including fMyBP-C associated with loss of cMyBP-C, providing insight into the molecular mechanisms by which fMyBP-C contributes to cardiac dysfunction.
-
140 GSE45820 从8-10周龄成年雄性黑瑞士小鼠左心室分选Tie2cre追踪成纤维细胞、非Tie2cre追踪成纤维细胞和内皮细胞,采用Affymetrix微阵列分析检测其基因表达。样本来自3只假手术组(SHAM)和3只TAC操作组,细胞分选于手术后一周进行,比较不同基因型与处理组间基因表达差异。
设计从8-10周龄成年雄性黑瑞士小鼠左心室分选Tie2cre追踪成纤维细胞、非Tie2cre追踪成纤维细胞和内皮细胞,采用Affymetrix微阵列分析检测其基因表达。样本来自3只假手术组(SHAM)和3只TAC操作组,细胞分选于手术后一周进行,比较不同基因型与处理组间基因表达差异。
摘要Accumulation of activated cardiac fibroblasts plays a key role in heart failure progression. These cells deposit excessive extracellular matrix that leads to mechanical stiffness, myocyte uncoupling and ischemia. To investigate whether two developmentally distinct cardiac fibroblast populations exhibit distinct expression profiles in response to cardiac injury, and therefore might necessitate distinct therapeutic targeting, we performed microarray analysis on FACS sorted cells. Tie2cre lineage traced CFs, non Tie2cre lineage traced cardiac fibroblasts and endothelial cells were isolated from left ventricle of SHAM operated and banded hearts at the onset of fibrosis, one week after surgery. We used microarrays to detail the global programme of gene expression in cardiac fibroblasts and endothelium following pressure overload. Tie2cre lineage traced, non-tie2cre lineage traced fibroblasts and endothelial cells were sorted from left ventricle of 3 SHAM operated and 3 TAC operated adult male Black Swiss mice.
-
141 GSE55280 对慢性心力衰竭小鼠与假手术对照小鼠的前额叶皮层、海马体及左心室心肌组织进行RNA测序,比较两组间基因表达差异。研究对象为C57BL/6雄性小鼠,通过心肌梗死诱导慢性心力衰竭,8周后采集组织样本。RNA提取后按3只慢性心力衰竭小鼠与6只假手术小鼠分别混池,每池最终含2µg RNA,形成6个独立测序池。检测方式为RNA-Seq,采用Illumina HiSeq 2000平台及CLC-Bio Genomics Workbench软件计算表达水平。
设计对慢性心力衰竭小鼠与假手术对照小鼠的前额叶皮层、海马体及左心室心肌组织进行RNA测序,比较两组间基因表达差异。研究对象为C57BL/6雄性小鼠,通过心肌梗死诱导慢性心力衰竭,8周后采集组织样本。RNA提取后按3只慢性心力衰竭小鼠与6只假手术小鼠分别混池,每池最终含2µg RNA,形成6个独立测序池。检测方式为RNA-Seq,采用Illumina HiSeq 2000平台及CLC-Bio Genomics Workbench软件计算表达水平。
摘要After induction of ischemic chronic heart failure (CHF), mice exhibited depression-like behavior, in terms of increased anhedonia, and decreased both exploratory activity and interest in novelty. On histology, ischemic CHF mice showed no alterations in overall cerebral morphology. To further evaluate relevant behavioral changes found in CHF mice, RNA-sequencing analysis of prefrontal cortex and hippocampus - the brain regions, whose structural and functional alterations are associated with an increased risk for developing major depressive disorder - and of left myocardial tissue was performed in CHF vs. sham-operated animals. RNA-sequencing revealed relevant changes in hippocampal or prefrontal cortical expression of genes responsible for axonal vesicle transport (Kif5b), signal transduction (Arc, Gabrb2), limitation of inflammation (RORA; Nr4a1) and of hypoxic brain damage (Hif3a). Besides, the actual literature describes some of the genes (RORA, Gabrb2, Npas4, and Junb) being associated with depression-like behavior. Nr4a1 significantly regulated in both brain and heart tissue after induction of ischemic CHF could be a potential link and reveals the central role of inflammation in the interrelation of the brain and the failing heart.
-
142 GSE56286 对3个月大的Des-/-小鼠和TNFαDes-/-小鼠的心肌组织进行基因表达分析,比较两组基因型的转录组差异。
设计对3个月大的Des-/-小鼠和TNFαDes-/-小鼠的心肌组织进行基因表达分析,比较两组基因型的转录组差异。
摘要Tumor Necrosis Factor-α is greatly implicated in heart pathophysiology, while it is upregulated in the failing myocardium. A major target in TNF-α-induced heart failure is the muscle specific intermediate filament cytoskeleton, comprised by desmin. We analysed the effect of cardiac-specific overexpression of TNF-α in the Des-/- myocardium, which is a known model of dilated cardiomyopathy.
-
143 GSE235934 将6个月龄的糖尿病db/db小鼠与非糖尿病WT小鼠按疾病状态分组,采集心脏组织进行RNA测序,比较两组基因表达差异。同时通过超声心动图检测心脏功能变化,评估糖尿病对心脏结构和功能的影响。
设计将6个月龄的糖尿病db/db小鼠与非糖尿病WT小鼠按疾病状态分组,采集心脏组织进行RNA测序,比较两组基因表达差异。同时通过超声心动图检测心脏功能变化,评估糖尿病对心脏结构和功能的影响。
摘要Type 2 diabetes mellitus (T2DM) is a metabolic disease associated with several comorbidities, including cardiac dysfunction leading to heart failure with preserved ejection fraction (HFpEF), in turn resulting in T2DM-induced cardiomyopathy (T2DM-CM). However, the molecular mechanisms underlying the development of T2DM-CM are poorly understood. It is hypothesized that molecular alterations in myopathic genes induced by diabetes promote the development of HFpEF, whereas cardiac myosin inhibitors can rescue the resultant T2DM-induced cardiomyopathy. To test this hypothesis, a Leptin receptor-deficient db/db homozygous (Lepr db/db) mouse model was used to define the pathogenesis of T2DM-CM. Echocardiographic studies at 4 and 6 months revealed that Lepr db/db hearts started developing cardiac dysfunction by four months, and left ventricular hypertrophy with diastolic dysfunction was evident at 6 months. Strikingly, the level of cardiac myosin binding protein-C phosphorylation was significantly increased in Lepr db/db mouse hearts. RNA-seq data analysis, followed by functional enrichment, revealed the differential regulation of genes related to cardiac dysfunction in Lepr db/db heart tissues. Finally, using isolated skinned papillary muscles and freshly isolated cardiomyocytes, CAMZYOS (mavacamten, which is a prescription heart medicine used for symptomatic obstructive hypertrophic cardiomyopathy treatment (herein after denotes as MYK-461), was tested for its ability to rescue T2DM-CM. Compared with controls, MYK-461 significantly reduced force generation in papillary muscle fibers and cardiomyocyte contractility in the db/db group. This line of evidence shows that 1) T2DM-CM is associated with hyperphosphorylation of cardiac myosin binding protein-C and 2) MYK-461 significantly lessened disease progression, suggesting its promise as a therapeutic treatment for HFpEF.
-
144 GSE215301 对心力衰竭小鼠模型的心肌细胞进行RNA测序与small RNA数据分析,比较TAC手术组(TAC1、TAC2)与假手术对照组(Sham1、Sham2)的基因表达差异。研究通过Ago2 CLIP-seq数据验证多个miRNA(let-7、mir-16、mir-208b)靶向RBFox2,分析其在心力衰竭阶段的上调情况及对RBFox2蛋白表达和下游效应(如Enah基因可变剪接、Jph2蛋白抑制导致E-C耦联障碍)的调控作用。
设计对心力衰竭小鼠模型的心肌细胞进行RNA测序与small RNA数据分析,比较TAC手术组(TAC1、TAC2)与假手术对照组(Sham1、Sham2)的基因表达差异。研究通过Ago2 CLIP-seq数据验证多个miRNA(let-7、mir-16、mir-208b)靶向RBFox2,分析其在心力衰竭阶段的上调情况及对RBFox2蛋白表达和下游效应(如Enah基因可变剪接、Jph2蛋白抑制导致E-C耦联障碍)的调控作用。
摘要Heart failure is the final stage of various cardiovascular diseases, which seriously threatens human health. Increasing mediators have been found to be involved in the pathogenesis of heart failure, including RNA binding protein RBFox2. It participates in regulation of cardiac function in multiple aspects and plays a critical role in the process of heart failure. However, how RBFox2 itself is regulated remains unclear. Here, we dissected transcriptomic signatures including mRNAs as well as miRNAs in the mouse model of heart failure after TAC surgery. Global and association analyses revealed that large-scale upregulation of miRNAs occurred at heart failure, which was not only responsible for degradation of numerous mRNA transcripts, but also suppressed the translation of key proteins such as RBfox2. With the aid of Ago2 CLIP-seq data, luciferase assays verified that RBfox2 was targeted by multiple miRNAs including let-7, mir-16 and mir-208b, which were critical for cardiac function and upregulated in heart failure stage. Overexpression of these miRNAs suppressed rbfox2 protein and its downstream effects in cardiomyocytes, evidenced by suppressed alternative splicing of Enah gene and impaired E-C coupling via repression of Jph2 protein. Inhibition of let-7, the most abundant of these miRNAs in the heart, could rescue Rbfox2 protein as well as its downstream effects in dysfunctional cardiomyocytes induced by ISO treatment. These findings not only revealed the mechanism leading to RBFox2 depression in heart failure, but also provided an approach to rescue RBFox2 by miRNAs inhibition for the treatment of heart failure.
猫单细胞
Cat · Single-cell
-
01 GSE184328 将雄性和雌性小猫分为主动脉缩窄组与假手术组,采集心脏左心室组织进行单核 RNA 测序,比较性别间转录差异。
设计将雄性和雌性小猫分为主动脉缩窄组与假手术组,采集心脏左心室组织进行单核 RNA 测序,比较性别间转录差异。
摘要In order to better understand sex-related differences of heart failure with preserved ejection fraction (HFpEF), male and female kittens underwent aortic contriction surgery (banding) or sham surgery (normal). Slow progressive pressure overload was then compared between male and female kittens, analyzing structural and functional phenotypes. Transcriptional differences between male and female kittens were investigated via single nuclear RNA sequencing (snRNA-seq) within left ventricle tissue.
猪单细胞
Pig · Single-cell
-
01 GSE335365 The purpose of this RNA-seq analysis is to investigate the effects of KBD expression on gene expression profiles in HFpEF pig hearts.
摘要The purpose of this RNA-seq analysis is to investigate the effects of KBD expression on gene expression profiles in HFpEF pig hearts.
大鼠单细胞
Rat · Single-cell
-
01 GSE330160 Pulmonary arterial hypertension (PAH) is a progressive disease marked by pulmonary vascular remodeling, elevated pulmonary pressures, and right ventricular (RV) failure. In this study, a sugen-hypoxia rat model of PAH was used to evaluate a novel, degradation-resistant apelin analog targeting the apelinergic pathway, which is implicated in pulmonary vascular remodeling. Treatment with the apelin analog reversed key pathological features of PAH, including pulmonary vascular lesions, elevated pulmonary arterial pressures, RV dilation and dysfunction, and early cardiorenal syndrome. The therapy also reduced RV cardiomyocyte and fibroblast activation caused by pressure overload. Single-nucleus RNA sequencing of the lungs and RV demonstrated that apelin analog treatment activated protective molecular programs, notably restoring balance between protective BMPR2 signaling and pathogenic TGFBR2 signaling. Overall, these findings suggest that exogenous apelin therapy may represent a promising strategy to reverse pulmonary vascular and cardiac remodeling in PAH and warrants further clinical investigation.
摘要Pulmonary arterial hypertension (PAH) is a progressive disease marked by pulmonary vascular remodeling, elevated pulmonary pressures, and right ventricular (RV) failure. In this study, a sugen-hypoxia rat model of PAH was used to evaluate a novel, degradation-resistant apelin analog targeting the apelinergic pathway, which is implicated in pulmonary vascular remodeling. Treatment with the apelin analog reversed key pathological features of PAH, including pulmonary vascular lesions, elevated pulmonary arterial pressures, RV dilation and dysfunction, and early cardiorenal syndrome. The therapy also reduced RV cardiomyocyte and fibroblast activation caused by pressure overload. Single-nucleus RNA sequencing of the lungs and RV demonstrated that apelin analog treatment activated protective molecular programs, notably restoring balance between protective BMPR2 signaling and pathogenic TGFBR2 signaling. Overall, these findings suggest that exogenous apelin therapy may represent a promising strategy to reverse pulmonary vascular and cardiac remodeling in PAH and warrants further clinical investigation.
-
02 GSE330964 将26周龄的雄性ZSF1肥胖大鼠分为semaglutide处理组(n=6)和vehicle对照组,每只大鼠取心脏和肝脏组织,进行单细胞RNA测序和蛋白质组学分析,比较两组在心脏和肝脏组织中的差异。
设计将26周龄的雄性ZSF1肥胖大鼠分为semaglutide处理组(n=6)和vehicle对照组,每只大鼠取心脏和肝脏组织,进行单细胞RNA测序和蛋白质组学分析,比较两组在心脏和肝脏组织中的差异。
摘要Heart failure with preserved ejection fraction (HFpEF) remains a therapeutic challenge. GLP-1 receptor agonists (GLP-1RAs) show clinical promise, and the prevailing hypothesis is that their benefits are primarily driven by weight loss and the downstream benefits of improved functional status. We investigated the weight loss- independent effects of low-dose GLP-1RA therapy in a clinically relevant rodent model of severe cardiometabolic HFpEF. Ten-week-old male ZSF1 obese rats with spontaneous HFpEF were treated with low-dose semaglutide (30 nmol/kg twice weekly, n=6) or vehicle for 16 weeks. Comprehensive assessments included body weight, 2-D echocardiography, invasive hemodynamics, exercise capacity as well as cardiac and hepatic fibrosis and lipid deposition. The study utilized advanced multi-omics approaches, including single-cell RNA sequencing of the heart and liver, as well as cardiac, hepatic and plasma proteomics, to explore underlying mechanisms. In ZSF1 obese rats, low-dose semaglutide in the absence of weight loss, significantly improved cardiac function, exercise tolerance, and attenuated fibrosis in the heart and liver. Interestingly, semaglutide therapy reduced cardiac and hepatic lipid content as well as lipid droplets in cardiac myocytes and hepatocytes. Mechanistically, multi-omics analyses of cardiac and hepatic tissues revealed that semaglutide exerted these benefits by improving cardiac metabolism, interfering with pro-fibrotic and pro-hypertrophic signals, and by reducing systemic inflammation. Low-dose semaglutide provides significant cardioprotective, hepatoprotective, and metabolic benefits in HFpEF independent of weight loss. Our findings support the investigation of lower GLP-1RA dosing in HFpEF and other cardiovascular conditions, including in non-obese patients, to expand the clinical utility of these potent drugs.
-
03 GSE253767 Adverse mechanical cues promote pathological remodeling of ischemic left ventricle, which leads to heart failure and mortality in ischemic cardiomyopathy (ICM) patients. Intramyocardial injection of hydrogels reduces the mechanical stress in left ventricular (LV) wall, thus preserves cardiac function and geometry. The therapeutic concept has been tested in clinical trials and presented exciting potential. However, the theory of intramyocardial hydrogel injection still needs to be improved as the molecular biological connection between the mechanical effect and therapeutic outcomes is weak, and it is difficult to clearly separate the contribution of hydrogel mechanical support from physiological reaction to hydrogel chemistry and combinational surgical procedures in previous clinical translation studies. In this study, we transendocardially injected alginate hydrogel via a percutaneous coronary intervention in 10 ICM patients with end-stage heart failure. Thirty days after injection, cardiac function was improved, and LV size was reduced. Stress in the myocardium decreased as evaluated by finite element analysis. Similar mechanical and functional effects by hydrogel injections were observed in rat myocardial infarction (MI) model. Bulk and single-cell RNA sequencing revealed restoration in transcription levels of mechanosensing, cardiac contraction genes and other important pathways, which was mainly attributed to changes in cardiomyocytes. Such effects were not observed in rats receiving diluted hydrogel, confirming that mechanical effect instead of material chemistry is the main contributor. The resemblance in transcriptomic profile and the effect of hydrogel injection on mechanical stress and remodeling of LV wall between ICM patients and diseased rats indicated the applicability of the major mechanistic conclusions in rat model to human.
摘要Adverse mechanical cues promote pathological remodeling of ischemic left ventricle, which leads to heart failure and mortality in ischemic cardiomyopathy (ICM) patients. Intramyocardial injection of hydrogels reduces the mechanical stress in left ventricular (LV) wall, thus preserves cardiac function and geometry. The therapeutic concept has been tested in clinical trials and presented exciting potential. However, the theory of intramyocardial hydrogel injection still needs to be improved as the molecular biological connection between the mechanical effect and therapeutic outcomes is weak, and it is difficult to clearly separate the contribution of hydrogel mechanical support from physiological reaction to hydrogel chemistry and combinational surgical procedures in previous clinical translation studies. In this study, we transendocardially injected alginate hydrogel via a percutaneous coronary intervention in 10 ICM patients with end-stage heart failure. Thirty days after injection, cardiac function was improved, and LV size was reduced. Stress in the myocardium decreased as evaluated by finite element analysis. Similar mechanical and functional effects by hydrogel injections were observed in rat myocardial infarction (MI) model. Bulk and single-cell RNA sequencing revealed restoration in transcription levels of mechanosensing, cardiac contraction genes and other important pathways, which was mainly attributed to changes in cardiomyocytes. Such effects were not observed in rats receiving diluted hydrogel, confirming that mechanical effect instead of material chemistry is the main contributor. The resemblance in transcriptomic profile and the effect of hydrogel injection on mechanical stress and remodeling of LV wall between ICM patients and diseased rats indicated the applicability of the major mechanistic conclusions in rat model to human.
cavia porcellusbulk 转录组
cavia porcellus · Bulk RNA-seq
-
01 GSE78077 对心力衰竭(HF)及猝死(SCD)豚鼠模型进行多组学整合分析,将雄性Hartley豚鼠分为假手术组(SHAM)、代偿性肥大组(ACi-2w)和失代偿性心力衰竭组(ACi-4w),每组6个心脏样本。通过DNA微阵列检测转录组,iTRAQ结合LC-MS/MS分析蛋白质组,LC-MS/MS或GC-MS检测代谢组。比较SHAM与HYP、SHAM与HF、HF与HYP三组间差异,评估心脏组织在肥大至心力衰竭过渡过程中的基因表达、蛋白丰度及代谢物变化。
设计对心力衰竭(HF)及猝死(SCD)豚鼠模型进行多组学整合分析,将雄性Hartley豚鼠分为假手术组(SHAM)、代偿性肥大组(ACi-2w)和失代偿性心力衰竭组(ACi-4w),每组6个心脏样本。通过DNA微阵列检测转录组,iTRAQ结合LC-MS/MS分析蛋白质组,LC-MS/MS或GC-MS检测代谢组。比较SHAM与HYP、SHAM与HF、HF与HYP三组间差异,评估心脏组织在肥大至心力衰竭过渡过程中的基因表达、蛋白丰度及代谢物变化。
摘要Sudden cardiac death (SCD) associated with heart failure (HF) is a multifactorial problem requiring a systems level approach applied to suitable experimental animal models with features of the human disease. Here we examine key regulatory pathways underlying the transition from compensated hypertrophy (HYP) to decompensated HF and SCD by integrated analysis of the transcriptome, proteome and metabolome. In a guinea pig model of acquired long QT syndrome and HF/SCD, relative protein abundances from sham-operated, HYP and HF hearts were assessed using isobaric tags for relative and absolute quantification (iTRAQ), prior to liquid chromatography and tandem mass spectrometry (LC-MS/MS). Metabolites were quantified by LC-MS/MS or gas chromatography coupled to MS (GC-MS). Transcriptome profiles were obtained using DNA microarrays. The guinea pig HF proteome exhibited classic biosignatures of cardiac HYP, left ventricular dysfunction, fibrosis, cellular degeneration, inflammation and extravasation. Fatty acid metabolism, mitochondrial transcription/translation factors, antioxidant enzymes, and other mitochondrial processes, were downregulated in HF, but not HYP. Proteins upregulated in HF are consistent with extracellular matrix remodeling, cytoskeletal remodeling, and acute phase inflammation markers. Among metabolites, downregulation of acyl-carnitines was observed in HYP, while fatty acids accumulated in HF. Levels of the tricarboxylic acid (TCA) cycle metabolite, citrate, and the potent inhibitor, 2-methylcitrate, increased upon transition from HYP to HF. Correlation of the magnitude of transcript and protein changes in HF is weak (R2=0.23), indicating that targeting transcript/proteome may reveal inform post-transcriptional gene regulation in HF. Proteome/Metabolome integration suggests metabolic bottlenecks in fatty acyl-CoA processing by carnitine palmitoyl transferase (CPT1B) as well as TCA cycle inhibition. We present a model in which hallmarks of acute signaling in HF, including Ca2+ dysregulation and low cAMP levels, are coupled to mitochondrial metabolic and antioxidant defects, through a CREB/PGC1-alpha transcriptional axis.
犬bulk 转录组
Dog · Bulk RNA-seq
-
01 GSE9794 对犬类左心室组织在心动过速诱导心力衰竭不同阶段进行基因表达谱分析,包括未刺激对照(Day-0)、心动过速3天(Day-3)、心动过速1周(Week-1)、心动过速2周(Week-2)和心动过速3-4周(End stage)五个时间点。每个时间点从3只独立犬中采集组织样本,每只犬的组织样本独立分离3个RNA技术重复,共获得45个RNA样本用于微阵列实验,比较各时间点基因表达差异及心动过速处理与对照的差异。
设计对犬类左心室组织在心动过速诱导心力衰竭不同阶段进行基因表达谱分析,包括未刺激对照(Day-0)、心动过速3天(Day-3)、心动过速1周(Week-1)、心动过速2周(Week-2)和心动过速3-4周(End stage)五个时间点。每个时间点从3只独立犬中采集组织样本,每只犬的组织样本独立分离3个RNA技术重复,共获得45个RNA样本用于微阵列实验,比较各时间点基因表达差异及心动过速处理与对照的差异。
摘要Analysis of changes of gene expression profiles in the left ventricle (LV) during the progression of heart failure (HF) in the canine tachypacing induced HF model. Gene expression profiling was performed on samples collected at different time points representing various stages of LV dysfunction, i.e. tachypaced for 3 days (Day-3), 1 week (Week-1), 2 weeks (Week-2), 3-4 weeks (End stage), and unpaced controls (Day-0). Results provide insights into molecular mechanisms of heart failure progression. Keywords: time course
-
02 GSE217750 We here report the results of a mitral valve transcriptome study designed to identify genes and molecular pathways involved in development of congestive heart failure (CHF) following myxomatous mitral valve disease (MMVD) in dogs. The study is focused on a cohort of elderly age-matched dogs (n=34, age ~10 years) from a single breed – Cavalier King Charles Spaniels (CKCS) – with a high incidence of MMVD. The cohort comprises 19 dogs (10♀, 9♂) without MMVD-associated CHF, and 15 dogs (6♀, 9♂) with CHF caused by MMVD. I.e. we compare gene expression in breed and age matched groups of dogs, which only differ with respect to CHF status. We identify 56 genes, which are differentially expressed between the two groups. In this list of genes, we confirm an enrichment of genes related to the TNFβ signaling pathway, extracellular matrix organization, vascular development, and endothelium damage, which also have been identified in previous studies. However, the genes with the greatest difference in expression between the two groups are CNTN3 and MYH1. Both genes encode proteins, which are predicted to have an effect on the contractile activity of myocardial cells, which in turn may have an effect on valvular performance and hemodynamics across the mitral valve. This may result in shear forces with impact on MMVD progression.
摘要We here report the results of a mitral valve transcriptome study designed to identify genes and molecular pathways involved in development of congestive heart failure (CHF) following myxomatous mitral valve disease (MMVD) in dogs. The study is focused on a cohort of elderly age-matched dogs (n=34, age ~10 years) from a single breed – Cavalier King Charles Spaniels (CKCS) – with a high incidence of MMVD. The cohort comprises 19 dogs (10♀, 9♂) without MMVD-associated CHF, and 15 dogs (6♀, 9♂) with CHF caused by MMVD. I.e. we compare gene expression in breed and age matched groups of dogs, which only differ with respect to CHF status. We identify 56 genes, which are differentially expressed between the two groups. In this list of genes, we confirm an enrichment of genes related to the TNFβ signaling pathway, extracellular matrix organization, vascular development, and endothelium damage, which also have been identified in previous studies. However, the genes with the greatest difference in expression between the two groups are CNTN3 and MYH1. Both genes encode proteins, which are predicted to have an effect on the contractile activity of myocardial cells, which in turn may have an effect on valvular performance and hemodynamics across the mitral valve. This may result in shear forces with impact on MMVD progression.
-
03 GSE123823 对犬右心房和右心室组织进行基因表达分析,将对照组与早期心力衰竭(2-3周心室心动过速)及晚期心力衰竭(5-6周心室心动过速)组分别采集,采用Affymetrix Canine_2 canFam2芯片(MAS 5.0分析,全局缩放标准化)检测转录组变化,比较不同阶段心力衰竭组织与对照组的基因表达差异。
设计对犬右心房和右心室组织进行基因表达分析,将对照组与早期心力衰竭(2-3周心室心动过速)及晚期心力衰竭(5-6周心室心动过速)组分别采集,采用Affymetrix Canine_2 canFam2芯片(MAS 5.0分析,全局缩放标准化)检测转录组变化,比较不同阶段心力衰竭组织与对照组的基因表达差异。
摘要Heart failure (HF) is a leading cause of mortality and is associated with cardiac remodeling. Vulnerability to atrial fibrillation (AF) has been shown to be greater in the early stages of HF, whereas ventricular tachycardia/fibrillation develop during late stages. Here, we explore changes in gene expression that underlie the differential development of fibrosis and structural alterations that predispose to atrial and ventricular arrhythmias.
-
04 GSE20665 将非心衰对照组与心衰组犬的右心房心肌组织进行基因表达比较,心衰组通过左束支消融后右心房起搏6周诱导,非心衰对照组未接受该处理,采集总RNA进行表达分析。
设计将非心衰对照组与心衰组犬的右心房心肌组织进行基因表达比较,心衰组通过左束支消融后右心房起搏6周诱导,非心衰对照组未接受该处理,采集总RNA进行表达分析。
摘要Gene expression in right atrial myocardium was compared between non-failing control and tachypaced dogs (heart failure was induced by tachycardic pacing for 6 weeks).
-
05 GSE14338 本研究对尸源犬心室前壁和侧壁心肌组织进行基因表达分析,比较非失败对照组(NF, n=14)、电机械不同步心力衰竭组(DHF, n=12)和心脏再同步治疗组(CRT, n=10)的转录组差异。NF组未进行左束支消融或起搏;DHF组在左束支消融后右心房以200次/分钟速率持续6周起搏;CRT组前3周单侧起搏,后3周双室起搏。样本通过TRIzol试剂提取总RNA,经NanoDrop和Bioanalyzer检测质量,使用犬特异性44K微阵列进行分析,采用2色设计(前壁Cy3、侧壁Cy5)并包含染色体交换。
设计本研究对尸源犬心室前壁和侧壁心肌组织进行基因表达分析,比较非失败对照组(NF, n=14)、电机械不同步心力衰竭组(DHF, n=12)和心脏再同步治疗组(CRT, n=10)的转录组差异。NF组未进行左束支消融或起搏;DHF组在左束支消融后右心房以200次/分钟速率持续6周起搏;CRT组前3周单侧起搏,后3周双室起搏。样本通过TRIzol试剂提取总RNA,经NanoDrop和Bioanalyzer检测质量,使用犬特异性44K微阵列进行分析,采用2色设计(前壁Cy3、侧壁Cy5)并包含染色体交换。
摘要Objectives: To test whether (1) electromechanical dyssynchrony induces region-specific alterations in the myocardial transcriptome and (2) dyssynchrony-induced gene expression changes can be corrected by cardiac resynchronization (CRT). Background: To date, CRT is the only heart failure treatment that can both acutely and chronically increase systolic function and prolong survival, something not yet achieved by a drug therapy. However, the mechanisms underlying the benefits of CRT remain elusive. Methods: Adult dogs underwent left bundle branch ablation (LBBB) and right atrial pacing at 200 bpm for either 6 weeks (dyssynchronous heart failure, DHF, n=12) or 3 weeks followed by 3 weeks of resynchronization by bi-ventricular pacing at the same pacing rate (CRT, n=10). Control animals without LBBB were not paced (NF, n=14). Echocardiography and invasive hemodynamic measurements were performed at 3 and 6 weeks. At 6 weeks, RNA was isolated from the anterior and lateral LV walls and hybridized onto canine-specific 44K microarrays. Results: In DHF, transcriptional changes consistent with re-expression of a fetal gene program were primarily observed in the anterior LV, resulting in increased regional heterogeneity of gene expression within the left ventricle. Dyssynchrony-induced region-specific expression changes in 1050 transcripts were reversed by CRT to levels of NF hearts (false discovery rate <5%). CRT remodeled transcripts with metabolic and cell signaling function and greatly reduced regional heterogeneity of gene expression compared with DHF. Conclusions: Our results demonstrate a profound effect of electromechanical dyssynchrony on the regional cardiac transcriptome, causing gene expression changes primarily in the anterior LV wall. CRT corrected the alterations in gene expression in the anterior wall by reversing the fetal gene expression pattern, supporting a global effect of biventricular pacing on the ventricular transcriptome that extends beyond the pacing site in the lateral wall.
-
06 GSE5247 We have used chronic cardiac pacing in conscious dogs to study mechanism related to the development of dilated cardiomyopathy and the transition from compensated dysfunction (CD) to decompensated heart failure (HF). This occurs from the 3rd to 4th week of pacing with end-stage HF at 30?1 days. Keywords: disease state analysis
摘要We have used chronic cardiac pacing in conscious dogs to study mechanism related to the development of dilated cardiomyopathy and the transition from compensated dysfunction (CD) to decompensated heart failure (HF). This occurs from the 3rd to 4th week of pacing with end-stage HF at 30?1 days. Keywords: disease state analysis
-
07 GSE472 Canine tachycardia-induced cardiomyopathy caused by several weeks of rapid ventricular pacing is a well-established animal model of congestive heart failure. However, little is known about the underlying changes in gene expression that occur in the canine myocardium after the induction of heart failure. This project aims to compare expression profiles in left ventricular free wall samples from control dogs and dogs with pacing-induced heart failure on the custom MuscleChip. Keywords: other
摘要Canine tachycardia-induced cardiomyopathy caused by several weeks of rapid ventricular pacing is a well-established animal model of congestive heart failure. However, little is known about the underlying changes in gene expression that occur in the canine myocardium after the induction of heart failure. This project aims to compare expression profiles in left ventricular free wall samples from control dogs and dogs with pacing-induced heart failure on the custom MuscleChip. Keywords: other
猪bulk 转录组
Pig · Bulk RNA-seq
-
01 GSE197049 将19只家猪按不同处理分组:DOX组(多柔比星治疗,n=5)、MYO组(脂质体多柔比星治疗,n=5)、Hyper组(人工胸主动脉狭窄诱导压力过载,n=3)、RemoLV组(心肌梗死后容积过载重塑,n=3)及对照组(假手术,n=3)。采集前壁和后壁心肌样本进行RNA测序,比较各组间基因表达差异。DOX和MYO组在3个月随访后因动物健康问题终止,Hyper和RemoLV组在6个月随访时采样。
设计将19只家猪按不同处理分组:DOX组(多柔比星治疗,n=5)、MYO组(脂质体多柔比星治疗,n=5)、Hyper组(人工胸主动脉狭窄诱导压力过载,n=3)、RemoLV组(心肌梗死后容积过载重塑,n=3)及对照组(假手术,n=3)。采集前壁和后壁心肌样本进行RNA测序,比较各组间基因表达差异。DOX和MYO组在3个月随访后因动物健康问题终止,Hyper和RemoLV组在6个月随访时采样。
摘要Objectives Transcriptome analysis of the left ventricle (LV) aimed to identify targets for prevention of myocardial fibrosis (MF). Background MF causing heart failure with reduced ejection fraction is generated by different pathological mechanisms. We have designed two types of MF by using translational animal models: reactive interstitial MF and replacement fibrosis. Methods Domestic pigs were treated with either doxorubicin (DOX, n=5) or a liposomal encapsulation of doxorubicin-citrate (Myocet®, MYO, n=5) to generate cardiotoxicity-induced MF. For pressure overload-induced MF, we used artificial isthmus stenosis with stepwise developing myocardial hypertrophy and final fibrosis (Hyper, n=3). Volume-overload MF was developed in adverse remodeled LV after myocardial infarction (RemoLV, n=3). Sham interventions served as controls (Control, n=3). Myocardial samples from the anterior wall of groups DOX, MYO, Hyper and Control, and from the non-ischemic remodeled posterior wall of animals in group RemoLV were subjected to RNA-sequencing following transcriptional analysis.
-
02 GSE31619 A porcine microarray study of acute right ventricular failure due to coronary artery ligation of the right ventricular free wall. 1. Baseline sample from the free right ventricular wall. 2. Ligation of the coronary arteries on the right ventricular free wall induced right ventricular heart failure. When the pressure in the right atrium rose to >20 mmHg, heart failure samples were taken from the free right ventricular wall.
摘要A porcine microarray study of acute right ventricular failure due to coronary artery ligation of the right ventricular free wall. 1. Baseline sample from the free right ventricular wall. 2. Ligation of the coronary arteries on the right ventricular free wall induced right ventricular heart failure. When the pressure in the right atrium rose to >20 mmHg, heart failure samples were taken from the free right ventricular wall.
-
03 GSE335057 对肥胖诱导的HFpEF猪心脏及对照组心脏进行总RNA提取,分别采用盐水处理和AAV9sc.KBD治疗,采集左心室组织进行RNA-Seq分析,比较不同处理条件下基因表达差异。
设计对肥胖诱导的HFpEF猪心脏及对照组心脏进行总RNA提取,分别采用盐水处理和AAV9sc.KBD治疗,采集左心室组织进行RNA-Seq分析,比较不同处理条件下基因表达差异。
摘要The purpose of this RNA-seq analysis is to investigate the effects of KBD expression on gene expression profiles in HFpEF pig hearts.
-
04 GSE291450 Anthracycline-induced metabolic remodeling and mitochondrial damage are critical early events that contribute to cardiac dysfunction. However, the gene regulatory pathways governing the derangements in myocardial bioenergetics have not yet been fully delineated. Estrogen-related receptor alpha (ERRα) is a key regulator of energy metabolism, especially in tissues with high energy demands. Here, we demonstrate that ERRα acts as a beneficial modulator of mitochondrial metabolism in anthracycline-induced cardiotoxicity (AIC). ERRα gain-of-function enhances cardiomyocyte metabolism and mitochondrial function, thereby alleviating AIC. Conversely, cardiomyocyte-specific knockdown of ERRα exacerbates mitochondrial bioenergetic collapse and worsens heart failure phenotypes in AIC mice. Additionally, our research identifies a top-ranking isoflavone phytoestrogen as a novel ERRα agonist with favorable pharmacological properties. This compound promotes the transcriptional activity of metabolic genes, representing a significant step toward developing natural ERRα agonists for AIC therapy.
摘要Anthracycline-induced metabolic remodeling and mitochondrial damage are critical early events that contribute to cardiac dysfunction. However, the gene regulatory pathways governing the derangements in myocardial bioenergetics have not yet been fully delineated. Estrogen-related receptor alpha (ERRα) is a key regulator of energy metabolism, especially in tissues with high energy demands. Here, we demonstrate that ERRα acts as a beneficial modulator of mitochondrial metabolism in anthracycline-induced cardiotoxicity (AIC). ERRα gain-of-function enhances cardiomyocyte metabolism and mitochondrial function, thereby alleviating AIC. Conversely, cardiomyocyte-specific knockdown of ERRα exacerbates mitochondrial bioenergetic collapse and worsens heart failure phenotypes in AIC mice. Additionally, our research identifies a top-ranking isoflavone phytoestrogen as a novel ERRα agonist with favorable pharmacological properties. This compound promotes the transcriptional activity of metabolic genes, representing a significant step toward developing natural ERRα agonists for AIC therapy.
-
05 GSE292769 对雄性农场猪心肌组织进行 RNA-seq 分析,比较 AAV5-hS100A1 治疗组与 AAV5-luc 对照组在 14 周 LCX 心肌梗死后基因表达差异。采用 CRID 静脉注射方式递送 AAV5 载体,检测转导效率与治疗效果,通过心脏偏倚启动子实现心肌特异性表达,未观察到临床毒性。
设计对雄性农场猪心肌组织进行 RNA-seq 分析,比较 AAV5-hS100A1 治疗组与 AAV5-luc 对照组在 14 周 LCX 心肌梗死后基因表达差异。采用 CRID 静脉注射方式递送 AAV5 载体,检测转导效率与治疗效果,通过心脏偏倚启动子实现心肌特异性表达,未观察到临床毒性。
摘要Background: Guided by long-term safety data for AAV5 in humans, our translational study investigated whether AAV5 effectively delivers genes to healthy and achieve therapeutic efficacy in dysfunctional human-sized hearts, using a clinically applicable mode of administration and vector dosages. Methods & Results: In a first biodistribution study, AAV5 (11013 vector genomes; vgs) - carrying the reporter gene luciferase (luc) - achieved broad and homogenous transduction of the left ventricle (LV) of healthy German farm pigs 30 days after percutaneous catheter-based retrograde intravenous delivery (CRID), as measured by vector genome and luc mRNA assessments. Both its myocardial and extra-cardiac distribution patterns were advantageous compared to AAV9-luc and AAV6-luc. Using the cardioprotective human gene S100A1 (hS100A1) in a subsequent therapy study, effective myocardial transduction with AAV5-hS100A1 (11013 vgcs) by CRID prevented LV myocardial infarction (MI) enlargement and improved systolic contractile performance after 3 months in a porcine model with chronic post-MI cardiac dysfunction, as assessed by serial cardiac magnetic resonance imaging. The use of a cardiac-biased promoter ensured cardiac-targeted hS100A1 expression without signs of clinical toxicity, as shown by RT-PCR analysis, clinical chemistry and blood count. A previously unknown anti-inflammatory effect of hS100A1 in damaged myocardium, detected and linked to the therapeutic actions by a cardiac transcriptome weighted gene coexpression network analysis, was confirmed using AAV5-hS100A1 therapy in a post-MI mouse model, as measured by RT-PCR and echocardiography. Conclusion: Providing the clinically relevant proof-of-concept for AAV5 to effectively transduce healthy and dysfunctional human-sized hearts, its clinical long-term safety, scalable producibility as well as low pre-existing immunity in humans may predestine AAV5 as an effective and safe gene carrier for a prevalent disease as chronic heart failure, using therapeutic genetic effectors, such as hS100A1 or others.
-
06 GSE167643 对Tibetan minipig的心脏组织进行RNA测序,比较Sham组(n=3)与descending aortic constriction (DAC)组(n=3)的基因表达差异。总RNA从假手术和DAC处理的ventricular组织中提取,每组包含3个独立样本,使用NEBNext® Ultra™ RNA Library Prep Kit for Illumina®构建测序库,3 µg RNA用于转录组测序。
设计对Tibetan minipig的心脏组织进行RNA测序,比较Sham组(n=3)与descending aortic constriction (DAC)组(n=3)的基因表达差异。总RNA从假手术和DAC处理的ventricular组织中提取,每组包含3个独立样本,使用NEBNext® Ultra™ RNA Library Prep Kit for Illumina®构建测序库,3 µg RNA用于转录组测序。
摘要In this study, we employed descending aortic constriction (DAC) technique to establish a minipig heart failure model. The cardiac phenotypes, pathological and cellular changes, fibrotic signaling activation, and gene expression profiles have been explored.
大鼠bulk 转录组
Rat · Bulk RNA-seq
-
01 GSE216264 对心力衰竭模型大鼠进行转录组分析,研究对象为左心室、右心室和室间隔组织,分组包括假手术组、肺动脉结扎组和主动脉结扎组,分别在代偿期和失代偿期采集样本进行 polyA mRNA 测序,比较不同处理组在不同时间点的转录特征差异。
设计对心力衰竭模型大鼠进行转录组分析,研究对象为左心室、右心室和室间隔组织,分组包括假手术组、肺动脉结扎组和主动脉结扎组,分别在代偿期和失代偿期采集样本进行 polyA mRNA 测序,比较不同处理组在不同时间点的转录特征差异。
摘要Heart failure is among the leading causes of death globally. Ventricular failure progresses through a hypertrophic compensatory phase followed by failure of the ventricle function through rapid decompensation. In order to unravel right heart specific mechanisms of disease, rat animal models were established that (i) reflect the slowly progressive mode of compensation / decompensation and (ii) allow comparative analyses of left versus right heart failure in the same experimental set up. Differential gene expression analysis was performed for all three treatment groups (sham, AOB, PAB), at both time points (compensation, decompensation) and for both ventricles as well as the septum
-
02 GSE216263 从渐进性心力衰竭的代偿期和失代偿期,以及相应的假手术对照动物中分离心肌细胞,提取总 RNA 并进行 RNA 测序,比较左心室与右心室在不同疾病阶段的转录组变化。
设计从渐进性心力衰竭的代偿期和失代偿期,以及相应的假手术对照动物中分离心肌细胞,提取总 RNA 并进行 RNA 测序,比较左心室与右心室在不同疾病阶段的转录组变化。
摘要Heart failure is among the leading causes of death globally. Ventricular failure progresses through a hypertrophic compensatory phase followed by failure of the ventricle function through rapid decompensation. In order to unravel right heart specific mechanisms of disease, rat animal models were established that (i) reflect the slowly progressive mode of compensation / decompensation and (ii) allow comparative analyses of left versus right heart failure in the same experimental set up. Non-restrictive clips around the pulmonary artery (pulmonary artery banding, PAB) or the aorta (aortic banding, AOB) were surgically implanted into weanling rats. Upon animal growth the clips become increasingly constrictive, leading to a compensatory, hypertrophic state at around 6 weeks and heart failure at 21 (PAB) or 24 weeks (AOB). Disease progression was monitored functionally and by sonography. Differential gene expression analysis was performed for all three treatment groups (sham, AOB, PAB), at both time points (compensation, decompensation) and for both ventricles.
-
03 GSE318811 将心肌梗死后的雌性F344/NJcl-rnu/rnu大鼠左心室组织分为梗死区(IZ)、边界区(BZ)和未损伤远程区(RZ),分别进行未移植对照组和hiPSC来源的心肌细胞(CM)移植组处理,采集样本时间为移植后第3天、1周和4周。移植组将hiPSC来源的CM补丁移植至梗死区,对照组不进行移植。所有样本进行RNA-Seq检测,检测结果仅保留与大鼠基因组(Rnor_6.0)唯一匹配的读数。
设计将心肌梗死后的雌性F344/NJcl-rnu/rnu大鼠左心室组织分为梗死区(IZ)、边界区(BZ)和未损伤远程区(RZ),分别进行未移植对照组和hiPSC来源的心肌细胞(CM)移植组处理,采集样本时间为移植后第3天、1周和4周。移植组将hiPSC来源的CM补丁移植至梗死区,对照组不进行移植。所有样本进行RNA-Seq检测,检测结果仅保留与大鼠基因组(Rnor_6.0)唯一匹配的读数。
摘要Myocardial infarction (MI) followed by chronic heart failure is the main cause of mortality of heart diseases. Although reparative cell transplantation therapies with pluripotent stem cell-derived cardiomyocytes (CMs) represent a promising therapeutic strategy, molecular mechanisms of the therapy remain elusive. Here, we show that transplantation of the hiPSC-derived CM patch onto the damaged heart after MI, increases the ratio of collagen type I against collagen type III to modulate alignment of the collagen fibers at the infarcted zone. As a result, tissue elasticity of the heart is improved and fibrosis at the remote zone is reduced. Mechanistically, we find that hiPSC-derived CM patches secrete TGF-β1, directly inducing collagen type I production in fibroblasts but not collagen type III. Our results suggest the direct effect of the transplanted CM patch on the cardiac fibroblasts to improve elasticity of the damaged heart, resulting in functional recovery after MI.
-
04 GSE42579 Right ventricular heart failure (RVF) associated with pulmonary hypertension (PH) is characterized by a distinct gene expression pattern when compared with functional compensatory hypertrophy. Carvedilol treatment after RVF has been established reduces right ventricle (RV) hypertrophy and improves the RV function. In addition, carvedilol treatment has been shown to alter the gene expression of select genes. We sought to identify, on a genome-wide basis, the effect of carvedilol on gene expression. RVF was induced in male Sprague-Dawley rats by the combination of VEGF-receptor blockade and chronic hypoxia; thereafter, one group was treated with carvedilol. RNA was isolated from the RV and subjected to microarray analysis. A prediction analysis of the carvedilol-treated RVs showed that carvedilol treated RVs most resembled in their expression pattern the RVF pattern. However, an analysis beyond the boundaries of the prediction set revealed a small set of genes associated with carvedilol reversal of RVF. Pathway analysis of this set of genes revealed expression changes of genes involved in cardiac hypertrophy, mitochondrial dysfunction, protein ubiquitination, and sphingolipid metabolism. Genes encoding proteins in the cardiac hypertrophy and protein ubiquitination pathways were downregulated in the RV by carvedilol, while genes encoding proteins in the mitochondrial dysfunction and sphingolipid metabolism pathways were upregulated by carvedilol.
摘要Right ventricular heart failure (RVF) associated with pulmonary hypertension (PH) is characterized by a distinct gene expression pattern when compared with functional compensatory hypertrophy. Carvedilol treatment after RVF has been established reduces right ventricle (RV) hypertrophy and improves the RV function. In addition, carvedilol treatment has been shown to alter the gene expression of select genes. We sought to identify, on a genome-wide basis, the effect of carvedilol on gene expression. RVF was induced in male Sprague-Dawley rats by the combination of VEGF-receptor blockade and chronic hypoxia; thereafter, one group was treated with carvedilol. RNA was isolated from the RV and subjected to microarray analysis. A prediction analysis of the carvedilol-treated RVs showed that carvedilol treated RVs most resembled in their expression pattern the RVF pattern. However, an analysis beyond the boundaries of the prediction set revealed a small set of genes associated with carvedilol reversal of RVF. Pathway analysis of this set of genes revealed expression changes of genes involved in cardiac hypertrophy, mitochondrial dysfunction, protein ubiquitination, and sphingolipid metabolism. Genes encoding proteins in the cardiac hypertrophy and protein ubiquitination pathways were downregulated in the RV by carvedilol, while genes encoding proteins in the mitochondrial dysfunction and sphingolipid metabolism pathways were upregulated by carvedilol.
-
05 GSE201717 对健康与心力衰竭大鼠心脏的多个部位(包括下窦房结、上窦房结、左心房、右心房和左心室)进行RNA测序,比较其基因表达差异。健康组为8-12周龄雄性Sprague-Dawley大鼠,心力衰竭组为10周龄雄性Sprague-Dawley大鼠,通过主动脉缩窄术诱导左心室肥厚和心力衰竭。样本组织储存于RNAlater和-80°C,提取总RNA并进行RNA-Seq分析。
设计对健康与心力衰竭大鼠心脏的多个部位(包括下窦房结、上窦房结、左心房、右心房和左心室)进行RNA测序,比较其基因表达差异。健康组为8-12周龄雄性Sprague-Dawley大鼠,心力衰竭组为10周龄雄性Sprague-Dawley大鼠,通过主动脉缩窄术诱导左心室肥厚和心力衰竭。样本组织储存于RNAlater和-80°C,提取总RNA并进行RNA-Seq分析。
摘要Objectives: This study aimed to determine the transcriptional basis of functional silencing of one of the two dominant pacemakers in failing rat hearts. Background: Recently, our laboratory presented functional and molecular evidence for the presence of two competing sinoatrial node (SAN) pacemakers in the healthy human and rat hearts. Anatomically localized near the superior vena cava and inferior vena cava, the superior and inferior SANs (sSAN and iSAN), respectively, preferentially control fast and slow normal heart rates. However, only one dominant pacemaker, primarily sSAN, was functional in the failing rat heart with hypertrophic cardiomyopathy. Methods: Ascending aortic constriction was performed on 1-week-old male Sprague-Dawley rat pups to induce left ventricular hypertrophy and heart failure. The dominant pacemaker was anatomically mapped in adult (8-12 weeks old) healthy and failing rat hearts using optical mapping in isolated right atrial tissue preparations. RNA sequencing was used to identify regional sSAN/iSAN gene expression differences between healthy and failing rat hearts. Results: In all failing rat hearts optically mapped in this study (n=4), only the sSAN pacemaker was functional, while the iSAN was silent. Compared to healthy rat hearts, a total of 3,640 genes were downregulated and 4,518 genes were upregulated in failing rat hearts. The functional quiescence of the iSAN in these failing rat hearts may be explained by their downregulation of sodium, potassium, and calcium ion channels as well as their downregulation of certain structural genes, including ankyrin, titin, and myosin heavy chain. Moreover, the iSAN showed predominant downregulation of several key transcription factors such as TBX5, TBX3, SHOX2, and SMAD9. Conclusions: Pressure-overload-induced heart failure resulted in significant downregulation of critical transcription factors, ion channels, and structural transcripts of the iSAN, which could explain the functional silencing of the iSAN in failing rat hearts.
-
06 GSE47495 对大鼠左心室组织及外周血单核细胞进行转录组分析,比较假手术组与不同梗死面积大小的 MI 组样本。实验分组包括假手术组(n=6)、小梗死组(n=6)、中梗死组(n=6)和大梗死组(n=5),所有样本均在手术后 2 个月采集。采用 Affymetrix 微阵列平台检测基因表达,通过 RMA 算法进行数据标准化处理,主要比较左心室与外周血单核细胞的转录组差异,以及不同梗死面积与假手术组的基因表达变化。
设计对大鼠左心室组织及外周血单核细胞进行转录组分析,比较假手术组与不同梗死面积大小的 MI 组样本。实验分组包括假手术组(n=6)、小梗死组(n=6)、中梗死组(n=6)和大梗死组(n=5),所有样本均在手术后 2 个月采集。采用 Affymetrix 微阵列平台检测基因表达,通过 RMA 算法进行数据标准化处理,主要比较左心室与外周血单核细胞的转录组差异,以及不同梗死面积与假手术组的基因表达变化。
摘要Myocardial infarction (MI) often results in left ventricular (LV) remodeling followed by heart failure (HF). It is of great clinical importance to understand the molecular mechanisms that trigger transition from compensated LV injury to HF and to identify relevant diagnostic biomarkers. In this study, we performed transcriptional profiling of LVs in rats with a wide range of experimentally induced infarct sizes and of peripheral blood mononuclear cells (PBMCs) in animals that developed HF. We used microarrays to investigate gene expression in the left ventricle (LV) accompanying myocardial infarction and concomitant heart failure (HF) in a well validated model of post-infarcted heart failure and to evaluate their reflection in peripheral blood mononuclear cells (PBMCs)
-
07 GSE108904 We aimed to characterize the complex cardiovascular effects of NOsGC stimulation using NO-independent stimulator BAY 41-8543 in a double transgenic rat (dTGR) model of HFpEF. We used microarrays to detail the effect of NOsGC-stimulation on cardiac gene expression in heart failure with preserved ejection fraction.
摘要We aimed to characterize the complex cardiovascular effects of NOsGC stimulation using NO-independent stimulator BAY 41-8543 in a double transgenic rat (dTGR) model of HFpEF. We used microarrays to detail the effect of NOsGC-stimulation on cardiac gene expression in heart failure with preserved ejection fraction.
-
08 GSE21021 将心力衰竭(HF)和假手术(SHAM)大鼠左心室组织分别按正常饮食(NC)或高饱和脂肪饮食(SAT)分组,每组 n=6。采用微阵列技术检测基因表达,同时通过 Millar 压力-体积导管评估心肌收缩功能,比较不同组别在基线、下腔静脉阻塞及多巴酚丁胺(DOB)应激下的功能差异及基因表达变化。
设计将心力衰竭(HF)和假手术(SHAM)大鼠左心室组织分别按正常饮食(NC)或高饱和脂肪饮食(SAT)分组,每组 n=6。采用微阵列技术检测基因表达,同时通过 Millar 压力-体积导管评估心肌收缩功能,比较不同组别在基线、下腔静脉阻塞及多巴酚丁胺(DOB)应激下的功能差异及基因表达变化。
摘要Impaired myocardial contractile function is a hallmark of heart failure (HF) which may present under resting conditions and/or during physiological stress. Previous studies reported that high fat feeding in HF is associated with improved myocardial contractile function at baseline. Our goal was to determine whether myocardial function is compromised in response to physiological stress and to evaluate the global gene expression profile of rats fed high dietary fat following infarction. Male Wistar rats underwent ligation or sham surgery and were fed normal (10% kcal fat) (SHAM+NC, HF+NC) or high fat (60% kcal saturated fat) (SHAM+SAT, HF+SAT) for 8 weeks. Myocardial contractile function was assessed using a Millar pressure-volume (PV) conductance catheter at baseline, during inferior vena caval occlusions and dobutamine (DOB) stress. Steady state indices of systolic function, left ventricular (LV)+dP/dtmax, stroke work and maximal power were increased in HF+SAT vs HF+NC; HF+NC were reduced vs SHAM+NC. Preload-recruitable measures of contractility [end systolic PV relationship, maximal elastance, preload recruitable SW and peak+dP/dtmax to end diastolic volume] were decreased in HF+NC but not HF+SAT. β-adrenergic responsiveness (delta-LV+dP/dtmax and delta-cardiac output DOB 0-10 µg•kg-1•min-1) was reduced in HF, but high fat feeding did not further impact contractile reserve in HF. Contractile reserve was reduced by high fat in SHAM+SAT. Microarray gene expression analysis reveals the majority of significantly altered pathways identified to contain multiple gene targets correspond to cell signaling pathways and energy metabolism. These findings suggest that high saturated fat improves myocardial function at rest and during physiological stress in infarcted hearts, but may negatively impact contractile reserve under non-pathological conditions. Furthermore, high fat feeding-induced alterations in gene expression related to energy metabolism and specific signaling pathways reveal promising targets through which high saturated fat potentially mediates cardioprotection in heart failure/LV dysfunction.
-
09 GSE2876 Impact of the obesity on RNA total levels of male SHHF left ventricular aged from 4 and 10 months old. Keywords: Comparative cDNA hybridization
-
10 GSE297653 将Wistar大鼠分为正常组、HFpEF组、卡普托普il治疗组和Sac/Val治疗组,所有动物均接受高脂肪饮食8周处理,其中治疗组额外给予对应药物干预,采集心脏组织进行RNA测序,比较各组基因表达差异。
设计将Wistar大鼠分为正常组、HFpEF组、卡普托普il治疗组和Sac/Val治疗组,所有动物均接受高脂肪饮食8周处理,其中治疗组额外给予对应药物干预,采集心脏组织进行RNA测序,比较各组基因表达差异。
摘要To investigate gene expression changes associated with the development of HFpEF and the preventive effects of pharmacological interventions against HFpEF onset, Wistar rats were administered N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase, and fed a high-fat diet for 8 weeks. Cardiac tissues were collected at the time of sacrifice.
-
11 GSE24110 Background: Vitamin D deficiency is associated with cardiac hypertrophy and heart failure, and vitamin D therapy prevents the progression of cardiac hypertrophy in animal models. Here, we examine whether vitamin D therapy regresses pre-existing cardiac hypertrophy, and prevents the progression to heart failure. Methods and Results: When male Dahl salt-sensitive (DSS) rats are fed a high salt (HS) diet, all rats develop cardiac hypertrophy after 5 weeks (H). Thereafter, rats were treated with vehicle (V), paricalcitol (PC, an active vitamin D analog at 200ng, IP 3x/wk), enalapril (EP, 90ug/day), and PC+EP. All groups were continued on the HS diet and evaluated after 4 weeks of therapy. The PC and PC+EP, but not the V and EP-only groups, showed significant regression of pre-existing cardiac hypertrophy. The signs of decompensated heart failure were evident in the vehicle-treated group; these heart failure parameters significantly improved with PC, EP or PC+EP therapy. The expression of PKCe, which is regulated by Ca2+ and known to stimulate cardiac hypertrophy, was significantly increased in the vehicle group, and PC, EP or PC+EP effectively decreased PKCe activation. We also observed normalization of genetic alterations during progression to heart failure with PC treatment. Conclusions: PC treatment resulted in both the regression of pre-existing cardiac hypertrophy, and the attenuation of the progression to heart failure, compared to improvement in progression to heart failure by EP alone. These beneficial findings in the heart were associated with inhibition of PKCe activation, and reversal of gene alterations.
摘要Background: Vitamin D deficiency is associated with cardiac hypertrophy and heart failure, and vitamin D therapy prevents the progression of cardiac hypertrophy in animal models. Here, we examine whether vitamin D therapy regresses pre-existing cardiac hypertrophy, and prevents the progression to heart failure. Methods and Results: When male Dahl salt-sensitive (DSS) rats are fed a high salt (HS) diet, all rats develop cardiac hypertrophy after 5 weeks (H). Thereafter, rats were treated with vehicle (V), paricalcitol (PC, an active vitamin D analog at 200ng, IP 3x/wk), enalapril (EP, 90ug/day), and PC+EP. All groups were continued on the HS diet and evaluated after 4 weeks of therapy. The PC and PC+EP, but not the V and EP-only groups, showed significant regression of pre-existing cardiac hypertrophy. The signs of decompensated heart failure were evident in the vehicle-treated group; these heart failure parameters significantly improved with PC, EP or PC+EP therapy. The expression of PKCe, which is regulated by Ca2+ and known to stimulate cardiac hypertrophy, was significantly increased in the vehicle group, and PC, EP or PC+EP effectively decreased PKCe activation. We also observed normalization of genetic alterations during progression to heart failure with PC treatment. Conclusions: PC treatment resulted in both the regression of pre-existing cardiac hypertrophy, and the attenuation of the progression to heart failure, compared to improvement in progression to heart failure by EP alone. These beneficial findings in the heart were associated with inhibition of PKCe activation, and reversal of gene alterations.
-
12 GSE4286 对转基因小鼠(TGR(mRen-2)27 (Ren-2))与Sprague Dawley背景野生型小鼠的左心室活检组织进行RNA表达分析,比较两种基因型在心脏肥大和心力衰竭模型中的差异。研究对象为雄性10周龄小鼠,采用Picopure RNA分离试剂盒提取总RNA,使用GPL1355平台进行表达谱分析,检测方式为基于阵列的表达分析。
设计对转基因小鼠(TGR(mRen-2)27 (Ren-2))与Sprague Dawley背景野生型小鼠的左心室活检组织进行RNA表达分析,比较两种基因型在心脏肥大和心力衰竭模型中的差异。研究对象为雄性10周龄小鼠,采用Picopure RNA分离试剂盒提取总RNA,使用GPL1355平台进行表达谱分析,检测方式为基于阵列的表达分析。
摘要The intercalated disc of cardiac myocytes is emerging as a crucial structure in the heart. Loss of intercalated disc proteins like N-cadherin causes lethal cardiac abnormalities, mutations in intercalated disc proteins cause human cardiomyopathy. A comprehensive screen for novel mechanisms in failing hearts demonstrated that expression of the lysosomal integral membrane protein-2 (LIMP-2) is increased in cardiac hypertrophy and heart failure in both rat and human myocardium. Complete loss of LIMP-2 in genetically engineered mice did not affect cardiac development; however these LIMP-2 null mice failed to mount a hypertrophic response to increased blood pressure but developed cardiomyopathy. Disturbed cadherin localization in these hearts suggested that LIMP-2 has important functions outside lysosomes. Indeed, we also find LIMP-2 in the intercalated disc, where it associates with cadherin. RNAi-mediated knockdown of LIMP-2 decreases the binding of phosphorylated b-catenin to cadherin, while overexpression of LIMP-2 has the opposite effect. Taken together, our data show that lysosomal integrated membrane protein-2 is crucial to mount the adaptive hypertrophic response to cardiac loading. We demonstrate a novel role for LIMP-2 as an important mediator of the intercalated disc. Keywords: heart failure, comparison
-
13 GSE12754 对28天假手术和分流操作的雄性Sprague-Dawley大鼠左心房及左心室组织进行基因表达分析,采集三个生物重复样本,采用微阵列技术检测正常与慢性容积超负荷状态下的转录组变化,比较分流组与假手术组的基因表达差异。
设计对28天假手术和分流操作的雄性Sprague-Dawley大鼠左心房及左心室组织进行基因表达分析,采集三个生物重复样本,采用微阵列技术检测正常与慢性容积超负荷状态下的转录组变化,比较分流组与假手术组的基因表达差异。
摘要Pharmacological and gene ablation studies have demonstrated a crucial role of the caridac natriuretic peptides (NP) hormones ANF and BNP in the maintenance of cardiovascular homeostasis. Considerable effort has been focused on the elucidation of the mechanistic underlying increased atrial ANF and BNP expression and secretion. These investigations are important because under chronic congestive heart failure, the secretion of NPs although increased and beneficial, is relatively insufficient as demonstrated by the fact that patients benefit form the unloading of the heart induced by therapeutic administration of either ANF or BNP. To identify genes involved in the transcriptional response of the endocrine heart under normal and stimulated states, we conducted differential gene expression studies of the rat atria and ventricles under normal or chronic volume overload, induced by aorto-caval shunt.
-
14 GSE19210 Full Title: Transition from Compensated Hypertrophy to Systolic Heart Failure in the Spontaneously Hypertensive Rat: Structure, Function, and Transcript Analysis Gene expression changes and left ventricular remodeling associated with the transition to systolic heart failure (HF) were determined in the spontaneously hypertensive rat (SHR). By combining transcriptomics of left ventricles from six SHR with HF with changes in function and structure we aimed to better understand the molecular events underlying the onset of systolic HF compared to six age-matched, SHR with compensated hypertrophy. Left ventricle (LV) ejection fraction was depressed (82±4 to 52±3 %) in compensated vs. failing animals. Systolic blood pressure decreased and LV end-diastolic and systolic volume increased with HF. Failing SHR hearts also demonstrated increases in left and right ventricular mass relative to non-failing SHRs. LV papillary muscle force development and shortening velocity decreased, β-adrenergic responsiveness was depressed, myocardial stiffness and myocardial fibrosis increased with HF relative to non-failing animals. Initial micro-array analysis revealed that 1,431 transcripts were differentially expressed with HF compared to non-failing SHR (p<0.05). Of the identified transcripts, lipopolysaccharide binding protein, the most highly expressed transcript with HF, was negatively correlated to myocardial force while elevated expression of the collagen cross-linking enzyme lysyl oxidase correlated positively with muscle stiffness. Besides these individual transcripts, gene set enrichment analysis (GSEA) identified multiple enriched pathways with HF, most prominent of the altered signaling pathways involved TGF-β and insulin signaling. GESA analysis additionally identified altered gene sets involving inflammation, oxidative stress, cell degradation and cell death, among others (all p<0.01). In contrast to diastolic HF where few transcripts are reported to be altered, our data indicate multiple genes and pathways involved in a variety of biological processes characterize the onset of systolic HF, consistent with many functional and structural changes present in the failing hypertensive heart.
摘要Full Title: Transition from Compensated Hypertrophy to Systolic Heart Failure in the Spontaneously Hypertensive Rat: Structure, Function, and Transcript Analysis Gene expression changes and left ventricular remodeling associated with the transition to systolic heart failure (HF) were determined in the spontaneously hypertensive rat (SHR). By combining transcriptomics of left ventricles from six SHR with HF with changes in function and structure we aimed to better understand the molecular events underlying the onset of systolic HF compared to six age-matched, SHR with compensated hypertrophy. Left ventricle (LV) ejection fraction was depressed (82±4 to 52±3 %) in compensated vs. failing animals. Systolic blood pressure decreased and LV end-diastolic and systolic volume increased with HF. Failing SHR hearts also demonstrated increases in left and right ventricular mass relative to non-failing SHRs. LV papillary muscle force development and shortening velocity decreased, β-adrenergic responsiveness was depressed, myocardial stiffness and myocardial fibrosis increased with HF relative to non-failing animals. Initial micro-array analysis revealed that 1,431 transcripts were differentially expressed with HF compared to non-failing SHR (p<0.05). Of the identified transcripts, lipopolysaccharide binding protein, the most highly expressed transcript with HF, was negatively correlated to myocardial force while elevated expression of the collagen cross-linking enzyme lysyl oxidase correlated positively with muscle stiffness. Besides these individual transcripts, gene set enrichment analysis (GSEA) identified multiple enriched pathways with HF, most prominent of the altered signaling pathways involved TGF-β and insulin signaling. GESA analysis additionally identified altered gene sets involving inflammation, oxidative stress, cell degradation and cell death, among others (all p<0.01). In contrast to diastolic HF where few transcripts are reported to be altered, our data indicate multiple genes and pathways involved in a variety of biological processes characterize the onset of systolic HF, consistent with many functional and structural changes present in the failing hypertensive heart.
-
15 GSE193432 Objective: To explore the protective effects of exercise-derived β-aminoisobutyric (BAIBA) on apoptosis and energy metabolism in rats with heart failure. Methods: A rat model of heart failure after myocardial infarction (MI) was started by ligating the left anterior descending branch of the coronary artery, the anterior descending branch of the rats in the SHAM group was only threaded and not ligated. Exercise intervention was given to rats with heart failure. The possible mechanisms by which exercise affected cardiac remodeling after MI were investigated using color ultrasound, HE, Masson, and TUNEL staining, and the detection of apoptosis-associated factors in cardiac tissue. High-throughput sequencing and mass spectrometry were used to measure the production of BAIBA and to explore its protective effects and molecular mechanisms. An in vitro model of apoptosis was created by the application of H2O2 to induce mitochondrial dysfunction. This was then transfected with miR-208b analogue and miR-208b-inhibitor. Apoptosis-related proteins were detected by Western blotting (WB), and ATP production was also assessed. After intervention with BAIBA and compound C, assessments were made of apoptosis, mitochondrial function, lipid uptake, utilization of related proteins, ATP changes, alterations in membrane potential (δψm), and changes in reactive oxygen species (ROS). Results: Compared with the control heart failure (HF) group, exercise improved the function of mitochondria, reversed the expression of apoptosis-related proteins, and increased ATP production. In both the normal and heart failure groups, exercise significantly increased the production of BAIBA. It was shown that BAIBA played a similar role to exercise in ameliorating heart failure. Transcriptome analysis confirmed that the expression of miR-208b was increased after BAIBA intervention, and transfection with miR-208b analogue increased both the expression of apoptosis-related proteins and energy metabolism in H9C2 cells induced by H2O2. Combined analysis of the transcriptome and metabolome identified AMPK as a target for BAIBA to improve metabolic stress. Cell experiments further confirmed that BAIBA increased AMPK phosphorylation and had a protective effect on downstream fatty acid uptake, oxidative efficiency, and mitochondrial function, which could be counteracted by the AMPK inhibitor compound C. Conclusion: Exercise-induced BAIBA can reduce the metabolic stress and apoptosis induced by mitochondrial dysfunction through the miR-208b/AMPK pathway.
摘要Objective: To explore the protective effects of exercise-derived β-aminoisobutyric (BAIBA) on apoptosis and energy metabolism in rats with heart failure. Methods: A rat model of heart failure after myocardial infarction (MI) was started by ligating the left anterior descending branch of the coronary artery, the anterior descending branch of the rats in the SHAM group was only threaded and not ligated. Exercise intervention was given to rats with heart failure. The possible mechanisms by which exercise affected cardiac remodeling after MI were investigated using color ultrasound, HE, Masson, and TUNEL staining, and the detection of apoptosis-associated factors in cardiac tissue. High-throughput sequencing and mass spectrometry were used to measure the production of BAIBA and to explore its protective effects and molecular mechanisms. An in vitro model of apoptosis was created by the application of H2O2 to induce mitochondrial dysfunction. This was then transfected with miR-208b analogue and miR-208b-inhibitor. Apoptosis-related proteins were detected by Western blotting (WB), and ATP production was also assessed. After intervention with BAIBA and compound C, assessments were made of apoptosis, mitochondrial function, lipid uptake, utilization of related proteins, ATP changes, alterations in membrane potential (δψm), and changes in reactive oxygen species (ROS). Results: Compared with the control heart failure (HF) group, exercise improved the function of mitochondria, reversed the expression of apoptosis-related proteins, and increased ATP production. In both the normal and heart failure groups, exercise significantly increased the production of BAIBA. It was shown that BAIBA played a similar role to exercise in ameliorating heart failure. Transcriptome analysis confirmed that the expression of miR-208b was increased after BAIBA intervention, and transfection with miR-208b analogue increased both the expression of apoptosis-related proteins and energy metabolism in H9C2 cells induced by H2O2. Combined analysis of the transcriptome and metabolome identified AMPK as a target for BAIBA to improve metabolic stress. Cell experiments further confirmed that BAIBA increased AMPK phosphorylation and had a protective effect on downstream fatty acid uptake, oxidative efficiency, and mitochondrial function, which could be counteracted by the AMPK inhibitor compound C. Conclusion: Exercise-induced BAIBA can reduce the metabolic stress and apoptosis induced by mitochondrial dysfunction through the miR-208b/AMPK pathway.
-
16 GSE202228 Pathologically elevated mechanical load promotes the adverse remodeling of left ventricle (LV) post myocardial infarction, which results in the progression from ischemic cardiomyopathy to heart failure. Cardiac patches could attenuate adverse LV remodeling by providing mechanical support to infarcted and border zone myocardium. However, the mechanism of the translation from mechanical effects to favorable therapeutic outcome is still not clear. This study aims to strengthen the foundation of the theory of cardiac patch treatment. By transcriptome analysis, we found that the myocardial transcription levels of mechanosensitive ion channel proteins Piezo1 and Piezo2 significantly increased in patients with ischemic cardiomyopathy. In vitro tensile tests with local tissue information and finite element modeling revealed a significant decrease in local strain and mechanical load in rat infarcts and sheep LV. Cardiac function and geometry were preserved compared to non-treated control. Further, in LV myocardium of the patch-treated group, MI induced expression levels of Piezo1/2 were significantly reverted to the similar levels of the control group, indicating that Piezo1/2 are key contributors as mechanosensor which initiated the signaling cascade and translated the beneficial mechanical support to therapeutic effects. These findings demonstrated the potential of cardiac patches in treating ICM patients with remodeling risks, and could provide guidance for improvement in next generation of patch devices.
摘要Pathologically elevated mechanical load promotes the adverse remodeling of left ventricle (LV) post myocardial infarction, which results in the progression from ischemic cardiomyopathy to heart failure. Cardiac patches could attenuate adverse LV remodeling by providing mechanical support to infarcted and border zone myocardium. However, the mechanism of the translation from mechanical effects to favorable therapeutic outcome is still not clear. This study aims to strengthen the foundation of the theory of cardiac patch treatment. By transcriptome analysis, we found that the myocardial transcription levels of mechanosensitive ion channel proteins Piezo1 and Piezo2 significantly increased in patients with ischemic cardiomyopathy. In vitro tensile tests with local tissue information and finite element modeling revealed a significant decrease in local strain and mechanical load in rat infarcts and sheep LV. Cardiac function and geometry were preserved compared to non-treated control. Further, in LV myocardium of the patch-treated group, MI induced expression levels of Piezo1/2 were significantly reverted to the similar levels of the control group, indicating that Piezo1/2 are key contributors as mechanosensor which initiated the signaling cascade and translated the beneficial mechanical support to therapeutic effects. These findings demonstrated the potential of cardiac patches in treating ICM patients with remodeling risks, and could provide guidance for improvement in next generation of patch devices.
-
17 GSE225149 将慢性心力衰竭大鼠模型与对照组进行比较,各组接受不同处理:对照组给予生理盐水,HF组通过异丙肾上腺素(5 mg/kg/d)注射造模10天,LC组给予canagliflozin(3 mg/kg/d)4周,LC-AE组接受canagliflozin联合有氧运动(60 min/d)4周。采集心脏组织进行RNA-Seq,比较Control、HF、LC及LC-AE组的基因表达差异,总样本数为11(按总单位数与组数估计)。
设计将慢性心力衰竭大鼠模型与对照组进行比较,各组接受不同处理:对照组给予生理盐水,HF组通过异丙肾上腺素(5 mg/kg/d)注射造模10天,LC组给予canagliflozin(3 mg/kg/d)4周,LC-AE组接受canagliflozin联合有氧运动(60 min/d)4周。采集心脏组织进行RNA-Seq,比较Control、HF、LC及LC-AE组的基因表达差异,总样本数为11(按总单位数与组数估计)。
摘要To determine the efficacy and potential protective mechanism of canagliflozin combined with aerobic exercise in treating chronic heart failure (CHF).During 10 days, isoproterenol (5 mg/kg/d) was injected into rats to create CHF models. The rats were then randomized into four groups and administered with saline, canagliflozin (3 mg/kg/d), aerobic exercise training, and canagliflozin combined with aerobic exercise training. Then, we performed gene expression profiling using the data obtained by RNA-seq in the Control, HF, LC and LC-AE groups.
-
18 GSE184649 将Sprague Dawley大鼠心脏组织分为对照组、心力衰竭模型组和Calycosin治疗组,采用RNA-Seq技术检测各组mRNA表达谱,通过比较Calycosin治疗组与模型组、模型组与对照组差异揭示其作用机制。
设计将Sprague Dawley大鼠心脏组织分为对照组、心力衰竭模型组和Calycosin治疗组,采用RNA-Seq技术检测各组mRNA表达谱,通过比较Calycosin治疗组与模型组、模型组与对照组差异揭示其作用机制。
摘要Aim: Inflammation and fibrosis have been shown to be critical factors in heart failure (HF) progression. Calycosin (Cal) is the major active component of Radix astragali and has been widely used to treat inflammation in clinical practice. However, whether Cal could ameliorate myocardial infarction (MI)-induced inflammation and fibrosis and precise mechanisms remain uncertain. The aim of this study is to explore the role of Cal in HF and to clarify the underlying mechanisms. Methods: For in vivo experiments, rats underwent left anterior descending (LAD) artery ligation for HF model, and the cardioprotective effects of Cal were measured by echocardiographic assessment and histological examination. RNA-seq approach was applied to explore potential differential genes and pathways. For further mechanistic study, pro-inflammatory conditioned media (CM)-induced H9C2 cells injury model and TGFβ-stimulated cardiac fibroblasts model were applied to determine the regulatory mechanisms of Cal. Results: In vivo experiment, echocardiography results showed that Cal significantly improved heart function. GO and Reactome enrichment revealed that inflammation and fibrosis pathway are involved in Cal-treated group. KEGG enrichment indicated that PI3K-AKT pathway is enriched in the Cal-treated group. Further experiments proved that Cal alleviated cardiomyocyte inflammatory responses evidenced by down-regulating the expressions of phosphorylated IκB kinase α/β (p-IKKα/β), phosphorylated nuclear factor kapa B (p-NFκB) and tumor necrosis factor α (TNFα). Besides, Cal effectively attenuated cardiac fibrosis through the inhibitions of expressions and depositions of collagen I and collagen III. In vitro experiments, the phosphatidylinositol 3 kinase (PI3K) inhibitor LY294002 could abrogate the anti-inflammation and anti-fibrosis therapeutic effects of Cal, demonstrating that the cardio-protective effects of Cal were mediated through upregulations of PI3K and serine/threonine kinase (AKT). Conclusion: Cal improves cardiac function against HF by inhibiting cardiomyocytes inflammation and fibroblasts fibrosis via activation of the PI3K-AKT pathway.
-
19 GSE229147 We tested it in an animal model of myocardial infarction to ensure whether early initiation of dapagliflozin (DAPA), or different orders of combination with sacubitril-valsartan would result in a greater improvement of heart function than sacubitril-valsartan alone in post-myocardial infarction heart failure.
摘要We tested it in an animal model of myocardial infarction to ensure whether early initiation of dapagliflozin (DAPA), or different orders of combination with sacubitril-valsartan would result in a greater improvement of heart function than sacubitril-valsartan alone in post-myocardial infarction heart failure.
-
20 GSE184120 RNA sequencing from sinoatrial node tissue was performed to identify transcriptomic changes in Dahl salt-sensitive rats fed with normal salt diet (0.4% NaCl, control group) or high-salt diet (8% NaCl, HFpEF group) for 11 weeks. Transcriptomic profiling revealed numerous changes in multiple disease-associated genes in HFpEF, which is functionally related to the observed physiological impairments and structural remodeling.
摘要RNA sequencing from sinoatrial node tissue was performed to identify transcriptomic changes in Dahl salt-sensitive rats fed with normal salt diet (0.4% NaCl, control group) or high-salt diet (8% NaCl, HFpEF group) for 11 weeks. Transcriptomic profiling revealed numerous changes in multiple disease-associated genes in HFpEF, which is functionally related to the observed physiological impairments and structural remodeling.
-
21 GSE126062 对健康与 HFpEF 大鼠心脏组织进行 RNA 表达检测,健康组采用低盐饮食,HFpEF 组采用高盐饮食诱导,各组包含 3 个重复样本,通过 RNA 微阵列分析基因表达差异。
设计对健康与 HFpEF 大鼠心脏组织进行 RNA 表达检测,健康组采用低盐饮食,HFpEF 组采用高盐饮食诱导,各组包含 3 个重复样本,通过 RNA 微阵列分析基因表达差异。
摘要Heart failure (HF) with preserved ejection fraction (HFpEF) is rising, whose morbidity, mortality and healthcare costs are similar to HF with reduced ejection fraction (HFrEF). Although substantial molecular pathways lead to the changes in organ and tissue levels, there are still lack of successful treatments for HFpEF given the complexity molecular networks remaining unknown. Here we report that the significantly changed genes of HFpEF rats associates positively with inflammatory processes and immune responses while negatively with calcium ion transport into cytosol. GSEA analysis shows several KEGG pathways are significantly enriched in HFpEF rats including p53 signaling pathway, Toll like receptor signaling pathway and so on. Our study provides new insights into HFpEF pathogenesis and a new therapeutic against HFpEF.
-
22 GSE632 对心力衰竭心脏与正常心脏组织的总RNA进行基因表达比较,采用微阵列技术检测,分别来自三个心力衰竭组和三个对照组。
设计对心力衰竭心脏与正常心脏组织的总RNA进行基因表达比较,采用微阵列技术检测,分别来自三个心力衰竭组和三个对照组。
摘要Congestive heart failure was done by artificial myocardial infarction. After extracting total RNA from control and infarcted ventricles with Triazol, messenger RNA was isolated with Qiagen mRNA isolation kit. About 1.5ug poly A+ RNA was taken for probe preparation. Probe was labeled with Alexa Fluor 546 and 657. Labeled probes were hybridized with Qiagen rat unigene oligo library. After 2 low and 1 high stringency washes Prolong Antifade was added to the slides to prevent bleaching effect. The data ratio was normalized using a location and intensity dependent Lowess formula. Keywords: other
斑马鱼bulk 转录组
Zebrafish · Bulk RNA-seq
-
01 GSE278040 Heart failure is a complex cardiac disorder characterized by ventricular dilation and disruption of the cardiac performance. After a cardiac injury, such as a myocardial infarction, the activation of sympathetic and adrenergic systems attempts to maintain cardiac output. However, sustained elevation of circulating catecholamines triggers maladaptive changes in the heart that eventually lead to heart failure. Chronic isoproterenol treatment is a well established approach to mimic the development of heart failure in animal models to study pathophysiological mechanisms.
摘要Heart failure is a complex cardiac disorder characterized by ventricular dilation and disruption of the cardiac performance. After a cardiac injury, such as a myocardial infarction, the activation of sympathetic and adrenergic systems attempts to maintain cardiac output. However, sustained elevation of circulating catecholamines triggers maladaptive changes in the heart that eventually lead to heart failure. Chronic isoproterenol treatment is a well established approach to mimic the development of heart failure in animal models to study pathophysiological mechanisms.

课题合作 · 扫码加微信
bioinformaticsboy